{
"document_name": "FAQ_on_Immunization_for_Health_Workers-English",

  "pages": [
    {
      "page": 1,
      "text": "    JSH\n    INDIA\n    Published by JSI India for the Ministry of Health & Family Welfare\n\n\n\n\n\n\n\n\n\n\n    Frequently Asked Questions on Immunization\n\n\n\n\n\n\n\n\n\n\n         Ministry of Health & Family Welfare\n         Government of India\n                                            224q ART\n    Hrave\n\n\n\n\n\n    Frequently Asked Questions on\n    Immunization\n\n(For Health Workers & Other Front-line Functionaries)\n                                                 2017\n\n\n\n\n\n\n\n\n\n\n    STOP\n    Do you need to open it !\n\n\n\n\n    EGet Be Wise!\n    fully yourchild\n         immunized",
      "md": "\n# Frequently Asked Questions on Immunization\n\n*(For Health Workers & Other Front-line Functionaries)*  \n2017\n\nMinistry of Health & Family Welfare  \nGovernment of India\n\nPublished by JSI India for the Ministry of Health & Family Welfare\n\n----\n\n**STOP**  \nDo you need to open it?\n\n----\n\n**Be Wise!**  \nGet your child fully immunized\n",
      "images": [
        {
          "name": "img_p0_1.jpg",
          "height": 370.269,
          "width": 450.906,
          "x": 589.846,
          "y": 373.407,
          "original_width": 1879,
          "original_height": 1543,
          "rotation": 0,
          "ocr": [
            {
              "x": 393,
              "y": 1416,
              "w": 153,
              "h": 19,
              "confidence": 0.962,
              "text": "Do you need to open it !"
            },
            {
              "x": 411,
              "y": 1363,
              "w": 114,
              "h": 40,
              "confidence": 1,
              "text": "STOP"
            }
          ]
        },
        {
          "name": "img_p0_2.jpg",
          "height": 36.497,
          "width": 49.676,
          "x": 36,
          "y": 755.607,
          "original_width": 294,
          "original_height": 216,
          "rotation": 0,
          "ocr": [
            {
              "x": 67,
              "y": 140,
              "w": 157,
              "h": 36,
              "confidence": 1,
              "text": "INDIA"
            },
            {
              "x": 37,
              "y": 26,
              "w": 252,
              "h": 111,
              "confidence": 0.899,
              "text": "JSH"
            }
          ]
        },
        {
          "name": "img_p0_3.jpg",
          "height": 47.867,
          "width": 117.782,
          "x": 1036.769,
          "y": 754.814,
          "original_width": 491,
          "original_height": 200,
          "rotation": 0,
          "ocr": [
            {
              "x": 253,
              "y": 150,
              "w": 224,
              "h": 32,
              "confidence": 1,
              "text": "immunized"
            },
            {
              "x": 149,
              "y": 145,
              "w": 94,
              "h": 43,
              "confidence": 1,
              "text": "fully"
            },
            {
              "x": 249,
              "y": 108,
              "w": 106,
              "h": 37,
              "confidence": 1,
              "text": "your"
            },
            {
              "x": 359,
              "y": 102,
              "w": 119,
              "h": 40,
              "confidence": 1,
              "text": "child"
            },
            {
              "x": 153,
              "y": 100,
              "w": 86,
              "h": 43,
              "confidence": 0.966,
              "text": "Get"
            },
            {
              "x": 102,
              "y": 86,
              "w": 50,
              "h": 55,
              "confidence": 0.582,
              "text": "E"
            },
            {
              "x": 351,
              "y": 52,
              "w": 127,
              "h": 38,
              "confidence": 0.999,
              "text": "Wise!"
            },
            {
              "x": 278,
              "y": 51,
              "w": 67,
              "h": 40,
              "confidence": 1,
              "text": "Be"
            }
          ]
        },
        {
          "name": "img_p0_4.png",
          "height": 45.143,
          "width": 58.024,
          "x": 1096.173,
          "y": 36,
          "original_width": 242,
          "original_height": 189,
          "rotation": 0,
          "ocr": [
            {
              "x": 159,
              "y": 170,
              "w": 44,
              "h": 18,
              "confidence": 0.426,
              "text": "ART"
            },
            {
              "x": 94,
              "y": 170,
              "w": 59,
              "h": 18,
              "confidence": 0.405,
              "text": "q"
            },
            {
              "x": 38,
              "y": 169,
              "w": 53,
              "h": 18,
              "confidence": 0.307,
              "text": "224"
            }
          ]
        },
        {
          "name": "img_p0_5.png",
          "height": 49.787,
          "width": 206.451,
          "x": 631.63,
          "y": 36,
          "original_width": 861,
          "original_height": 208,
          "rotation": 0,
          "ocr": [
            {
              "x": 21,
              "y": 190,
              "w": 88,
              "h": 18,
              "confidence": 0.585,
              "text": "Hrave"
            },
            {
              "x": 148,
              "y": 119,
              "w": 387,
              "h": 40,
              "confidence": 1,
              "text": "Government of India"
            },
            {
              "x": 148,
              "y": 67,
              "w": 712,
              "h": 43,
              "confidence": 0.986,
              "text": "Ministry of Health & Family Welfare"
            }
          ]
        },
        {
          "name": "page_1.jpg",
          "height": 841.89,
          "width": 1190.55,
          "x": 0,
          "y": 0,
          "original_width": 3200,
          "original_height": 2263,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "Frequently Asked Questions on Immunization",
          "md": "# Frequently Asked Questions on Immunization",
          "bBox": {
            "x": 565.36,
            "y": 156.28,
            "w": 595.5,
            "h": 435.95
          }
        },
        {
          "type": "text",
          "value": "*(For Health Workers & Other Front-line Functionaries)*  \n2017",
          "md": "*(For Health Workers & Other Front-line Functionaries)*  \n2017",
          "bBox": {
            "x": 702.1,
            "y": 240.84,
            "w": 458.78,
            "h": 40.21
          }
        },
        {
          "type": "text",
          "value": "Ministry of Health & Family Welfare  \nGovernment of India",
          "md": "Ministry of Health & Family Welfare  \nGovernment of India",
          "bBox": {
            "x": 47.32,
            "y": 52.04,
            "w": 790.52,
            "h": 733.31
          }
        },
        {
          "type": "text",
          "value": "Published by JSI India for the Ministry of Health & Family Welfare",
          "md": "Published by JSI India for the Ministry of Health & Family Welfare",
          "bBox": {
            "x": 36,
            "y": 52.04,
            "w": 801.84,
            "h": 753.85
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 1190.55,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**STOP**  \nDo you need to open it?",
          "md": "**STOP**  \nDo you need to open it?",
          "bBox": {
            "x": 688.47,
            "y": 700.48,
            "w": 27.36,
            "h": 9.6
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 1190.55,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Be Wise!**  \nGet your child fully immunized",
          "md": "**Be Wise!**  \nGet your child fully immunized",
          "bBox": {
            "x": 1097.46,
            "y": 767.02,
            "w": 53.97,
            "h": 31.35
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 1190.55,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 2,
      "text": "            Frequently Asked Questions on\n                     Immunization\n(For Health Workers & Other Front-line Functionaries)\n                         2017\n\n\n\n\n\n\n\n\n\n\nMinistry of Health and Family Welfare\n         Government of India",
      "md": "\n# Frequently Asked Questions on Immunization  \n*(For Health Workers & Other Front-line Functionaries)*  \n**2017**\n\nMinistry of Health and Family Welfare  \nGovernment of India\n",
      "images": [
        {
          "name": "img_p1_1.png",
          "height": 59.28,
          "width": 375.6,
          "x": 117.294,
          "y": 58.388,
          "original_width": 1565,
          "original_height": 247,
          "rotation": 0
        },
        {
          "name": "img_p1_2.png",
          "height": 59.76,
          "width": 376.56,
          "x": 108.686,
          "y": 49.9,
          "original_width": 1569,
          "original_height": 249,
          "rotation": 0
        },
        {
          "name": "img_p1_3.png",
          "height": 60.24,
          "width": 377.52,
          "x": 109.886,
          "y": 52.06,
          "original_width": 1573,
          "original_height": 251,
          "rotation": 0
        },
        {
          "name": "img_p1_4.jpg",
          "height": 54,
          "width": 370.08,
          "x": 117.326,
          "y": 58.3,
          "original_width": 1542,
          "original_height": 225,
          "rotation": 0
        },
        {
          "name": "img_p1_5.png",
          "height": 57.6,
          "width": 375.36,
          "x": 109.886,
          "y": 52.06,
          "original_width": 1564,
          "original_height": 240,
          "rotation": 0
        },
        {
          "name": "img_p1_6.jpg",
          "height": 51.36,
          "width": 367.92,
          "x": 117.326,
          "y": 58.3,
          "original_width": 1533,
          "original_height": 214,
          "rotation": 0
        },
        {
          "name": "page_2.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "Frequently Asked Questions on Immunization",
          "md": "# Frequently Asked Questions on Immunization  ",
          "bBox": {
            "x": 115.01,
            "y": 51.7,
            "w": 365.47,
            "h": 52
          }
        },
        {
          "type": "text",
          "value": "*(For Health Workers & Other Front-line Functionaries)*  \n**2017**",
          "md": "*(For Health Workers & Other Front-line Functionaries)*  \n**2017**",
          "bBox": {
            "x": 72.77,
            "y": 110.07,
            "w": 450.04,
            "h": 45.2
          }
        },
        {
          "type": "text",
          "value": "Ministry of Health and Family Welfare  \nGovernment of India",
          "md": "Ministry of Health and Family Welfare  \nGovernment of India",
          "bBox": {
            "x": 119.79,
            "y": 701.25,
            "w": 356,
            "h": 52.99
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 3,
      "text": "NO_CONTENT_HERE",
      "md": "NO_CONTENT_HERE",
      "images": [
        {
          "name": "page_3.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        },
        {
          "name": "page_3.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "NO_CONTENT_HERE",
          "md": "NO_CONTENT_HERE",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": true,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 4,
      "text": "TABLE OF CONTENTS\n\n\nImmunity and Vaccines                                                               1\n\nUniversal Immunization Programme (UIP) and National Immunization Schedule (NIS)     7\n\nVaccination of Pregnant Women                                                       13\n\nNew-born Vaccination                                                                15\n\nSide Effects, Adverse Events, and Contraindications                                 17\n\nVaccine Handling, Administration, and Injection Safety                              21\n\nCold Chain                                                                          27\n\nBio-medical Waste Management                                                        37\n\nImmunization Campaigns                                                              41\n\nVitamin-A                                                                           45\n\nProgram Planning and Implementation                                                 49\n\nVaccination Scenarios                                                               53\n\nNational Immunization Schedule                                                      61",
      "md": "\n# TABLE OF CONTENTS\n\n* Immunity and Vaccines  \n* Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)  \n* Vaccination of Pregnant Women  \n* New-born Vaccination  \n* Side Effects, Adverse Events, and Contraindications  \n* Vaccine Handling, Administration, and Injection Safety  \n* Cold Chain  \n* Bio-medical Waste Management  \n* Immunization Campaigns  \n* Vitamin-A  \n* Program Planning and Implementation  \n* Vaccination Scenarios  \n* National Immunization Schedule  \n",
      "images": [
        {
          "name": "img_p3_1.png",
          "height": 351.624,
          "width": 351.266,
          "x": -0.715,
          "y": -0.663,
          "original_width": 982,
          "original_height": 983,
          "rotation": 0
        },
        {
          "name": "img_p3_2.png",
          "height": 527.258,
          "width": 246.101,
          "x": 349.836,
          "y": -0.663,
          "original_width": 688,
          "original_height": 1474,
          "rotation": 0
        },
        {
          "name": "img_p3_3.png",
          "height": 351.982,
          "width": 351.266,
          "x": -0.715,
          "y": 350.246,
          "original_width": 982,
          "original_height": 984,
          "rotation": 0
        },
        {
          "name": "img_p3_4.png",
          "height": 316.569,
          "width": 246.101,
          "x": 349.836,
          "y": 525.879,
          "original_width": 688,
          "original_height": 885,
          "rotation": 0
        },
        {
          "name": "img_p3_5.png",
          "height": 140.936,
          "width": 351.266,
          "x": -0.715,
          "y": 701.512,
          "original_width": 982,
          "original_height": 394,
          "rotation": 0
        },
        {
          "name": "page_4.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "TABLE OF CONTENTS",
          "md": "# TABLE OF CONTENTS",
          "bBox": {
            "x": 58.5,
            "y": 53.3,
            "w": 199.73,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "* Immunity and Vaccines  \n* Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)  \n* Vaccination of Pregnant Women  \n* New-born Vaccination  \n* Side Effects, Adverse Events, and Contraindications  \n* Vaccine Handling, Administration, and Injection Safety  \n* Cold Chain  \n* Bio-medical Waste Management  \n* Immunization Campaigns  \n* Vitamin-A  \n* Program Planning and Implementation  \n* Vaccination Scenarios  \n* National Immunization Schedule",
          "md": "* Immunity and Vaccines  \n* Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)  \n* Vaccination of Pregnant Women  \n* New-born Vaccination  \n* Side Effects, Adverse Events, and Contraindications  \n* Vaccine Handling, Administration, and Injection Safety  \n* Cold Chain  \n* Bio-medical Waste Management  \n* Immunization Campaigns  \n* Vitamin-A  \n* Program Planning and Implementation  \n* Vaccination Scenarios  \n* National Immunization Schedule",
          "bBox": {
            "x": 63.68,
            "y": 107.27,
            "w": 419.42,
            "h": 336.66
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.964
    },
    {
      "page": 5,
      "text": "NO_CONTENT_HERE",
      "md": "NO_CONTENT_HERE",
      "images": [
        {
          "name": "page_5.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        },
        {
          "name": "page_5.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "NO_CONTENT_HERE",
          "md": "NO_CONTENT_HERE",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": true,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 6,
      "text": "LIST OF TABLES\n\nTable 1:Types of vaccines                                            3\n\nTable 2: Vaccines and disease prevented                              8\n\nTable 3: Sequence of vaccination at 6, 10, 14 weeks and 9 months     23\n\nTable 4: Vitamin A dosage during a measles outbreak                  47\n\nTable 5:National Immunization Schedule                               61\n\n\nLIST OF FIGURES\n\nFigure 1: Vaccines protect against infection                             2\n\nFigure 2: Depiction of herd immunity                                     5\n\nFigure 3: Using cold compresses for pain at injection site               18\n\nFigure 4: Child with sites of multiple vaccines                          22\n\nFigure 5: Using AD syringe                                               25\n\nFigure 6: Storage and transportation of vaccines (Cold Chain System)     27\n\nFigure 7: ILR with vaccine arrangement (Front view)                      28\n\nFigure 8: Vaccine carrier                                                29\n\nFigure 9: Ice-pack with vials kept on it                                 30\n\nFigure 10: Freezing and conditioning of ice-packs                        31\n\nFigure 11: Procedure of reconstitution                                   32\n\nFigure 12: VVM different stages                                          33\n\nFigure 13: VVM placement on vials                                        33\n\nFigure 14: Points to be checked as per Open Vial Policy                  34\n\nFigure 15: Bio-medical waste management                                  39\n\nFigure 16: Vitamin-A and formulation                                     46\n\nFigure 17: Four key messages                                             51",
      "md": "\n# LIST OF TABLES\n\n* Table 1: Types of vaccines ........................................................................ 3\n* Table 2: Vaccines and disease prevented ............................................... 8\n* Table 3: Sequence of vaccination at 6, 10, 14 weeks and 9 months .......... 23\n* Table 4: Vitamin A dosage during a measles outbreak ............................ 47\n* Table 5: National Immunization Schedule ............................................. 61\n\n# LIST OF FIGURES\n\n* Figure 1: Vaccines protect against infection ........................................ 2\n* Figure 2: Depiction of herd immunity .................................................. 5\n* Figure 3: Using cold compresses for pain at injection site ..................... 18\n* Figure 4: Child with sites of multiple vaccines ..................................... 22\n* Figure 5: Using AD syringe ........................................................................ 25\n* Figure 6: Storage and transportation of vaccines (Cold Chain System) .... 27\n* Figure 7: ILR with vaccine arrangement (Front view) ............................ 28\n* Figure 8: Vaccine carrier ............................................................................. 29\n* Figure 9: Ice-pack with vials kept on it .................................................. 30\n* Figure 10: Freezing and conditioning of ice-packs .................................. 31\n* Figure 11: Procedure of reconstitution .................................................. 32\n* Figure 12: VVM different stages ............................................................ 33\n* Figure 13: VVM placement on vials ....................................................... 33\n* Figure 14: Points to be checked as per Open Vial Policy ........................ 34\n* Figure 15: Bio-medical waste management ............................................. 39\n* Figure 16: Vitamin-A and formulation .................................................... 46\n* Figure 17: Four key messages .................................................................... 51\n",
      "images": [
        {
          "name": "img_p5_1.png",
          "height": 351.624,
          "width": 351.266,
          "x": -0.715,
          "y": -0.663,
          "original_width": 982,
          "original_height": 983,
          "rotation": 0
        },
        {
          "name": "img_p5_2.png",
          "height": 527.258,
          "width": 246.101,
          "x": 349.836,
          "y": -0.663,
          "original_width": 688,
          "original_height": 1474,
          "rotation": 0
        },
        {
          "name": "img_p5_3.png",
          "height": 351.982,
          "width": 351.266,
          "x": -0.715,
          "y": 350.246,
          "original_width": 982,
          "original_height": 984,
          "rotation": 0
        },
        {
          "name": "img_p3_4.png",
          "height": 316.569,
          "width": 246.101,
          "x": 349.836,
          "y": 525.879,
          "original_width": 688,
          "original_height": 885,
          "rotation": 0
        },
        {
          "name": "img_p5_5.png",
          "height": 140.936,
          "width": 351.266,
          "x": -0.715,
          "y": 701.512,
          "original_width": 982,
          "original_height": 394,
          "rotation": 0
        },
        {
          "name": "page_6.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "LIST OF TABLES",
          "md": "# LIST OF TABLES",
          "bBox": {
            "x": 58.5,
            "y": 53.3,
            "w": 146.78,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "* Table 1: Types of vaccines ........................................................................ 3\n* Table 2: Vaccines and disease prevented ............................................... 8\n* Table 3: Sequence of vaccination at 6, 10, 14 weeks and 9 months .......... 23\n* Table 4: Vitamin A dosage during a measles outbreak ............................ 47\n* Table 5: National Immunization Schedule ............................................. 61",
          "md": "* Table 1: Types of vaccines ........................................................................ 3\n* Table 2: Vaccines and disease prevented ............................................... 8\n* Table 3: Sequence of vaccination at 6, 10, 14 weeks and 9 months .......... 23\n* Table 4: Vitamin A dosage during a measles outbreak ............................ 47\n* Table 5: National Immunization Schedule ............................................. 61",
          "bBox": {
            "x": 62.5,
            "y": 96.01,
            "w": 464.36,
            "h": 236.49
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "LIST OF FIGURES",
          "md": "# LIST OF FIGURES",
          "bBox": {
            "x": 58.5,
            "y": 252.61,
            "w": 155.8,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "* Figure 1: Vaccines protect against infection ........................................ 2\n* Figure 2: Depiction of herd immunity .................................................. 5\n* Figure 3: Using cold compresses for pain at injection site ..................... 18\n* Figure 4: Child with sites of multiple vaccines ..................................... 22\n* Figure 5: Using AD syringe ........................................................................ 25\n* Figure 6: Storage and transportation of vaccines (Cold Chain System) .... 27\n* Figure 7: ILR with vaccine arrangement (Front view) ............................ 28\n* Figure 8: Vaccine carrier ............................................................................. 29\n* Figure 9: Ice-pack with vials kept on it .................................................. 30\n* Figure 10: Freezing and conditioning of ice-packs .................................. 31\n* Figure 11: Procedure of reconstitution .................................................. 32\n* Figure 12: VVM different stages ............................................................ 33\n* Figure 13: VVM placement on vials ....................................................... 33\n* Figure 14: Points to be checked as per Open Vial Policy ........................ 34\n* Figure 15: Bio-medical waste management ............................................. 39\n* Figure 16: Vitamin-A and formulation .................................................... 46\n* Figure 17: Four key messages .................................................................... 51",
          "md": "* Figure 1: Vaccines protect against infection ........................................ 2\n* Figure 2: Depiction of herd immunity .................................................. 5\n* Figure 3: Using cold compresses for pain at injection site ..................... 18\n* Figure 4: Child with sites of multiple vaccines ..................................... 22\n* Figure 5: Using AD syringe ........................................................................ 25\n* Figure 6: Storage and transportation of vaccines (Cold Chain System) .... 27\n* Figure 7: ILR with vaccine arrangement (Front view) ............................ 28\n* Figure 8: Vaccine carrier ............................................................................. 29\n* Figure 9: Ice-pack with vials kept on it .................................................. 30\n* Figure 10: Freezing and conditioning of ice-packs .................................. 31\n* Figure 11: Procedure of reconstitution .................................................. 32\n* Figure 12: VVM different stages ............................................................ 33\n* Figure 13: VVM placement on vials ....................................................... 33\n* Figure 14: Points to be checked as per Open Vial Policy ........................ 34\n* Figure 15: Bio-medical waste management ............................................. 39\n* Figure 16: Vitamin-A and formulation .................................................... 46\n* Figure 17: Four key messages .................................................................... 51",
          "bBox": {
            "x": 62.5,
            "y": 96.01,
            "w": 465.19,
            "h": 650.13
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.989
    },
    {
      "page": 7,
      "text": "NO_CONTENT_HERE",
      "md": "NO_CONTENT_HERE",
      "images": [
        {
          "name": "page_7.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        },
        {
          "name": "page_7.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "NO_CONTENT_HERE",
          "md": "NO_CONTENT_HERE",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": true,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 8,
      "text": "SECTION: 1\nImmunity and Vaccines\n\n\n\n\n\n\n\n         1. What is immunity?\n\nAns.     Immunity refers to resistance against infection caused by microorganisms (bacteria and\n         viruses) and their products (toxins).\n\nQ 2. What is immunization?\nAns.     Immunization is the process whereby a person is made immune or resistant to an infectious\n         disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own\n         immune system to protect the person against subsequent infection or disease.¹\n\nQ 3. Do children have natural immunity against diseases?\nAns.     Babies are born with natural immunity against some diseases, which they get from their\n         mothers (in utero) and by breastfeeding in the early days of their life. But as they grow,\n         this immunity gradually decreases. Immunization further enhances their immunity and\n         protects them against vaccine-preventable diseases.\n\n\n\n\n\n\n\n\n\n\n1Health Topics: Immunization (WHO) at http://www.who.int/topics/immunization/en/\n\n                                                                                FAQs on ImmunizationI 1",
      "md": "\n# SECTION: 1  \n## Immunity and Vaccines\n\n**Q 1. What is immunity?**  \nAns. Immunity refers to resistance against infection caused by microorganisms (bacteria and viruses) and their products (toxins).\n\n**Q 2. What is immunization?**  \nAns. Immunization is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease.¹\n\n**Q 3. Do children have natural immunity against diseases?**  \nAns. Babies are born with natural immunity against some diseases, which they get from their mothers (in utero) and by breastfeeding in the early days of their life. But as they grow, this immunity gradually decreases. Immunization further enhances their immunity and protects them against vaccine-preventable diseases.\n\n----\n\n¹Health Topics: Immunization (WHO) at http://www.who.int/topics/immunization/en/\n",
      "images": [
        {
          "name": "img_p7_1.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p7_3.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p7_4.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p7_5.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p7_6.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p7_7.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p7_8.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_9.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_10.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p7_11.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p7_12.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 339.57,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_13.png",
          "height": 35.475,
          "width": 169.57,
          "x": 95.028,
          "y": 322.306,
          "original_width": 714,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "img_p7_14.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 436.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_15.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 548.13,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_16.jpg",
          "height": 18.72,
          "width": 34.069,
          "x": 58.464,
          "y": 357.984,
          "original_width": 142,
          "original_height": 78,
          "rotation": 0
        },
        {
          "name": "img_p7_17.jpg",
          "height": 21.697,
          "width": 34.069,
          "x": 58.464,
          "y": 339.909,
          "original_width": 142,
          "original_height": 91,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_19.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 58.464,
          "y": 548.483,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_20.jpg",
          "height": 152.962,
          "width": 228.837,
          "x": 106.814,
          "y": -33.697,
          "original_width": 916,
          "original_height": 555,
          "rotation": 0
        },
        {
          "name": "img_p7_21.jpg",
          "height": 76.858,
          "width": 114.69,
          "x": -0.519,
          "y": -11.135,
          "original_width": 459,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_22.png",
          "height": 91.891,
          "width": 257.723,
          "x": 324.887,
          "y": -27.6,
          "original_width": 1068,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_23.jpg",
          "height": 40.459,
          "width": 75.56,
          "x": 42.018,
          "y": 53.923,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p7_24.jpg",
          "height": 202.986,
          "width": 92.642,
          "x": 510.457,
          "y": 37.457,
          "original_width": 307,
          "original_height": 832,
          "rotation": 0
        },
        {
          "name": "img_p7_25.png",
          "height": 47.964,
          "width": 146.959,
          "x": 331.725,
          "y": 48.738,
          "original_width": 611,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p7_26.jpg",
          "height": 80.635,
          "width": 150.625,
          "x": 299.197,
          "y": 84.902,
          "original_width": 612,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_27.png",
          "height": 40.67,
          "width": 75.35,
          "x": 227.798,
          "y": 99.96,
          "original_width": 306,
          "original_height": 141,
          "rotation": 0
        },
        {
          "name": "img_p7_28.png",
          "height": 101.74,
          "width": 46.463,
          "x": 445.896,
          "y": 113.796,
          "original_width": 154,
          "original_height": 417,
          "rotation": 0
        },
        {
          "name": "img_p7_29.jpg",
          "height": 40.46,
          "width": 75.56,
          "x": 377.669,
          "y": 149.959,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p7_30.jpg",
          "height": 69.328,
          "width": 43.056,
          "x": 488.409,
          "y": 174.867,
          "original_width": 154,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "page_8.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 1",
          "md": "# SECTION: 1  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 105.8,
            "h": 20
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Immunity and Vaccines",
          "md": "## Immunity and Vaccines",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 262.06,
            "h": 24
          }
        },
        {
          "type": "text",
          "value": "**Q 1. What is immunity?**  \nAns. Immunity refers to resistance against infection caused by microorganisms (bacteria and viruses) and their products (toxins).",
          "md": "**Q 1. What is immunity?**  \nAns. Immunity refers to resistance against infection caused by microorganisms (bacteria and viruses) and their products (toxins).",
          "bBox": {
            "x": 58.5,
            "y": 345.71,
            "w": 478.27,
            "h": 256.59
          }
        },
        {
          "type": "text",
          "value": "**Q 2. What is immunization?**  \nAns. Immunization is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease.¹",
          "md": "**Q 2. What is immunization?**  \nAns. Immunization is the process whereby a person is made immune or resistant to an infectious disease, typically by the administration of a vaccine. Vaccines stimulate the body’s own immune system to protect the person against subsequent infection or disease.¹",
          "bBox": {
            "x": 58.46,
            "y": 381.72,
            "w": 478.31,
            "h": 220.57
          }
        },
        {
          "type": "text",
          "value": "**Q 3. Do children have natural immunity against diseases?**  \nAns. Babies are born with natural immunity against some diseases, which they get from their mothers (in utero) and by breastfeeding in the early days of their life. But as they grow, this immunity gradually decreases. Immunization further enhances their immunity and protects them against vaccine-preventable diseases.",
          "md": "**Q 3. Do children have natural immunity against diseases?**  \nAns. Babies are born with natural immunity against some diseases, which they get from their mothers (in utero) and by breastfeeding in the early days of their life. But as they grow, this immunity gradually decreases. Immunization further enhances their immunity and protects them against vaccine-preventable diseases.",
          "bBox": {
            "x": 58.46,
            "y": 381.72,
            "w": 478.32,
            "h": 264.06
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "¹Health Topics: Immunization (WHO) at http://www.who.int/topics/immunization/en/",
          "md": "¹Health Topics: Immunization (WHO) at http://www.who.int/topics/immunization/en/",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.979
    },
    {
      "page": 9,
      "text": "Q 4. How do vaccines protect from disease-causing organisms?\nAns.     Vaccines contain either weakened or killed versions of viruses or bacteria, or an\n         antigenic substance prepared from the causative agent, or a synthetic substitute.\n         Once administered in the body by injection, mouth or by aerosol, stimulate the\n         immune response to produce “antibodies” targeting those infectious agents,\n         thereby producing protection against infections. Each vaccine provides immunity\n         against a particular disease; therefore, a number of vaccines are administered to\n         children and pregnant women to protect them from many vaccine-preventable\n         diseases.²\n\n\n\n\ntectᴬᵍᵃⁱⁿˢᵗIn\nos\nPolio    Rotavirus\n         Diarrhoea\n\n\n\n\n\nPeeodAecns\n\nTetanus    Pertussis\n\n\n         Figure 1: Vaccines protect against infection\n\nQ 5. What is the duration of immunity provided by immunization?\nAns.     The duration of immunity varies with different diseases and different vaccines. Life-\n         long immunity is not always provided by either natural infection or vaccination. The\n         protection provided by vaccines decreases gradually over time. Therefore, booster\n         doses are sometimes recommended for certain vaccines, at specific age groups.\n\nQ 6. When does the process of child immunization start?\nAns.     Immunization process starts when a child is in utero. Immunity developed from TT\n         vaccine given to pregnant women passes to her child and protects from neonatal\n         tetanus. Immunity against some infections, like measles, is transferred to child as\n         passive immunity and protects from infection for some period after birth. Under\n         National Immunization Schedule, BCG, OPV, and Hep B vaccines are given to child\n         immediately after birth.\n\n2Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n\n\n2 IFAQs on Immunization",
      "md": "\n**4. How do vaccines protect from disease-causing organisms?**  \n**Ans.** Vaccines contain either weakened or killed versions of viruses or bacteria, or an antigenic substance prepared from the causative agent, or a synthetic substitute. Once administered in the body by injection, mouth or by aerosol, stimulate the immune response to produce **“antibodies”** targeting those infectious agents, thereby producing protection against infections. Each vaccine provides immunity against a particular disease; therefore, a number of vaccines are administered to children and pregnant women to protect them from many vaccine-preventable diseases.²\n\n<table>\n  <tr>\n    <td colspan=\"3\" style=\"text-align:center;\">\n      <b>Vaccines Protect Against Infection</b>\n    </td>\n  </tr>\n<tr>\n    <td style=\"text-align:center;\">\n      <b>Polio</b><br>\n      [Angry Earth-like virus cartoon]\n    </td>\n    <td style=\"text-align:center;\">\n      <b>Mother with children</b><br>\n      [Central image of a pregnant woman with children around]\n    </td>\n    <td style=\"text-align:center;\">\n      <b>Rotavirus Diarrhoea</b><br>\n      [Angry purple virus cartoon]\n    </td>\n  </tr>\n<tr>\n    <td style=\"text-align:center;\">\n      <b>Tetanus</b><br>\n      [Yellow angry virus cartoon]\n    </td>\n<td></td>\n    <td style=\"text-align:center;\">\n      <b>Pertussis</b><br>\n      [Green bacteria cartoon]\n    </td>\n  </tr>\n</table>\n\n*Figure 1: Vaccines protect against infection*\n\n**5. What is the duration of immunity provided by immunization?**  \n**Ans.** The duration of immunity varies with different diseases and different vaccines. Life-long immunity is not always provided by either natural infection or vaccination. The protection provided by vaccines decreases gradually over time. Therefore, booster doses are sometimes recommended for certain vaccines, at specific age groups.\n\n**6. When does the process of child immunization start?**  \n**Ans.** Immunization process starts when a child is in utero. Immunity developed from TT vaccine given to pregnant women passes to her child and protects from neonatal tetanus. Immunity against some infections, like measles, is transferred to child as passive immunity and protects from infection for some period after birth. Under National Immunization Schedule, **BCG, OPV, and Hep B** vaccines are given to child immediately after birth.\n\n----\n\n² Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_2.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 58.05,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_4.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 634.29,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_7.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 634.514,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_8.jpg",
          "height": 69.389,
          "width": 70.402,
          "x": 144.412,
          "y": 230.309,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_9.jpg",
          "height": 69.389,
          "width": 70.474,
          "x": 214.669,
          "y": 230.309,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 199,
              "y": 245,
              "w": 39,
              "h": 39,
              "confidence": 0.844,
              "text": "os"
            }
          ]
        },
        {
          "name": "img_p8_10.jpg",
          "height": 69.389,
          "width": 70.401,
          "x": 284.999,
          "y": 230.309,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 158,
              "w": 82,
              "h": 69,
              "confidence": 0.901,
              "text": "tect"
            },
            {
              "x": 243,
              "y": 145,
              "w": 51,
              "h": 50,
              "confidence": 0.998,
              "text": "In"
            },
            {
              "x": 83,
              "y": 137,
              "w": 159,
              "h": 48,
              "confidence": 0.917,
              "text": "Against"
            }
          ]
        },
        {
          "name": "img_p8_11.jpg",
          "height": 69.389,
          "width": 70.474,
          "x": 355.256,
          "y": 230.309,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_12.jpg",
          "height": 69.389,
          "width": 70.402,
          "x": 425.585,
          "y": 230.309,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_13.jpg",
          "height": 69.388,
          "width": 70.402,
          "x": 144.412,
          "y": 299.554,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 178,
              "y": 43,
              "w": 105,
              "h": 45,
              "confidence": 1,
              "text": "Polio"
            }
          ]
        },
        {
          "name": "img_p8_14.jpg",
          "height": 69.388,
          "width": 70.474,
          "x": 214.669,
          "y": 299.554,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_15.jpg",
          "height": 69.388,
          "width": 70.401,
          "x": 284.999,
          "y": 299.554,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_16.jpg",
          "height": 69.388,
          "width": 70.474,
          "x": 355.256,
          "y": 299.554,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_17.jpg",
          "height": 69.388,
          "width": 70.402,
          "x": 425.585,
          "y": 299.554,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 15,
              "y": 90,
              "w": 194,
              "h": 42,
              "confidence": 1,
              "text": "Diarrhoea"
            },
            {
              "x": 16,
              "y": 51,
              "w": 186,
              "h": 36,
              "confidence": 1,
              "text": "Rotavirus"
            }
          ]
        },
        {
          "name": "img_p8_18.jpg",
          "height": 69.388,
          "width": 70.402,
          "x": 144.412,
          "y": 368.798,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_19.jpg",
          "height": 69.388,
          "width": 70.474,
          "x": 214.669,
          "y": 368.798,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 218,
              "y": 166,
              "w": 76,
              "h": 73,
              "confidence": 0.417,
              "text": "Pee"
            }
          ]
        },
        {
          "name": "img_p8_20.jpg",
          "height": 69.388,
          "width": 70.401,
          "x": 284.999,
          "y": 368.798,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0,
          "ocr": [
            {
              "x": 77,
              "y": 244,
              "w": 177,
              "h": 46,
              "confidence": 0.42,
              "text": "Aecns"
            },
            {
              "x": 0,
              "y": 197,
              "w": 80,
              "h": 77,
              "confidence": 0.736,
              "text": "od"
            }
          ]
        },
        {
          "name": "img_p8_21.jpg",
          "height": 69.388,
          "width": 70.474,
          "x": 355.256,
          "y": 368.798,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_22.jpg",
          "height": 69.388,
          "width": 70.402,
          "x": 425.585,
          "y": 368.798,
          "original_width": 294,
          "original_height": 290,
          "rotation": 0
        },
        {
          "name": "img_p8_23.jpg",
          "height": 34.73,
          "width": 140.731,
          "x": 144.412,
          "y": 438.042,
          "original_width": 587,
          "original_height": 145,
          "rotation": 0,
          "ocr": [
            {
              "x": 303,
              "y": 13,
              "w": 163,
              "h": 42,
              "confidence": 1,
              "text": "Tetanus"
            }
          ]
        },
        {
          "name": "img_p8_24.jpg",
          "height": 34.73,
          "width": 140.731,
          "x": 284.999,
          "y": 438.042,
          "original_width": 587,
          "original_height": 145,
          "rotation": 0,
          "ocr": [
            {
              "x": 374,
              "y": 15,
              "w": 175,
              "h": 37,
              "confidence": 1,
              "text": "Pertussis"
            }
          ]
        },
        {
          "name": "img_p8_25.jpg",
          "height": 34.73,
          "width": 70.402,
          "x": 425.585,
          "y": 438.042,
          "original_width": 294,
          "original_height": 145,
          "rotation": 0
        },
        {
          "name": "page_9.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**4. How do vaccines protect from disease-causing organisms?**  \n**Ans.** Vaccines contain either weakened or killed versions of viruses or bacteria, or an antigenic substance prepared from the causative agent, or a synthetic substitute. Once administered in the body by injection, mouth or by aerosol, stimulate the immune response to produce **“antibodies”** targeting those infectious agents, thereby producing protection against infections. Each vaccine provides immunity against a particular disease; therefore, a number of vaccines are administered to children and pregnant women to protect them from many vaccine-preventable diseases.²",
          "md": "**4. How do vaccines protect from disease-causing organisms?**  \n**Ans.** Vaccines contain either weakened or killed versions of viruses or bacteria, or an antigenic substance prepared from the causative agent, or a synthetic substitute. Once administered in the body by injection, mouth or by aerosol, stimulate the immune response to produce **“antibodies”** targeting those infectious agents, thereby producing protection against infections. Each vaccine provides immunity against a particular disease; therefore, a number of vaccines are administered to children and pregnant women to protect them from many vaccine-preventable diseases.²",
          "bBox": {
            "x": 86.4,
            "y": 100.28,
            "w": 450.39,
            "h": 588.04
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "<br/>[Angry Earth-like virus cartoon]",
              "<br/>[Central image of a pregnant woman with children around]",
              "<br/>[Angry purple virus cartoon]"
            ],
            [
              "<br/>[Yellow angry virus cartoon]",
              "",
              "<br/>[Green bacteria cartoon]"
            ]
          ],
          "html": "<table>\n  <tr>\n    <td colspan=\"3\" style=\"text-align:center;\">\n      <b>Vaccines Protect Against Infection</b>\n    </td>\n  </tr>\n<tr>\n    <td style=\"text-align:center;\">\n      <b>Polio</b><br />\n      [Angry Earth-like virus cartoon]\n    </td>\n    <td style=\"text-align:center;\">\n      <b>Mother with children</b><br />\n      [Central image of a pregnant woman with children around]\n    </td>\n    <td style=\"text-align:center;\">\n      <b>Rotavirus Diarrhoea</b><br />\n      [Angry purple virus cartoon]\n    </td>\n  </tr>\n<tr>\n    <td style=\"text-align:center;\">\n      <b>Tetanus</b><br />\n      [Yellow angry virus cartoon]\n    </td>\n<td></td>\n    <td style=\"text-align:center;\">\n      <b>Pertussis</b><br />\n      [Green bacteria cartoon]\n    </td>\n  </tr>\n</table>",
          "md": "| **Vaccines Protect Against Infection**          |                                                                                        |                                                           |\n| ----------------------------------------------- | -------------------------------------------------------------------------------------- | --------------------------------------------------------- |\n| **Polio**<br/>\\[Angry Earth-like virus cartoon] | **Mother with children**<br/>\\[Central image of a pregnant woman with children around] | **Rotavirus Diarrhoea**<br/>\\[Angry purple virus cartoon] |\n| **Tetanus**<br/>\\[Yellow angry virus cartoon]   |                                                                                        | **Pertussis**<br/>\\[Green bacteria cartoon]               |",
          "isPerfectTable": false,
          "csv": "\"<br/>[Angry Earth-like virus cartoon]\",\"<br/>[Central image of a pregnant woman with children around]\",\"<br/>[Angry purple virus cartoon]\"\n\"<br/>[Yellow angry virus cartoon]\",\"\",\"<br/>[Green bacteria cartoon]\"",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.43,
            "h": 770.25
          }
        },
        {
          "type": "text",
          "value": "*Figure 1: Vaccines protect against infection*",
          "md": "*Figure 1: Vaccines protect against infection*",
          "bBox": {
            "x": 240.79,
            "y": 489.13,
            "w": 160.14,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "**5. What is the duration of immunity provided by immunization?**  \n**Ans.** The duration of immunity varies with different diseases and different vaccines. Life-long immunity is not always provided by either natural infection or vaccination. The protection provided by vaccines decreases gradually over time. Therefore, booster doses are sometimes recommended for certain vaccines, at specific age groups.",
          "md": "**5. What is the duration of immunity provided by immunization?**  \n**Ans.** The duration of immunity varies with different diseases and different vaccines. Life-long immunity is not always provided by either natural infection or vaccination. The protection provided by vaccines decreases gradually over time. Therefore, booster doses are sometimes recommended for certain vaccines, at specific age groups.",
          "bBox": {
            "x": 86.4,
            "y": 100.28,
            "w": 450.4,
            "h": 588.04
          }
        },
        {
          "type": "text",
          "value": "**6. When does the process of child immunization start?**  \n**Ans.** Immunization process starts when a child is in utero. Immunity developed from TT vaccine given to pregnant women passes to her child and protects from neonatal tetanus. Immunity against some infections, like measles, is transferred to child as passive immunity and protects from infection for some period after birth. Under National Immunization Schedule, **BCG, OPV, and Hep B** vaccines are given to child immediately after birth.",
          "md": "**6. When does the process of child immunization start?**  \n**Ans.** Immunization process starts when a child is in utero. Immunity developed from TT vaccine given to pregnant women passes to her child and protects from neonatal tetanus. Immunity against some infections, like measles, is transferred to child as passive immunity and protects from infection for some period after birth. Under National Immunization Schedule, **BCG, OPV, and Hep B** vaccines are given to child immediately after birth.",
          "bBox": {
            "x": 86.4,
            "y": 100.28,
            "w": 450.38,
            "h": 660.52
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "² Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "md": "² Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.922
    },
    {
      "page": 10,
      "text": "Q 7. Why is timely vaccination important?\nAns.     Age of administration of vaccines is decided by medical and public health experts\n         after careful study of disease epidemiology and protective efficacy of different\n         vaccines. Vaccines ensure best protection when they are given at the right time.\n         India’s National Immunization Schedule has been designed to protect children since\n         birth, and at the ages when they are vulnerable to specific vaccine-preventable\n         diseases.\n\n         The recommended age for vaccination by different vaccines aims to achieve the best\n         immune protection to cover the period in life when vulnerability to disease is highest.\n         When children are not vaccinated at all or get vaccinated beyond the recommended\n         age, they remain unprotected and may get infected from a vaccine-preventable\n         disease.\n\nQ 8. What are the various types of vaccines?\nAns.     Vaccines can be categorized on the basis of their composition, which also decides its\n         mechanism of action once introduced into the body. Broadly, there are four types of\n         vaccines:³\n\n         Vaccine Type                       Description                           Examples\n\n                               Contains live form of disease- causing         BCG, Oral polio\n                             agents (virus or bacteria), that have been        vaccine (OPV),\n           Live-               weakened under laboratory conditions.  Measles/ Measles-\n           Attenuated          These agents replicate in the body of           Rubella (MR),\n           Vaccines            vaccinated individual and cause a mild          Rotavirus and\n                             form of self-limiting disease, followed by    Japanese encephalitis\n                                       long lasting immunity.                  (JE) vaccines\n\n                                Contain inactivated form of disease              Pertussis,\n\n            Inactivated       causing agent (virus or bacteria). They           Haemophilus\n            (or killed)        cannot replicate but induce an immune          influenza type B\n            vaccines           response leading to protection against      (Hib) and Inactivated\n                              specific disease. These vaccines require       Poliovirus Vaccine\n                               multiple doses to induce, and booster               (IPV)\n                                    doses to maintain immunity.\n\n          Recombinant       Contain genetically modified form of\n          (or sub-unit)     disease causing agent, which produce    Hepatitis B vaccine\n          vaccines          antigenic proteins in vaccinated individual,\n                            thus inducing immunity.\n\n             Toxoid              Contain inactivated form of toxins            Diphtheria and\n             vaccines            produced by disease causing agent,         Tetanus toxoid (TT)\n                               which elicit immune response producing             vaccines\n                                   immunity against the disease.\n                            Table 1:Types of vaccines\n\n3Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n\n\nFAQs on ImmunizationI 3",
      "md": "\n**7. Why is timely vaccination important?**  \n**Ans.** Age of administration of vaccines is decided by medical and public health experts after careful study of disease epidemiology and protective efficacy of different vaccines. Vaccines ensure best protection when they are given at the right time. India’s National Immunization Schedule has been designed to protect children since birth, and at the ages when they are vulnerable to specific vaccine-preventable diseases.\n\nThe recommended age for vaccination by different vaccines aims to achieve the best immune protection to cover the period in life when vulnerability to disease is highest. When children are not vaccinated at all or get vaccinated beyond the recommended age, they remain unprotected and may get infected from a vaccine-preventable disease.\n\n**8. What are the various types of vaccines?**  \n**Ans.** Vaccines can be categorized on the basis of their composition, which also decides its mechanism of action once introduced into the body. Broadly, there are four types of vaccines:³\n\n<table>\n<thead>\n<tr>\n<th>Vaccine Type</th>\n<th>Description</th>\n<th>Examples</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Live-Attenuated Vaccines</td>\n<td>Contains live form of disease-causing agents (virus or bacteria), that have been weakened under laboratory conditions. These agents replicate in the body of vaccinated individual and cause a mild form of self-limiting disease, followed by long lasting immunity.</td>\n<td>BCG, Oral polio vaccine (OPV), Measles/ Measles-Rubella (MR), Rotavirus and Japanese encephalitis (JE) vaccines</td>\n</tr>\n<tr>\n<td>Inactivated (or killed) vaccines</td>\n<td>Contain inactivated form of disease causing agent (virus or bacteria). They cannot replicate but induce an immune response leading to protection against specific disease. These vaccines require multiple doses to induce, and booster doses to maintain immunity.</td>\n<td>Pertussis, Haemophilus influenza type B (Hib) and Inactivated Poliovirus Vaccine (IPV)</td>\n</tr>\n<tr>\n<td>Recombinant (or sub-unit) vaccines</td>\n<td>Contain genetically modified form of disease causing agent, which produce antigenic proteins in vaccinated individual, thus inducing immunity.</td>\n<td>Hepatitis B vaccine</td>\n</tr>\n<tr>\n<td>Toxoid vaccines</td>\n<td>Contain inactivated form of toxins produced by disease causing agent, which elicit immune response producing immunity against the disease.</td>\n<td>Diphtheria and Tetanus toxoid (TT) vaccines</td>\n</tr>\n</tbody>\n</table>\n\n³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_3.png",
          "height": 37.68,
          "width": 414.72,
          "x": 96.72,
          "y": 290.61,
          "original_width": 1728,
          "original_height": 157,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p9_5.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 58.464,
          "y": 291.053,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_10.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**7. Why is timely vaccination important?**  \n**Ans.** Age of administration of vaccines is decided by medical and public health experts after careful study of disease epidemiology and protective efficacy of different vaccines. Vaccines ensure best protection when they are given at the right time. India’s National Immunization Schedule has been designed to protect children since birth, and at the ages when they are vulnerable to specific vaccine-preventable diseases.",
          "md": "**7. Why is timely vaccination important?**  \n**Ans.** Age of administration of vaccines is decided by medical and public health experts after careful study of disease epidemiology and protective efficacy of different vaccines. Vaccines ensure best protection when they are given at the right time. India’s National Immunization Schedule has been designed to protect children since birth, and at the ages when they are vulnerable to specific vaccine-preventable diseases.",
          "bBox": {
            "x": 58.5,
            "y": 99.28,
            "w": 452.72,
            "h": 630.36
          }
        },
        {
          "type": "text",
          "value": "The recommended age for vaccination by different vaccines aims to achieve the best immune protection to cover the period in life when vulnerability to disease is highest. When children are not vaccinated at all or get vaccinated beyond the recommended age, they remain unprotected and may get infected from a vaccine-preventable disease.",
          "md": "The recommended age for vaccination by different vaccines aims to achieve the best immune protection to cover the period in life when vulnerability to disease is highest. When children are not vaccinated at all or get vaccinated beyond the recommended age, they remain unprotected and may get infected from a vaccine-preventable disease.",
          "bBox": {
            "x": 100.5,
            "y": 195.25,
            "w": 410.72,
            "h": 534.39
          }
        },
        {
          "type": "text",
          "value": "**8. What are the various types of vaccines?**  \n**Ans.** Vaccines can be categorized on the basis of their composition, which also decides its mechanism of action once introduced into the body. Broadly, there are four types of vaccines:³",
          "md": "**8. What are the various types of vaccines?**  \n**Ans.** Vaccines can be categorized on the basis of their composition, which also decides its mechanism of action once introduced into the body. Broadly, there are four types of vaccines:³",
          "bBox": {
            "x": 58.5,
            "y": 99.28,
            "w": 452.7,
            "h": 630.36
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Vaccine Type",
              "Description",
              "Examples"
            ],
            [
              "Live-Attenuated Vaccines",
              "Contains live form of disease-causing agents (virus or bacteria), that have been weakened under laboratory conditions. These agents replicate in the body of vaccinated individual and cause a mild form of self-limiting disease, followed by long lasting immunity.",
              "BCG, Oral polio vaccine (OPV), Measles/ Measles-Rubella (MR), Rotavirus and Japanese encephalitis (JE) vaccines"
            ],
            [
              "Inactivated (or killed) vaccines",
              "Contain inactivated form of disease causing agent (virus or bacteria). They cannot replicate but induce an immune response leading to protection against specific disease. These vaccines require multiple doses to induce, and booster doses to maintain immunity.",
              "Pertussis, Haemophilus influenza type B (Hib) and Inactivated Poliovirus Vaccine (IPV)"
            ],
            [
              "Recombinant (or sub-unit) vaccines",
              "Contain genetically modified form of disease causing agent, which produce antigenic proteins in vaccinated individual, thus inducing immunity.",
              "Hepatitis B vaccine"
            ],
            [
              "Toxoid vaccines",
              "Contain inactivated form of toxins produced by disease causing agent, which elicit immune response producing immunity against the disease.",
              "Diphtheria and Tetanus toxoid (TT) vaccines"
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>Vaccine Type</th>\n<th>Description</th>\n<th>Examples</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Live-Attenuated Vaccines</td>\n<td>Contains live form of disease-causing agents (virus or bacteria), that have been weakened under laboratory conditions. These agents replicate in the body of vaccinated individual and cause a mild form of self-limiting disease, followed by long lasting immunity.</td>\n<td>BCG, Oral polio vaccine (OPV), Measles/ Measles-Rubella (MR), Rotavirus and Japanese encephalitis (JE) vaccines</td>\n</tr>\n<tr>\n<td>Inactivated (or killed) vaccines</td>\n<td>Contain inactivated form of disease causing agent (virus or bacteria). They cannot replicate but induce an immune response leading to protection against specific disease. These vaccines require multiple doses to induce, and booster doses to maintain immunity.</td>\n<td>Pertussis, Haemophilus influenza type B (Hib) and Inactivated Poliovirus Vaccine (IPV)</td>\n</tr>\n<tr>\n<td>Recombinant (or sub-unit) vaccines</td>\n<td>Contain genetically modified form of disease causing agent, which produce antigenic proteins in vaccinated individual, thus inducing immunity.</td>\n<td>Hepatitis B vaccine</td>\n</tr>\n<tr>\n<td>Toxoid vaccines</td>\n<td>Contain inactivated form of toxins produced by disease causing agent, which elicit immune response producing immunity against the disease.</td>\n<td>Diphtheria and Tetanus toxoid (TT) vaccines</td>\n</tr>\n</tbody>\n</table>",
          "md": "| Vaccine Type                       | Description                                                                                                                                                                                                                                                           | Examples                                                                                                        |\n| ---------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------- |\n| Live-Attenuated Vaccines           | Contains live form of disease-causing agents (virus or bacteria), that have been weakened under laboratory conditions. These agents replicate in the body of vaccinated individual and cause a mild form of self-limiting disease, followed by long lasting immunity. | BCG, Oral polio vaccine (OPV), Measles/ Measles-Rubella (MR), Rotavirus and Japanese encephalitis (JE) vaccines |\n| Inactivated (or killed) vaccines   | Contain inactivated form of disease causing agent (virus or bacteria). They cannot replicate but induce an immune response leading to protection against specific disease. These vaccines require multiple doses to induce, and booster doses to maintain immunity.   | Pertussis, Haemophilus influenza type B (Hib) and Inactivated Poliovirus Vaccine (IPV)                          |\n| Recombinant (or sub-unit) vaccines | Contain genetically modified form of disease causing agent, which produce antigenic proteins in vaccinated individual, thus inducing immunity.                                                                                                                        | Hepatitis B vaccine                                                                                             |\n| Toxoid vaccines                    | Contain inactivated form of toxins produced by disease causing agent, which elicit immune response producing immunity against the disease.                                                                                                                            | Diphtheria and Tetanus toxoid (TT) vaccines                                                                     |",
          "isPerfectTable": true,
          "csv": "\"Vaccine Type\",\"Description\",\"Examples\"\n\"Live-Attenuated Vaccines\",\"Contains live form of disease-causing agents (virus or bacteria), that have been weakened under laboratory conditions. These agents replicate in the body of vaccinated individual and cause a mild form of self-limiting disease, followed by long lasting immunity.\",\"BCG, Oral polio vaccine (OPV), Measles/ Measles-Rubella (MR), Rotavirus and Japanese encephalitis (JE) vaccines\"\n\"Inactivated (or killed) vaccines\",\"Contain inactivated form of disease causing agent (virus or bacteria). They cannot replicate but induce an immune response leading to protection against specific disease. These vaccines require multiple doses to induce, and booster doses to maintain immunity.\",\"Pertussis, Haemophilus influenza type B (Hib) and Inactivated Poliovirus Vaccine (IPV)\"\n\"Recombinant (or sub-unit) vaccines\",\"Contain genetically modified form of disease causing agent, which produce antigenic proteins in vaccinated individual, thus inducing immunity.\",\"Hepatitis B vaccine\"\n\"Toxoid vaccines\",\"Contain inactivated form of toxins produced by disease causing agent, which elicit immune response producing immunity against the disease.\",\"Diphtheria and Tetanus toxoid (TT) vaccines\"",
          "bBox": {
            "x": 103.87,
            "y": 388.91,
            "w": 393.77,
            "h": 264.7
          }
        },
        {
          "type": "text",
          "value": "³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "md": "³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.991
    },
    {
      "page": 11,
      "text": "Q 9. Why do private providers offer some vaccines that are ⁿᵒᵗ\n         available in Government’s programme?\nAns.     Government’s immunization programme serves to a wider community, while\n         private providers serve only to families that approach to them for services. Universal\n         Immunization Programme (UIP) implemented by Ministry of Health & Family\n         Welfare (MoHFW), Government of India includes vaccines recommended by WHO\n         and National Technical Advisory Group on Immunization (NTAGI). Its objective is\n         to control transmission of diseases having public health significance that can lead to\n         high mortality and morbidity among the community.\n         Private providers, on the other hand, follow immunization schedule recommended\n         by Indian Academy of Paediatrics (IAP). It includes some vaccines that are not of\n         public health significance and do not pose threat to a larger community. Therefore,\n         vaccines provided in government’s programme are fewer as compared to those\n         provided by private providers.\n\n\n         10. Is there any difference in the vaccine quality provided by\n          private practitioners and those provided at the government\n          health facilities?\nAns.     Both government and private sectors have same regulatory mechanisms and all\n         vaccines are procured from government approved manufacturers. All vaccines are\n         approved by Central Drugs and Standards Control Organization (CDSCO) which\n         is the National Regulatory Authority (NRA). Drug Controller General of India (DCGI)\n         heads the CDSCO and grants permission to conduct clinical trials; registers and\n         controls the quality of vaccines.⁴\n\n\n                       11. Which diseases have been successfully eliminated/ eradicated\n        by use of vaccines in routine immunization?\n\nAns.     Use of vaccines in India’s Universal Immunization Programme (UIP) has resulted\nQ\nQ\nQ in successful eradication/elimination of three diseases from the country. These are\n        smallpox (1977), poliomyelitis (2014) and maternal and neonatal tetanus (2015).\n\n\n         12. Is it true that individual vaccination also ensures protection of\n         community at large? What is herd immunity?\n\nAns.     Yes. It is true that individual vaccination against a disease-causing pathogen can\n         protect even those individuals in a community who have not been vaccinated\n         against that disease or pathogen. A population with a high number of members with\n         immunity to a particular disease or pathogen may give protection from that infection\n         to the small number of its non-immune members. This phenomenon is known as\n         “herd immunity” or “community immunity” or “population immunity”. This is only\n         achieved when a very high proportion of community members are vaccinated, so\n         it is difficult for the disease-causing organism to spread to unprotected persons\n         because there are few of those people left.\n\n4 National Vaccine Policy, Ministry of Health & Family Welfare, Government of India, April 2011\n\n4 IFAQs on Immunization",
      "md": "\n**Q 9. Why do private providers offer some vaccines that are not available in Government’s programme?**  \n**Ans.** Government’s immunization programme serves to a wider community, while private providers serve only to families that approach to them for services. Universal Immunization Programme (UIP) implemented by Ministry of Health & Family Welfare (MoHFW), Government of India includes vaccines recommended by **WHO and National Technical Advisory Group on Immunization (NTAGI)**. Its objective is to control transmission of diseases having public health significance that can lead to high mortality and morbidity among the community.\n\nPrivate providers, on the other hand, follow immunization schedule recommended by Indian Academy of Paediatrics (IAP). It includes some vaccines that are not of public health significance and do not pose threat to a larger community. Therefore, vaccines provided in government’s programme are fewer as compared to those provided by private providers.\n\n----\n\n**Q 10. Is there any difference in the vaccine quality provided by private practitioners and those provided at the government health facilities?**  \n**Ans.** Both government and private sectors have same regulatory mechanisms and all vaccines are procured from government approved manufacturers. All vaccines are approved by **Central Drugs and Standards Control Organization (CDSCO)** which is the National Regulatory Authority (NRA). Drug Controller General of India (DCGI) heads the CDSCO and grants permission to conduct clinical trials; registers and controls the quality of vaccines.⁴\n\n----\n\n**Q 11. Which diseases have been successfully eliminated/eradicated by use of vaccines in routine immunization?**  \n**Ans.** Use of vaccines in India’s Universal Immunization Programme (UIP) has resulted in successful eradication/elimination of three diseases from the country. These are smallpox (1977), poliomyelitis (2014) and maternal and neonatal tetanus (2015).\n\n----\n\n**Q 12. Is it true that individual vaccination also ensures protection of community at large? What is herd immunity?**  \n**Ans.** **Yes.** It is true that individual vaccination against a disease-causing pathogen can protect even those individuals in a community who have not been vaccinated against that disease or pathogen. A population with a high number of members with immunity to a particular disease or pathogen may give protection from that infection to the small number of its non-immune members. This phenomenon is known as “herd immunity” or “community immunity” or “population immunity”. This is only achieved when a very high proportion of community members are vaccinated, so it is difficult for the disease-causing organism to spread to unprotected persons because there are few of those people left.\n\n----\n\n⁴ National Vaccine Policy, Ministry of Health & Family Welfare, Government of India, April 2011\n",
      "images": [
        {
          "name": "img_p10_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p10_2.png",
          "height": 51.36,
          "width": 412.56,
          "x": 124.56,
          "y": 302.85,
          "original_width": 1719,
          "original_height": 214,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p10_5.png",
          "height": 37.44,
          "width": 412.32,
          "x": 124.8,
          "y": 577.41,
          "original_width": 1718,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_11.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q 9. Why do private providers offer some vaccines that are not available in Government’s programme?**  \n**Ans.** Government’s immunization programme serves to a wider community, while private providers serve only to families that approach to them for services. Universal Immunization Programme (UIP) implemented by Ministry of Health & Family Welfare (MoHFW), Government of India includes vaccines recommended by **WHO and National Technical Advisory Group on Immunization (NTAGI)**. Its objective is to control transmission of diseases having public health significance that can lead to high mortality and morbidity among the community.",
          "md": "**Q 9. Why do private providers offer some vaccines that are not available in Government’s programme?**  \n**Ans.** Government’s immunization programme serves to a wider community, while private providers serve only to families that approach to them for services. Universal Immunization Programme (UIP) implemented by Ministry of Health & Family Welfare (MoHFW), Government of India includes vaccines recommended by **WHO and National Technical Advisory Group on Immunization (NTAGI)**. Its objective is to control transmission of diseases having public health significance that can lead to high mortality and morbidity among the community.",
          "bBox": {
            "x": 86.36,
            "y": 76.55,
            "w": 450.42,
            "h": 557.11
          }
        },
        {
          "type": "text",
          "value": "Private providers, on the other hand, follow immunization schedule recommended by Indian Academy of Paediatrics (IAP). It includes some vaccines that are not of public health significance and do not pose threat to a larger community. Therefore, vaccines provided in government’s programme are fewer as compared to those provided by private providers.",
          "md": "Private providers, on the other hand, follow immunization schedule recommended by Indian Academy of Paediatrics (IAP). It includes some vaccines that are not of public health significance and do not pose threat to a larger community. Therefore, vaccines provided in government’s programme are fewer as compared to those provided by private providers.",
          "bBox": {
            "x": 128.4,
            "y": 208.08,
            "w": 408.4,
            "h": 69.98
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 10. Is there any difference in the vaccine quality provided by private practitioners and those provided at the government health facilities?**  \n**Ans.** Both government and private sectors have same regulatory mechanisms and all vaccines are procured from government approved manufacturers. All vaccines are approved by **Central Drugs and Standards Control Organization (CDSCO)** which is the National Regulatory Authority (NRA). Drug Controller General of India (DCGI) heads the CDSCO and grants permission to conduct clinical trials; registers and controls the quality of vaccines.⁴",
          "md": "**Q 10. Is there any difference in the vaccine quality provided by private practitioners and those provided at the government health facilities?**  \n**Ans.** Both government and private sectors have same regulatory mechanisms and all vaccines are procured from government approved manufacturers. All vaccines are approved by **Central Drugs and Standards Control Organization (CDSCO)** which is the National Regulatory Authority (NRA). Drug Controller General of India (DCGI) heads the CDSCO and grants permission to conduct clinical trials; registers and controls the quality of vaccines.⁴",
          "bBox": {
            "x": 86.36,
            "y": 97.61,
            "w": 450.43,
            "h": 536.05
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 11. Which diseases have been successfully eliminated/eradicated by use of vaccines in routine immunization?**  \n**Ans.** Use of vaccines in India’s Universal Immunization Programme (UIP) has resulted in successful eradication/elimination of three diseases from the country. These are smallpox (1977), poliomyelitis (2014) and maternal and neonatal tetanus (2015).",
          "md": "**Q 11. Which diseases have been successfully eliminated/eradicated by use of vaccines in routine immunization?**  \n**Ans.** Use of vaccines in India’s Universal Immunization Programme (UIP) has resulted in successful eradication/elimination of three diseases from the country. These are smallpox (1977), poliomyelitis (2014) and maternal and neonatal tetanus (2015).",
          "bBox": {
            "x": 86.36,
            "y": 97.61,
            "w": 450.46,
            "h": 536.05
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 12. Is it true that individual vaccination also ensures protection of community at large? What is herd immunity?**  \n**Ans.** **Yes.** It is true that individual vaccination against a disease-causing pathogen can protect even those individuals in a community who have not been vaccinated against that disease or pathogen. A population with a high number of members with immunity to a particular disease or pathogen may give protection from that infection to the small number of its non-immune members. This phenomenon is known as “herd immunity” or “community immunity” or “population immunity”. This is only achieved when a very high proportion of community members are vaccinated, so it is difficult for the disease-causing organism to spread to unprotected persons because there are few of those people left.",
          "md": "**Q 12. Is it true that individual vaccination also ensures protection of community at large? What is herd immunity?**  \n**Ans.** **Yes.** It is true that individual vaccination against a disease-causing pathogen can protect even those individuals in a community who have not been vaccinated against that disease or pathogen. A population with a high number of members with immunity to a particular disease or pathogen may give protection from that infection to the small number of its non-immune members. This phenomenon is known as “herd immunity” or “community immunity” or “population immunity”. This is only achieved when a very high proportion of community members are vaccinated, so it is difficult for the disease-causing organism to spread to unprotected persons because there are few of those people left.",
          "bBox": {
            "x": 86.36,
            "y": 97.61,
            "w": 450.43,
            "h": 652.02
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "⁴ National Vaccine Policy, Ministry of Health & Family Welfare, Government of India, April 2011",
          "md": "⁴ National Vaccine Policy, Ministry of Health & Family Welfare, Government of India, April 2011",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.995
    },
    {
      "page": 12,
      "text": "It is only true for diseases where there is a person to person transmission. Herd\nimmunity makes it difficult for disease-causing organism to spread through cycle of\ninfection, multiplication and circulation among the vulnerable population.\n\nnot immunized but    not immunized, sick,    immunized and\nstill healthy        and contagious          healthy\n\n\n\n          No one is immunized\n           Contagious disease\n          spreads through the\n               population\n\n              Some of the\n            population gets\n               immunized\n           Contagious disease\n            spreads through\n              some of the\n               population\n\n                               Most of the population\n             gets immunized\n          Spread of contagious\n          disease is contained\n                               Figure 2: Depiction of herd immunity\n\nQ\nQ 13. What is the reason that some children suffer from ᵛᵃᶜᶜⁱⁿᵉ\n          preventable disease though they have been vaccinated against\n          that disease?\nAns.     Vaccines have been used for decades and have proven to be effective. Like any other\n         medicine, no vaccine is 100% efficacious. The immunity produced by vaccines varies\n         from child to child. There may be children who do not develop sufficient protective\n         immunity against a disease-causing pathogen due to malnutrition, repeated\n         episodes of diarrhoea leading to diminished immunity or individual specific immune\n         response to a vaccine.\n         Because of these reasons, some children suffer from vaccine-preventable disease\n         despite receiving vaccination against it. However, in such cases the disease is of less\n         severity than in children who have never been vaccinated.\n\n\n         14. What are vaccine hesitancy and vaccine confidence?\n\nAns.     Vaccine hesitancy is the behaviour of parents, caregivers, or the community, who\n         hesitate to get their children vaccinated in spite of immunization services being\n         available and accessible. Inadequate immunization services due to non-availability\n         of vaccines, absenteeism of vaccinators and long distances to vaccination centres\n\n\n\n\nFAQs on ImmunizationI 5",
      "md": "\nIt is only true for diseases where there is a person to person transmission. Herd immunity makes it difficult for disease-causing organism to spread through cycle of infection, multiplication and circulation among the vulnerable population.\n\n<table>\n<thead>\n<tr>\n<th>not immunized but still healthy</th>\n<th>not immunized, sick, and contagious</th>\n<th>immunized and healthy</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>🟣</td>\n<td>🔴</td>\n<td>🟢</td>\n</tr>\n<tr>\n<td>🟣 🟣 🟣 🔴 🟣 🟣</td>\n<td colspan=\"2\">No one is immunized → Contagious disease spreads through the population → 🔴 🔴 🔴 🟣 🔴 🔴 🔴</td>\n</tr>\n<tr>\n<td>🟣 🟢 🔴 🔴 🟣 🔴 🟢</td>\n<td colspan=\"2\">Some of the population gets immunized → Contagious disease spreads through some of the population → 🔴 🔴 🔴 🟣 🔴 🟢</td>\n</tr>\n<tr>\n<td>🟢 🟢 🔴 🟢 🟢 🟢 🟣</td>\n<td colspan=\"2\">Most of the population gets immunized → Spread of contagious disease is contained → 🟢 🟢 🔴 🟢 🟢 🟢 🟣</td>\n</tr>\n</tbody>\n</table>\n\nFigure 2: Depiction of herd immunity\n\n**Q 13. What is the reason that some children suffer from vaccine preventable disease though they have been vaccinated against that disease?**\n\n**Ans.** Vaccines have been used for decades and have proven to be effective. Like any other medicine, no vaccine is 100% efficacious. The immunity produced by vaccines varies from child to child. There may be children who do not develop sufficient protective immunity against a disease-causing pathogen due to malnutrition, repeated episodes of diarrhoea leading to diminished immunity or individual specific immune response to a vaccine.\n\nBecause of these reasons, some children suffer from vaccine-preventable disease despite receiving vaccination against it. However, in such cases the disease is of less severity than in children who have never been vaccinated.\n\n**14. What are vaccine hesitancy and vaccine confidence?**\n\n**Ans.**  \n**Vaccine hesitancy** is the behaviour of parents, caregivers, or the community, who hesitate to get their children vaccinated in spite of immunization services being available and accessible. Inadequate immunization services due to non-availability of vaccines, absenteeism of vaccinators and long distances to vaccination centres\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p11_2.png",
          "height": 48.72,
          "width": 414.72,
          "x": 96.72,
          "y": 435.57,
          "original_width": 1728,
          "original_height": 203,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p11_6.jpg",
          "height": 36.494,
          "width": 30.554,
          "x": 120.94,
          "y": 110.838,
          "original_width": 128,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_7.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 252.619,
          "y": 110.733,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_8.jpg",
          "height": 32.251,
          "width": 36.494,
          "x": 104.848,
          "y": 354.606,
          "original_width": 153,
          "original_height": 135,
          "rotation": 0
        },
        {
          "name": "img_p11_9.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 180.55,
          "y": 352.485,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_10.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 123.774,
          "y": 357.666,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_11.jpg",
          "height": 29.138,
          "width": 17.539,
          "x": 123.774,
          "y": 357.666,
          "original_width": 74,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p11_9.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 180.55,
          "y": 352.485,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_13.jpg",
          "height": 31.26,
          "width": 17.54,
          "x": 199.475,
          "y": 357.666,
          "original_width": 74,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_14.jpg",
          "height": 36.494,
          "width": 36.495,
          "x": 161.624,
          "y": 357.666,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_15.jpg",
          "height": 31.26,
          "width": 17.54,
          "x": 180.579,
          "y": 357.666,
          "original_width": 74,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_16.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 218.401,
          "y": 352.485,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_17.png",
          "height": 31.261,
          "width": 17.539,
          "x": 218.401,
          "y": 357.718,
          "original_width": 74,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_9.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 180.55,
          "y": 352.485,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_19.jpg",
          "height": 31.261,
          "width": 17.54,
          "x": 142.699,
          "y": 357.718,
          "original_width": 74,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_20.jpg",
          "height": 31.261,
          "width": 17.54,
          "x": 161.653,
          "y": 357.718,
          "original_width": 74,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_6.jpg",
          "height": 36.494,
          "width": 30.554,
          "x": 120.94,
          "y": 110.838,
          "original_width": 128,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_22.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 183.068,
          "y": 181.556,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_23.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 125.755,
          "y": 186.62,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_24.jpg",
          "height": 31.402,
          "width": 14.853,
          "x": 125.755,
          "y": 186.62,
          "original_width": 62,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_25.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 201.423,
          "y": 186.62,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_26.jpg",
          "height": 31.402,
          "width": 18.106,
          "x": 201.423,
          "y": 186.62,
          "original_width": 76,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_7.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 252.619,
          "y": 110.733,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_28.jpg",
          "height": 31.402,
          "width": 17.115,
          "x": 183.093,
          "y": 186.62,
          "original_width": 72,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p11_22.jpg",
          "height": 36.494,
          "width": 36.494,
          "x": 183.068,
          "y": 181.556,
          "original_width": 153,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "img_p11_30.jpg",
          "height": 31.402,
          "width": 17.823,
          "x": 144.36,
          "y": 186.648,
          "original_width": 75,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "page_12.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "It is only true for diseases where there is a person to person transmission. Herd immunity makes it difficult for disease-causing organism to spread through cycle of infection, multiplication and circulation among the vulnerable population.",
          "md": "It is only true for diseases where there is a person to person transmission. Herd immunity makes it difficult for disease-causing organism to spread through cycle of infection, multiplication and circulation among the vulnerable population.",
          "bBox": {
            "x": 100.5,
            "y": 55.42,
            "w": 410.7,
            "h": 268.52
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "not immunized but still healthy",
              "not immunized, sick, and contagious",
              "immunized and healthy"
            ],
            [
              "🟣",
              "🔴",
              "🟢"
            ],
            [
              "🟣 🟣 🟣 🔴 🟣 🟣",
              "No one is immunized → Contagious disease spreads through the population → 🔴 🔴 🔴 🟣 🔴 🔴 🔴",
              ""
            ],
            [
              "🟣 🟢 🔴 🔴 🟣 🔴 🟢",
              "Some of the population gets immunized → Contagious disease spreads through some of the population → 🔴 🔴 🔴 🟣 🔴 🟢",
              ""
            ],
            [
              "🟢 🟢 🔴 🟢 🟢 🟢 🟣",
              "Most of the population gets immunized → Spread of contagious disease is contained → 🟢 🟢 🔴 🟢 🟢 🟢 🟣",
              ""
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>not immunized but still healthy</th>\n<th>not immunized, sick, and contagious</th>\n<th>immunized and healthy</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>🟣</td>\n<td>🔴</td>\n<td>🟢</td>\n</tr>\n<tr>\n<td>🟣 🟣 🟣 🔴 🟣 🟣</td>\n<td colspan=\"2\">No one is immunized → Contagious disease spreads through the population → 🔴 🔴 🔴 🟣 🔴 🔴 🔴</td>\n</tr>\n<tr>\n<td>🟣 🟢 🔴 🔴 🟣 🔴 🟢</td>\n<td colspan=\"2\">Some of the population gets immunized → Contagious disease spreads through some of the population → 🔴 🔴 🔴 🟣 🔴 🟢</td>\n</tr>\n<tr>\n<td>🟢 🟢 🔴 🟢 🟢 🟢 🟣</td>\n<td colspan=\"2\">Most of the population gets immunized → Spread of contagious disease is contained → 🟢 🟢 🔴 🟢 🟢 🟢 🟣</td>\n</tr>\n</tbody>\n</table>",
          "md": "| not immunized but still healthy | not immunized, sick, and contagious                                                                                   | immunized and healthy |\n| ------------------------------- | --------------------------------------------------------------------------------------------------------------------- | --------------------- |\n| 🟣                              | 🔴                                                                                                                    | 🟢                    |\n| 🟣 🟣 🟣 🔴 🟣 🟣               | No one is immunized → Contagious disease spreads through the population → 🔴 🔴 🔴 🟣 🔴 🔴 🔴                        |                       |\n| 🟣 🟢 🔴 🔴 🟣 🔴 🟢            | Some of the population gets immunized → Contagious disease spreads through some of the population → 🔴 🔴 🔴 🟣 🔴 🟢 |                       |\n| 🟢 🟢 🔴 🟢 🟢 🟢 🟣            | Most of the population gets immunized → Spread of contagious disease is contained → 🟢 🟢 🔴 🟢 🟢 🟢 🟣              |                       |",
          "isPerfectTable": true,
          "csv": "\"not immunized but still healthy\",\"not immunized, sick, and contagious\",\"immunized and healthy\"\n\"🟣\",\"🔴\",\"🟢\"\n\"🟣 🟣 🟣 🔴 🟣 🟣\",\"No one is immunized → Contagious disease spreads through the population → 🔴 🔴 🔴 🟣 🔴 🔴 🔴\",\"\"\n\"🟣 🟢 🔴 🔴 🟣 🔴 🟢\",\"Some of the population gets immunized → Contagious disease spreads through some of the population → 🔴 🔴 🔴 🟣 🔴 🟢\",\"\"\n\"🟢 🟢 🔴 🟢 🟢 🟢 🟣\",\"Most of the population gets immunized → Spread of contagious disease is contained → 🟢 🟢 🔴 🟢 🟢 🟢 🟣\",\"\"",
          "bBox": {
            "x": 58.46,
            "y": 55.42,
            "w": 452.76,
            "h": 773.29
          }
        },
        {
          "type": "text",
          "value": "Figure 2: Depiction of herd immunity",
          "md": "Figure 2: Depiction of herd immunity",
          "bBox": {
            "x": 236.15,
            "y": 402.53,
            "w": 137.95,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "**Q 13. What is the reason that some children suffer from vaccine preventable disease though they have been vaccinated against that disease?**",
          "md": "**Q 13. What is the reason that some children suffer from vaccine preventable disease though they have been vaccinated against that disease?**",
          "bBox": {
            "x": 58.46,
            "y": 436.63,
            "w": 452.76,
            "h": 44.4
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Vaccines have been used for decades and have proven to be effective. Like any other medicine, no vaccine is 100% efficacious. The immunity produced by vaccines varies from child to child. There may be children who do not develop sufficient protective immunity against a disease-causing pathogen due to malnutrition, repeated episodes of diarrhoea leading to diminished immunity or individual specific immune response to a vaccine.",
          "md": "**Ans.** Vaccines have been used for decades and have proven to be effective. Like any other medicine, no vaccine is 100% efficacious. The immunity produced by vaccines varies from child to child. There may be children who do not develop sufficient protective immunity against a disease-causing pathogen due to malnutrition, repeated episodes of diarrhoea leading to diminished immunity or individual specific immune response to a vaccine.",
          "bBox": {
            "x": 58.6,
            "y": 490.87,
            "w": 452.63,
            "h": 217.32
          }
        },
        {
          "type": "text",
          "value": "Because of these reasons, some children suffer from vaccine-preventable disease despite receiving vaccination against it. However, in such cases the disease is of less severity than in children who have never been vaccinated.",
          "md": "Because of these reasons, some children suffer from vaccine-preventable disease despite receiving vaccination against it. However, in such cases the disease is of less severity than in children who have never been vaccinated.",
          "bBox": {
            "x": 100.7,
            "y": 586.85,
            "w": 410.52,
            "h": 40.99
          }
        },
        {
          "type": "text",
          "value": "**14. What are vaccine hesitancy and vaccine confidence?**",
          "md": "**14. What are vaccine hesitancy and vaccine confidence?**",
          "bBox": {
            "x": 102.47,
            "y": 662.16,
            "w": 347.36,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "**Ans.**  \n**Vaccine hesitancy** is the behaviour of parents, caregivers, or the community, who hesitate to get their children vaccinated in spite of immunization services being available and accessible. Inadequate immunization services due to non-availability of vaccines, absenteeism of vaccinators and long distances to vaccination centres",
          "md": "**Ans.**  \n**Vaccine hesitancy** is the behaviour of parents, caregivers, or the community, who hesitate to get their children vaccinated in spite of immunization services being available and accessible. Inadequate immunization services due to non-availability of vaccines, absenteeism of vaccinators and long distances to vaccination centres",
          "bBox": {
            "x": 58.46,
            "y": 436.63,
            "w": 452.74,
            "h": 315.05
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.996
    },
    {
      "page": 13,
      "text": "Q contribute to this hesitancy. Other reasons for vaccine hesitancy are low perception\nof the benefits of vaccines, loss of wages, social beliefs, fear of AEFIs, inadequate\nIPC skills of health workers, geographical barriers.\nVaccine confidence is when parents, caregivers or the community understand\nthe value of vaccination and voluntarily demand vaccination services as a right,\nwhether these vaccinations are part of the RI schedule for their children or part of\nadult vaccinations such as TT for pregnant women. Vaccine confidence comes from\nadequate awareness about the benefits of vaccines, both to the individual and to\nthe community, and the trust in the immunization service delivery system to be able\nto provide quality vaccination.⁵\n\n\n15.           Why have certain vaccines been introduced in some states\n              only?\nAns.     Vaccines are introduced in National Immunization Schedule for diseases that lead\n         to high mortality and morbidity among children. Certain vaccines are introduced in\n         selected states due to the following reasons;\n          à  Whenever new vaccines are introduced in UIP, then initially, they are rolled out\n             in some states (phased-wise introduction) and gradually expanded across all\n             states and districts of the country. For example, Rotavirus Vaccine and PCV.\n          à  Secondly, diseases, like Japanese Encephalitis, are endemic in certain districts\n             and states only (i.e. restricted to a certain place due to environmental\n             conditions). For such diseases, vaccines are introduced only in those areas\n             which are affected by them.\n          à  There are initiatives by the state government to introduce additional vaccines\n             in their routine immunization, which are not part of the National Immunization\n             Schedule.\n\n\n\n\n\n\n\n\n\n\n5Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n\n6 IFAQs on Immunization",
      "md": "\ncontribute to this hesitancy. Other reasons for vaccine hesitancy are low perception of the benefits of vaccines, loss of wages, social beliefs, fear of AEFIs, inadequate IPC skills of health workers, geographical barriers.\n\n**Vaccine confidence** is when parents, caregivers or the community understand the value of vaccination and voluntarily demand vaccination services as a right, whether these vaccinations are part of the RI schedule for their children or part of adult vaccinations such as TT for pregnant women. Vaccine confidence comes from adequate awareness about the benefits of vaccines, both to the individual and to the community, and the trust in the immunization service delivery system to be able to provide quality vaccination.⁵\n\n----\n\n### 15. Why have certain vaccines been introduced in some states only?\n\n**Ans.** Vaccines are introduced in National Immunization Schedule for diseases that lead to high mortality and morbidity among children. Certain vaccines are introduced in selected states due to the following reasons;\n\n* Whenever new vaccines are introduced in UIP, then initially, they are rolled out in some states (phased-wise introduction) and gradually expanded across all states and districts of the country. For example, Rotavirus Vaccine and PCV.\n* Secondly, diseases, like Japanese Encephalitis, are endemic in certain districts and states only (i.e. restricted to a certain place due to environmental conditions). For such diseases, vaccines are introduced only in those areas which are affected by them.\n* There are initiatives by the state government to introduce additional vaccines in their routine immunization, which are not part of the National Immunization Schedule.\n\n----\n\n⁵ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n",
      "images": [
        {
          "name": "img_p12_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p12_2.png",
          "height": 37.44,
          "width": 414.96,
          "x": 122.16,
          "y": 234.45,
          "original_width": 1729,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_13.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "contribute to this hesitancy. Other reasons for vaccine hesitancy are low perception of the benefits of vaccines, loss of wages, social beliefs, fear of AEFIs, inadequate IPC skills of health workers, geographical barriers.",
          "md": "contribute to this hesitancy. Other reasons for vaccine hesitancy are low perception of the benefits of vaccines, loss of wages, social beliefs, fear of AEFIs, inadequate IPC skills of health workers, geographical barriers.",
          "bBox": {
            "x": 128.4,
            "y": 69.92,
            "w": 408.39,
            "h": 26.5
          }
        },
        {
          "type": "text",
          "value": "**Vaccine confidence** is when parents, caregivers or the community understand the value of vaccination and voluntarily demand vaccination services as a right, whether these vaccinations are part of the RI schedule for their children or part of adult vaccinations such as TT for pregnant women. Vaccine confidence comes from adequate awareness about the benefits of vaccines, both to the individual and to the community, and the trust in the immunization service delivery system to be able to provide quality vaccination.⁵",
          "md": "**Vaccine confidence** is when parents, caregivers or the community understand the value of vaccination and voluntarily demand vaccination services as a right, whether these vaccinations are part of the RI schedule for their children or part of adult vaccinations such as TT for pregnant women. Vaccine confidence comes from adequate awareness about the benefits of vaccines, both to the individual and to the community, and the trust in the immunization service delivery system to be able to provide quality vaccination.⁵",
          "bBox": {
            "x": 128.4,
            "y": 122.41,
            "w": 408.39,
            "h": 84.48
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "15. Why have certain vaccines been introduced in some states only?",
          "md": "### 15. Why have certain vaccines been introduced in some states only?",
          "bBox": {
            "x": 125.03,
            "y": 236.81,
            "w": 411.74,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Vaccines are introduced in National Immunization Schedule for diseases that lead to high mortality and morbidity among children. Certain vaccines are introduced in selected states due to the following reasons;",
          "md": "**Ans.** Vaccines are introduced in National Immunization Schedule for diseases that lead to high mortality and morbidity among children. Certain vaccines are introduced in selected states due to the following reasons;",
          "bBox": {
            "x": 86.4,
            "y": 275.59,
            "w": 450.39,
            "h": 40.99
          }
        },
        {
          "type": "text",
          "value": "* Whenever new vaccines are introduced in UIP, then initially, they are rolled out in some states (phased-wise introduction) and gradually expanded across all states and districts of the country. For example, Rotavirus Vaccine and PCV.\n* Secondly, diseases, like Japanese Encephalitis, are endemic in certain districts and states only (i.e. restricted to a certain place due to environmental conditions). For such diseases, vaccines are introduced only in those areas which are affected by them.\n* There are initiatives by the state government to introduce additional vaccines in their routine immunization, which are not part of the National Immunization Schedule.",
          "md": "* Whenever new vaccines are introduced in UIP, then initially, they are rolled out in some states (phased-wise introduction) and gradually expanded across all states and districts of the country. For example, Rotavirus Vaccine and PCV.\n* Secondly, diseases, like Japanese Encephalitis, are endemic in certain districts and states only (i.e. restricted to a certain place due to environmental conditions). For such diseases, vaccines are introduced only in those areas which are affected by them.\n* There are initiatives by the state government to introduce additional vaccines in their routine immunization, which are not part of the National Immunization Schedule.",
          "bBox": {
            "x": 152.4,
            "y": 326.15,
            "w": 384.38,
            "h": 150.28
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "⁵ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "md": "⁵ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.993
    },
    {
      "page": 14,
      "text": "SECTION: 2\nUniversal Immunization Programme\n(UIP) and National Immunization\nSchedule (NIS)\n\n\n\n\n\n\n      16. What is the National Immunization Schedule under Universal\n         Immunization Programme?\nAns.  National Immunization Schedule is a vaccination plan that all children and pregnant\nQ women should follow and complete to ensure protection against ᵛᵃᶜᶜⁱⁿᵉ⁻ᵖʳᵉᵛᵉⁿᵗᵃᵇˡᵉ\nQ diseases.\n      This schedule includes:\n      à  Name of vaccine\n      à  Recommended age/s of administration\n      à  Total doses required\n      à  Route and site of administration\n      à  Volumes of doses\n\n\n         17. Which vaccines are currently given to a child in India’s Universal\n          Immunization       Programme and against which diseases                   these\n          vaccines prevent?\nAns.     Under India’s Universal Immunization Programme 12 different vaccines are provided to\n         beneficiaries free of cost, through government health system. These are – BCG, OPV,\n         Hepatitis B, Pentavalent, Rotavirus, PCV, IPV, Measles/MR, JE, DPT, and TT.\n         Out of these, Rotavirus Vaccine, PCV and MR are being introduced in a phased-wise\n         manner across different states. JE vaccine is given only in the districts where Japanese\n         Encephalitis is endemic. The vaccines administered in UIP and the diseases prevented by\n         them are as follows;\n\n\n\nFAQs on ImmunizationI 7",
      "md": "\n# SECTION: 2  \n# Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)\n\n----\n\n### 16. What is the National Immunization Schedule under Universal Immunization Programme?  \n**Ans.** National Immunization Schedule is a vaccination plan that all children and pregnant women should follow and complete to ensure protection against vaccine-preventable diseases.\n\nThis schedule includes:  \n* Name of vaccine  \n* Recommended age/s of administration  \n* Total doses required  \n* Route and site of administration  \n* Volumes of doses  \n\n----\n\n### 17. Which vaccines are currently given to a child in India’s Universal Immunization Programme and against which diseases these vaccines prevent?  \n**Ans.** Under India’s Universal Immunization Programme 12 different vaccines are provided to beneficiaries free of cost, through government health system. These are – **BCG, OPV, Hepatitis B, Pentavalent, Rotavirus, PCV, IPV, Measles/MR, JE, DPT, and TT.**\n\nOut of these, Rotavirus Vaccine, PCV and MR are being introduced in a phased-wise manner across different states. JE vaccine is given only in the districts where Japanese Encephalitis is endemic. The vaccines administered in UIP and the diseases prevented by them are as follows;\n\n",
      "images": [
        {
          "name": "img_p7_1.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p7_3.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p7_4.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p7_5.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p7_6.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p7_7.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p7_8.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_9.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_10.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p7_11.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p7_14.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 436.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p13_13.png",
          "height": 45.6,
          "width": 440.4,
          "x": 96.72,
          "y": 605.73,
          "original_width": 1835,
          "original_height": 190,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_20.jpg",
          "height": 152.962,
          "width": 228.837,
          "x": 106.814,
          "y": -33.697,
          "original_width": 916,
          "original_height": 555,
          "rotation": 0
        },
        {
          "name": "img_p7_21.jpg",
          "height": 76.858,
          "width": 114.69,
          "x": -0.519,
          "y": -11.135,
          "original_width": 459,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_22.png",
          "height": 91.891,
          "width": 257.723,
          "x": 324.887,
          "y": -27.6,
          "original_width": 1068,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_23.jpg",
          "height": 40.459,
          "width": 75.56,
          "x": 42.018,
          "y": 53.923,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p7_24.jpg",
          "height": 202.986,
          "width": 92.642,
          "x": 510.457,
          "y": 37.457,
          "original_width": 307,
          "original_height": 832,
          "rotation": 0
        },
        {
          "name": "img_p13_21.png",
          "height": 109.269,
          "width": 118.097,
          "x": 331.725,
          "y": 52.491,
          "original_width": 459,
          "original_height": 417,
          "rotation": 0
        },
        {
          "name": "img_p13_22.jpg",
          "height": 44.447,
          "width": 111.284,
          "x": 227.798,
          "y": 96.183,
          "original_width": 459,
          "original_height": 141,
          "rotation": 0
        },
        {
          "name": "img_p13_23.png",
          "height": 36.708,
          "width": 39.86,
          "x": 302.629,
          "y": 128.829,
          "original_width": 155,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p13_24.png",
          "height": 73.081,
          "width": 78.756,
          "x": 449.303,
          "y": 142.455,
          "original_width": 306,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_29.jpg",
          "height": 40.46,
          "width": 75.56,
          "x": 377.669,
          "y": 149.959,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p13_26.jpg",
          "height": 36.682,
          "width": 39.625,
          "x": 491.84,
          "y": 207.513,
          "original_width": 154,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p13_27.jpg",
          "height": 112.176,
          "width": 106.035,
          "x": 430.99,
          "y": 44.618,
          "original_width": 449,
          "original_height": 475,
          "rotation": 0
        },
        {
          "name": "page_14.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 2",
          "md": "# SECTION: 2  ",
          "bBox": {
            "x": 58.5,
            "y": 197.33,
            "w": 105.8,
            "h": 20
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)",
          "md": "# Universal Immunization Programme (UIP) and National Immunization Schedule (NIS)",
          "bBox": {
            "x": 58.5,
            "y": 224.53,
            "w": 408.17,
            "h": 409.09
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "16. What is the National Immunization Schedule under Universal Immunization Programme?",
          "md": "### 16. What is the National Immunization Schedule under Universal Immunization Programme?  ",
          "bBox": {
            "x": 58.5,
            "y": 224.53,
            "w": 478.3,
            "h": 409.09
          }
        },
        {
          "type": "text",
          "value": "**Ans.** National Immunization Schedule is a vaccination plan that all children and pregnant women should follow and complete to ensure protection against vaccine-preventable diseases.",
          "md": "**Ans.** National Immunization Schedule is a vaccination plan that all children and pregnant women should follow and complete to ensure protection against vaccine-preventable diseases.",
          "bBox": {
            "x": 58.5,
            "y": 418.32,
            "w": 478.27,
            "h": 246.14
          }
        },
        {
          "type": "text",
          "value": "This schedule includes:  \n* Name of vaccine  \n* Recommended age/s of administration  \n* Total doses required  \n* Route and site of administration  \n* Volumes of doses",
          "md": "This schedule includes:  \n* Name of vaccine  \n* Recommended age/s of administration  \n* Total doses required  \n* Route and site of administration  \n* Volumes of doses",
          "bBox": {
            "x": 100.5,
            "y": 470.81,
            "w": 235.15,
            "h": 162.82
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "17. Which vaccines are currently given to a child in India’s Universal Immunization Programme and against which diseases these vaccines prevent?",
          "md": "### 17. Which vaccines are currently given to a child in India’s Universal Immunization Programme and against which diseases these vaccines prevent?  ",
          "bBox": {
            "x": 58.5,
            "y": 224.53,
            "w": 478.3,
            "h": 424.09
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Under India’s Universal Immunization Programme 12 different vaccines are provided to beneficiaries free of cost, through government health system. These are – **BCG, OPV, Hepatitis B, Pentavalent, Rotavirus, PCV, IPV, Measles/MR, JE, DPT, and TT.**",
          "md": "**Ans.** Under India’s Universal Immunization Programme 12 different vaccines are provided to beneficiaries free of cost, through government health system. These are – **BCG, OPV, Hepatitis B, Pentavalent, Rotavirus, PCV, IPV, Measles/MR, JE, DPT, and TT.**",
          "bBox": {
            "x": 58.5,
            "y": 224.53,
            "w": 478.29,
            "h": 468.92
          }
        },
        {
          "type": "text",
          "value": "Out of these, Rotavirus Vaccine, PCV and MR are being introduced in a phased-wise manner across different states. JE vaccine is given only in the districts where Japanese Encephalitis is endemic. The vaccines administered in UIP and the diseases prevented by them are as follows;",
          "md": "Out of these, Rotavirus Vaccine, PCV and MR are being introduced in a phased-wise manner across different states. JE vaccine is given only in the districts where Japanese Encephalitis is endemic. The vaccines administered in UIP and the diseases prevented by them are as follows;",
          "bBox": {
            "x": 100.5,
            "y": 619.63,
            "w": 436.29,
            "h": 140.81
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.983
    },
    {
      "page": 15,
      "text": "Vaccine  Disease Prevented\n\n\nBCG    Childhood Tuberculosis (or Primary Complex)\n\n\nOPV    Poliomyelitis\n\n\nHepatitis B\nHepatitis B    Hepatitis B (affecting liver)\n\n\nPenta     Diphtheria (Gal Ghotu), Pertussis (Whooping Cough, Kaali Khansi/ Kukkar Khansi), Tetanus\n          (Dhanustambh), Hib infection (causing pneumonia and meningitis), and Hepatitis B\n\nRVV*      Rotavirus diarrhoea\n\n\nIPV    Poliomyelitis\n\n\nMeasles  Measles (Khasra or Govar)\nMeasles\n\n\nMR*    Measles and Rubella\n\n\nJE*    Japanese Encephalitis or Acute Encephalitis Syndrome (AES)\n       or Brain Fever (Dimagi Bukhar)\n\nDPT    Diphtheria, Pertussis, and Tetanus\n\n\nQ TT         Tetanus (in new-born and pregnant women)\n             PCV*    Pneumococcal Pneumonia\n\n                     Table 2: Vaccines and disease prevented    *Wherever applicable\n\n         18. What is the meaning of a fully immunized child?\n\nAns.     A fully immunized child is one who has received all vaccines recommended in the\n         National Immunization Schedule in required doses, before completing one year of\n         age.\n\n         For the purpose of monitoring and evaluating the programme, a child below 1 year\n         of age who has received one dose of BCG, Measles/MR along with 3 doses of OPV,\n         Pentavalent Vaccine and two doses of IPV is said to be fully immunized. However, for\n\n\n\n\n\n8 IFAQs on Immunization",
      "md": "\n\n<table>\n  <thead>\n    <tr>\n      <th>Vaccine</th>\n      <th>Disease Prevented</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>BCG</td>\n<td>Childhood Tuberculosis (or Primary Complex)</td>\n    </tr>\n<tr>\n      <td>OPV</td>\n<td>Poliomyelitis</td>\n    </tr>\n<tr>\n      <td>Hepatitis B</td>\n<td>Hepatitis B (affecting liver)</td>\n    </tr>\n<tr>\n      <td>Penta</td>\n<td>\n        Diphtheria (<i>Gal Ghotu</i>), Pertussis (Whooping Cough, <i>Kaali Khansi/ Kukkar Khansi</i>), Tetanus (<i>Dhanustambh</i>), Hib infection (causing pneumonia and meningitis), and Hepatitis B\n      </td>\n    </tr>\n<tr>\n      <td>RVV*</td>\n<td>Rotavirus diarrhoea</td>\n    </tr>\n<tr>\n      <td>IPV</td>\n<td>Poliomyelitis</td>\n    </tr>\n<tr>\n      <td>Measles</td>\n<td>Measles (<i>Khasra or Govar</i>)</td>\n    </tr>\n<tr>\n      <td>MR*</td>\n<td>Measles and Rubella</td>\n    </tr>\n<tr>\n      <td>JE*</td>\n<td>Japanese Encephalitis or Acute Encephalitis Syndrome (AES) or Brain Fever (<i>Dimagi Bukhar</i>)</td>\n    </tr>\n<tr>\n      <td>DPT</td>\n<td>Diphtheria, Pertussis, and Tetanus</td>\n    </tr>\n<tr>\n      <td>TT</td>\n<td>Tetanus (in new-born and pregnant women)</td>\n    </tr>\n<tr>\n      <td>PCV*</td>\n<td>Pneumococcal Pneumonia</td>\n    </tr>\n  </tbody>\n</table>\n\n<p><i>*Wherever applicable</i></p>\n\n<h2>18. What is the meaning of a fully immunized child?</h2>\n\n<p><b>Ans.</b> A fully immunized child is one who has received all vaccines recommended in the National Immunization Schedule in required doses, before completing one year of age.</p>\n\n<p>For the purpose of monitoring and evaluating the programme, a child below 1 year of age who has received one dose of BCG, Measles/MR along with 3 doses of OPV, Pentavalent Vaccine and two doses of IPV is said to be fully immunized. However, for</p>\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p14_4.png",
          "height": 42.72,
          "width": 86.64,
          "x": 466.347,
          "y": 55.369,
          "original_width": 361,
          "original_height": 178,
          "rotation": 0
        },
        {
          "name": "img_p14_7.jpg",
          "height": 12.479,
          "width": 310.32,
          "x": 231.136,
          "y": 84.501,
          "original_width": 1293,
          "original_height": 52,
          "rotation": 0
        },
        {
          "name": "img_p14_9.jpg",
          "height": 29.52,
          "width": 312,
          "x": 231.136,
          "y": 55.46,
          "original_width": 1300,
          "original_height": 123,
          "rotation": 0
        },
        {
          "name": "img_p14_11.png",
          "height": 29.76,
          "width": 12,
          "x": 316.924,
          "y": 142.533,
          "original_width": 50,
          "original_height": 124,
          "rotation": 0
        },
        {
          "name": "img_p14_14.png",
          "height": 6.48,
          "width": 86.16,
          "x": 231.313,
          "y": 165.665,
          "original_width": 359,
          "original_height": 27,
          "rotation": 0
        },
        {
          "name": "img_p14_15.jpg",
          "height": 23.76,
          "width": 11.28,
          "x": 306.913,
          "y": 142.385,
          "original_width": 47,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p14_16.png",
          "height": 42.72,
          "width": 207.6,
          "x": 344.271,
          "y": 217.698,
          "original_width": 865,
          "original_height": 178,
          "rotation": 0
        },
        {
          "name": "img_p14_19.jpg",
          "height": 12.72,
          "width": 308.88,
          "x": 231.419,
          "y": 246.589,
          "original_width": 1287,
          "original_height": 53,
          "rotation": 0
        },
        {
          "name": "img_p14_22.jpg",
          "height": 29.28,
          "width": 144.48,
          "x": 395.819,
          "y": 217.789,
          "original_width": 602,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p14_23.jpg",
          "height": 26.4,
          "width": 15.6,
          "x": 526.139,
          "y": 220.669,
          "original_width": 65,
          "original_height": 110,
          "rotation": 0
        },
        {
          "name": "img_p14_25.png",
          "height": 28.32,
          "width": 12.24,
          "x": 327.147,
          "y": 304.862,
          "original_width": 51,
          "original_height": 118,
          "rotation": 0
        },
        {
          "name": "img_p14_29.jpg",
          "height": 23.76,
          "width": 11.28,
          "x": 317.416,
          "y": 304.714,
          "original_width": 47,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p14_30.png",
          "height": 36.72,
          "width": 12.24,
          "x": 386.187,
          "y": 380.027,
          "original_width": 51,
          "original_height": 153,
          "rotation": 0
        },
        {
          "name": "page_15.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "table",
          "rows": [
            [
              "Vaccine",
              "Disease Prevented"
            ],
            [
              "BCG",
              "Childhood Tuberculosis (or Primary Complex)"
            ],
            [
              "OPV",
              "Poliomyelitis"
            ],
            [
              "Hepatitis B",
              "Hepatitis B (affecting liver)"
            ],
            [
              "Penta",
              "Diphtheria (), Pertussis (Whooping Cough, ), Tetanus (), Hib infection (causing pneumonia and meningitis), and Hepatitis B"
            ],
            [
              "RVV*",
              "Rotavirus diarrhoea"
            ],
            [
              "IPV",
              "Poliomyelitis"
            ],
            [
              "Measles",
              "Measles ()"
            ],
            [
              "MR*",
              "Measles and Rubella"
            ],
            [
              "JE*",
              "Japanese Encephalitis or Acute Encephalitis Syndrome (AES) or Brain Fever ()"
            ],
            [
              "DPT",
              "Diphtheria, Pertussis, and Tetanus"
            ],
            [
              "TT",
              "Tetanus (in new-born and pregnant women)"
            ],
            [
              "PCV*",
              "Pneumococcal Pneumonia"
            ]
          ],
          "html": "<table>\n  <thead>\n    <tr>\n      <th>Vaccine</th>\n      <th>Disease Prevented</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>BCG</td>\n<td>Childhood Tuberculosis (or Primary Complex)</td>\n    </tr>\n<tr>\n      <td>OPV</td>\n<td>Poliomyelitis</td>\n    </tr>\n<tr>\n      <td>Hepatitis B</td>\n<td>Hepatitis B (affecting liver)</td>\n    </tr>\n<tr>\n      <td>Penta</td>\n<td>\n        Diphtheria (<i>Gal Ghotu</i>), Pertussis (Whooping Cough, <i>Kaali Khansi/ Kukkar Khansi</i>), Tetanus (<i>Dhanustambh</i>), Hib infection (causing pneumonia and meningitis), and Hepatitis B\n      </td>\n    </tr>\n<tr>\n      <td>RVV*</td>\n<td>Rotavirus diarrhoea</td>\n    </tr>\n<tr>\n      <td>IPV</td>\n<td>Poliomyelitis</td>\n    </tr>\n<tr>\n      <td>Measles</td>\n<td>Measles (<i>Khasra or Govar</i>)</td>\n    </tr>\n<tr>\n      <td>MR*</td>\n<td>Measles and Rubella</td>\n    </tr>\n<tr>\n      <td>JE*</td>\n<td>Japanese Encephalitis or Acute Encephalitis Syndrome (AES) or Brain Fever (<i>Dimagi Bukhar</i>)</td>\n    </tr>\n<tr>\n      <td>DPT</td>\n<td>Diphtheria, Pertussis, and Tetanus</td>\n    </tr>\n<tr>\n      <td>TT</td>\n<td>Tetanus (in new-born and pregnant women)</td>\n    </tr>\n<tr>\n      <td>PCV*</td>\n<td>Pneumococcal Pneumonia</td>\n    </tr>\n  </tbody>\n</table>",
          "md": "| Vaccine     | Disease Prevented                                                                                                                                                               |\n| ----------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| BCG         | Childhood Tuberculosis (or Primary Complex)                                                                                                                                     |\n| OPV         | Poliomyelitis                                                                                                                                                                   |\n| Hepatitis B | Hepatitis B (affecting liver)                                                                                                                                                   |\n| Penta       | Diphtheria (*Gal Ghotu*), Pertussis (Whooping Cough, *Kaali Khansi/ Kukkar Khansi*), Tetanus (*Dhanustambh*), Hib infection (causing pneumonia and meningitis), and Hepatitis B |\n| RVV\\*       | Rotavirus diarrhoea                                                                                                                                                             |\n| IPV         | Poliomyelitis                                                                                                                                                                   |\n| Measles     | Measles (*Khasra or Govar*)                                                                                                                                                     |\n| MR\\*        | Measles and Rubella                                                                                                                                                             |\n| JE\\*        | Japanese Encephalitis or Acute Encephalitis Syndrome (AES) or Brain Fever (*Dimagi Bukhar*)                                                                                     |\n| DPT         | Diphtheria, Pertussis, and Tetanus                                                                                                                                              |\n| TT          | Tetanus (in new-born and pregnant women)                                                                                                                                        |\n| PCV\\*       | Pneumococcal Pneumonia                                                                                                                                                          |",
          "isPerfectTable": true,
          "csv": "\"Vaccine\",\"Disease Prevented\"\n\"BCG\",\"Childhood Tuberculosis (or Primary Complex)\"\n\"OPV\",\"Poliomyelitis\"\n\"Hepatitis B\",\"Hepatitis B (affecting liver)\"\n\"Penta\",\"Diphtheria (), Pertussis (Whooping Cough, ), Tetanus (), Hib infection (causing pneumonia and meningitis), and Hepatitis B\"\n\"RVV*\",\"Rotavirus diarrhoea\"\n\"IPV\",\"Poliomyelitis\"\n\"Measles\",\"Measles ()\"\n\"MR*\",\"Measles and Rubella\"\n\"JE*\",\"Japanese Encephalitis or Acute Encephalitis Syndrome (AES) or Brain Fever ()\"\n\"DPT\",\"Diphtheria, Pertussis, and Tetanus\"\n\"TT\",\"Tetanus (in new-born and pregnant women)\"\n\"PCV*\",\"Pneumococcal Pneumonia\"",
          "bBox": {
            "x": 86.36,
            "y": 65.19,
            "w": 450.41,
            "h": 681.18
          }
        },
        {
          "type": "text",
          "value": "<p><i>*Wherever applicable</i></p>",
          "md": "<p><i>*Wherever applicable</i></p>",
          "bBox": {
            "x": 447.51,
            "y": 576.07,
            "w": 89.82,
            "h": 10
          }
        },
        {
          "type": "text",
          "value": "<h2>18. What is the meaning of a fully immunized child?</h2>",
          "md": "<h2>18. What is the meaning of a fully immunized child?</h2>",
          "bBox": {
            "x": 130.38,
            "y": 616.26,
            "w": 323.41,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "<p><b>Ans.</b> A fully immunized child is one who has received all vaccines recommended in the National Immunization Schedule in required doses, before completing one year of age.</p>",
          "md": "<p><b>Ans.</b> A fully immunized child is one who has received all vaccines recommended in the National Immunization Schedule in required doses, before completing one year of age.</p>",
          "bBox": {
            "x": 86.4,
            "y": 65.19,
            "w": 450.38,
            "h": 628.7
          }
        },
        {
          "type": "text",
          "value": "<p>For the purpose of monitoring and evaluating the programme, a child below 1 year of age who has received one dose of BCG, Measles/MR along with 3 doses of OPV, Pentavalent Vaccine and two doses of IPV is said to be fully immunized. However, for</p>",
          "md": "<p>For the purpose of monitoring and evaluating the programme, a child below 1 year of age who has received one dose of BCG, Measles/MR along with 3 doses of OPV, Pentavalent Vaccine and two doses of IPV is said to be fully immunized. However, for</p>",
          "bBox": {
            "x": 128.4,
            "y": 65.19,
            "w": 408.38,
            "h": 681.18
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.988
    },
    {
      "page": 16,
      "text": "Q the purpose of the programme and to ensure that the child is completely protected,\n         all other vaccines applicable to a child below one year of age should be provided\n         as per the immunization schedule, like PCV (3 doses), RVV (3 doses), JE (1 dose),\n         wherever applicable.\n\n          19. What is the meaning of a completely immunized child?\n\nAns.     A child who has received all vaccines recommended for the first and second year in\n         the National Immunization Schedule is said to be completely immunized.\n          à  First year: One dose of BCG, Measles/MR* and JE vaccines*, 3 doses of OPV,\n             Pentavalent vaccine, Rotavirus vaccine* and PCV*, and 2 doses of IPV\n          à  Second year: Second dose of Measles/ MR* and JE vaccines*, and one booster\n             dose of OPV and DPT    *Wherever applicable\n\n\n          20. What are left outs and drop outs?\n\nAns.     From a service delivery perspective:\n          à  Left outs are those children who have never been vaccinated or reached (thus\n             remaining unimmunized);\n          à  Drop outs are those children who started vaccination but did not complete the\n             schedule (thus remaining partially immunized).\n\nQ From behavioural perspective, a large percentage of dropouts is a serious problem\nQ\nQ because it reflects the poor perception of the parents/caregivers about the ᵇᵉⁿᵉᶠⁱᵗˢ\n         of vaccination or of the immunization service delivery system, or both, combined\n         with other barriers that forces them to place immunization on a low priority.⁶\n\n          21. Which vaccines have been introduced in recent years?\n\nAns.     Vaccines introduced in Universal Immunization Programme during last few years are\n         JE (2006), Hepatitis B (2007), Pentavalent (2011), IPV (2015) and Rotavirus Vaccine\n         (2016). Pneumococcal Conjugate Vaccine (PCV) and Measles-Rubella (MR) are the\n         latest additions rolled out under UIP (2017).\n\n              If a child is brought late for a subsequent dose of multi-dose\n          22. vaccines (for example, after more than the recommended one\n              month), should the health worker restart the series from the\n              first dose?\nAns.     No.There is no need to restart the series or schedule again in case a child has received\n         some doses of scheduled vaccines but is brought late for the subsequent doses. If\n         the child is brought late, you should give the next dose of the vaccine and motivate\n         the parents to bring the child for the remaining doses at the recommended interval\n         as per the immunization schedule.\n\n6Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n\n                                                           FAQs on ImmunizationI 9",
      "md": "\nthe purpose of the programme and to ensure that the child is completely protected, all other vaccines applicable to a child below one year of age should be provided as per the immunization schedule, like PCV (3 doses), RVV (3 doses), JE (1 dose), wherever applicable.\n\n**19. What is the meaning of a completely immunized child?**\n\nAns.  \nA child who has received all vaccines recommended for the first and second year in the National Immunization Schedule is said to be completely immunized.  \n* First year: One dose of BCG, Measles/MR* and JE vaccines*, 3 doses of OPV, Pentavalent vaccine, Rotavirus vaccine* and PCV*, and 2 doses of IPV  \n* Second year: Second dose of Measles/ MR* and JE vaccines*, and one booster dose of OPV and DPT  \n*Wherever applicable\n\n**20. What are left outs and drop outs?**\n\nAns.  \nFrom a service delivery perspective:  \n* **Left outs** are those children who have never been vaccinated or reached (thus remaining unimmunized);  \n* **Drop outs** are those children who started vaccination but did not complete the schedule (thus remaining partially immunized).\n\nFrom behavioural perspective, a large percentage of dropouts is a serious problem because it reflects the poor perception of the parents/caregivers about the benefits of vaccination or of the immunization service delivery system, or both, combined with other barriers that forces them to place immunization on a low priority.⁶\n\n**21. Which vaccines have been introduced in recent years?**\n\nAns.  \nVaccines introduced in Universal Immunization Programme during last few years are JE (2006), Hepatitis B (2007), Pentavalent (2011), IPV (2015) and Rotavirus Vaccine (2016). Pneumococcal Conjugate Vaccine (PCV) and Measles-Rubella (MR) are the latest additions rolled out under UIP (2017).\n\n> **22. If a child is brought late for a subsequent dose of multi-dose vaccines (for example, after more than the recommended one month), should the health worker restart the series from the first dose?**\n\nAns.  \nNo. There is no need to restart the series or schedule again in case a child has received some doses of scheduled vaccines but is brought late for the subsequent doses. If the child is brought late, you should give the next dose of the vaccine and motivate the parents to bring the child for the remaining doses at the recommended interval as per the immunization schedule.\n\n----\n\n⁶ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p15_5.png",
          "height": 65.52,
          "width": 414.72,
          "x": 96.72,
          "y": 620.85,
          "original_width": 1728,
          "original_height": 273,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_16.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "the purpose of the programme and to ensure that the child is completely protected, all other vaccines applicable to a child below one year of age should be provided as per the immunization schedule, like PCV (3 doses), RVV (3 doses), JE (1 dose), wherever applicable.",
          "md": "the purpose of the programme and to ensure that the child is completely protected, all other vaccines applicable to a child below one year of age should be provided as per the immunization schedule, like PCV (3 doses), RVV (3 doses), JE (1 dose), wherever applicable.",
          "bBox": {
            "x": 100.5,
            "y": 69.92,
            "w": 410.71,
            "h": 40.99
          }
        },
        {
          "type": "text",
          "value": "**19. What is the meaning of a completely immunized child?**",
          "md": "**19. What is the meaning of a completely immunized child?**",
          "bBox": {
            "x": 102.48,
            "y": 137.8,
            "w": 364.41,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "Ans.  \nA child who has received all vaccines recommended for the first and second year in the National Immunization Schedule is said to be completely immunized.  \n* First year: One dose of BCG, Measles/MR* and JE vaccines*, 3 doses of OPV, Pentavalent vaccine, Rotavirus vaccine* and PCV*, and 2 doses of IPV  \n* Second year: Second dose of Measles/ MR* and JE vaccines*, and one booster dose of OPV and DPT  \n*Wherever applicable",
          "md": "Ans.  \nA child who has received all vaccines recommended for the first and second year in the National Immunization Schedule is said to be completely immunized.  \n* First year: One dose of BCG, Measles/MR* and JE vaccines*, 3 doses of OPV, Pentavalent vaccine, Rotavirus vaccine* and PCV*, and 2 doses of IPV  \n* Second year: Second dose of Measles/ MR* and JE vaccines*, and one booster dose of OPV and DPT  \n*Wherever applicable",
          "bBox": {
            "x": 58.5,
            "y": 174.43,
            "w": 452.72,
            "h": 528.71
          }
        },
        {
          "type": "text",
          "value": "**20. What are left outs and drop outs?**",
          "md": "**20. What are left outs and drop outs?**",
          "bBox": {
            "x": 102.48,
            "y": 302.08,
            "w": 236.31,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "Ans.  \nFrom a service delivery perspective:  \n* **Left outs** are those children who have never been vaccinated or reached (thus remaining unimmunized);  \n* **Drop outs** are those children who started vaccination but did not complete the schedule (thus remaining partially immunized).",
          "md": "Ans.  \nFrom a service delivery perspective:  \n* **Left outs** are those children who have never been vaccinated or reached (thus remaining unimmunized);  \n* **Drop outs** are those children who started vaccination but did not complete the schedule (thus remaining partially immunized).",
          "bBox": {
            "x": 58.5,
            "y": 174.43,
            "w": 298.02,
            "h": 528.71
          }
        },
        {
          "type": "text",
          "value": "From behavioural perspective, a large percentage of dropouts is a serious problem because it reflects the poor perception of the parents/caregivers about the benefits of vaccination or of the immunization service delivery system, or both, combined with other barriers that forces them to place immunization on a low priority.⁶",
          "md": "From behavioural perspective, a large percentage of dropouts is a serious problem because it reflects the poor perception of the parents/caregivers about the benefits of vaccination or of the immunization service delivery system, or both, combined with other barriers that forces them to place immunization on a low priority.⁶",
          "bBox": {
            "x": 100.5,
            "y": 457.47,
            "w": 410.71,
            "h": 26.5
          }
        },
        {
          "type": "text",
          "value": "**21. Which vaccines have been introduced in recent years?**",
          "md": "**21. Which vaccines have been introduced in recent years?**",
          "bBox": {
            "x": 102.48,
            "y": 509.42,
            "w": 357.71,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "Ans.  \nVaccines introduced in Universal Immunization Programme during last few years are JE (2006), Hepatitis B (2007), Pentavalent (2011), IPV (2015) and Rotavirus Vaccine (2016). Pneumococcal Conjugate Vaccine (PCV) and Measles-Rubella (MR) are the latest additions rolled out under UIP (2017).",
          "md": "Ans.  \nVaccines introduced in Universal Immunization Programme during last few years are JE (2006), Hepatitis B (2007), Pentavalent (2011), IPV (2015) and Rotavirus Vaccine (2016). Pneumococcal Conjugate Vaccine (PCV) and Measles-Rubella (MR) are the latest additions rolled out under UIP (2017).",
          "bBox": {
            "x": 58.5,
            "y": 174.43,
            "w": 452.71,
            "h": 528.71
          }
        },
        {
          "type": "text",
          "value": "> **22. If a child is brought late for a subsequent dose of multi-dose vaccines (for example, after more than the recommended one month), should the health worker restart the series from the first dose?**",
          "md": "> **22. If a child is brought late for a subsequent dose of multi-dose vaccines (for example, after more than the recommended one month), should the health worker restart the series from the first dose?**",
          "bBox": {
            "x": 58.46,
            "y": 436.63,
            "w": 452.76,
            "h": 244.66
          }
        },
        {
          "type": "text",
          "value": "Ans.  \nNo. There is no need to restart the series or schedule again in case a child has received some doses of scheduled vaccines but is brought late for the subsequent doses. If the child is brought late, you should give the next dose of the vaccine and motivate the parents to bring the child for the remaining doses at the recommended interval as per the immunization schedule.",
          "md": "Ans.  \nNo. There is no need to restart the series or schedule again in case a child has received some doses of scheduled vaccines but is brought late for the subsequent doses. If the child is brought late, you should give the next dose of the vaccine and motivate the parents to bring the child for the remaining doses at the recommended interval as per the immunization schedule.",
          "bBox": {
            "x": 58.46,
            "y": 174.43,
            "w": 452.75,
            "h": 586.7
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "⁶ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "md": "⁶ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers, 2016",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.992
    },
    {
      "page": 17,
      "text": "Q 23. What are the upper age limits for various vaccines?\nAns.     According to National Immunization Schedule some vaccines have an upper age\n         limit for administration and these vaccines should not be administered once that\n         age limit is crossed.\n         The vaccines should be given till the following ages as per UIP guidelines:\n          à  BCG: up to one year of age\n          à  OPV: up to five years (OPV zero dose till 15 days of birth)\n          à  Measles/MR: up to five years (in MR campaigns, vaccine is given to 9 months to\n             15 years age group)\n          à  DPT: up to 7 years\n          à  JE: up to 15 years\n         Only the above-mentioned vaccines have upper age limits. Efforts should be made\n         to ensure that all vaccines are given at the recommended ages, or closer to it.\n         For pentavalent, IPV, PCV and Rotavirus vaccines, if at least one dose is given before\n         one year of age, then remaining doses can be administered and schedule must be\n         completed irrespective of the age of child. If the first dose is not administered before\n         one year of age, then these vaccines cannot be administered to the child under UIP.\n\n\n         24. Why are some vaccines not administered after a reaching a\n         certain age?\nAns.     Age of administration for different vaccines has been recommended in National\n         Immunization Schedule taking into consideration maximum benefit in terms of\n         immunity generation, reduction in disease incidence, and mortality and morbidity.\n         The schedule has been designed to ensure protection against vaccine preventable\n\nQ diseases to children at ages when they are most vulnerable.\nQ After attaining a certain age, children acquire natural immunity to some infections\n         (like childhood tuberculosis), or cross vulnerable age period when a vaccine-\n         preventable disease can be life threatening.\n\n\n         25. Why are booster doses required after receiving initial doses of\n         some vaccines?\nAns.     Immunity or protective effect generated by some vaccines gradually diminishes\n         over time and increases vulnerability to target infections. For such vaccines,\n         booster doses are administered after receiving initial doses as it boosts immunity\n         and enhances protection level against specific vaccine-preventable disease. For\n         example: DPT, OPV and PCV.\n\n\n\n\n\n\n\n\n10 IFAQs on Immunization",
      "md": "\n## 23. What are the upper age limits for various vaccines?\n\n**Ans.** According to National Immunization Schedule some vaccines have an upper age limit for administration and these vaccines should not be administered once that age limit is crossed.\n\nThe vaccines should be given till the following ages as per UIP guidelines:  \n* BCG: up to one year of age  \n* OPV: up to five years (OPV zero dose till 15 days of birth)  \n* Measles/MR: up to five years (in MR campaigns, vaccine is given to 9 months to 15 years age group)  \n* DPT: up to 7 years  \n* JE: up to 15 years  \n\nOnly the above-mentioned vaccines have upper age limits. Efforts should be made to ensure that all vaccines are given at the recommended ages, or closer to it.\n\nFor pentavalent, IPV, PCV and Rotavirus vaccines, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child. If the first dose is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.\n\n----\n\n## 24. Why are some vaccines not administered after a reaching a certain age?\n\n**Ans.** Age of administration for different vaccines has been recommended in National Immunization Schedule taking into consideration maximum benefit in terms of immunity generation, reduction in disease incidence, and mortality and morbidity. The schedule has been designed to ensure protection against vaccine preventable diseases to children at ages when they are most vulnerable.\n\nAfter attaining a certain age, children acquire natural immunity to some infections (like childhood tuberculosis), or cross vulnerable age period when a vaccine-preventable disease can be life threatening.\n\n----\n\n## 25. Why are booster doses required after receiving initial doses of some vaccines?\n\n**Ans.** Immunity or protective effect generated by some vaccines gradually diminishes over time and increases vulnerability to target infections. For such vaccines, booster doses are administered after receiving initial doses as it boosts immunity and enhances protection level against specific vaccine-preventable disease. For example: DPT, OPV and PCV.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p16_3.png",
          "height": 37.68,
          "width": 412.56,
          "x": 124.56,
          "y": 407.97,
          "original_width": 1719,
          "original_height": 157,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_17.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 2,
          "value": "23. What are the upper age limits for various vaccines?",
          "md": "## 23. What are the upper age limits for various vaccines?",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Ans.** According to National Immunization Schedule some vaccines have an upper age limit for administration and these vaccines should not be administered once that age limit is crossed.",
          "md": "**Ans.** According to National Immunization Schedule some vaccines have an upper age limit for administration and these vaccines should not be administered once that age limit is crossed.",
          "bBox": {
            "x": 86.4,
            "y": 97.88,
            "w": 450.39,
            "h": 551.81
          }
        },
        {
          "type": "text",
          "value": "The vaccines should be given till the following ages as per UIP guidelines:  \n* BCG: up to one year of age  \n* OPV: up to five years (OPV zero dose till 15 days of birth)  \n* Measles/MR: up to five years (in MR campaigns, vaccine is given to 9 months to 15 years age group)  \n* DPT: up to 7 years  \n* JE: up to 15 years",
          "md": "The vaccines should be given till the following ages as per UIP guidelines:  \n* BCG: up to one year of age  \n* OPV: up to five years (OPV zero dose till 15 days of birth)  \n* Measles/MR: up to five years (in MR campaigns, vaccine is given to 9 months to 15 years age group)  \n* DPT: up to 7 years  \n* JE: up to 15 years",
          "bBox": {
            "x": 128.4,
            "y": 150.37,
            "w": 408.37,
            "h": 128.06
          }
        },
        {
          "type": "text",
          "value": "Only the above-mentioned vaccines have upper age limits. Efforts should be made to ensure that all vaccines are given at the recommended ages, or closer to it.",
          "md": "Only the above-mentioned vaccines have upper age limits. Efforts should be made to ensure that all vaccines are given at the recommended ages, or closer to it.",
          "bBox": {
            "x": 128.4,
            "y": 288.49,
            "w": 408.39,
            "h": 26.5
          }
        },
        {
          "type": "text",
          "value": "For pentavalent, IPV, PCV and Rotavirus vaccines, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child. If the first dose is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "md": "For pentavalent, IPV, PCV and Rotavirus vaccines, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child. If the first dose is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "bBox": {
            "x": 128.4,
            "y": 326.48,
            "w": 408.39,
            "h": 55.49
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "24. Why are some vaccines not administered after a reaching a certain age?",
          "md": "## 24. Why are some vaccines not administered after a reaching a certain age?",
          "bBox": {
            "x": 130.38,
            "y": 410.52,
            "w": 406.42,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Age of administration for different vaccines has been recommended in National Immunization Schedule taking into consideration maximum benefit in terms of immunity generation, reduction in disease incidence, and mortality and morbidity. The schedule has been designed to ensure protection against vaccine preventable diseases to children at ages when they are most vulnerable.",
          "md": "**Ans.** Age of administration for different vaccines has been recommended in National Immunization Schedule taking into consideration maximum benefit in terms of immunity generation, reduction in disease incidence, and mortality and morbidity. The schedule has been designed to ensure protection against vaccine preventable diseases to children at ages when they are most vulnerable.",
          "bBox": {
            "x": 86.4,
            "y": 97.88,
            "w": 450.38,
            "h": 551.81
          }
        },
        {
          "type": "text",
          "value": "After attaining a certain age, children acquire natural immunity to some infections (like childhood tuberculosis), or cross vulnerable age period when a vaccine-preventable disease can be life threatening.",
          "md": "After attaining a certain age, children acquire natural immunity to some infections (like childhood tuberculosis), or cross vulnerable age period when a vaccine-preventable disease can be life threatening.",
          "bBox": {
            "x": 128.4,
            "y": 544.48,
            "w": 408.38,
            "h": 26.5
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "25. Why are booster doses required after receiving initial doses of some vaccines?",
          "md": "## 25. Why are booster doses required after receiving initial doses of some vaccines?",
          "bBox": {
            "x": 130.38,
            "y": 599.1,
            "w": 406.41,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Immunity or protective effect generated by some vaccines gradually diminishes over time and increases vulnerability to target infections. For such vaccines, booster doses are administered after receiving initial doses as it boosts immunity and enhances protection level against specific vaccine-preventable disease. For example: DPT, OPV and PCV.",
          "md": "**Ans.** Immunity or protective effect generated by some vaccines gradually diminishes over time and increases vulnerability to target infections. For such vaccines, booster doses are administered after receiving initial doses as it boosts immunity and enhances protection level against specific vaccine-preventable disease. For example: DPT, OPV and PCV.",
          "bBox": {
            "x": 86.4,
            "y": 97.88,
            "w": 450.4,
            "h": 609.79
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.994
    },
    {
      "page": 18,
      "text": "Q 26. If a child has ˢᵘᶠᶠered from a vaccine-preventable disease in the\n         past, will s/he still require vaccination against that disease?\nAns.     Yes. Most vaccine-preventable diseases (for example, Diphtheria,Tetanus, Rotavirus\n         diarrhoea, Hib pneumonia and JE) after an episode of full-blown infection and disease\n         do not confer long-term immunity. Therefore, in these cases a child will still require\n         all recommended doses of the vaccine as per the national immunization schedule.\n         Some vaccine-preventable diseases are caused by different strains of same\n         pathogenic organism. In these cases, infection by one strain does not confer immunity\n         against other strains and will require vaccination to ensure full protection. Example:\n         Bivalent OPV as currently given in UIP provides protection against poliovirus types\n         1 and 3. Therefore, administration of this vaccine will still be required for a child who\n         got infected by the type 1 poliovirus in past, as s/he is vulnerable for infection from\n         type 3 poliovirus.\n\n\n\n\n\n\n\n\n\n\nFAQs on ImmunizationI 11",
      "md": "\n**26. If a child has suffered from a vaccine-preventable disease in the past, will s/he still require vaccination against that disease?**\n\n**Ans.** Yes. Most vaccine-preventable diseases (for example, Diphtheria, Tetanus, Rotavirus diarrhoea, Hib pneumonia and JE) after an episode of full-blown infection and disease do not confer long-term immunity. Therefore, in these cases a child will still require all recommended doses of the vaccine as per the national immunization schedule.\n\nSome vaccine-preventable diseases are caused by different strains of same pathogenic organism. In these cases, infection by one strain does not confer immunity against other strains and will require vaccination to ensure full protection. Example: Bivalent OPV as currently given in UIP provides protection against poliovirus types 1 and 3. Therefore, administration of this vaccine will still be required for a child who got infected by the type 1 poliovirus in past, as s/he is vulnerable for infection from type 3 poliovirus.\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p17_2.png",
          "height": 37.44,
          "width": 414.24,
          "x": 97.2,
          "y": 58.05,
          "original_width": 1726,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_18.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**26. If a child has suffered from a vaccine-preventable disease in the past, will s/he still require vaccination against that disease?**",
          "md": "**26. If a child has suffered from a vaccine-preventable disease in the past, will s/he still require vaccination against that disease?**",
          "bBox": {
            "x": 138.44,
            "y": 75.56,
            "w": 354.82,
            "h": 14
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Yes. Most vaccine-preventable diseases (for example, Diphtheria, Tetanus, Rotavirus diarrhoea, Hib pneumonia and JE) after an episode of full-blown infection and disease do not confer long-term immunity. Therefore, in these cases a child will still require all recommended doses of the vaccine as per the national immunization schedule.",
          "md": "**Ans.** Yes. Most vaccine-preventable diseases (for example, Diphtheria, Tetanus, Rotavirus diarrhoea, Hib pneumonia and JE) after an episode of full-blown infection and disease do not confer long-term immunity. Therefore, in these cases a child will still require all recommended doses of the vaccine as per the national immunization schedule.",
          "bBox": {
            "x": 58.5,
            "y": 98.6,
            "w": 452.71,
            "h": 55.49
          }
        },
        {
          "type": "text",
          "value": "Some vaccine-preventable diseases are caused by different strains of same pathogenic organism. In these cases, infection by one strain does not confer immunity against other strains and will require vaccination to ensure full protection. Example: Bivalent OPV as currently given in UIP provides protection against poliovirus types 1 and 3. Therefore, administration of this vaccine will still be required for a child who got infected by the type 1 poliovirus in past, as s/he is vulnerable for infection from type 3 poliovirus.",
          "md": "Some vaccine-preventable diseases are caused by different strains of same pathogenic organism. In these cases, infection by one strain does not confer immunity against other strains and will require vaccination to ensure full protection. Example: Bivalent OPV as currently given in UIP provides protection against poliovirus types 1 and 3. Therefore, administration of this vaccine will still be required for a child who got infected by the type 1 poliovirus in past, as s/he is vulnerable for infection from type 3 poliovirus.",
          "bBox": {
            "x": 100.5,
            "y": 165.58,
            "w": 410.71,
            "h": 98.98
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.981
    },
    {
      "page": 19,
      "text": "12 IFAQs on Immunization",
      "md": "12 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_3.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 420.69,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_4.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 420.69,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_7.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": -0.27,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_4.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 420.69,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_19.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "12 IFAQs on Immunization",
          "md": "12 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 135.46,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 20,
      "text": "SECTION: 3\nVaccination of Pregnant Women\n\n\n\n\n\n\n\n         27. What vaccines are recommended for pregnant women in National\n         Immunization Schedule?\nAns.     In National Immunization Schedule, two doses of Tetanus Toxoid (TT) vaccine are\n         recommended for all pregnant women. First dose is given as soon as the pregnancy is\n         confirmed, and the second dose 4 weeks after the first dose.\n         However, if any pregnant woman has not received TT vaccination during her pregnancy,\n         she should be given one dose of TT at the time of labour.\n\n         28. Why do pregnant women require vaccination against Tetanus?\n\nAns.     Tetanus, also known as Lockjaw, is a life-threatening disease causing seizures and severe\n         muscle spasms, often leading to death by respiratory failure. In new-borns, disease\n         present as tightly closed mouth due to spasm of jaw muscles. As a result, they cannot\n         take feeds, and in the majority of cases die.\n         Tetanus Toxoid (TT) vaccine is given to all pregnant women to protect them and their new-\n         born babies from Tetanus. Due to sustained efforts over years, India has been successful\n         in eliminating Maternal and Neonatal Tetanus, and to sustain this status administration of\n         TT vaccine to all pregnant women need to be ensured.\n\n         29. Is it safe to give TT doses in all pregnancies?\n\nAns.     Yes. Recommended doses of TT vaccine should be given to a woman every time she gets\n         pregnant. Repeat doses only enhance immunity and do not cause any harm to the woman\n         or her child.\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  13\n                 13",
      "md": "\n# SECTION: 3  \n# Vaccination of Pregnant Women\n\n**27. What vaccines are recommended for pregnant women in National Immunization Schedule?**  \n**Ans.** In National Immunization Schedule, two doses of **Tetanus Toxoid (TT)** vaccine are recommended for all pregnant women. First dose is given as soon as the pregnancy is confirmed, and the second dose 4 weeks after the first dose.  \n\nHowever, if any pregnant woman has not received TT vaccination during her pregnancy, she should be given one dose of TT at the time of labour.\n\n**28. Why do pregnant women require vaccination against Tetanus?**  \n**Ans.** Tetanus, also known as Lockjaw, is a life-threatening disease causing seizures and severe muscle spasms, often leading to death by respiratory failure. In new-borns, disease presents as tightly closed mouth due to spasm of jaw muscles. As a result, they cannot take feeds, and in the majority of cases die.  \n\nTetanus Toxoid (TT) vaccine is given to all pregnant women to protect them and their new-born babies from Tetanus. Due to sustained efforts over years, India has been successful in eliminating Maternal and Neonatal Tetanus, and to sustain this status administration of TT vaccine to all pregnant women need to be ensured.\n\n**29. Is it safe to give TT doses in all pregnancies?**  \n**Ans.** **Yes.** Recommended doses of TT vaccine should be given to a woman every time she gets pregnant. Repeat doses only enhance immunity and do not cause any harm to the woman or her child.\n",
      "images": [
        {
          "name": "img_p19_1.png",
          "height": 140.88,
          "width": 420.72,
          "x": -0.24,
          "y": 701.25,
          "original_width": 1753,
          "original_height": 587,
          "rotation": 0
        },
        {
          "name": "img_p19_2.png",
          "height": 140.88,
          "width": 175.92,
          "x": 419.76,
          "y": 701.25,
          "original_width": 733,
          "original_height": 587,
          "rotation": 0
        },
        {
          "name": "img_p19_3.png",
          "height": 351.6,
          "width": 105.6,
          "x": -0.24,
          "y": 350.37,
          "original_width": 440,
          "original_height": 1465,
          "rotation": 0
        },
        {
          "name": "img_p19_4.png",
          "height": 421.68,
          "width": 70.8,
          "x": 524.88,
          "y": 280.29,
          "original_width": 295,
          "original_height": 1757,
          "rotation": 0
        },
        {
          "name": "img_p19_5.png",
          "height": 246.24,
          "width": 246,
          "x": 104.64,
          "y": 420.69,
          "original_width": 1025,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_6.png",
          "height": 316.56,
          "width": 175.68,
          "x": 349.92,
          "y": 350.37,
          "original_width": 732,
          "original_height": 1319,
          "rotation": 0
        },
        {
          "name": "img_p19_7.png",
          "height": 71.04,
          "width": 246,
          "x": 104.64,
          "y": 350.37,
          "original_width": 1025,
          "original_height": 296,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_9.png",
          "height": 35.76,
          "width": 280.8,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1170,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_12.png",
          "height": 175.92,
          "width": 35.76,
          "x": 559.92,
          "y": -0.27,
          "original_width": 149,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p19_13.jpg",
          "height": 367.842,
          "width": 74.431,
          "x": -0.519,
          "y": -3.606,
          "original_width": 154,
          "original_height": 1550,
          "rotation": 0
        },
        {
          "name": "img_p19_14.jpg",
          "height": 334.751,
          "width": 71.186,
          "x": 38.661,
          "y": 25.733,
          "original_width": 155,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p19_15.jpg",
          "height": 309.374,
          "width": 139.129,
          "x": 78.051,
          "y": 47.333,
          "original_width": 459,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p19_16.jpg",
          "height": 272.481,
          "width": 99.714,
          "x": 188.865,
          "y": 72.945,
          "original_width": 306,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_19.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p19_20.jpg",
          "height": 169.64,
          "width": 53.832,
          "x": 413.714,
          "y": 153.248,
          "original_width": 155,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p19_21.jpg",
          "height": 140.253,
          "width": 85.816,
          "x": 453.129,
          "y": 178.859,
          "original_width": 306,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_23.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_29.png",
          "height": 37.44,
          "width": 439.92,
          "x": 97.2,
          "y": 339.57,
          "original_width": 1833,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p19_30.png",
          "height": 35.425,
          "width": 169.1,
          "x": 95.498,
          "y": 322.306,
          "original_width": 712,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "page_20.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 3",
          "md": "# SECTION: 3  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "Vaccination of Pregnant Women",
          "md": "# Vaccination of Pregnant Women",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**27. What vaccines are recommended for pregnant women in National Immunization Schedule?**  \n**Ans.** In National Immunization Schedule, two doses of **Tetanus Toxoid (TT)** vaccine are recommended for all pregnant women. First dose is given as soon as the pregnancy is confirmed, and the second dose 4 weeks after the first dose.",
          "md": "**27. What vaccines are recommended for pregnant women in National Immunization Schedule?**  \n**Ans.** In National Immunization Schedule, two doses of **Tetanus Toxoid (TT)** vaccine are recommended for all pregnant women. First dose is given as soon as the pregnancy is confirmed, and the second dose 4 weeks after the first dose.",
          "bBox": {
            "x": 58.5,
            "y": 342.01,
            "w": 478.31,
            "h": 486.7
          }
        },
        {
          "type": "text",
          "value": "However, if any pregnant woman has not received TT vaccination during her pregnancy, she should be given one dose of TT at the time of labour.",
          "md": "However, if any pregnant woman has not received TT vaccination during her pregnancy, she should be given one dose of TT at the time of labour.",
          "bBox": {
            "x": 100.5,
            "y": 432.58,
            "w": 436.28,
            "h": 396.14
          }
        },
        {
          "type": "text",
          "value": "**28. Why do pregnant women require vaccination against Tetanus?**  \n**Ans.** Tetanus, also known as Lockjaw, is a life-threatening disease causing seizures and severe muscle spasms, often leading to death by respiratory failure. In new-borns, disease presents as tightly closed mouth due to spasm of jaw muscles. As a result, they cannot take feeds, and in the majority of cases die.",
          "md": "**28. Why do pregnant women require vaccination against Tetanus?**  \n**Ans.** Tetanus, also known as Lockjaw, is a life-threatening disease causing seizures and severe muscle spasms, often leading to death by respiratory failure. In new-borns, disease presents as tightly closed mouth due to spasm of jaw muscles. As a result, they cannot take feeds, and in the majority of cases die.",
          "bBox": {
            "x": 58.5,
            "y": 380.09,
            "w": 478.29,
            "h": 448.62
          }
        },
        {
          "type": "text",
          "value": "Tetanus Toxoid (TT) vaccine is given to all pregnant women to protect them and their new-born babies from Tetanus. Due to sustained efforts over years, India has been successful in eliminating Maternal and Neonatal Tetanus, and to sustain this status administration of TT vaccine to all pregnant women need to be ensured.",
          "md": "Tetanus Toxoid (TT) vaccine is given to all pregnant women to protect them and their new-born babies from Tetanus. Due to sustained efforts over years, India has been successful in eliminating Maternal and Neonatal Tetanus, and to sustain this status administration of TT vaccine to all pregnant women need to be ensured.",
          "bBox": {
            "x": 100.5,
            "y": 587.74,
            "w": 436.28,
            "h": 240.98
          }
        },
        {
          "type": "text",
          "value": "**29. Is it safe to give TT doses in all pregnancies?**  \n**Ans.** **Yes.** Recommended doses of TT vaccine should be given to a woman every time she gets pregnant. Repeat doses only enhance immunity and do not cause any harm to the woman or her child.",
          "md": "**29. Is it safe to give TT doses in all pregnancies?**  \n**Ans.** **Yes.** Recommended doses of TT vaccine should be given to a woman every time she gets pregnant. Repeat doses only enhance immunity and do not cause any harm to the woman or her child.",
          "bBox": {
            "x": 58.5,
            "y": 380.09,
            "w": 478.27,
            "h": 448.62
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.988
    },
    {
      "page": 21,
      "text": "14 IFAQs on Immunization",
      "md": "14 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p12_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_21.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "14 IFAQs on Immunization",
          "md": "14 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 133.13,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 22,
      "text": "SECTION: 4\nNew-born Vaccination\n\n\n\n\n\n\n\n          30. What vaccines should be given to a new-born?\n\nAns.     According to National Immunization Schedule, one dose each of three vaccines, OPV,\n         BCG and Hepatitis B, should be given to new-borns irrespective of the place of delivery.\n         This is recommended for all institutional and non-institutional deliveries, in both public\n         and private sectors.\nQ\nQ 31. Is there any time limit for these vaccines recommended for new-\n             borns?\nAns.     Yes. Time limit for vaccines recommended for new-borns is as follows:\n          à  Hepatitis B (known as “birth dose”): should be given within 24 hours of birth to\n             protect the new-born from possible Hepatitis B infection that gets transferred from\n             mother during delivery. If birth dose of Hepatitis B vaccine is given beyond 24 hours,\n             then it will not provide this protection. However, maximum protection against\n             Hepatitis B transmission is provided if the vaccine is given within 12 hours of birth.⁷\n          à  OPV (known as “zero dose”): should be given within 15 days of birth, day of birth\n             taken as day zero.\n          à  BCG: should be given as early as possible after birth to provide maximum protection\n             from childhood tuberculosis infection. BCG vaccine should not be given to the child\n             beyond one year of age.\n\n          32. Why is the dose of polio vaccine that is given within 15 days of birth\n             called the “zero dose”?\nAns.     The dose of OPV given at birth is called the “zero dose” because:\n          à  It is an “extra” dose that adds to the protection of the individual and the community\n          à  It is given before the scheduled three primary doses\n\n7Mortality and Morbidity Weekly Report, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of\nInfants, Children, and Adolescents, December 23, 2005/54 (RR16); 1-23\n\n                                                                     FAQs on ImmunizationI 15",
      "md": "\n# SECTION: 4  \n# New-born Vaccination\n\n**30. What vaccines should be given to a new-born?**  \n**Ans.** According to National Immunization Schedule, one dose each of three vaccines, **OPV, BCG and Hepatitis B**, should be given to new-borns irrespective of the place of delivery. This is recommended for all institutional and non-institutional deliveries, in both public and private sectors.\n\n**31. Is there any time limit for these vaccines recommended for new-borns?**  \n**Ans.** **Yes.** Time limit for vaccines recommended for new-borns is as follows:  \n* Hepatitis B (known as “birth dose”): should be given within 24 hours of birth to protect the new-born from possible Hepatitis B infection that gets transferred from mother during delivery. If birth dose of Hepatitis B vaccine is given beyond 24 hours, then it will not provide this protection. However, maximum protection against Hepatitis B transmission is provided if the vaccine is given within 12 hours of birth.⁷  \n* OPV (known as “zero dose”): should be given within 15 days of birth, day of birth taken as day zero.  \n* BCG: should be given as early as possible after birth to provide maximum protection from childhood tuberculosis infection. BCG vaccine should not be given to the child beyond one year of age.\n\n**32. Why is the dose of polio vaccine that is given within 15 days of birth called the “zero dose”?**  \n**Ans.** The dose of OPV given at birth is called the “zero dose” because:  \n* It is an “extra” dose that adds to the protection of the individual and the community  \n* It is given before the scheduled three primary doses\n\n> ⁷Mortality and Morbidity Weekly Report, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents, December 23, 2005/54 (RR16); 1-23\n",
      "images": [
        {
          "name": "img_p7_1.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p7_3.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p7_4.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p7_5.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p7_6.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p7_7.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p7_8.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_9.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p7_10.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p7_11.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p7_20.jpg",
          "height": 152.962,
          "width": 228.837,
          "x": 106.814,
          "y": -33.697,
          "original_width": 916,
          "original_height": 555,
          "rotation": 0
        },
        {
          "name": "img_p7_21.jpg",
          "height": 76.858,
          "width": 114.69,
          "x": -0.519,
          "y": -11.135,
          "original_width": 459,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p21_14.png",
          "height": 59.479,
          "width": 254.317,
          "x": 324.887,
          "y": -27.6,
          "original_width": 1068,
          "original_height": 141,
          "rotation": 0
        },
        {
          "name": "img_p21_15.jpg",
          "height": 231.62,
          "width": 60.114,
          "x": 542.985,
          "y": 5.046,
          "original_width": 154,
          "original_height": 970,
          "rotation": 0
        },
        {
          "name": "img_p21_16.png",
          "height": 141.681,
          "width": 121.503,
          "x": 328.319,
          "y": 20.079,
          "original_width": 459,
          "original_height": 555,
          "rotation": 0
        },
        {
          "name": "img_p7_23.jpg",
          "height": 40.459,
          "width": 75.56,
          "x": 42.018,
          "y": 53.923,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p13_22.jpg",
          "height": 44.447,
          "width": 111.284,
          "x": 227.798,
          "y": 96.183,
          "original_width": 459,
          "original_height": 141,
          "rotation": 0
        },
        {
          "name": "img_p13_23.png",
          "height": 36.708,
          "width": 39.86,
          "x": 302.629,
          "y": 128.829,
          "original_width": 155,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p21_20.png",
          "height": 76.858,
          "width": 114.69,
          "x": 449.303,
          "y": 138.678,
          "original_width": 459,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "img_p7_29.jpg",
          "height": 40.46,
          "width": 75.56,
          "x": 377.669,
          "y": 149.959,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p21_22.jpg",
          "height": 40.459,
          "width": 75.56,
          "x": 491.84,
          "y": 203.736,
          "original_width": 307,
          "original_height": 140,
          "rotation": 0
        },
        {
          "name": "img_p7_14.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 436.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p21_24.png",
          "height": 46.283,
          "width": 221.572,
          "x": 94.461,
          "y": 311.498,
          "original_width": 933,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p7_14.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 436.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_14.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 436.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p21_27.jpg",
          "height": 13.341,
          "width": 34.069,
          "x": 58.464,
          "y": 357.963,
          "original_width": 142,
          "original_height": 56,
          "rotation": 0
        },
        {
          "name": "img_p21_28.jpg",
          "height": 27.112,
          "width": 34.069,
          "x": 58.464,
          "y": 334.509,
          "original_width": 142,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_22.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 4",
          "md": "# SECTION: 4  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 105.8,
            "h": 20
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "New-born Vaccination",
          "md": "# New-born Vaccination",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 252.55,
            "h": 24
          }
        },
        {
          "type": "text",
          "value": "**30. What vaccines should be given to a new-born?**  \n**Ans.** According to National Immunization Schedule, one dose each of three vaccines, **OPV, BCG and Hepatitis B**, should be given to new-borns irrespective of the place of delivery. This is recommended for all institutional and non-institutional deliveries, in both public and private sectors.",
          "md": "**30. What vaccines should be given to a new-born?**  \n**Ans.** According to National Immunization Schedule, one dose each of three vaccines, **OPV, BCG and Hepatitis B**, should be given to new-borns irrespective of the place of delivery. This is recommended for all institutional and non-institutional deliveries, in both public and private sectors.",
          "bBox": {
            "x": 58.5,
            "y": 340.31,
            "w": 478.28,
            "h": 378.34
          }
        },
        {
          "type": "text",
          "value": "**31. Is there any time limit for these vaccines recommended for new-borns?**  \n**Ans.** **Yes.** Time limit for vaccines recommended for new-borns is as follows:  \n* Hepatitis B (known as “birth dose”): should be given within 24 hours of birth to protect the new-born from possible Hepatitis B infection that gets transferred from mother during delivery. If birth dose of Hepatitis B vaccine is given beyond 24 hours, then it will not provide this protection. However, maximum protection against Hepatitis B transmission is provided if the vaccine is given within 12 hours of birth.⁷  \n* OPV (known as “zero dose”): should be given within 15 days of birth, day of birth taken as day zero.  \n* BCG: should be given as early as possible after birth to provide maximum protection from childhood tuberculosis infection. BCG vaccine should not be given to the child beyond one year of age.",
          "md": "**31. Is there any time limit for these vaccines recommended for new-borns?**  \n**Ans.** **Yes.** Time limit for vaccines recommended for new-borns is as follows:  \n* Hepatitis B (known as “birth dose”): should be given within 24 hours of birth to protect the new-born from possible Hepatitis B infection that gets transferred from mother during delivery. If birth dose of Hepatitis B vaccine is given beyond 24 hours, then it will not provide this protection. However, maximum protection against Hepatitis B transmission is provided if the vaccine is given within 12 hours of birth.⁷  \n* OPV (known as “zero dose”): should be given within 15 days of birth, day of birth taken as day zero.  \n* BCG: should be given as early as possible after birth to provide maximum protection from childhood tuberculosis infection. BCG vaccine should not be given to the child beyond one year of age.",
          "bBox": {
            "x": 58.5,
            "y": 372.85,
            "w": 478.29,
            "h": 345.8
          }
        },
        {
          "type": "text",
          "value": "**32. Why is the dose of polio vaccine that is given within 15 days of birth called the “zero dose”?**  \n**Ans.** The dose of OPV given at birth is called the “zero dose” because:  \n* It is an “extra” dose that adds to the protection of the individual and the community  \n* It is given before the scheduled three primary doses",
          "md": "**32. Why is the dose of polio vaccine that is given within 15 days of birth called the “zero dose”?**  \n**Ans.** The dose of OPV given at birth is called the “zero dose” because:  \n* It is an “extra” dose that adds to the protection of the individual and the community  \n* It is given before the scheduled three primary doses",
          "bBox": {
            "x": 58.5,
            "y": 372.85,
            "w": 478.3,
            "h": 387.49
          }
        },
        {
          "type": "text",
          "value": "> ⁷Mortality and Morbidity Weekly Report, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents, December 23, 2005/54 (RR16); 1-23",
          "md": "> ⁷Mortality and Morbidity Weekly Report, Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part 1: Immunization of Infants, Children, and Adolescents, December 23, 2005/54 (RR16); 1-23",
          "bBox": {
            "x": 58.5,
            "y": 788.13,
            "w": 230.1,
            "h": 8
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.99
    },
    {
      "page": 23,
      "text": "16 IFAQs on Immunization",
      "md": "16 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_23.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "16 IFAQs on Immunization",
          "md": "16 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 135.63,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 24,
      "text": "SECTION: 5\nSide Effects, Adverse Events,\nand Contraindications\n\n\n\n\n\n         33. What are the side effects of vaccination?\n\nAns.     All vaccines induce immunity by causing the recipient’s immune system to react to the\n         vaccine. Therefore, local reactions, fever and systemic symptoms can result as part of\n         the immune response. In addition, some of the vaccine’s components (e.g. aluminium\n         adjuvant, stabilizers or preservatives) can also lead to reactions.⁸\n\n\n         34. If fever does not come after giving injectable vaccine, does this\n          mean that vaccine has not been effective and needs to be re-\n          administered? Is it necessary to get a fever after vaccination?\nAns.     No.Though mild fever comes in majority of children who receive injectable vaccines, there\n         are few children in which the immune response elicited by vaccine does not cause rise in\n         body’s temperature. This is normal in some children, and there is no need to re-administer\n         vaccine if fever does not come after vaccination.\n\n         35. Why is there pain and swelling at the injection site? How it can be\n          managed?\nAns.     In case of injectable vaccines (like Hepatitis B, pentavalent and IPV), infants may have\n         redness, mild pain, and swelling at the injection site. This is mainly due to rupture of some\n         muscle fibres by the needle getting injected into the muscle tissue. In addition, some of\n         the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can lead\n         to local inflammatory reactions. These symptoms generally appear on the day after the\n         injection is given and last from 1 to 3 days.\n         Cold compresses can be used to control swelling and redness. You should recommend\n         Paracetamol (syrup or tablet, in divided doses) for providing symptomatic relief to child.\n\n8Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers 2016\n\n                                                                                                            I\n                                                          FAQs                                              I\n                                                          FAQs on\n                                                                                             on Immunization\n                                                                                                Immunization  17\n                                                                                                              17",
      "md": "\n# SECTION: 5  \n## Side Effects, Adverse Events, and Contraindications\n\n**33. What are the side effects of vaccination?**  \n**Ans.** All vaccines induce immunity by causing the recipient’s immune system to react to the vaccine. Therefore, local reactions, fever and systemic symptoms can result as part of the immune response. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can also lead to reactions.⁸\n\n**34. If fever does not come after giving injectable vaccine, does this mean that vaccine has not been effective and needs to be re-administered? Is it necessary to get a fever after vaccination?**  \n**Ans.** No. Though mild fever comes in majority of children who receive injectable vaccines, there are few children in which the immune response elicited by vaccine does not cause rise in body’s temperature. This is normal in some children, and there is no need to re-administer vaccine if fever does not come after vaccination.\n\n**35. Why is there pain and swelling at the injection site? How it can be managed?**  \n**Ans.** In case of injectable vaccines (like Hepatitis B, pentavalent and IPV), infants may have redness, mild pain, and swelling at the injection site. This is mainly due to rupture of some muscle fibres by the needle getting injected into the muscle tissue. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can lead to local inflammatory reactions. These symptoms generally appear on the day after the injection is given and last from 1 to 3 days.\n\nCold compresses can be used to control swelling and redness. You should recommend Paracetamol (syrup or tablet, in divided doses) for providing symptomatic relief to child.\n\n----\n\n⁸ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers 2016\n",
      "images": [
        {
          "name": "img_p23_1.png",
          "height": 246.24,
          "width": 245.76,
          "x": -0.24,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_4.png",
          "height": 246.24,
          "width": 245.76,
          "x": -0.24,
          "y": 350.37,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_5.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 350.37,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_7.png",
          "height": 35.76,
          "width": 245.76,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1024,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_18.jpg",
          "height": 136.5,
          "width": 50.117,
          "x": 560.462,
          "y": 171.33,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p23_27.png",
          "height": 37.44,
          "width": 440.16,
          "x": 96.96,
          "y": 339.57,
          "original_width": 1834,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p23_28.png",
          "height": 35.45,
          "width": 169.335,
          "x": 95.263,
          "y": 322.306,
          "original_width": 713,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "img_p23_29.png",
          "height": 51.36,
          "width": 440.16,
          "x": 96.96,
          "y": 457.89,
          "original_width": 1834,
          "original_height": 214,
          "rotation": 0
        },
        {
          "name": "img_p23_30.png",
          "height": 37.44,
          "width": 440.16,
          "x": 96.96,
          "y": 590.61,
          "original_width": 1834,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "page_24.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 5",
          "md": "# SECTION: 5  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Side Effects, Adverse Events, and Contraindications",
          "md": "## Side Effects, Adverse Events, and Contraindications",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**33. What are the side effects of vaccination?**  \n**Ans.** All vaccines induce immunity by causing the recipient’s immune system to react to the vaccine. Therefore, local reactions, fever and systemic symptoms can result as part of the immune response. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can also lead to reactions.⁸",
          "md": "**33. What are the side effects of vaccination?**  \n**Ans.** All vaccines induce immunity by causing the recipient’s immune system to react to the vaccine. Therefore, local reactions, fever and systemic symptoms can result as part of the immune response. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can also lead to reactions.⁸",
          "bBox": {
            "x": 58.73,
            "y": 345.71,
            "w": 478.07,
            "h": 483
          }
        },
        {
          "type": "text",
          "value": "**34. If fever does not come after giving injectable vaccine, does this mean that vaccine has not been effective and needs to be re-administered? Is it necessary to get a fever after vaccination?**  \n**Ans.** No. Though mild fever comes in majority of children who receive injectable vaccines, there are few children in which the immune response elicited by vaccine does not cause rise in body’s temperature. This is normal in some children, and there is no need to re-administer vaccine if fever does not come after vaccination.",
          "md": "**34. If fever does not come after giving injectable vaccine, does this mean that vaccine has not been effective and needs to be re-administered? Is it necessary to get a fever after vaccination?**  \n**Ans.** No. Though mild fever comes in majority of children who receive injectable vaccines, there are few children in which the immune response elicited by vaccine does not cause rise in body’s temperature. This is normal in some children, and there is no need to re-administer vaccine if fever does not come after vaccination.",
          "bBox": {
            "x": 58.73,
            "y": 378.25,
            "w": 478.06,
            "h": 450.47
          }
        },
        {
          "type": "text",
          "value": "**35. Why is there pain and swelling at the injection site? How it can be managed?**  \n**Ans.** In case of injectable vaccines (like Hepatitis B, pentavalent and IPV), infants may have redness, mild pain, and swelling at the injection site. This is mainly due to rupture of some muscle fibres by the needle getting injected into the muscle tissue. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can lead to local inflammatory reactions. These symptoms generally appear on the day after the injection is given and last from 1 to 3 days.",
          "md": "**35. Why is there pain and swelling at the injection site? How it can be managed?**  \n**Ans.** In case of injectable vaccines (like Hepatitis B, pentavalent and IPV), infants may have redness, mild pain, and swelling at the injection site. This is mainly due to rupture of some muscle fibres by the needle getting injected into the muscle tissue. In addition, some of the vaccine’s components (e.g. aluminium adjuvant, stabilizers or preservatives) can lead to local inflammatory reactions. These symptoms generally appear on the day after the injection is given and last from 1 to 3 days.",
          "bBox": {
            "x": 58.73,
            "y": 378.25,
            "w": 478.17,
            "h": 450.47
          }
        },
        {
          "type": "text",
          "value": "Cold compresses can be used to control swelling and redness. You should recommend Paracetamol (syrup or tablet, in divided doses) for providing symptomatic relief to child.",
          "md": "Cold compresses can be used to control swelling and redness. You should recommend Paracetamol (syrup or tablet, in divided doses) for providing symptomatic relief to child.",
          "bBox": {
            "x": 100.85,
            "y": 727.99,
            "w": 436.05,
            "h": 100.73
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "⁸ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers 2016",
          "md": "⁸ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officers 2016",
          "bBox": {
            "x": 424.49,
            "y": 804.71,
            "w": 74.96,
            "h": 24
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.99
    },
    {
      "page": 25,
      "text": "1 Soak a clean cloth in cold water\nand squeeze the excess water\n\n\n\n\n\n\n\nPlace the cloth on injection site 2\nwhere there is pain and swelling\n\n\n\n         Figure 3: Using cold compresses for pain at injection site\n\n         36. Can a sick child be vaccinated? Is cough, cold and mild fever\n         contra-indications for immunization?\nAns.     Yes. A sick child suffering from mild illness can be safely vaccinated. Symptoms\n         of mild illness (like cough, cold, mild fever or mild diarrhoea) are not contra-\n         indications to vaccination. However, a child with moderate to severe illness requiring\n         hospitalization (high grade fever, severe diarrhoea, etc.), should not be vaccinated\n         during the acute phase.\n\n                             37. Can vaccines, especially oral vaccines, be administered to a\n         child with diarrhoea and vomiting?\nAns.     Oral vaccines can be given to a child with mild diarrhoea. However, if a child has\n       Q severe diarrhoea requiring hospitalization, oral vaccines should be given only ᵃᶠᵗᵉʳ\nQ\n        Q diarrhoea is controlled. Oral vaccines should not be given to child who is vomiting\n         recurrently, until vomiting is controlled.\n\n                              38. What is the meaning ofAdverse Events Following Immunization\n         (AEFI)?\nAns.     Adverse events are any untoward medical occurrence which follows immunization\n         and which does not necessarily have a causal relationship with the usage of the\n         vaccine. The reported events may be a result of vaccine or immunization process,\n         or they may be coincidental events that are not due to vaccine or immunization\n         process but simply something that occurred soon after immunization.\n         Though, the occurrence is not due to a particular vaccine, but unless there is a\n         thorough investigation to determine the cause, such occurrences are assumed to\n         be due to vaccines and immunization. All cases of serious/severe AEFI should be\n         reported and investigated as per guidelines.\n\n\n\n\n\n18 IFAQs on Immunization",
      "md": "\n1. Soak a clean cloth in cold water and squeeze the excess water\n\n2. Place the cloth on injection site where there is pain and swelling\n\nFigure 3: Using cold compresses for pain at injection site\n\n----\n\n**36. Can a sick child be vaccinated? Is cough, cold and mild fever contra-indications for immunization?**  \n**Ans.** Yes. A sick child suffering from mild illness can be safely vaccinated. Symptoms of mild illness (like cough, cold, mild fever or mild diarrhoea) are not contra-indications to vaccination. However, a child with moderate to severe illness requiring hospitalization (high grade fever, severe diarrhoea, etc.), should not be vaccinated during the acute phase.\n\n----\n\n**37. Can vaccines, especially oral vaccines, be administered to a child with diarrhoea and vomiting?**  \n**Ans.** Oral vaccines can be given to a child with mild diarrhoea. However, if a child has severe diarrhoea requiring hospitalization, oral vaccines should be given only after diarrhoea is controlled. Oral vaccines should not be given to child who is vomiting recurrently, until vomiting is controlled.\n\n----\n\n**38. What is the meaning of Adverse Events Following Immunization (AEFI)?**  \n**Ans.** Adverse events are any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The reported events may be a result of vaccine or immunization process, or they may be coincidental events that are not due to vaccine or immunization process but simply something that occurred soon after immunization.\n\nThough, the occurrence is not due to a particular vaccine, but unless there is a thorough investigation to determine the cause, such occurrences are assumed to be due to vaccines and immunization. All cases of serious/severe AEFI should be reported and investigated as per guidelines.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p24_8.jpg",
          "height": 154.859,
          "width": 147.805,
          "x": 152.854,
          "y": 65.168,
          "original_width": 440,
          "original_height": 461,
          "rotation": 0
        },
        {
          "name": "img_p24_9.jpg",
          "height": 125.763,
          "width": 127.46,
          "x": 342.757,
          "y": 155.809,
          "original_width": 532,
          "original_height": 525,
          "rotation": 0
        },
        {
          "name": "img_p24_10.jpg",
          "height": 125.763,
          "width": 63.925,
          "x": 469.956,
          "y": 155.809,
          "original_width": 267,
          "original_height": 525,
          "rotation": 0
        },
        {
          "name": "page_25.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "1. Soak a clean cloth in cold water and squeeze the excess water",
          "md": "1. Soak a clean cloth in cold water and squeeze the excess water",
          "bBox": {
            "x": 86.36,
            "y": 122.68,
            "w": 396.4,
            "h": 431.08
          }
        },
        {
          "type": "text",
          "value": "2. Place the cloth on injection site where there is pain and swelling",
          "md": "2. Place the cloth on injection site where there is pain and swelling",
          "bBox": {
            "x": 155.17,
            "y": 183.59,
            "w": 187.56,
            "h": 74.02
          }
        },
        {
          "type": "text",
          "value": "Figure 3: Using cold compresses for pain at injection site",
          "md": "Figure 3: Using cold compresses for pain at injection site",
          "bBox": {
            "x": 231.29,
            "y": 296.45,
            "w": 208.95,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**36. Can a sick child be vaccinated? Is cough, cold and mild fever contra-indications for immunization?**  \n**Ans.** Yes. A sick child suffering from mild illness can be safely vaccinated. Symptoms of mild illness (like cough, cold, mild fever or mild diarrhoea) are not contra-indications to vaccination. However, a child with moderate to severe illness requiring hospitalization (high grade fever, severe diarrhoea, etc.), should not be vaccinated during the acute phase.",
          "md": "**36. Can a sick child be vaccinated? Is cough, cold and mild fever contra-indications for immunization?**  \n**Ans.** Yes. A sick child suffering from mild illness can be safely vaccinated. Symptoms of mild illness (like cough, cold, mild fever or mild diarrhoea) are not contra-indications to vaccination. However, a child with moderate to severe illness requiring hospitalization (high grade fever, severe diarrhoea, etc.), should not be vaccinated during the acute phase.",
          "bBox": {
            "x": 86.36,
            "y": 328.83,
            "w": 450.44,
            "h": 291.64
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**37. Can vaccines, especially oral vaccines, be administered to a child with diarrhoea and vomiting?**  \n**Ans.** Oral vaccines can be given to a child with mild diarrhoea. However, if a child has severe diarrhoea requiring hospitalization, oral vaccines should be given only after diarrhoea is controlled. Oral vaccines should not be given to child who is vomiting recurrently, until vomiting is controlled.",
          "md": "**37. Can vaccines, especially oral vaccines, be administered to a child with diarrhoea and vomiting?**  \n**Ans.** Oral vaccines can be given to a child with mild diarrhoea. However, if a child has severe diarrhoea requiring hospitalization, oral vaccines should be given only after diarrhoea is controlled. Oral vaccines should not be given to child who is vomiting recurrently, until vomiting is controlled.",
          "bBox": {
            "x": 86.36,
            "y": 366.83,
            "w": 450.41,
            "h": 253.63
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**38. What is the meaning of Adverse Events Following Immunization (AEFI)?**  \n**Ans.** Adverse events are any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The reported events may be a result of vaccine or immunization process, or they may be coincidental events that are not due to vaccine or immunization process but simply something that occurred soon after immunization.",
          "md": "**38. What is the meaning of Adverse Events Following Immunization (AEFI)?**  \n**Ans.** Adverse events are any untoward medical occurrence which follows immunization and which does not necessarily have a causal relationship with the usage of the vaccine. The reported events may be a result of vaccine or immunization process, or they may be coincidental events that are not due to vaccine or immunization process but simply something that occurred soon after immunization.",
          "bBox": {
            "x": 86.4,
            "y": 366.83,
            "w": 450.41,
            "h": 311.62
          }
        },
        {
          "type": "text",
          "value": "Though, the occurrence is not due to a particular vaccine, but unless there is a thorough investigation to determine the cause, such occurrences are assumed to be due to vaccines and immunization. All cases of serious/severe AEFI should be reported and investigated as per guidelines.",
          "md": "Though, the occurrence is not due to a particular vaccine, but unless there is a thorough investigation to determine the cause, such occurrences are assumed to be due to vaccines and immunization. All cases of serious/severe AEFI should be reported and investigated as per guidelines.",
          "bBox": {
            "x": 128.4,
            "y": 689.94,
            "w": 408.39,
            "h": 55.49
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.997
    },
    {
      "page": 26,
      "text": "Q 39. Are there any medical conditions for which ˢᵖᵉᶜⁱᶠⁱc vaccines\n             should not be given?\nAns.     There are a few medical conditions for which vaccines should be delayed or should\n         not be given. These are as follows:\n          à  A child who has had a severe (allergic) reaction to earlier dose of any vaccine\n             should not be given another dose of the same vaccine. This is an absolute\n             contra-indication applicable for all vaccines.\n          à  If a child has allergy to one conjugate vaccine (like DPT), any other conjugated\n             vaccine (like PCV) should not be given (or may be given under medical\n             observations) to the child.\n          à  IPV should not be given to children allergic to streptomycin, neomycin or\n             polymyxin B.\n          à  Vaccination should be given only after medical advice if a child is allergic to egg\n             proteins.\n          à  Rotavirus vaccine should not be given to children who have history of\n             intussusception, or abdominal surgery, or intestinal malformation.\n          à  Live vaccines should not be given to immune-compromised children (e.g. HIV,\n             Leukaemia), and those taking steroid therapy or immune-suppressant drugs.\n          à  Vaccines should not be given to hospitalized or unconscious child, or those\n             having convulsions.\n          à  Immunization should also be withheld during moderate to severe acute illness,\n             since vaccines may not elicit immune response in such conditions.\nQ\nQ 40. Can a child delivered by surgery (Caesarean section) or a child\n             who has delivered prematurely also receive vaccination?\nAns.     Yes. Vaccination should be provided to all children. It does not matter if:\n          à  They are delivered by surgery or by normal delivery\n          à  They are delivered at a private or government health facility or at home\n          à  They are delivered before completing 9 months of gestation period (premature)\n          à  Mother is suffering from any medical condition\n          à  Has a low birth weight\n         The immunization schedule should start at birth irrespective of the age of gestation\n         and weight of the child.\n\n          41. What precautions should be taken after vaccination?\n\nAns.     As a health worker, you should ensure that the parents/caretakers wait for 30\n         minutes at the health facility or the session site after vaccination. This is required to\n         ensure that immediate care can be sought if there is any side effect or adverse event.\n         Breastfeeding can be done after vaccination, even after giving oral vaccines. There is\n\n\n\n\nFAQs on ImmunizationI 19",
      "md": "\n**Q 39. Are there any medical conditions for which specific vaccines should not be given?**  \n**Ans.** There are a few medical conditions for which vaccines should be delayed or should not be given. These are as follows:  \n* A child who has had a severe (allergic) reaction to earlier dose of any vaccine should not be given another dose of the same vaccine. This is an absolute contra-indication applicable for all vaccines.  \n* If a child has allergy to one conjugate vaccine (like DPT), any other conjugated vaccine (like PCV) should not be given (or may be given under medical observations) to the child.  \n* IPV should not be given to children allergic to streptomycin, neomycin or polymyxin B.  \n* Vaccination should be given only after medical advice if a child is allergic to egg proteins.  \n* Rotavirus vaccine should not be given to children who have history of intussusception, or abdominal surgery, or intestinal malformation.  \n* Live vaccines should not be given to immune-compromised children (e.g. HIV, Leukaemia), and those taking steroid therapy or immune-suppressant drugs.  \n* Vaccines should not be given to hospitalized or unconscious child, or those having convulsions.  \n* Immunization should also be withheld during moderate to severe acute illness, since vaccines may not elicit immune response in such conditions.  \n\n**Q 40. Can a child delivered by surgery (Caesarean section) or a child who has delivered prematurely also receive vaccination?**  \n**Ans.** **Yes.** Vaccination should be provided to all children. It does not matter if:  \n* They are delivered by surgery or by normal delivery  \n* They are delivered at a private or government health facility or at home  \n* They are delivered before completing 9 months of gestation period (premature)  \n* Mother is suffering from any medical condition  \n* Has a low birth weight  \n\nThe immunization schedule should start at birth irrespective of the age of gestation and weight of the child.  \n\n**Q 41. What precautions should be taken after vaccination?**  \n**Ans.** As a health worker, you should ensure that the parents/caretakers wait for 30 minutes at the health facility or the session site after vaccination. This is required to ensure that immediate care can be sought if there is any side effect or adverse event. Breastfeeding can be done after vaccination, even after giving oral vaccines. There is\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_26.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q 39. Are there any medical conditions for which specific vaccines should not be given?**  \n**Ans.** There are a few medical conditions for which vaccines should be delayed or should not be given. These are as follows:  \n* A child who has had a severe (allergic) reaction to earlier dose of any vaccine should not be given another dose of the same vaccine. This is an absolute contra-indication applicable for all vaccines.  \n* If a child has allergy to one conjugate vaccine (like DPT), any other conjugated vaccine (like PCV) should not be given (or may be given under medical observations) to the child.  \n* IPV should not be given to children allergic to streptomycin, neomycin or polymyxin B.  \n* Vaccination should be given only after medical advice if a child is allergic to egg proteins.  \n* Rotavirus vaccine should not be given to children who have history of intussusception, or abdominal surgery, or intestinal malformation.  \n* Live vaccines should not be given to immune-compromised children (e.g. HIV, Leukaemia), and those taking steroid therapy or immune-suppressant drugs.  \n* Vaccines should not be given to hospitalized or unconscious child, or those having convulsions.  \n* Immunization should also be withheld during moderate to severe acute illness, since vaccines may not elicit immune response in such conditions.",
          "md": "**Q 39. Are there any medical conditions for which specific vaccines should not be given?**  \n**Ans.** There are a few medical conditions for which vaccines should be delayed or should not be given. These are as follows:  \n* A child who has had a severe (allergic) reaction to earlier dose of any vaccine should not be given another dose of the same vaccine. This is an absolute contra-indication applicable for all vaccines.  \n* If a child has allergy to one conjugate vaccine (like DPT), any other conjugated vaccine (like PCV) should not be given (or may be given under medical observations) to the child.  \n* IPV should not be given to children allergic to streptomycin, neomycin or polymyxin B.  \n* Vaccination should be given only after medical advice if a child is allergic to egg proteins.  \n* Rotavirus vaccine should not be given to children who have history of intussusception, or abdominal surgery, or intestinal malformation.  \n* Live vaccines should not be given to immune-compromised children (e.g. HIV, Leukaemia), and those taking steroid therapy or immune-suppressant drugs.  \n* Vaccines should not be given to hospitalized or unconscious child, or those having convulsions.  \n* Immunization should also be withheld during moderate to severe acute illness, since vaccines may not elicit immune response in such conditions.",
          "bBox": {
            "x": 58.46,
            "y": 76.38,
            "w": 452.75,
            "h": 634.64
          }
        },
        {
          "type": "text",
          "value": "**Q 40. Can a child delivered by surgery (Caesarean section) or a child who has delivered prematurely also receive vaccination?**  \n**Ans.** **Yes.** Vaccination should be provided to all children. It does not matter if:  \n* They are delivered by surgery or by normal delivery  \n* They are delivered at a private or government health facility or at home  \n* They are delivered before completing 9 months of gestation period (premature)  \n* Mother is suffering from any medical condition  \n* Has a low birth weight",
          "md": "**Q 40. Can a child delivered by surgery (Caesarean section) or a child who has delivered prematurely also receive vaccination?**  \n**Ans.** **Yes.** Vaccination should be provided to all children. It does not matter if:  \n* They are delivered by surgery or by normal delivery  \n* They are delivered at a private or government health facility or at home  \n* They are delivered before completing 9 months of gestation period (premature)  \n* Mother is suffering from any medical condition  \n* Has a low birth weight",
          "bBox": {
            "x": 58.46,
            "y": 97.61,
            "w": 452.74,
            "h": 613.4
          }
        },
        {
          "type": "text",
          "value": "The immunization schedule should start at birth irrespective of the age of gestation and weight of the child.",
          "md": "The immunization schedule should start at birth irrespective of the age of gestation and weight of the child.",
          "bBox": {
            "x": 100.5,
            "y": 611.19,
            "w": 410.7,
            "h": 26.5
          }
        },
        {
          "type": "text",
          "value": "**Q 41. What precautions should be taken after vaccination?**  \n**Ans.** As a health worker, you should ensure that the parents/caretakers wait for 30 minutes at the health facility or the session site after vaccination. This is required to ensure that immediate care can be sought if there is any side effect or adverse event. Breastfeeding can be done after vaccination, even after giving oral vaccines. There is",
          "md": "**Q 41. What precautions should be taken after vaccination?**  \n**Ans.** As a health worker, you should ensure that the parents/caretakers wait for 30 minutes at the health facility or the session site after vaccination. This is required to ensure that immediate care can be sought if there is any side effect or adverse event. Breastfeeding can be done after vaccination, even after giving oral vaccines. There is",
          "bBox": {
            "x": 58.46,
            "y": 97.61,
            "w": 452.74,
            "h": 656.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.992
    },
    {
      "page": 27,
      "text": "         no effect of breast milk on efficacy of the vaccines.\n         You should ensure that parents/caretakers do not apply any medicines or herbs\n         at the injection site. In case of redness or swelling at the injection site, cold water\n         compresses (i.e. a pad of clean cloth dipped into cold water) can be used. Please\n         recommend Paracetamol for providing symptomatic relief to the child.\n\nQ 42. Why should the parents be asked to wait for some time ᵃᶠᵗᵉʳ\n               vaccination?\nAns.     In rare cases, vaccines can lead to an allergic reaction or any other kind of adverse\n         event. These events require early diagnosis and management. Therefore, it is\n         advised that parents/caretakers are asked to stay at the session site for at least 30\n         minutes after receiving vaccination.\n\nQ 43. Does the child’s leg become weak due to vaccination?\nAns.     No. The child’s leg does not become weak due to vaccination. However, in some\n         cases child may avoid leg movement to avoid pain at the injection site. This can be\n         managed by cold compresses at the injection site, or by giving paracetamol tablet\n         or syrup in recommended dose.\n\nQ 44. Can any vaccine, like OPV, lead to infertility or impotency?\nAns.     No. All vaccines used in Universal Immunization Programme are pre-tested and\n         recommended by WHO. All these vaccines are highly safe and effective, and are\n         being used in many other countries besides India. No vaccine can lead to infertility\n         or impotency, and this, like many other myths related to vaccines, is baseless and\n         wrong.\n\nQ 45. Can Measles/MR vaccine lead to autism in children?\nAns.     There is strong scientific evidence that measles/MR vaccination is not linked to\n         autism, or any other conditions like inflammatory bowel disease or permanent\n         neurological sequelae, which have been wrongly associated with this vaccine.⁹\n\nQ 46. Can vaccines cause allergy?\nAns.     Vaccines are generally safe. However, some children may be allergic to certain\n         vaccines or a component                 of vaccine (like antibiotic or preservative), and\n         administration of vaccine in such children can result in allergic reaction, like itching,\n         or appearance of red spots on the body, soon after immunization. These cases need\n         to be managed immediately and in some cases may also require referral.\n         After an allergic reaction, DO NOT repeat or provide subsequent doses of the same\n         vaccine without consultation and advice of medical officer.\n\n9Measles vaccines: WHO Position Paper, April 2017\n\n20 IFAQs on Immunization",
      "md": "\nno effect of breast milk on efficacy of the vaccines.  \nYou should ensure that parents/caretakers do not apply any medicines or herbs at the injection site. In case of redness or swelling at the injection site, cold water compresses (i.e. a pad of clean cloth dipped into cold water) can be used. Please recommend Paracetamol for providing symptomatic relief to the child.\n\n**Q 42. Why should the parents be asked to wait for some time after vaccination?**  \nAns. In rare cases, vaccines can lead to an allergic reaction or any other kind of adverse event. These events require early diagnosis and management. Therefore, it is advised that parents/caretakers are asked to stay at the session site for at least 30 minutes after receiving vaccination.\n\n**Q 43. Does the child’s leg become weak due to vaccination?**  \nAns. No. The child’s leg does not become weak due to vaccination. However, in some cases child may avoid leg movement to avoid pain at the injection site. This can be managed by cold compresses at the injection site, or by giving paracetamol tablet or syrup in recommended dose.\n\n**Q 44. Can any vaccine, like OPV, lead to infertility or impotency?**  \nAns. No. All vaccines used in Universal Immunization Programme are pre-tested and recommended by WHO. All these vaccines are highly safe and effective, and are being used in many other countries besides India. No vaccine can lead to infertility or impotency, and this, like many other myths related to vaccines, is baseless and wrong.\n\n**Q 45. Can Measles/MR vaccine lead to autism in children?**  \nAns. There is strong scientific evidence that measles/MR vaccination is not linked to autism, or any other conditions like inflammatory bowel disease or permanent neurological sequelae, which have been wrongly associated with this vaccine.⁹\n\n**Q 46. Can vaccines cause allergy?**  \nAns. Vaccines are generally safe. However, some children may be allergic to certain vaccines or a component of vaccine (like antibiotic or preservative), and administration of vaccine in such children can result in allergic reaction, like itching, or appearance of red spots on the body, soon after immunization. These cases need to be managed immediately and in some cases may also require referral.  \nAfter an allergic reaction, **DO NOT** repeat or provide subsequent doses of the same vaccine without consultation and advice of medical officer.\n\n---\n⁹Measles vaccines: WHO Position Paper, April 2017\n",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p26_5.png",
          "height": 421.68,
          "width": 71.04,
          "x": 66.96,
          "y": -0.27,
          "original_width": 296,
          "original_height": 1757,
          "rotation": 0
        },
        {
          "name": "img_p26_6.png",
          "height": 421.68,
          "width": 71.04,
          "x": 524.64,
          "y": -0.27,
          "original_width": 296,
          "original_height": 1757,
          "rotation": 0
        },
        {
          "name": "img_p26_7.png",
          "height": 211.2,
          "width": 282.48,
          "x": 137.28,
          "y": 174.93,
          "original_width": 1177,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p26_8.png",
          "height": 386.4,
          "width": 106.32,
          "x": 419.04,
          "y": -0.27,
          "original_width": 443,
          "original_height": 1610,
          "rotation": 0
        },
        {
          "name": "img_p26_9.png",
          "height": 175.92,
          "width": 282.48,
          "x": 137.28,
          "y": -0.27,
          "original_width": 1177,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p26_11.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 153.57,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_12.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 269.01,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_13.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 384.21,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_14.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 513.57,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_15.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 612.93,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_16.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 153.953,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_17.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 269.314,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_18.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 384.564,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_19.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 513.854,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_20.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 613.304,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_27.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "no effect of breast milk on efficacy of the vaccines.  \nYou should ensure that parents/caretakers do not apply any medicines or herbs at the injection site. In case of redness or swelling at the injection site, cold water compresses (i.e. a pad of clean cloth dipped into cold water) can be used. Please recommend Paracetamol for providing symptomatic relief to the child.",
          "md": "no effect of breast milk on efficacy of the vaccines.  \nYou should ensure that parents/caretakers do not apply any medicines or herbs at the injection site. In case of redness or swelling at the injection site, cold water compresses (i.e. a pad of clean cloth dipped into cold water) can be used. Please recommend Paracetamol for providing symptomatic relief to the child.",
          "bBox": {
            "x": 128.4,
            "y": 55.43,
            "w": 408.39,
            "h": 623.71
          }
        },
        {
          "type": "text",
          "value": "**Q 42. Why should the parents be asked to wait for some time after vaccination?**  \nAns. In rare cases, vaccines can lead to an allergic reaction or any other kind of adverse event. These events require early diagnosis and management. Therefore, it is advised that parents/caretakers are asked to stay at the session site for at least 30 minutes after receiving vaccination.",
          "md": "**Q 42. Why should the parents be asked to wait for some time after vaccination?**  \nAns. In rare cases, vaccines can lead to an allergic reaction or any other kind of adverse event. These events require early diagnosis and management. Therefore, it is advised that parents/caretakers are asked to stay at the session site for at least 30 minutes after receiving vaccination.",
          "bBox": {
            "x": 86.4,
            "y": 171.05,
            "w": 450.39,
            "h": 508.09
          }
        },
        {
          "type": "text",
          "value": "**Q 43. Does the child’s leg become weak due to vaccination?**  \nAns. No. The child’s leg does not become weak due to vaccination. However, in some cases child may avoid leg movement to avoid pain at the injection site. This can be managed by cold compresses at the injection site, or by giving paracetamol tablet or syrup in recommended dose.",
          "md": "**Q 43. Does the child’s leg become weak due to vaccination?**  \nAns. No. The child’s leg does not become weak due to vaccination. However, in some cases child may avoid leg movement to avoid pain at the injection site. This can be managed by cold compresses at the injection site, or by giving paracetamol tablet or syrup in recommended dose.",
          "bBox": {
            "x": 86.36,
            "y": 171.05,
            "w": 450.42,
            "h": 508.09
          }
        },
        {
          "type": "text",
          "value": "**Q 44. Can any vaccine, like OPV, lead to infertility or impotency?**  \nAns. No. All vaccines used in Universal Immunization Programme are pre-tested and recommended by WHO. All these vaccines are highly safe and effective, and are being used in many other countries besides India. No vaccine can lead to infertility or impotency, and this, like many other myths related to vaccines, is baseless and wrong.",
          "md": "**Q 44. Can any vaccine, like OPV, lead to infertility or impotency?**  \nAns. No. All vaccines used in Universal Immunization Programme are pre-tested and recommended by WHO. All these vaccines are highly safe and effective, and are being used in many other countries besides India. No vaccine can lead to infertility or impotency, and this, like many other myths related to vaccines, is baseless and wrong.",
          "bBox": {
            "x": 86.36,
            "y": 193.29,
            "w": 450.42,
            "h": 485.85
          }
        },
        {
          "type": "text",
          "value": "**Q 45. Can Measles/MR vaccine lead to autism in children?**  \nAns. There is strong scientific evidence that measles/MR vaccination is not linked to autism, or any other conditions like inflammatory bowel disease or permanent neurological sequelae, which have been wrongly associated with this vaccine.⁹",
          "md": "**Q 45. Can Measles/MR vaccine lead to autism in children?**  \nAns. There is strong scientific evidence that measles/MR vaccination is not linked to autism, or any other conditions like inflammatory bowel disease or permanent neurological sequelae, which have been wrongly associated with this vaccine.⁹",
          "bBox": {
            "x": 86.36,
            "y": 193.29,
            "w": 450.42,
            "h": 485.85
          }
        },
        {
          "type": "text",
          "value": "**Q 46. Can vaccines cause allergy?**  \nAns. Vaccines are generally safe. However, some children may be allergic to certain vaccines or a component of vaccine (like antibiotic or preservative), and administration of vaccine in such children can result in allergic reaction, like itching, or appearance of red spots on the body, soon after immunization. These cases need to be managed immediately and in some cases may also require referral.  \nAfter an allergic reaction, **DO NOT** repeat or provide subsequent doses of the same vaccine without consultation and advice of medical officer.",
          "md": "**Q 46. Can vaccines cause allergy?**  \nAns. Vaccines are generally safe. However, some children may be allergic to certain vaccines or a component of vaccine (like antibiotic or preservative), and administration of vaccine in such children can result in allergic reaction, like itching, or appearance of red spots on the body, soon after immunization. These cases need to be managed immediately and in some cases may also require referral.  \nAfter an allergic reaction, **DO NOT** repeat or provide subsequent doses of the same vaccine without consultation and advice of medical officer.",
          "bBox": {
            "x": 86.36,
            "y": 193.29,
            "w": 450.43,
            "h": 567.33
          }
        },
        {
          "type": "text",
          "value": "---\n⁹Measles vaccines: WHO Position Paper, April 2017",
          "md": "---\n⁹Measles vaccines: WHO Position Paper, April 2017",
          "bBox": {
            "x": 128.4,
            "y": 667.14,
            "w": 203.11,
            "h": 12
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.998
    },
    {
      "page": 28,
      "text": "SECTION: 6\nVaccine Handling, Administration,\nand Injection Safety\n\n\n\n\n\n          47. Can more than one vaccine be administered to a child at the\n             same time?\nAns.     Yes. More than one vaccine can be administered to a child at the same time. Different\n         vaccines have different mechanism of generating immune responses in the body.\n         Inactivated vaccines do not interfere with the effect of any other inactivated, live, or\n         toxoid vaccines. Therefore, it is completely safe to administer more than one vaccine\n         to a child at the same time. Doing this has no effect on efficacy of individual vaccines.\n         Following precautions must be taken when more than one vaccine is to be\n         administered to a child:\n          à  Two or more vaccines should not be mixed in the same syringe.\n          à  If two injectable vaccines are given on the same site, they should be given 2.5\n             cm (1 inch) apart.\n\n\n\n         48. Is there any benefit administering more than one vaccine at\n         the same time?\nAns.     From public health perspective, administration of more than one vaccine as per\n         the schedule at the same time reduces the number of visits to the health facilities,\n         thereby reducing drop outs. Also, giving multiple vaccinations during the same visit\n         does not result in a higher incidence of adverse events.\n\n\n\n\n\n\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  21\n                 21",
      "md": "\n# SECTION: 6  \n## Vaccine Handling, Administration, and Injection Safety\n\n**47. Can more than one vaccine be administered to a child at the same time?**  \n**Ans.** Yes. More than one vaccine can be administered to a child at the same time. Different vaccines have different mechanism of generating immune responses in the body. Inactivated vaccines do not interfere with the effect of any other inactivated, live, or toxoid vaccines. Therefore, it is completely safe to administer more than one vaccine to a child at the same time. Doing this has no effect on efficacy of individual vaccines.\n\nFollowing precautions must be taken when more than one vaccine is to be administered to a child:  \n* Two or more vaccines should not be mixed in the same syringe.  \n* If two injectable vaccines are given on the same site, they should be given 2.5 cm (1 inch) apart.\n\n**48. Is there any benefit administering more than one vaccine at the same time?**  \n**Ans.** From public health perspective, administration of more than one vaccine as per the schedule at the same time reduces the number of visits to the health facilities, thereby reducing drop outs. Also, giving multiple vaccinations during the same visit does not result in a higher incidence of adverse events.\n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_7.png",
          "height": 35.76,
          "width": 245.76,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1024,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_20.jpg",
          "height": 169.64,
          "width": 53.832,
          "x": 413.714,
          "y": 153.248,
          "original_width": 155,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_18.jpg",
          "height": 136.5,
          "width": 50.117,
          "x": 560.462,
          "y": 171.33,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_21.jpg",
          "height": 140.253,
          "width": 85.816,
          "x": 453.129,
          "y": 178.859,
          "original_width": 306,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p27_27.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 339.57,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p27_28.png",
          "height": 35.475,
          "width": 169.57,
          "x": 95.028,
          "y": 322.306,
          "original_width": 714,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "img_p27_29.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 578.85,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p27_30.jpg",
          "height": 18.72,
          "width": 34.069,
          "x": 58.464,
          "y": 357.984,
          "original_width": 142,
          "original_height": 78,
          "rotation": 0
        },
        {
          "name": "page_28.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 6",
          "md": "# SECTION: 6  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Vaccine Handling, Administration, and Injection Safety",
          "md": "## Vaccine Handling, Administration, and Injection Safety",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**47. Can more than one vaccine be administered to a child at the same time?**  \n**Ans.** Yes. More than one vaccine can be administered to a child at the same time. Different vaccines have different mechanism of generating immune responses in the body. Inactivated vaccines do not interfere with the effect of any other inactivated, live, or toxoid vaccines. Therefore, it is completely safe to administer more than one vaccine to a child at the same time. Doing this has no effect on efficacy of individual vaccines.",
          "md": "**47. Can more than one vaccine be administered to a child at the same time?**  \n**Ans.** Yes. More than one vaccine can be administered to a child at the same time. Different vaccines have different mechanism of generating immune responses in the body. Inactivated vaccines do not interfere with the effect of any other inactivated, live, or toxoid vaccines. Therefore, it is completely safe to administer more than one vaccine to a child at the same time. Doing this has no effect on efficacy of individual vaccines.",
          "bBox": {
            "x": 58.5,
            "y": 342.66,
            "w": 452.71,
            "h": 486.05
          }
        },
        {
          "type": "text",
          "value": "Following precautions must be taken when more than one vaccine is to be administered to a child:  \n* Two or more vaccines should not be mixed in the same syringe.  \n* If two injectable vaccines are given on the same site, they should be given 2.5 cm (1 inch) apart.",
          "md": "Following precautions must be taken when more than one vaccine is to be administered to a child:  \n* Two or more vaccines should not be mixed in the same syringe.  \n* If two injectable vaccines are given on the same site, they should be given 2.5 cm (1 inch) apart.",
          "bBox": {
            "x": 100.5,
            "y": 460.73,
            "w": 410.71,
            "h": 367.99
          }
        },
        {
          "type": "text",
          "value": "**48. Is there any benefit administering more than one vaccine at the same time?**  \n**Ans.** From public health perspective, administration of more than one vaccine as per the schedule at the same time reduces the number of visits to the health facilities, thereby reducing drop outs. Also, giving multiple vaccinations during the same visit does not result in a higher incidence of adverse events.",
          "md": "**48. Is there any benefit administering more than one vaccine at the same time?**  \n**Ans.** From public health perspective, administration of more than one vaccine as per the schedule at the same time reduces the number of visits to the health facilities, thereby reducing drop outs. Also, giving multiple vaccinations during the same visit does not result in a higher incidence of adverse events.",
          "bBox": {
            "x": 58.5,
            "y": 357.66,
            "w": 452.71,
            "h": 471.06
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.99
    },
    {
      "page": 29,
      "text": "Q\nQ 49. What should be the interval between administrations of ᵗʷᵒ\n          doses of same vaccine as per the National Immunization\n          Schedule?\nAns.     There should be minimum 4 weeks of interval between administration of two\n         doses of same multi-dose vaccine (like, Pentavalent and Rotavirus vaccines), except\n         for PCV which is 2 months and JE vaccine which is 3 months. For booster doses, the\n         recommended interval can be 6 months to more than one year after the primary doses.\n         Decreasing the interval between two doses of multi-dose vaccine may interfere with\n         the antibody response and protection. Longer than normal recommended intervals\n         between two subsequent doses of multi-dose vaccines normally does not impair the\n         immunologic response. Therefore, interruption in the recommended schedule does\n         not require a re-start from beginning.\n\n\n         50. Why are vaccines in NIS administered at specific sites only?\n\nAns.     Each vaccine is normally administered at the same, specific site on the body to\n         maintain uniformity and to help determine vaccination history by asking from\n         beneficiary or caretaker (in case immunization card is not available or lost). Specific\n         sites of administration also help parents and caretakers recall previous vaccinations\n         during the follow-up visits and household surveys.\n\n                                                           Oral Administration\n         Oral Polio                                        Rotavirus  Vitamin\n          Vaccine                                          Vaccine*    A\n\n\n        Upper Arm-Right                    Upper Arm-Leﬅ\n              IPV          Measles/MR*     BCG     JE*\n         (Intra-dermal)    (Sub-cutaneous)    (Intra-dermal)  (Sub-cutaneous)\n\nQ Antero-lateral side of mid-thigh-Right      Antero-lateral side of mid-thigh-Leﬅ\n        (Intra-muscular)                      HepB            (Intra-muscular)\n                             PCV*             Birth Dose      Penta  DPT Booster\n\n                                              Figure 4: Child with sites of multiple vaccines    *Wherever applicable\n\n         51. Why are some vaccines now being administered in thigh\n           instead of buttocks?\nAns.     Mid-thigh is the correct site for administering injectable vaccines in young children,\n         especially up to five years of age. This site is recommended under UIP and therefore\n         should be followed uniformly.\n         There are three reasons for administering some injectable vaccines in mid-thigh\n         (anterolateral aspect). These are:\n         à Sciatic nerve, a major nerve for lower legs, passes through the buttocks (gluteal\n\n\n\n22 IFAQs on Immunization",
      "md": "\n**Q 49. What should be the interval between administrations of two doses of same vaccine as per the National Immunization Schedule?**\n\nAns. There should be minimum 4 weeks of interval between administration of two doses of same multi-dose vaccine (like, Pentavalent and Rotavirus vaccines), except for PCV which is 2 months and JE vaccine which is 3 months. For booster doses, the recommended interval can be 6 months to more than one year after the primary doses.\n\nDecreasing the interval between two doses of multi-dose vaccine may interfere with the antibody response and protection. Longer than normal recommended intervals between two subsequent doses of multi-dose vaccines normally does not impair the immunologic response. Therefore, interruption in the recommended schedule does not require a re-start from beginning.\n\n----\n\n**Q 50. Why are vaccines in NIS administered at specific sites only?**\n\nAns. Each vaccine is normally administered at the same, specific site on the body to maintain uniformity and to help determine vaccination history by asking from beneficiary or caretaker (in case immunization card is not available or lost). Specific sites of administration also help parents and caretakers recall previous vaccinations during the follow-up visits and household surveys.\n\n<table>\n<thead>\n<tr>\n<th colspan=\"3\">Oral Administration</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Oral Polio Vaccine</td>\n<td>Rotavirus Vaccine*</td>\n<td>Vitamin A</td>\n</tr>\n</tbody>\n</table>\n\n<table>\n<thead>\n<tr>\n<th>Upper Arm-Right</th>\n<th>Upper Arm-Left</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>IPV (Intra-dermal)</td>\n<td>BCG (Intra-dermal)</td>\n</tr>\n<tr>\n<td>Measles/MR* (Sub-cutaneous)</td>\n<td>JE* (Sub-cutaneous)</td>\n</tr>\n</tbody>\n</table>\n\n<table>\n<thead>\n<tr>\n<th>Antero-lateral side of mid-thigh-Right (Intra-muscular)</th>\n<th>Antero-lateral side of mid-thigh-Left (Intra-muscular)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>PCV*</td>\n<td>HepB Birth Dose</td>\n</tr>\n<tr>\n<td></td>\n<td>Penta</td>\n</tr>\n<tr>\n<td></td>\n<td>DPT Booster</td>\n</tr>\n</tbody>\n</table>\n\n*Wherever applicable\n\n*Figure 4: Child with sites of multiple vaccines*\n\n----\n\n**Q 51. Why are some vaccines now being administered in thigh instead of buttocks?**\n\nAns. Mid-thigh is the correct site for administering injectable vaccines in young children, especially up to five years of age. This site is recommended under UIP and therefore should be followed uniformly.\n\nThere are three reasons for administering some injectable vaccines in mid-thigh (anterolateral aspect). These are:\n\n* Sciatic nerve, a major nerve for lower legs, passes through the buttocks (gluteal\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p28_2.png",
          "height": 48.96,
          "width": 412.56,
          "x": 124.56,
          "y": 58.05,
          "original_width": 1719,
          "original_height": 204,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p28_8.jpg",
          "height": 96.295,
          "width": 85.892,
          "x": 267.942,
          "y": 397.137,
          "original_width": 358,
          "original_height": 402,
          "rotation": 0
        },
        {
          "name": "img_p28_9.jpg",
          "height": 192.324,
          "width": 28.72,
          "x": 353.656,
          "y": 397.137,
          "original_width": 120,
          "original_height": 802,
          "rotation": 0
        },
        {
          "name": "img_p28_10.jpg",
          "height": 96.206,
          "width": 85.892,
          "x": 267.942,
          "y": 493.255,
          "original_width": 358,
          "original_height": 401,
          "rotation": 0
        },
        {
          "name": "img_p28_11.jpg",
          "height": 54.416,
          "width": 44.635,
          "x": 337.652,
          "y": 401.316,
          "original_width": 186,
          "original_height": 227,
          "rotation": 0
        },
        {
          "name": "img_p28_12.jpg",
          "height": 57.083,
          "width": 46.503,
          "x": 335.784,
          "y": 464.802,
          "original_width": 194,
          "original_height": 238,
          "rotation": 0
        },
        {
          "name": "img_p28_13.jpg",
          "height": 57.083,
          "width": 37.7,
          "x": 268.031,
          "y": 464.802,
          "original_width": 158,
          "original_height": 238,
          "rotation": 0
        },
        {
          "name": "img_p28_14.jpg",
          "height": 57.084,
          "width": 49.526,
          "x": 332.761,
          "y": 530.955,
          "original_width": 207,
          "original_height": 238,
          "rotation": 0
        },
        {
          "name": "img_p28_15.jpg",
          "height": 57.084,
          "width": 41.968,
          "x": 268.031,
          "y": 530.955,
          "original_width": 175,
          "original_height": 238,
          "rotation": 0
        },
        {
          "name": "img_p28_16.jpg",
          "height": 19.76,
          "width": 24.561,
          "x": 356.602,
          "y": 414.172,
          "original_width": 103,
          "original_height": 83,
          "rotation": 0
        },
        {
          "name": "img_p28_17.png",
          "height": 19.76,
          "width": 24.562,
          "x": 381.139,
          "y": 414.172,
          "original_width": 103,
          "original_height": 83,
          "rotation": 0
        },
        {
          "name": "img_p28_18.jpg",
          "height": 19.759,
          "width": 24.561,
          "x": 356.602,
          "y": 433.908,
          "original_width": 103,
          "original_height": 83,
          "rotation": 0
        },
        {
          "name": "img_p28_19.jpg",
          "height": 19.759,
          "width": 24.562,
          "x": 381.139,
          "y": 433.908,
          "original_width": 103,
          "original_height": 83,
          "rotation": 0
        },
        {
          "name": "img_p28_20.jpg",
          "height": 51.504,
          "width": 51.014,
          "x": 371.05,
          "y": 468.533,
          "original_width": 213,
          "original_height": 215,
          "rotation": 0
        },
        {
          "name": "img_p28_21.jpg",
          "height": 51.504,
          "width": 51.504,
          "x": 228.567,
          "y": 468.278,
          "original_width": 215,
          "original_height": 215,
          "rotation": 0
        },
        {
          "name": "img_p28_22.jpg",
          "height": 47.855,
          "width": 23.991,
          "x": 378.747,
          "y": 534.963,
          "original_width": 200,
          "original_height": 100,
          "rotation": 0
        },
        {
          "name": "img_p28_23.jpg",
          "height": 47.855,
          "width": 23.991,
          "x": 402.653,
          "y": 534.963,
          "original_width": 200,
          "original_height": 100,
          "rotation": 0
        },
        {
          "name": "img_p28_24.jpg",
          "height": 47.855,
          "width": 23.991,
          "x": 254.054,
          "y": 534.963,
          "original_width": 200,
          "original_height": 100,
          "rotation": 0
        },
        {
          "name": "img_p28_25.jpg",
          "height": 47.855,
          "width": 23.948,
          "x": 230.191,
          "y": 534.963,
          "original_width": 200,
          "original_height": 100,
          "rotation": 0
        },
        {
          "name": "page_29.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q 49. What should be the interval between administrations of two doses of same vaccine as per the National Immunization Schedule?**",
          "md": "**Q 49. What should be the interval between administrations of two doses of same vaccine as per the National Immunization Schedule?**",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.44,
            "h": 370.46
          }
        },
        {
          "type": "text",
          "value": "Ans. There should be minimum 4 weeks of interval between administration of two doses of same multi-dose vaccine (like, Pentavalent and Rotavirus vaccines), except for PCV which is 2 months and JE vaccine which is 3 months. For booster doses, the recommended interval can be 6 months to more than one year after the primary doses.",
          "md": "Ans. There should be minimum 4 weeks of interval between administration of two doses of same multi-dose vaccine (like, Pentavalent and Rotavirus vaccines), except for PCV which is 2 months and JE vaccine which is 3 months. For booster doses, the recommended interval can be 6 months to more than one year after the primary doses.",
          "bBox": {
            "x": 86.4,
            "y": 109.43,
            "w": 454.15,
            "h": 562.57
          }
        },
        {
          "type": "text",
          "value": "Decreasing the interval between two doses of multi-dose vaccine may interfere with the antibody response and protection. Longer than normal recommended intervals between two subsequent doses of multi-dose vaccines normally does not impair the immunologic response. Therefore, interruption in the recommended schedule does not require a re-start from beginning.",
          "md": "Decreasing the interval between two doses of multi-dose vaccine may interfere with the antibody response and protection. Longer than normal recommended intervals between two subsequent doses of multi-dose vaccines normally does not impair the immunologic response. Therefore, interruption in the recommended schedule does not require a re-start from beginning.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.41,
            "h": 370.46
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 50. Why are vaccines in NIS administered at specific sites only?**",
          "md": "**Q 50. Why are vaccines in NIS administered at specific sites only?**",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 433.62,
            "h": 370.46
          }
        },
        {
          "type": "text",
          "value": "Ans. Each vaccine is normally administered at the same, specific site on the body to maintain uniformity and to help determine vaccination history by asking from beneficiary or caretaker (in case immunization card is not available or lost). Specific sites of administration also help parents and caretakers recall previous vaccinations during the follow-up visits and household surveys.",
          "md": "Ans. Each vaccine is normally administered at the same, specific site on the body to maintain uniformity and to help determine vaccination history by asking from beneficiary or caretaker (in case immunization card is not available or lost). Specific sites of administration also help parents and caretakers recall previous vaccinations during the follow-up visits and household surveys.",
          "bBox": {
            "x": 86.4,
            "y": 109.43,
            "w": 450.38,
            "h": 562.57
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Oral Administration",
              "Oral Administration",
              "Oral Administration"
            ],
            [
              "Oral Polio Vaccine",
              "Rotavirus Vaccine*",
              "Vitamin A"
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th colspan=\"3\">Oral Administration</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>Oral Polio Vaccine</td>\n<td>Rotavirus Vaccine*</td>\n<td>Vitamin A</td>\n</tr>\n</tbody>\n</table>",
          "md": "| Oral Administration | Oral Administration | Oral Administration |\n| ------------------- | ------------------- | ------------------- |\n| Oral Polio Vaccine  | Rotavirus Vaccine\\* | Vitamin A           |",
          "isPerfectTable": true,
          "csv": "\"Oral Administration\",\"Oral Administration\",\"Oral Administration\"\n\"Oral Polio Vaccine\",\"Rotavirus Vaccine*\",\"Vitamin A\"",
          "bBox": {
            "x": 470.22,
            "y": 402.05,
            "w": 62.79,
            "h": 7.35
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Upper Arm-Right",
              "Upper Arm-Left"
            ],
            [
              "IPV (Intra-dermal)",
              "BCG (Intra-dermal)"
            ],
            [
              "Measles/MR* (Sub-cutaneous)",
              "JE* (Sub-cutaneous)"
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>Upper Arm-Right</th>\n<th>Upper Arm-Left</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>IPV (Intra-dermal)</td>\n<td>BCG (Intra-dermal)</td>\n</tr>\n<tr>\n<td>Measles/MR* (Sub-cutaneous)</td>\n<td>JE* (Sub-cutaneous)</td>\n</tr>\n</tbody>\n</table>",
          "md": "| Upper Arm-Right              | Upper Arm-Left       |\n| ---------------------------- | -------------------- |\n| IPV (Intra-dermal)           | BCG (Intra-dermal)   |\n| Measles/MR\\* (Sub-cutaneous) | JE\\* (Sub-cutaneous) |",
          "isPerfectTable": true,
          "csv": "\"Upper Arm-Right\",\"Upper Arm-Left\"\n\"IPV (Intra-dermal)\",\"BCG (Intra-dermal)\"\n\"Measles/MR* (Sub-cutaneous)\",\"JE* (Sub-cutaneous)\"",
          "bBox": {
            "x": 125.46,
            "y": 466.17,
            "w": 52.91,
            "h": 7.35
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Antero-lateral side of mid-thigh-Right (Intra-muscular)",
              "Antero-lateral side of mid-thigh-Left (Intra-muscular)"
            ],
            [
              "PCV*",
              "HepB Birth Dose"
            ],
            [
              "",
              "Penta"
            ],
            [
              "",
              "DPT Booster"
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>Antero-lateral side of mid-thigh-Right (Intra-muscular)</th>\n<th>Antero-lateral side of mid-thigh-Left (Intra-muscular)</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>PCV*</td>\n<td>HepB Birth Dose</td>\n</tr>\n<tr>\n<td></td>\n<td>Penta</td>\n</tr>\n<tr>\n<td></td>\n<td>DPT Booster</td>\n</tr>\n</tbody>\n</table>",
          "md": "| Antero-lateral side of mid-thigh-Right (Intra-muscular) | Antero-lateral side of mid-thigh-Left (Intra-muscular) |\n| ------------------------------------------------------- | ------------------------------------------------------ |\n| PCV\\*                                                   | HepB Birth Dose                                        |\n|                                                         | Penta                                                  |\n|                                                         | DPT Booster                                            |",
          "isPerfectTable": true,
          "csv": "\"Antero-lateral side of mid-thigh-Right (Intra-muscular)\",\"Antero-lateral side of mid-thigh-Left (Intra-muscular)\"\n\"PCV*\",\"HepB Birth Dose\"\n\"\",\"Penta\"\n\"\",\"DPT Booster\"",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 454.19,
            "h": 770.25
          }
        },
        {
          "type": "text",
          "value": "*Wherever applicable",
          "md": "*Wherever applicable",
          "bBox": {
            "x": 464.94,
            "y": 421.92,
            "w": 71.86,
            "h": 173.33
          }
        },
        {
          "type": "text",
          "value": "*Figure 4: Child with sites of multiple vaccines*",
          "md": "*Figure 4: Child with sites of multiple vaccines*",
          "bBox": {
            "x": 231.99,
            "y": 421.1,
            "w": 287.24,
            "h": 175.72
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 51. Why are some vaccines now being administered in thigh instead of buttocks?**",
          "md": "**Q 51. Why are some vaccines now being administered in thigh instead of buttocks?**",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.43,
            "h": 591.6
          }
        },
        {
          "type": "text",
          "value": "Ans. Mid-thigh is the correct site for administering injectable vaccines in young children, especially up to five years of age. This site is recommended under UIP and therefore should be followed uniformly.",
          "md": "Ans. Mid-thigh is the correct site for administering injectable vaccines in young children, especially up to five years of age. This site is recommended under UIP and therefore should be followed uniformly.",
          "bBox": {
            "x": 86.4,
            "y": 109.43,
            "w": 450.38,
            "h": 591.56
          }
        },
        {
          "type": "text",
          "value": "There are three reasons for administering some injectable vaccines in mid-thigh (anterolateral aspect). These are:",
          "md": "There are three reasons for administering some injectable vaccines in mid-thigh (anterolateral aspect). These are:",
          "bBox": {
            "x": 128.4,
            "y": 421.1,
            "w": 408.39,
            "h": 317.88
          }
        },
        {
          "type": "text",
          "value": "* Sciatic nerve, a major nerve for lower legs, passes through the buttocks (gluteal",
          "md": "* Sciatic nerve, a major nerve for lower legs, passes through the buttocks (gluteal",
          "bBox": {
            "x": 152.4,
            "y": 421.92,
            "w": 384.39,
            "h": 338.62
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.988
    },
    {
      "page": 30,
      "text": "Q region). This nerve may get accidentally damaged in case of injection, leading\n   to weakness or paralysis of lower limb.\nà  There is lot of fat in the buttocks. Vaccine gets deposited in this fat and either\n   does not elicit or elicits a delayed or partial immune response.\nà  Anterolateral aspect (front and outer part) of mid-thigh is preferred site for\n   giving injection in children as it provides the largest muscle mass, leading to\n   quick absorption of vaccine into the blood capillaries.\n\n\n         52. Sometimes the same vaccine is of different colour in different\n         vials. Does this have any effect on its efficacy?\nAns.     No. All vaccines supplied for immunization programme undergo strict quality checks.\n         There can be instances that colour of vaccine is slightly different in different vials,\n         but this in no way affects the efficacy of vaccine.\n\n         53. What should be done if child spits out or vomits immediately\n         after taking vaccine orally?\nAns.     If a child vomits immediately after taking vaccine orally, like OPV and rotavirus\n         vaccines, then the vaccine dose should be given again. However, a repeat dose\n         should be given after ensuring that child does not vomit it out again.\n\n\n         54. During 6th, 10th, 14th weeks and 9 months when more than\n           one vaccine is to be administered on the same day, is there a\nQ          definite sequence in which vaccines need to be given?\nQ\nAns.     During 6th, 10th, 14th weeks and 9 months, when multiple vaccines are to be\n         administered, it is preferable for health workers/ vaccinators to follow the sequence\n         as given below, for the sake of programmatic consistency and uniformity;\n\n          6 Weeks       10 Weeks       14 Weeks                                         9 Months\n\n          1             1              1                                             1\n               OPV           OPV            OPV                                      1  Vit A\n\n                        2              2                                             2  Measles\n          2    RVV*          RVV*           RVV*                                     2  /MR*\n\n          3    fIPV     3    Penta     3    fIPV                                     3  PCV-B*\n              H\n\n          4    PCV*                    4    PCV*                                     4  JE*\n              H\n\n          5    Penta                   5    Penta\n              H\n                                                                                     *Wherever applicable\n                     Table 3: Sequence of vaccination at 6, 10, 14 weeks and 9 months\n\n\n\nFAQs on ImmunizationI 23",
      "md": "\n* region). This nerve may get accidentally damaged in case of injection, leading to weakness or paralysis of lower limb.  \n* There is lot of fat in the buttocks. Vaccine gets deposited in this fat and either does not elicit or elicits a delayed or partial immune response.  \n* Anterolateral aspect (front and outer part) of mid-thigh is preferred site for giving injection in children as it provides the largest muscle mass, leading to quick absorption of vaccine into the blood capillaries.\n\n----\n\n### 52. Sometimes the same vaccine is of different colour in different vials. Does this have any effect on its efficacy?  \n**Ans.** No. All vaccines supplied for immunization programme undergo strict quality checks. There can be instances that colour of vaccine is slightly different in different vials, but this in no way affects the efficacy of vaccine.\n\n----\n\n### 53. What should be done if child spits out or vomits immediately after taking vaccine orally?  \n**Ans.** If a child vomits immediately after taking vaccine orally, like OPV and rotavirus vaccines, then the vaccine dose should be given again. However, a repeat dose should be given after ensuring that child does not vomit it out again.\n\n----\n\n### 54. During 6th, 10th, 14th weeks and 9 months when more than one vaccine is to be administered on the same day, is there a definite sequence in which vaccines need to be given?  \n**Ans.** During 6th, 10th, 14th weeks and 9 months, when multiple vaccines are to be administered, it is preferable for health workers/ vaccinators to follow the sequence as given below, for the sake of programmatic consistency and uniformity;\n\n<table>\n<thead>\n<tr>\n<th>6 Weeks</th>\n<th>10 Weeks</th>\n<th>14 Weeks</th>\n<th>9 Months</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>1<br>OPV</td>\n<td>1<br>OPV</td>\n<td>1<br>OPV</td>\n<td>1<br>Vit A</td>\n</tr>\n<tr>\n<td>2<br>RVV*</td>\n<td>2<br>RVV*</td>\n<td>2<br>RVV*</td>\n<td>2<br>Measles / MR*</td>\n</tr>\n<tr>\n<td>3<br>fIPV</td>\n<td>3<br>Penta</td>\n<td>3<br>fIPV</td>\n<td>3<br>PCV-B*</td>\n</tr>\n<tr>\n<td>4<br>PCV*</td>\n<td></td>\n<td>4<br>PCV*</td>\n<td>4<br>JE*</td>\n</tr>\n<tr>\n<td>5<br>Penta</td>\n<td></td>\n<td>5<br>Penta</td>\n<td></td>\n</tr>\n</tbody>\n</table>\n\n*Wherever applicable\n\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p29_4.png",
          "height": 46.8,
          "width": 414.72,
          "x": 96.72,
          "y": 396.69,
          "original_width": 1728,
          "original_height": 195,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p29_8.png",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 632.046,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_9.png",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 632.046,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_10.jpg",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 632.046,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 15,
              "y": 22,
              "w": 58,
              "h": 58,
              "confidence": 0.264,
              "text": "H"
            }
          ]
        },
        {
          "name": "img_p29_11.png",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 671.169,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_12.png",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 671.169,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_13.jpg",
          "height": 23.277,
          "width": 23.277,
          "x": 130.436,
          "y": 671.169,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 15,
              "y": 22,
              "w": 58,
              "h": 58,
              "confidence": 0.264,
              "text": "H"
            }
          ]
        },
        {
          "name": "img_p29_14.png",
          "height": 23.278,
          "width": 23.277,
          "x": 130.436,
          "y": 709.954,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_15.png",
          "height": 23.278,
          "width": 23.277,
          "x": 130.436,
          "y": 709.954,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p29_16.jpg",
          "height": 23.278,
          "width": 23.277,
          "x": 130.436,
          "y": 709.954,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 15,
              "y": 22,
              "w": 58,
              "h": 58,
              "confidence": 0.264,
              "text": "H"
            }
          ]
        },
        {
          "name": "img_p29_18.png",
          "height": 14.493,
          "width": 14.493,
          "x": 129.088,
          "y": 561.915,
          "original_width": 61,
          "original_height": 61,
          "rotation": 0
        },
        {
          "name": "img_p29_21.png",
          "height": 14.493,
          "width": 14.493,
          "x": 137.8,
          "y": 561.915,
          "original_width": 61,
          "original_height": 61,
          "rotation": 0
        },
        {
          "name": "page_30.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "* region). This nerve may get accidentally damaged in case of injection, leading to weakness or paralysis of lower limb.  \n* There is lot of fat in the buttocks. Vaccine gets deposited in this fat and either does not elicit or elicits a delayed or partial immune response.  \n* Anterolateral aspect (front and outer part) of mid-thigh is preferred site for giving injection in children as it provides the largest muscle mass, leading to quick absorption of vaccine into the blood capillaries.",
          "md": "* region). This nerve may get accidentally damaged in case of injection, leading to weakness or paralysis of lower limb.  \n* There is lot of fat in the buttocks. Vaccine gets deposited in this fat and either does not elicit or elicits a delayed or partial immune response.  \n* Anterolateral aspect (front and outer part) of mid-thigh is preferred site for giving injection in children as it provides the largest muscle mass, leading to quick absorption of vaccine into the blood capillaries.",
          "bBox": {
            "x": 58.46,
            "y": 69.43,
            "w": 452.74,
            "h": 659.72
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "52. Sometimes the same vaccine is of different colour in different vials. Does this have any effect on its efficacy?",
          "md": "### 52. Sometimes the same vaccine is of different colour in different vials. Does this have any effect on its efficacy?  ",
          "bBox": {
            "x": 102.48,
            "y": 190.01,
            "w": 405.74,
            "h": 539.15
          }
        },
        {
          "type": "text",
          "value": "**Ans.** No. All vaccines supplied for immunization programme undergo strict quality checks. There can be instances that colour of vaccine is slightly different in different vials, but this in no way affects the efficacy of vaccine.",
          "md": "**Ans.** No. All vaccines supplied for immunization programme undergo strict quality checks. There can be instances that colour of vaccine is slightly different in different vials, but this in no way affects the efficacy of vaccine.",
          "bBox": {
            "x": 58.46,
            "y": 229.11,
            "w": 452.74,
            "h": 500.05
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "53. What should be done if child spits out or vomits immediately after taking vaccine orally?",
          "md": "### 53. What should be done if child spits out or vomits immediately after taking vaccine orally?  ",
          "bBox": {
            "x": 102.48,
            "y": 295.83,
            "w": 405.74,
            "h": 433.32
          }
        },
        {
          "type": "text",
          "value": "**Ans.** If a child vomits immediately after taking vaccine orally, like OPV and rotavirus vaccines, then the vaccine dose should be given again. However, a repeat dose should be given after ensuring that child does not vomit it out again.",
          "md": "**Ans.** If a child vomits immediately after taking vaccine orally, like OPV and rotavirus vaccines, then the vaccine dose should be given again. However, a repeat dose should be given after ensuring that child does not vomit it out again.",
          "bBox": {
            "x": 58.5,
            "y": 229.11,
            "w": 452.71,
            "h": 500.05
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "54. During 6th, 10th, 14th weeks and 9 months when more than one vaccine is to be administered on the same day, is there a definite sequence in which vaccines need to be given?",
          "md": "### 54. During 6th, 10th, 14th weeks and 9 months when more than one vaccine is to be administered on the same day, is there a definite sequence in which vaccines need to be given?  ",
          "bBox": {
            "x": 58.46,
            "y": 396.32,
            "w": 449.74,
            "h": 332.83
          }
        },
        {
          "type": "text",
          "value": "**Ans.** During 6th, 10th, 14th weeks and 9 months, when multiple vaccines are to be administered, it is preferable for health workers/ vaccinators to follow the sequence as given below, for the sake of programmatic consistency and uniformity;",
          "md": "**Ans.** During 6th, 10th, 14th weeks and 9 months, when multiple vaccines are to be administered, it is preferable for health workers/ vaccinators to follow the sequence as given below, for the sake of programmatic consistency and uniformity;",
          "bBox": {
            "x": 58.46,
            "y": 229.11,
            "w": 452.75,
            "h": 500.05
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "6 Weeks",
              "10 Weeks",
              "14 Weeks",
              "9 Months"
            ],
            [
              "1<br/>OPV",
              "1<br/>OPV",
              "1<br/>OPV",
              "1<br/>Vit A"
            ],
            [
              "2<br/>RVV*",
              "2<br/>RVV*",
              "2<br/>RVV*",
              "2<br/>Measles / MR*"
            ],
            [
              "3<br/>fIPV",
              "3<br/>Penta",
              "3<br/>fIPV",
              "3<br/>PCV-B*"
            ],
            [
              "4<br/>PCV*",
              "",
              "4<br/>PCV*",
              "4<br/>JE*"
            ],
            [
              "5<br/>Penta",
              "",
              "5<br/>Penta",
              ""
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>6 Weeks</th>\n<th>10 Weeks</th>\n<th>14 Weeks</th>\n<th>9 Months</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>1<br />OPV</td>\n<td>1<br />OPV</td>\n<td>1<br />OPV</td>\n<td>1<br />Vit A</td>\n</tr>\n<tr>\n<td>2<br />RVV*</td>\n<td>2<br />RVV*</td>\n<td>2<br />RVV*</td>\n<td>2<br />Measles / MR*</td>\n</tr>\n<tr>\n<td>3<br />fIPV</td>\n<td>3<br />Penta</td>\n<td>3<br />fIPV</td>\n<td>3<br />PCV-B*</td>\n</tr>\n<tr>\n<td>4<br />PCV*</td>\n<td></td>\n<td>4<br />PCV*</td>\n<td>4<br />JE*</td>\n</tr>\n<tr>\n<td>5<br />Penta</td>\n<td></td>\n<td>5<br />Penta</td>\n<td></td>\n</tr>\n</tbody>\n</table>",
          "md": "| 6 Weeks     | 10 Weeks    | 14 Weeks    | 9 Months             |\n| ----------- | ----------- | ----------- | -------------------- |\n| 1<br/>OPV   | 1<br/>OPV   | 1<br/>OPV   | 1<br/>Vit A          |\n| 2<br/>RVV\\* | 2<br/>RVV\\* | 2<br/>RVV\\* | 2<br/>Measles / MR\\* |\n| 3<br/>fIPV  | 3<br/>Penta | 3<br/>fIPV  | 3<br/>PCV-B\\*        |\n| 4<br/>PCV\\* |             | 4<br/>PCV\\* | 4<br/>JE\\*           |\n| 5<br/>Penta |             | 5<br/>Penta |                      |",
          "isPerfectTable": false,
          "csv": "\"6 Weeks\",\"10 Weeks\",\"14 Weeks\",\"9 Months\"\n\"1<br/>OPV\",\"1<br/>OPV\",\"1<br/>OPV\",\"1<br/>Vit A\"\n\"2<br/>RVV*\",\"2<br/>RVV*\",\"2<br/>RVV*\",\"2<br/>Measles / MR*\"\n\"3<br/>fIPV\",\"3<br/>Penta\",\"3<br/>fIPV\",\"3<br/>PCV-B*\"\n\"4<br/>PCV*\",\"\",\"4<br/>PCV*\",\"4<br/>JE*\"\n\"5<br/>Penta\",\"\",\"5<br/>Penta\",\"\"",
          "bBox": {
            "x": 58.46,
            "y": 55.42,
            "w": 454.44,
            "h": 773.29
          }
        },
        {
          "type": "text",
          "value": "*Wherever applicable",
          "md": "*Wherever applicable",
          "bBox": {
            "x": 134.04,
            "y": 637.33,
            "w": 377.18,
            "h": 113.48
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 31,
      "text": "Q\nQ 55. What precautions should be taken at time of opening a vaccine\n             vial?\nAns.     Before opening vaccine vial, check the following;\n          à  Label for type of vaccine, the label must be readable\n          à  Expiry date\n          à  Status of VVM\n          à  Cap or bottle is not cracked\n          à  The vaccine is not visibly frozen, in case the vaccine is freeze-sensitive\n         Note: Just after opening the vial (and reconstituting it, when applicable), health\n         worker/vaccinator should mention the date and time of opening on the vial.\n\n          56. What specific precautions should be taken during vaccine\n             administration?\nAns.     There are few specific precautions that should be taken by you. These are:\n          à  Check the label for expiry date and the VVM label of the vaccine vials and\n             diluents before use.\n          à  Always use a new AD syringe for administering injectable vaccine.\n          à  Always use a new syringe for reconstituting the vaccine (BCG, Measles/MR and\n             JE vaccines).\n          à  Ensure that the vaccine and diluents are of the same temperature and supplied\n             by the same manufacturer (bundled) before reconstituting.\n          à  Check expiry date and packaging of AD syringe before opening it.\n          à  Never mix two or more injectable vaccines in the same syringe.\n          à  Never use spirit, soap or liquid antibiotic to clean injection site. Water swab is\nQ à adequate.\n             Never rub or touch injection site after vaccine administration.\n\n          57. What are AD syringes?\n\nAns.     AD or Auto Disabled syringes are specialized plastic syringes introduced in UIP for\n         administering injectable vaccines. Once used, these syringes get locked, as the\n         plunger cannot be withdrawn to refill the syringe with vaccine again. This avoids\n         reuse or misuse of used syringes, and prevents transmission of infections from one\n         child or a pregnant woman to another.\n         Care should be taken that under no condition different vaccines are withdrawn\n         or mixed in the same syringe. You must use a new AD syringe for every vaccine\n         administered to a child. The syringe should be opened from the plunger-end and\n         only when vaccine is to be administered.\n\n\n\n\n\n24 IFAQs on Immunization",
      "md": "\n**Q 55. What precautions should be taken at time of opening a vaccine vial?**  \n**Ans.** Before opening vaccine vial, check the following;  \n* Label for type of vaccine, the label must be readable  \n* Expiry date  \n* Status of VVM  \n* Cap or bottle is not cracked  \n* The vaccine is not visibly frozen, in case the vaccine is freeze-sensitive  \n\n**Note:** Just after opening the vial (and reconstituting it, when applicable), health worker/vaccinator should mention the date and time of opening on the vial.\n\n----\n\n**Q 56. What specific precautions should be taken during vaccine administration?**  \n**Ans.** There are few specific precautions that should be taken by you. These are:  \n* Check the label for expiry date and the VVM label of the vaccine vials and diluents before use.  \n* Always use a new AD syringe for administering injectable vaccine.  \n* Always use a new syringe for reconstituting the vaccine (BCG, Measles/MR and JE vaccines).  \n* Ensure that the vaccine and diluents are of the same temperature and supplied by the same manufacturer (bundled) before reconstituting.  \n* Check expiry date and packaging of AD syringe before opening it.  \n* Never mix two or more injectable vaccines in the same syringe.  \n* Never use spirit, soap or liquid antibiotic to clean injection site. Water swab is adequate.  \n* Never rub or touch injection site after vaccine administration.\n\n----\n\n**Q 57. What are AD syringes?**  \n**Ans.** AD or Auto Disabled syringes are specialized plastic syringes introduced in UIP for administering injectable vaccines. Once used, these syringes get locked, as the plunger cannot be withdrawn to refill the syringe with vaccine again. This avoids reuse or misuse of used syringes, and prevents transmission of infections from one child or a pregnant woman to another.  \n\nCare should be taken that under no condition different vaccines are withdrawn or mixed in the same syringe. You must use a new AD syringe for every vaccine administered to a child. The syringe should be opened from the plunger-end and only when vaccine is to be administered.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_31.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q 55. What precautions should be taken at time of opening a vaccine vial?**  \n**Ans.** Before opening vaccine vial, check the following;  \n* Label for type of vaccine, the label must be readable  \n* Expiry date  \n* Status of VVM  \n* Cap or bottle is not cracked  \n* The vaccine is not visibly frozen, in case the vaccine is freeze-sensitive",
          "md": "**Q 55. What precautions should be taken at time of opening a vaccine vial?**  \n**Ans.** Before opening vaccine vial, check the following;  \n* Label for type of vaccine, the label must be readable  \n* Expiry date  \n* Status of VVM  \n* Cap or bottle is not cracked  \n* The vaccine is not visibly frozen, in case the vaccine is freeze-sensitive",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.45,
            "h": 554.3
          }
        },
        {
          "type": "text",
          "value": "**Note:** Just after opening the vial (and reconstituting it, when applicable), health worker/vaccinator should mention the date and time of opening on the vial.",
          "md": "**Note:** Just after opening the vial (and reconstituting it, when applicable), health worker/vaccinator should mention the date and time of opening on the vial.",
          "bBox": {
            "x": 128.4,
            "y": 238.28,
            "w": 388.83,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 56. What specific precautions should be taken during vaccine administration?**  \n**Ans.** There are few specific precautions that should be taken by you. These are:  \n* Check the label for expiry date and the VVM label of the vaccine vials and diluents before use.  \n* Always use a new AD syringe for administering injectable vaccine.  \n* Always use a new syringe for reconstituting the vaccine (BCG, Measles/MR and JE vaccines).  \n* Ensure that the vaccine and diluents are of the same temperature and supplied by the same manufacturer (bundled) before reconstituting.  \n* Check expiry date and packaging of AD syringe before opening it.  \n* Never mix two or more injectable vaccines in the same syringe.  \n* Never use spirit, soap or liquid antibiotic to clean injection site. Water swab is adequate.  \n* Never rub or touch injection site after vaccine administration.",
          "md": "**Q 56. What specific precautions should be taken during vaccine administration?**  \n**Ans.** There are few specific precautions that should be taken by you. These are:  \n* Check the label for expiry date and the VVM label of the vaccine vials and diluents before use.  \n* Always use a new AD syringe for administering injectable vaccine.  \n* Always use a new syringe for reconstituting the vaccine (BCG, Measles/MR and JE vaccines).  \n* Ensure that the vaccine and diluents are of the same temperature and supplied by the same manufacturer (bundled) before reconstituting.  \n* Check expiry date and packaging of AD syringe before opening it.  \n* Never mix two or more injectable vaccines in the same syringe.  \n* Never use spirit, soap or liquid antibiotic to clean injection site. Water swab is adequate.  \n* Never rub or touch injection site after vaccine administration.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.43,
            "h": 554.3
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q 57. What are AD syringes?**  \n**Ans.** AD or Auto Disabled syringes are specialized plastic syringes introduced in UIP for administering injectable vaccines. Once used, these syringes get locked, as the plunger cannot be withdrawn to refill the syringe with vaccine again. This avoids reuse or misuse of used syringes, and prevents transmission of infections from one child or a pregnant woman to another.",
          "md": "**Q 57. What are AD syringes?**  \n**Ans.** AD or Auto Disabled syringes are specialized plastic syringes introduced in UIP for administering injectable vaccines. Once used, these syringes get locked, as the plunger cannot be withdrawn to refill the syringe with vaccine again. This avoids reuse or misuse of used syringes, and prevents transmission of infections from one child or a pregnant woman to another.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.42,
            "h": 612.28
          }
        },
        {
          "type": "text",
          "value": "Care should be taken that under no condition different vaccines are withdrawn or mixed in the same syringe. You must use a new AD syringe for every vaccine administered to a child. The syringe should be opened from the plunger-end and only when vaccine is to be administered.",
          "md": "Care should be taken that under no condition different vaccines are withdrawn or mixed in the same syringe. You must use a new AD syringe for every vaccine administered to a child. The syringe should be opened from the plunger-end and only when vaccine is to be administered.",
          "bBox": {
            "x": 128.4,
            "y": 682.24,
            "w": 408.38,
            "h": 55.49
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.994
    },
    {
      "page": 32,
      "text": "    Hub\n\n\n    Needle Cap    -Stop\n\n\n\n    Needle    Syringe    Plunger\n\n\n\n\n\n            Aﬅer withdrawing\nTear the package    Remove the needle cap   Invert the vial and     the vaccine, tap the barrel\nfrom the plunger    by holding the sy-      insert the needle       to bring the bubbles\n    side            ringe(not plunger)      through the septum      towards the tip\n\n\n    Plunger\n\n\n\n\n\n\n\n\n\n\n    DO NOT touch the needle  DO NOT recap the needle  DO NOT bend the needle\n\n\n\n\n\n\n\n\n\n    X\n    X\n    X\n\n\n    Figure 5: Using AD syringe\n\n\n\n\n\n\n\n\n\n\n    FAQs on ImmunizationI 25",
      "md": "    Hub\n\n    Needle Cap    -Stop\n\n    Needle    Syringe    Plunger\n\n            Aﬅer withdrawing\nTear the package    Remove the needle cap   Invert the vial and     the vaccine, tap the barrel\nfrom the plunger    by holding the sy-      insert the needle       to bring the bubbles\n    side            ringe(not plunger)      through the septum      towards the tip\n\n    Plunger\n\n    DO NOT touch the needle  DO NOT recap the needle  DO NOT bend the needle\n\n    X\n    X\n    X\n\n    Figure 5: Using AD syringe\n\n    FAQs on ImmunizationI 25",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p31_2.jpg",
          "height": 26.887,
          "width": 29.637,
          "x": 117.731,
          "y": 423.925,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_3.jpg",
          "height": 26.887,
          "width": 29.599,
          "x": 147.292,
          "y": 423.925,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_4.png",
          "height": 26.887,
          "width": 29.636,
          "x": 176.816,
          "y": 423.925,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_5.jpg",
          "height": 26.888,
          "width": 29.637,
          "x": 117.731,
          "y": 450.737,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_6.jpg",
          "height": 26.888,
          "width": 29.599,
          "x": 147.292,
          "y": 450.737,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_7.jpg",
          "height": 26.888,
          "width": 29.636,
          "x": 176.816,
          "y": 450.737,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_8.jpg",
          "height": 26.888,
          "width": 29.637,
          "x": 117.731,
          "y": 477.549,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_9.jpg",
          "height": 26.888,
          "width": 29.599,
          "x": 147.292,
          "y": 477.549,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_10.jpg",
          "height": 26.888,
          "width": 29.636,
          "x": 176.816,
          "y": 477.549,
          "original_width": 124,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_11.jpg",
          "height": 37.802,
          "width": 38.312,
          "x": 179.285,
          "y": 488.638,
          "original_width": 160,
          "original_height": 158,
          "rotation": 0,
          "ocr": [
            {
              "x": 2,
              "y": 2,
              "w": 150,
              "h": 149,
              "confidence": 0.793,
              "text": "X"
            }
          ]
        },
        {
          "name": "img_p31_12.jpg",
          "height": 15.741,
          "width": 27.114,
          "x": 179.301,
          "y": 488.658,
          "original_width": 113,
          "original_height": 66,
          "rotation": 0
        },
        {
          "name": "img_p31_13.png",
          "height": 26.92,
          "width": 32.329,
          "x": 179.285,
          "y": 488.638,
          "original_width": 135,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p31_14.jpg",
          "height": 34.11,
          "width": 35.283,
          "x": 232.553,
          "y": 426.106,
          "original_width": 148,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_15.jpg",
          "height": 34.11,
          "width": 35.246,
          "x": 267.76,
          "y": 426.106,
          "original_width": 147,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_16.jpg",
          "height": 34.11,
          "width": 35.283,
          "x": 302.93,
          "y": 426.106,
          "original_width": 148,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_17.jpg",
          "height": 34.111,
          "width": 35.283,
          "x": 232.553,
          "y": 460.141,
          "original_width": 148,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_18.jpg",
          "height": 34.111,
          "width": 35.246,
          "x": 267.76,
          "y": 460.141,
          "original_width": 147,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_19.jpg",
          "height": 34.111,
          "width": 35.283,
          "x": 302.93,
          "y": 460.141,
          "original_width": 148,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p31_11.jpg",
          "height": 37.802,
          "width": 38.312,
          "x": 179.285,
          "y": 488.638,
          "original_width": 160,
          "original_height": 158,
          "rotation": 0,
          "ocr": [
            {
              "x": 2,
              "y": 2,
              "w": 150,
              "h": 149,
              "confidence": 0.793,
              "text": "X"
            }
          ]
        },
        {
          "name": "img_p31_22.png",
          "height": 23.61,
          "width": 24.247,
          "x": 310.951,
          "y": 488.638,
          "original_width": 102,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p31_23.jpg",
          "height": 25.502,
          "width": 92.868,
          "x": 369.091,
          "y": 426.968,
          "original_width": 387,
          "original_height": 107,
          "rotation": 0
        },
        {
          "name": "img_p31_24.jpg",
          "height": 25.451,
          "width": 92.868,
          "x": 369.091,
          "y": 452.369,
          "original_width": 387,
          "original_height": 107,
          "rotation": 0
        },
        {
          "name": "img_p31_25.jpg",
          "height": 25.502,
          "width": 92.868,
          "x": 369.091,
          "y": 477.719,
          "original_width": 387,
          "original_height": 107,
          "rotation": 0
        },
        {
          "name": "img_p31_11.jpg",
          "height": 37.802,
          "width": 38.312,
          "x": 179.285,
          "y": 488.638,
          "original_width": 160,
          "original_height": 158,
          "rotation": 0,
          "ocr": [
            {
              "x": 2,
              "y": 2,
              "w": 150,
              "h": 149,
              "confidence": 0.793,
              "text": "X"
            }
          ]
        },
        {
          "name": "img_p31_27.png",
          "height": 14.544,
          "width": 27.623,
          "x": 434.285,
          "y": 488.627,
          "original_width": 116,
          "original_height": 61,
          "rotation": 0
        },
        {
          "name": "img_p31_28.png",
          "height": 23.738,
          "width": 24.438,
          "x": 434.284,
          "y": 488.638,
          "original_width": 102,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p31_29.jpg",
          "height": 82.668,
          "width": 339.39,
          "x": 147.163,
          "y": 60.514,
          "original_width": 1868,
          "original_height": 455,
          "rotation": 0,
          "ocr": [
            {
              "x": 1114,
              "y": 160,
              "w": 179,
              "h": 68,
              "confidence": 0.918,
              "text": "-Stop"
            }
          ]
        },
        {
          "name": "img_p31_30.jpg",
          "height": 27.459,
          "width": 34.727,
          "x": 412.695,
          "y": 268.81,
          "original_width": 145,
          "original_height": 115,
          "rotation": 0
        },
        {
          "name": "page_32.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "Hub",
          "md": "Hub",
          "bBox": {
            "x": 273.8,
            "y": 66.23,
            "w": 14.83,
            "h": 8.41
          }
        },
        {
          "type": "text",
          "value": "Needle Cap    -Stop",
          "md": "Needle Cap    -Stop",
          "bBox": {
            "x": 76.9,
            "y": 89.58,
            "w": 305.18,
            "h": 63.07
          }
        },
        {
          "type": "text",
          "value": "Needle    Syringe    Plunger",
          "md": "Needle    Syringe    Plunger",
          "bBox": {
            "x": 107.11,
            "y": 144.24,
            "w": 365.18,
            "h": 135.47
          }
        },
        {
          "type": "text",
          "value": "Aﬅer withdrawing\nTear the package    Remove the needle cap   Invert the vial and     the vaccine, tap the barrel\nfrom the plunger    by holding the sy-      insert the needle       to bring the bubbles\n    side            ringe(not plunger)      through the septum      towards the tip",
          "md": "Aﬅer withdrawing\nTear the package    Remove the needle cap   Invert the vial and     the vaccine, tap the barrel\nfrom the plunger    by holding the sy-      insert the needle       to bring the bubbles\n    side            ringe(not plunger)      through the septum      towards the tip",
          "bBox": {
            "x": 76.9,
            "y": 97,
            "w": 418.49,
            "h": 182.71
          }
        },
        {
          "type": "text",
          "value": "Plunger",
          "md": "Plunger",
          "bBox": {
            "x": 107.11,
            "y": 144.24,
            "w": 365.18,
            "h": 135.47
          }
        },
        {
          "type": "text",
          "value": "DO NOT touch the needle  DO NOT recap the needle  DO NOT bend the needle",
          "md": "DO NOT touch the needle  DO NOT recap the needle  DO NOT bend the needle",
          "bBox": {
            "x": 114.11,
            "y": 144.24,
            "w": 345.55,
            "h": 253.9
          }
        },
        {
          "type": "text",
          "value": "X\n    X\n    X",
          "md": "X\n    X\n    X",
          "bBox": {
            "x": 179.76,
            "y": 489.12,
            "w": 35.92,
            "h": 35.65
          }
        },
        {
          "type": "text",
          "value": "Figure 5: Using AD syringe",
          "md": "Figure 5: Using AD syringe",
          "bBox": {
            "x": 240.89,
            "y": 144.24,
            "w": 163.38,
            "h": 417.72
          }
        },
        {
          "type": "text",
          "value": "FAQs on ImmunizationI 25",
          "md": "FAQs on ImmunizationI 25",
          "bBox": {
            "x": 377.72,
            "y": 804.71,
            "w": 135.5,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 33,
      "text": "26 IFAQs on Immunization",
      "md": "26 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_33.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "26 IFAQs on Immunization",
          "md": "26 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 136.38,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 34,
      "text": "SECTION: 7\nCold Chain\n\n\n\n\n\n\n\n         58. What is “Cold Chain” for vaccines?\n\nAns.     Cold chain is a system for storing and transporting vaccines at recommended temperatures\n         from the point of manufacture till the point of use (administration to beneficiary). The\n         system comprises of walk-in freezers, walk-in coolers, deep freezers, ice-lined refrigerators\n         installed at different levels for the storage of vaccines, and refrigerated vaccine vans/\n         insulated vaccine vans, vaccine carriers and insulated cold boxes for transportation. Entire\n         system is closely monitored to ensure delivery of potent and effective vaccines to the\n         beneficiary.\n\n             Primary Store     District Vaccine Store    Immunization\n             (GMSD &/ State)    ILR & DF                 Session Site\n             WIC & WIF\n\n\n\n\n\n\n\nInsulated Van  Insulated Van  Insulated Van  Vaccine Carrier\n\nVaccine                                                     Mother and\nManufacturer                                                Child\n\n\nState Store    Primary Health Centre\nWIC & WIF      ILR\n\nFigure 6: Storage and transportation of vaccines (Cold Chain System)\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  27\n                 27",
      "md": "\n# SECTION: 7  \n## Cold Chain\n\n**58. What is “Cold Chain” for vaccines?**\n\n**Ans.** Cold chain is a system for storing and transporting vaccines at recommended temperatures from the point of manufacture till the point of use (administration to beneficiary). The system comprises of walk-in freezers, walk-in coolers, deep freezers, ice-lined refrigerators installed at different levels for the storage of vaccines, and refrigerated vaccine vans/insulated vaccine vans, vaccine carriers and insulated cold boxes for transportation. Entire system is closely monitored to ensure delivery of potent and effective vaccines to the beneficiary.\n\n<table>\n  <tr>\n    <td>Primary Store<br>(GMSD &/ State)<br>WIC & WIF</td>\n<td>District Vaccine Store<br>ILR & DF</td>\n<td>Immunization<br>Session Site</td>\n  </tr>\n<tr>\n    <td colspan=\"3\" style=\"text-align:center;\">Insulated Van → Insulated Van → Insulated Van → Vaccine Carrier</td>\n  </tr>\n<tr>\n    <td>Vaccine Manufacturer</td>\n<td></td>\n<td>Mother and Child</td>\n  </tr>\n<tr>\n    <td>State Store<br>WIC & WIF</td>\n<td>Primary Health Centre<br>ILR</td>\n<td></td>\n  </tr>\n</table>\n\n*Figure 6: Storage and transportation of vaccines (Cold Chain System)*\n\n",
      "images": [
        {
          "name": "img_p19_1.png",
          "height": 140.88,
          "width": 420.72,
          "x": -0.24,
          "y": 701.25,
          "original_width": 1753,
          "original_height": 587,
          "rotation": 0
        },
        {
          "name": "img_p19_2.png",
          "height": 140.88,
          "width": 175.92,
          "x": 419.76,
          "y": 701.25,
          "original_width": 733,
          "original_height": 587,
          "rotation": 0
        },
        {
          "name": "img_p19_3.png",
          "height": 351.6,
          "width": 105.6,
          "x": -0.24,
          "y": 350.37,
          "original_width": 440,
          "original_height": 1465,
          "rotation": 0
        },
        {
          "name": "img_p19_4.png",
          "height": 421.68,
          "width": 70.8,
          "x": 524.88,
          "y": 280.29,
          "original_width": 295,
          "original_height": 1757,
          "rotation": 0
        },
        {
          "name": "img_p33_5.png",
          "height": 141.12,
          "width": 420.96,
          "x": 104.64,
          "y": 350.37,
          "original_width": 1754,
          "original_height": 588,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_9.png",
          "height": 35.76,
          "width": 280.8,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1170,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_12.png",
          "height": 175.92,
          "width": 35.76,
          "x": 559.92,
          "y": -0.27,
          "original_width": 149,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_19.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p33_28.png",
          "height": 238.08,
          "width": 136.32,
          "x": 93.84,
          "y": 482.13,
          "original_width": 568,
          "original_height": 992,
          "rotation": 0
        },
        {
          "name": "img_p33_29.png",
          "height": 34.8,
          "width": 306,
          "x": 229.44,
          "y": 685.41,
          "original_width": 1275,
          "original_height": 145,
          "rotation": 0
        },
        {
          "name": "img_p33_30.png",
          "height": 204,
          "width": 271.92,
          "x": 263.52,
          "y": 482.13,
          "original_width": 1133,
          "original_height": 850,
          "rotation": 0
        },
        {
          "name": "page_34.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 7",
          "md": "# SECTION: 7  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Cold Chain",
          "md": "## Cold Chain",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**58. What is “Cold Chain” for vaccines?**",
          "md": "**58. What is “Cold Chain” for vaccines?**",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Cold chain is a system for storing and transporting vaccines at recommended temperatures from the point of manufacture till the point of use (administration to beneficiary). The system comprises of walk-in freezers, walk-in coolers, deep freezers, ice-lined refrigerators installed at different levels for the storage of vaccines, and refrigerated vaccine vans/insulated vaccine vans, vaccine carriers and insulated cold boxes for transportation. Entire system is closely monitored to ensure delivery of potent and effective vaccines to the beneficiary.",
          "md": "**Ans.** Cold chain is a system for storing and transporting vaccines at recommended temperatures from the point of manufacture till the point of use (administration to beneficiary). The system comprises of walk-in freezers, walk-in coolers, deep freezers, ice-lined refrigerators installed at different levels for the storage of vaccines, and refrigerated vaccine vans/insulated vaccine vans, vaccine carriers and insulated cold boxes for transportation. Entire system is closely monitored to ensure delivery of potent and effective vaccines to the beneficiary.",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 478.29,
            "h": 604.55
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Primary Store<br/>(GMSD &/ State)<br/>WIC & WIF",
              "District Vaccine Store<br/>ILR & DF",
              "Immunization<br/>Session Site"
            ],
            [
              "Insulated Van → Insulated Van → Insulated Van → Vaccine Carrier",
              "",
              ""
            ],
            [
              "Vaccine Manufacturer",
              "",
              "Mother and Child"
            ],
            [
              "State Store<br/>WIC & WIF",
              "Primary Health Centre<br/>ILR",
              ""
            ]
          ],
          "html": "<table>\n  <tr>\n    <td>Primary Store<br />(GMSD &#x26;/ State)<br />WIC &#x26; WIF</td>\n<td>District Vaccine Store<br />ILR &#x26; DF</td>\n<td>Immunization<br />Session Site</td>\n  </tr>\n<tr>\n    <td colspan=\"3\" style=\"text-align:center;\">Insulated Van → Insulated Van → Insulated Van → Vaccine Carrier</td>\n  </tr>\n<tr>\n    <td>Vaccine Manufacturer</td>\n<td></td>\n<td>Mother and Child</td>\n  </tr>\n<tr>\n    <td>State Store<br />WIC &#x26; WIF</td>\n<td>Primary Health Centre<br />ILR</td>\n<td></td>\n  </tr>\n</table>",
          "md": "| Primary Store<br/>(GMSD &/ State)<br/>WIC & WIF                 | District Vaccine Store<br/>ILR & DF | Immunization<br/>Session Site |\n| --------------------------------------------------------------- | ----------------------------------- | ----------------------------- |\n| Insulated Van → Insulated Van → Insulated Van → Vaccine Carrier |                                     |                               |\n| Vaccine Manufacturer                                            |                                     | Mother and Child              |\n| State Store<br/>WIC & WIF                                       | Primary Health Centre<br/>ILR       |                               |",
          "isPerfectTable": false,
          "csv": "\"Primary Store<br/>(GMSD &/ State)<br/>WIC & WIF\",\"District Vaccine Store<br/>ILR & DF\",\"Immunization<br/>Session Site\"\n\"Insulated Van → Insulated Van → Insulated Van → Vaccine Carrier\",\"\",\"\"\n\"Vaccine Manufacturer\",\"\",\"Mother and Child\"\n\"State Store<br/>WIC & WIF\",\"Primary Health Centre<br/>ILR\",\"\"",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 478.29,
            "h": 632.31
          }
        },
        {
          "type": "text",
          "value": "*Figure 6: Storage and transportation of vaccines (Cold Chain System)*",
          "md": "*Figure 6: Storage and transportation of vaccines (Cold Chain System)*",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.986
    },
    {
      "page": 35,
      "text": "    Q\n    Q 59. What is the recommended temperature for storage of vaccines\n             at the health facilities and immunization session sites?\n    Ans.     At health facilities and immunization session sites, all vaccines should always be\n             stored at the recommended temperature between +2ᴼC to +8ᴼC.\n             Care should be taken to avoid keeping vaccines in conditions where the temperature\n             is much lower (for example, freezers that are used for preparing ice), or where\n             temperature is higher (for example, in direct sunlight). If a vaccine is not stored or\n             transported at recommended temperature, there may be decline in potency and\n             efficacy of the vaccine.\n\n             60. What should be the order from bottom to top for storing\n             vaccines inside ice lined refrigerator?\n    Ans.     The order of different vaccines from bottom to top inside an ice lined refrigerator\n             should be;\n             OPV (bottom most), Measles/MR, BCG, JE, Rotavirus, TT, DPT, IPV, Pentavalent,\n             PCV, Hepatitis B, followed by diluents (top most).\n\n\n                                                        To\n                                                        To be\n                                                                             be used\n                                                                                used\n                                            O7           Opened vials of Hep. B, DPT, TT,\n                                                         Pentavalent, OPV, IPV and PCV provided;\n                                                           1. VVM is intact and in usable stage\n                                                           2. Date and time of opening is mentioned\n                                                           on the vial\n                                                           3. Vial is within 28 days of opening\n                                                           4. Date of expiry has not reached/crossed\n                                                           5. The vaccine vial septum is not contaminated\n\n Diluents        Diluents     Diluents       Diluents\n  Hep B          Hep B         Hep B          Hep B     Not to be used\n    Pentavalent  Pentavalent    PCV            PCV      Not to be used\n   DPT             DPT          IPV            IPV\n    TT             TT            TT             TT         1. Opened vials of BCG, Measles/MR, JE and RVV\n   Rota            Rota         Rota           Rota        2. All empty vaccine vials\n     ~~BCG~~        ~~BCG~~       ~~JE~~         ~~JE~~  \nMeasles/MR        Measles/MR     Measles/MR Measles/MR     3. VVM is not in usable stage\n   OPV             OPV          OPV            OPV         4. Date and time of opening is not mentioned\n                                                           5. 28 days of opening of vial have passed\n\n                                            *These vials should be discarded after 48 hours or before the\n                                           next session, whichever is earlier as per the CPCB guidelines.\n\n                                 Figure 7: ILR with vaccine arrangement (Front view)\n\n\n\n\n\n\n\n\n\n\n    28 IFAQs on Immunization",
      "md": "\n**Q59. What is the recommended temperature for storage of vaccines at the health facilities and immunization session sites?**\n\n**Ans.** At health facilities and immunization session sites, all vaccines should always be stored at the recommended temperature between +2°C to +8°C.\n\nCare should be taken to avoid keeping vaccines in conditions where the temperature is much lower (for example, freezers that are used for preparing ice), or where temperature is higher (for example, in direct sunlight). If a vaccine is not stored or transported at recommended temperature, there may be decline in potency and efficacy of the vaccine.\n\n----\n\n**Q60. What should be the order from bottom to top for storing vaccines inside ice lined refrigerator?**\n\n**Ans.** The order of different vaccines from bottom to top inside an ice lined refrigerator should be;\n\n**OPV (bottom most), Measles/MR, BCG, JE, Rotavirus, TT, DPT, IPV, Pentavalent, PCV, Hepatitis B, followed by diluents (top most).**\n\n----\n\n<table>\n  <thead>\n    <tr>\n      <th colspan=\"4\">Diluents</th>\n      <th rowspan=\"10\" style=\"vertical-align:top; border-left: 2px solid black;\">\n        <b>Not to be used</b><br>\n        1. Opened vials of BCG, Measles/MR, JE and RVV<br>\n        2. All empty vaccine vials<br>\n        3. VVM is not in usable stage<br>\n        4. Date and time of opening is not mentioned<br>\n        5. 28 days of opening of vial have passed<br><br>\n        <i>*These vials should be discarded after 48 hours or before the next session, whichever is earlier as per the CPCB guidelines.</i>\n      </th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>Hep B</td>\n<td>Hep B</td>\n<td>Hep B</td>\n<td>Hep B</td>\n    </tr>\n<tr>\n      <td>Pentavalent</td>\n<td>Pentavalent</td>\n<td>PCV</td>\n<td>PCV</td>\n    </tr>\n<tr>\n      <td>DPT</td>\n<td>DPT</td>\n<td>IPV</td>\n<td>IPV</td>\n    </tr>\n<tr>\n      <td>TT</td>\n<td>TT</td>\n<td>TT</td>\n<td>TT</td>\n    </tr>\n<tr>\n      <td>Rota</td>\n<td>Rota</td>\n<td>Rota</td>\n<td>Rota</td>\n    </tr>\n<tr>\n      <td><s>BCG</s></td>\n<td><s>BCG</s></td>\n<td><s>JE</s></td>\n<td><s>JE</s></td>\n    </tr>\n<tr>\n      <td>Measles/MR</td>\n<td>Measles/MR</td>\n<td>Measles/MR</td>\n<td>Measles/MR</td>\n    </tr>\n<tr>\n      <td>OPV</td>\n<td>OPV</td>\n<td>OPV</td>\n<td>OPV</td>\n    </tr>\n  </tbody>\n</table>\n\n----\n\n> ### To be used  \n> Opened vials of Hep. B, DPT, TT, Pentavalent, OPV, IPV and PCV provided;  \n> 1. VVM is intact and in usable stage  \n> 2. Date and time of opening is mentioned on the vial  \n> 3. Vial is within 28 days of opening  \n> 4. Date of expiry has not reached/crossed  \n> 5. The vaccine vial septum is not contaminated  \n\n----\n\n*Figure 7: ILR with vaccine arrangement (Front view)*\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p34_6.jpg",
          "height": 63.292,
          "width": 100.605,
          "x": 113.864,
          "y": 388.933,
          "original_width": 420,
          "original_height": 264,
          "rotation": 0
        },
        {
          "name": "img_p34_7.jpg",
          "height": 63.292,
          "width": 100.604,
          "x": 214.304,
          "y": 388.933,
          "original_width": 420,
          "original_height": 264,
          "rotation": 0,
          "ocr": [
            {
              "x": 61,
              "y": 37,
              "w": 21,
              "h": 15,
              "confidence": 0.54,
              "text": "O7"
            }
          ]
        },
        {
          "name": "img_p34_8.jpg",
          "height": 63.377,
          "width": 100.605,
          "x": 113.864,
          "y": 452.055,
          "original_width": 420,
          "original_height": 265,
          "rotation": 0
        },
        {
          "name": "img_p34_9.jpg",
          "height": 63.377,
          "width": 100.604,
          "x": 214.304,
          "y": 452.055,
          "original_width": 420,
          "original_height": 265,
          "rotation": 0
        },
        {
          "name": "img_p34_10.png",
          "height": 94.895,
          "width": 33.645,
          "x": 113.864,
          "y": 515.262,
          "original_width": 141,
          "original_height": 396,
          "rotation": 0
        },
        {
          "name": "img_p34_11.jpg",
          "height": 94.895,
          "width": 33.645,
          "x": 180.824,
          "y": 515.262,
          "original_width": 141,
          "original_height": 396,
          "rotation": 0
        },
        {
          "name": "img_p34_12.jpg",
          "height": 94.895,
          "width": 67.125,
          "x": 247.783,
          "y": 515.262,
          "original_width": 280,
          "original_height": 396,
          "rotation": 0
        },
        {
          "name": "img_p34_13.jpg",
          "height": 31.774,
          "width": 33.645,
          "x": 147.344,
          "y": 578.383,
          "original_width": 141,
          "original_height": 133,
          "rotation": 0
        },
        {
          "name": "img_p34_14.jpg",
          "height": 31.774,
          "width": 33.645,
          "x": 214.304,
          "y": 578.383,
          "original_width": 141,
          "original_height": 133,
          "rotation": 0
        },
        {
          "name": "img_p34_15.jpg",
          "height": 14.566,
          "width": 32.735,
          "x": 117.419,
          "y": 502.399,
          "original_width": 137,
          "original_height": 61,
          "rotation": 0
        },
        {
          "name": "img_p34_16.jpg",
          "height": 8.348,
          "width": 32.239,
          "x": 117.915,
          "y": 503.591,
          "original_width": 135,
          "original_height": 35,
          "rotation": 0
        },
        {
          "name": "img_p34_18.png",
          "height": 14.566,
          "width": 32.653,
          "x": 193.058,
          "y": 502.399,
          "original_width": 137,
          "original_height": 61,
          "rotation": 0
        },
        {
          "name": "img_p34_19.jpg",
          "height": 8.348,
          "width": 32.239,
          "x": 193.472,
          "y": 503.591,
          "original_width": 135,
          "original_height": 35,
          "rotation": 0
        },
        {
          "name": "page_35.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q59. What is the recommended temperature for storage of vaccines at the health facilities and immunization session sites?**",
          "md": "**Q59. What is the recommended temperature for storage of vaccines at the health facilities and immunization session sites?**",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 449.76,
            "h": 490.82
          }
        },
        {
          "type": "text",
          "value": "**Ans.** At health facilities and immunization session sites, all vaccines should always be stored at the recommended temperature between +2°C to +8°C.",
          "md": "**Ans.** At health facilities and immunization session sites, all vaccines should always be stored at the recommended temperature between +2°C to +8°C.",
          "bBox": {
            "x": 86.4,
            "y": 99.67,
            "w": 450.38,
            "h": 449.62
          }
        },
        {
          "type": "text",
          "value": "Care should be taken to avoid keeping vaccines in conditions where the temperature is much lower (for example, freezers that are used for preparing ice), or where temperature is higher (for example, in direct sunlight). If a vaccine is not stored or transported at recommended temperature, there may be decline in potency and efficacy of the vaccine.",
          "md": "Care should be taken to avoid keeping vaccines in conditions where the temperature is much lower (for example, freezers that are used for preparing ice), or where temperature is higher (for example, in direct sunlight). If a vaccine is not stored or transported at recommended temperature, there may be decline in potency and efficacy of the vaccine.",
          "bBox": {
            "x": 128.4,
            "y": 137.66,
            "w": 408.4,
            "h": 251.94
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Q60. What should be the order from bottom to top for storing vaccines inside ice lined refrigerator?**",
          "md": "**Q60. What should be the order from bottom to top for storing vaccines inside ice lined refrigerator?**",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 449.77,
            "h": 490.82
          }
        },
        {
          "type": "text",
          "value": "**Ans.** The order of different vaccines from bottom to top inside an ice lined refrigerator should be;",
          "md": "**Ans.** The order of different vaccines from bottom to top inside an ice lined refrigerator should be;",
          "bBox": {
            "x": 86.4,
            "y": 99.67,
            "w": 450.4,
            "h": 449.62
          }
        },
        {
          "type": "text",
          "value": "**OPV (bottom most), Measles/MR, BCG, JE, Rotavirus, TT, DPT, IPV, Pentavalent, PCV, Hepatitis B, followed by diluents (top most).**",
          "md": "**OPV (bottom most), Measles/MR, BCG, JE, Rotavirus, TT, DPT, IPV, Pentavalent, PCV, Hepatitis B, followed by diluents (top most).**",
          "bBox": {
            "x": 123.42,
            "y": 309.54,
            "w": 413.35,
            "h": 273.96
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Diluents",
              "Diluents",
              "Diluents",
              "Diluents",
              "1. Opened vials of BCG, Measles/MR, JE and RVV 2. All empty vaccine vials 3. VVM is not in usable stage 4. Date and time of opening is not mentioned 5. 28 days of opening of vial have passed"
            ],
            [
              "Hep B",
              "Hep B",
              "Hep B",
              "Hep B",
              ""
            ],
            [
              "Pentavalent",
              "Pentavalent",
              "PCV",
              "PCV",
              ""
            ],
            [
              "DPT",
              "DPT",
              "IPV",
              "IPV",
              ""
            ],
            [
              "TT",
              "TT",
              "TT",
              "TT",
              ""
            ],
            [
              "Rota",
              "Rota",
              "Rota",
              "Rota",
              ""
            ],
            [
              "Measles/MR",
              "Measles/MR",
              "Measles/MR",
              "Measles/MR",
              ""
            ],
            [
              "OPV",
              "OPV",
              "OPV",
              "OPV",
              ""
            ]
          ],
          "html": "<table>\n  <thead>\n    <tr>\n      <th colspan=\"4\">Diluents</th>\n      <th rowspan=\"10\" style=\"vertical-align:top; border-left: 2px solid black;\">\n        <b>Not to be used</b><br />\n        1. Opened vials of BCG, Measles/MR, JE and RVV<br />\n        2. All empty vaccine vials<br />\n        3. VVM is not in usable stage<br />\n        4. Date and time of opening is not mentioned<br />\n        5. 28 days of opening of vial have passed<br /><br />\n        <i>*These vials should be discarded after 48 hours or before the next session, whichever is earlier as per the CPCB guidelines.</i>\n      </th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>Hep B</td>\n<td>Hep B</td>\n<td>Hep B</td>\n<td>Hep B</td>\n    </tr>\n<tr>\n      <td>Pentavalent</td>\n<td>Pentavalent</td>\n<td>PCV</td>\n<td>PCV</td>\n    </tr>\n<tr>\n      <td>DPT</td>\n<td>DPT</td>\n<td>IPV</td>\n<td>IPV</td>\n    </tr>\n<tr>\n      <td>TT</td>\n<td>TT</td>\n<td>TT</td>\n<td>TT</td>\n    </tr>\n<tr>\n      <td>Rota</td>\n<td>Rota</td>\n<td>Rota</td>\n<td>Rota</td>\n    </tr>\n<tr>\n      <td><s>BCG</s></td>\n<td><s>BCG</s></td>\n<td><s>JE</s></td>\n<td><s>JE</s></td>\n    </tr>\n<tr>\n      <td>Measles/MR</td>\n<td>Measles/MR</td>\n<td>Measles/MR</td>\n<td>Measles/MR</td>\n    </tr>\n<tr>\n      <td>OPV</td>\n<td>OPV</td>\n<td>OPV</td>\n<td>OPV</td>\n    </tr>\n  </tbody>\n</table>",
          "md": "| Diluents    | Diluents    | Diluents   | Diluents   | 1. Opened vials of BCG, Measles/MR, JE and RVV 2. All empty vaccine vials 3. VVM is not in usable stage 4. Date and time of opening is not mentioned 5. 28 days of opening of vial have passed |\n| ----------- | ----------- | ---------- | ---------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |\n| Hep B       | Hep B       | Hep B      | Hep B      |                                                                                                                                                                                                |\n| Pentavalent | Pentavalent | PCV        | PCV        |                                                                                                                                                                                                |\n| DPT         | DPT         | IPV        | IPV        |                                                                                                                                                                                                |\n| TT          | TT          | TT         | TT         |                                                                                                                                                                                                |\n| Rota        | Rota        | Rota       | Rota       |                                                                                                                                                                                                |\n| ~~BCG~~     | ~~BCG~~     | ~~JE~~     | ~~JE~~     |                                                                                                                                                                                                |\n| Measles/MR  | Measles/MR  | Measles/MR | Measles/MR |                                                                                                                                                                                                |\n| OPV         | OPV         | OPV        | OPV        |                                                                                                                                                                                                |",
          "isPerfectTable": false,
          "csv": "\"Diluents\",\"Diluents\",\"Diluents\",\"Diluents\",\"1. Opened vials of BCG, Measles/MR, JE and RVV 2. All empty vaccine vials 3. VVM is not in usable stage 4. Date and time of opening is not mentioned 5. 28 days of opening of vial have passed\"\n\"Hep B\",\"Hep B\",\"Hep B\",\"Hep B\",\"\"\n\"Pentavalent\",\"Pentavalent\",\"PCV\",\"PCV\",\"\"\n\"DPT\",\"DPT\",\"IPV\",\"IPV\",\"\"\n\"TT\",\"TT\",\"TT\",\"TT\",\"\"\n\"Rota\",\"Rota\",\"Rota\",\"Rota\",\"\"\n\"Measles/MR\",\"Measles/MR\",\"Measles/MR\",\"Measles/MR\",\"\"\n\"OPV\",\"OPV\",\"OPV\",\"OPV\",\"\"",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.44,
            "h": 770.25
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "> ### To be used  \n> Opened vials of Hep. B, DPT, TT, Pentavalent, OPV, IPV and PCV provided;  \n> 1. VVM is intact and in usable stage  \n> 2. Date and time of opening is mentioned on the vial  \n> 3. Vial is within 28 days of opening  \n> 4. Date of expiry has not reached/crossed  \n> 5. The vaccine vial septum is not contaminated",
          "md": "> ### To be used  \n> Opened vials of Hep. B, DPT, TT, Pentavalent, OPV, IPV and PCV provided;  \n> 1. VVM is intact and in usable stage  \n> 2. Date and time of opening is mentioned on the vial  \n> 3. Vial is within 28 days of opening  \n> 4. Date of expiry has not reached/crossed  \n> 5. The vaccine vial septum is not contaminated",
          "bBox": {
            "x": 123.93,
            "y": 377.92,
            "w": 386.6,
            "h": 205.57
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "*Figure 7: ILR with vaccine arrangement (Front view)*",
          "md": "*Figure 7: ILR with vaccine arrangement (Front view)*",
          "bBox": {
            "x": 197.23,
            "y": 645.85,
            "w": 192.25,
            "h": 9.11
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.988
    },
    {
      "page": 36,
      "text": "Q 61. What is a vaccine carrier?\nAns.     Vaccine carrier is an insulated       box\n         used for transporting limited number\n         of vaccine vials and diluents from cold\n         chain point to outreach session sites,\n         for storing vials at the session site,\n         and to return back unused, partially\n         used and completely used vials back to\n         cold chain point on the same day. It is    @\n         packed with four conditioned ice packs\n         and can maintain storage temperature       STOR\n         of +2ᴼC to +8ᴼC for 12 hours, if not\n         opened  frequently. Vaccine carriers\n         are used globally for the purpose of\n         transporting vaccines to the point of use.\n         Note: Droppers and Syringes should\n         not be kept in the vaccine carrier         Figure 8: Vaccine carrier\n\n\n         62. How should you ensure that cold chain is maintained at the\n         outreach immunization session sites?\n\nAns.     At outreach immunization session sites (villages and mohallas); a health worker is\n         responsible for maintaining appropriate cold chain for vaccines.\nQ\nQ You should ensure that once the vaccines are transported to the session sites, the\n         vaccine carrier is placed in shade and not in direct exposure to sunlight. During the\n         session, avoid opening vaccine carrier frequently as this breaks the cold chain for\n         vials stored inside. To address this, take out one conditioned ice pack outside the\n         vaccine carrier and place non freeze-sensitive, opened vaccine vials on it, to maintain\n         the recommended temperature.\n\n\n         63. During an immunization session, can vaccine vials be placed on\n         ice pack taken out from vaccine carrier?\n\nAns.     As per guidelines, during an immunization session, take out one ice pack from\n         vaccine carrier and place non freeze-sensitive, opened vaccine vials on it to maintain\n         cold chain. This helps ensure that vaccine carrier is not opened again and again.\n         The vaccine vials that should be placed on ice pack are – BCG, Measles, OPV,\n         Rotavirus and JE. BCG and Measles vials are placed in the pits provided on ice packs,\n         while OPV, Rotavirus and JE are placed on the surface of ice pack.\n         The freeze-sensitive vaccine vials should NEVER be placed on ice pack. IPV, TT, DPT,\n         PCV and Pentavalent vaccine vials should never be kept on the ice-pack.\n\n\n\n\n\n\nFAQs on ImmunizationI 29",
      "md": "\n## 61. What is a vaccine carrier?\n\n**Ans.** Vaccine carrier is an insulated box used for transporting limited number of vaccine vials and diluents from cold chain point to outreach session sites, for storing vials at the session site, and to return back unused, partially used and completely used vials back to cold chain point on the same day. It is packed with four conditioned ice packs and can maintain storage temperature of +2°C to +8°C for 12 hours, if not opened frequently. Vaccine carriers are used globally for the purpose of transporting vaccines to the point of use.  \n**Note: Droppers and Syringes should not be kept in the vaccine carrier**\n\n[Figure 8: Vaccine carrier]  \n*The image shows a hand placing a sealed plastic bag containing vaccine vials into an insulated vaccine carrier filled with ice packs. There is a red stop sign on the carrier. A small inset image shows a crossed-out syringe and dropper, indicating they should not be kept in the vaccine carrier.*\n\n----\n\n## 62. How should you ensure that cold chain is maintained at the outreach immunization session sites?\n\n**Ans.** At outreach immunization session sites (villages and mohallas); a health worker is responsible for maintaining appropriate cold chain for vaccines.\n\nYou should ensure that once the vaccines are transported to the session sites, the vaccine carrier is placed in shade and not in direct exposure to sunlight. During the session, avoid opening vaccine carrier frequently as this breaks the cold chain for vials stored inside. To address this, take out one conditioned ice pack outside the vaccine carrier and place non freeze-sensitive, opened vaccine vials on it, to maintain the recommended temperature.\n\n----\n\n## 63. During an immunization session, can vaccine vials be placed on ice pack taken out from vaccine carrier?\n\n**Ans.** As per guidelines, during an immunization session, take out one ice pack from vaccine carrier and place non freeze-sensitive, opened vaccine vials on it to maintain cold chain. This helps ensure that vaccine carrier is not opened again and again.\n\nThe vaccine vials that should be placed on ice pack are – BCG, Measles, OPV, Rotavirus and JE. BCG and Measles vials are placed in the pits provided on ice packs, while OPV, Rotavirus and JE are placed on the surface of ice pack.\n\nThe freeze-sensitive vaccine vials should **NEVER** be placed on ice pack. IPV, TT, DPT, PCV and Pentavalent vaccine vials should never be kept on the ice-pack.\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p35_8.jpg",
          "height": 35.72,
          "width": 67.845,
          "x": 303.558,
          "y": 124.547,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_9.jpg",
          "height": 35.72,
          "width": 67.79,
          "x": 371.295,
          "y": 124.547,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_10.jpg",
          "height": 35.72,
          "width": 67.845,
          "x": 438.976,
          "y": 124.547,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_11.jpg",
          "height": 35.773,
          "width": 67.845,
          "x": 303.558,
          "y": 160.158,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0
        },
        {
          "name": "img_p35_12.jpg",
          "height": 35.773,
          "width": 67.79,
          "x": 371.295,
          "y": 160.158,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0
        },
        {
          "name": "img_p35_13.jpg",
          "height": 35.773,
          "width": 67.845,
          "x": 438.976,
          "y": 160.158,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0
        },
        {
          "name": "img_p35_14.jpg",
          "height": 35.719,
          "width": 67.845,
          "x": 303.558,
          "y": 195.823,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_15.jpg",
          "height": 35.719,
          "width": 67.79,
          "x": 371.295,
          "y": 195.823,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0,
          "ocr": [
            {
              "x": 55,
              "y": 61,
              "w": 21,
              "h": 24,
              "confidence": 0.62,
              "text": "@"
            }
          ]
        },
        {
          "name": "img_p35_16.jpg",
          "height": 35.719,
          "width": 67.845,
          "x": 438.976,
          "y": 195.823,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_17.jpg",
          "height": 35.774,
          "width": 67.845,
          "x": 303.558,
          "y": 231.433,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0,
          "ocr": [
            {
              "x": 183,
              "y": 15,
              "w": 100,
              "h": 94,
              "confidence": 0.862,
              "text": "STOR"
            }
          ]
        },
        {
          "name": "img_p35_18.jpg",
          "height": 35.774,
          "width": 67.79,
          "x": 371.295,
          "y": 231.433,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0
        },
        {
          "name": "img_p35_19.jpg",
          "height": 35.774,
          "width": 67.845,
          "x": 438.976,
          "y": 231.433,
          "original_width": 283,
          "original_height": 150,
          "rotation": 0
        },
        {
          "name": "img_p35_20.jpg",
          "height": 35.719,
          "width": 67.845,
          "x": 303.558,
          "y": 267.098,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_21.jpg",
          "height": 35.719,
          "width": 67.79,
          "x": 371.295,
          "y": 267.098,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_22.jpg",
          "height": 35.719,
          "width": 67.845,
          "x": 438.976,
          "y": 267.098,
          "original_width": 283,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_23.jpg",
          "height": 71.384,
          "width": 34.467,
          "x": 302.034,
          "y": 124.547,
          "original_width": 144,
          "original_height": 298,
          "rotation": 0
        },
        {
          "name": "img_p35_24.jpg",
          "height": 71.384,
          "width": 34.467,
          "x": 473.879,
          "y": 124.547,
          "original_width": 144,
          "original_height": 298,
          "rotation": 0
        },
        {
          "name": "img_p35_25.jpg",
          "height": 71.384,
          "width": 34.467,
          "x": 302.034,
          "y": 195.823,
          "original_width": 144,
          "original_height": 298,
          "rotation": 0
        },
        {
          "name": "img_p35_26.png",
          "height": 71.384,
          "width": 34.467,
          "x": 473.879,
          "y": 195.823,
          "original_width": 144,
          "original_height": 298,
          "rotation": 0
        },
        {
          "name": "img_p35_27.jpg",
          "height": 35.719,
          "width": 34.467,
          "x": 302.034,
          "y": 267.098,
          "original_width": 144,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p35_28.png",
          "height": 35.719,
          "width": 34.467,
          "x": 473.879,
          "y": 267.098,
          "original_width": 144,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "page_36.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 2,
          "value": "61. What is a vaccine carrier?",
          "md": "## 61. What is a vaccine carrier?",
          "bBox": {
            "x": 100.5,
            "y": 102.86,
            "w": 148.26,
            "h": 171.5
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Vaccine carrier is an insulated box used for transporting limited number of vaccine vials and diluents from cold chain point to outreach session sites, for storing vials at the session site, and to return back unused, partially used and completely used vials back to cold chain point on the same day. It is packed with four conditioned ice packs and can maintain storage temperature of +2°C to +8°C for 12 hours, if not opened frequently. Vaccine carriers are used globally for the purpose of transporting vaccines to the point of use.  \n**Note: Droppers and Syringes should not be kept in the vaccine carrier**",
          "md": "**Ans.** Vaccine carrier is an insulated box used for transporting limited number of vaccine vials and diluents from cold chain point to outreach session sites, for storing vials at the session site, and to return back unused, partially used and completely used vials back to cold chain point on the same day. It is packed with four conditioned ice packs and can maintain storage temperature of +2°C to +8°C for 12 hours, if not opened frequently. Vaccine carriers are used globally for the purpose of transporting vaccines to the point of use.  \n**Note: Droppers and Syringes should not be kept in the vaccine carrier**",
          "bBox": {
            "x": 58.46,
            "y": 102.86,
            "w": 312.94,
            "h": 508.24
          }
        },
        {
          "type": "text",
          "value": "[Figure 8: Vaccine carrier]  \n*The image shows a hand placing a sealed plastic bag containing vaccine vials into an insulated vaccine carrier filled with ice packs. There is a red stop sign on the carrier. A small inset image shows a crossed-out syringe and dropper, indicating they should not be kept in the vaccine carrier.*",
          "md": "[Figure 8: Vaccine carrier]  \n*The image shows a hand placing a sealed plastic bag containing vaccine vials into an insulated vaccine carrier filled with ice packs. There is a red stop sign on the carrier. A small inset image shows a crossed-out syringe and dropper, indicating they should not be kept in the vaccine carrier.*",
          "bBox": {
            "x": 100.5,
            "y": 102.86,
            "w": 349.88,
            "h": 229.58
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "62. How should you ensure that cold chain is maintained at the outreach immunization session sites?",
          "md": "## 62. How should you ensure that cold chain is maintained at the outreach immunization session sites?",
          "bBox": {
            "x": 102.48,
            "y": 102.86,
            "w": 408.72,
            "h": 288.45
          }
        },
        {
          "type": "text",
          "value": "**Ans.** At outreach immunization session sites (villages and mohallas); a health worker is responsible for maintaining appropriate cold chain for vaccines.",
          "md": "**Ans.** At outreach immunization session sites (villages and mohallas); a health worker is responsible for maintaining appropriate cold chain for vaccines.",
          "bBox": {
            "x": 58.5,
            "y": 102.86,
            "w": 452.71,
            "h": 508.24
          }
        },
        {
          "type": "text",
          "value": "You should ensure that once the vaccines are transported to the session sites, the vaccine carrier is placed in shade and not in direct exposure to sunlight. During the session, avoid opening vaccine carrier frequently as this breaks the cold chain for vials stored inside. To address this, take out one conditioned ice pack outside the vaccine carrier and place non freeze-sensitive, opened vaccine vials on it, to maintain the recommended temperature.",
          "md": "You should ensure that once the vaccines are transported to the session sites, the vaccine carrier is placed in shade and not in direct exposure to sunlight. During the session, avoid opening vaccine carrier frequently as this breaks the cold chain for vials stored inside. To address this, take out one conditioned ice pack outside the vaccine carrier and place non freeze-sensitive, opened vaccine vials on it, to maintain the recommended temperature.",
          "bBox": {
            "x": 58.46,
            "y": 102.86,
            "w": 452.74,
            "h": 424.2
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "63. During an immunization session, can vaccine vials be placed on ice pack taken out from vaccine carrier?",
          "md": "## 63. During an immunization session, can vaccine vials be placed on ice pack taken out from vaccine carrier?",
          "bBox": {
            "x": 100.5,
            "y": 102.86,
            "w": 410.72,
            "h": 482.98
          }
        },
        {
          "type": "text",
          "value": "**Ans.** As per guidelines, during an immunization session, take out one ice pack from vaccine carrier and place non freeze-sensitive, opened vaccine vials on it to maintain cold chain. This helps ensure that vaccine carrier is not opened again and again.",
          "md": "**Ans.** As per guidelines, during an immunization session, take out one ice pack from vaccine carrier and place non freeze-sensitive, opened vaccine vials on it to maintain cold chain. This helps ensure that vaccine carrier is not opened again and again.",
          "bBox": {
            "x": 58.5,
            "y": 102.86,
            "w": 452.71,
            "h": 537.23
          }
        },
        {
          "type": "text",
          "value": "The vaccine vials that should be placed on ice pack are – BCG, Measles, OPV, Rotavirus and JE. BCG and Measles vials are placed in the pits provided on ice packs, while OPV, Rotavirus and JE are placed on the surface of ice pack.",
          "md": "The vaccine vials that should be placed on ice pack are – BCG, Measles, OPV, Rotavirus and JE. BCG and Measles vials are placed in the pits provided on ice packs, while OPV, Rotavirus and JE are placed on the surface of ice pack.",
          "bBox": {
            "x": 100.5,
            "y": 102.86,
            "w": 410.71,
            "h": 589.72
          }
        },
        {
          "type": "text",
          "value": "The freeze-sensitive vaccine vials should **NEVER** be placed on ice pack. IPV, TT, DPT, PCV and Pentavalent vaccine vials should never be kept on the ice-pack.",
          "md": "The freeze-sensitive vaccine vials should **NEVER** be placed on ice pack. IPV, TT, DPT, PCV and Pentavalent vaccine vials should never be kept on the ice-pack.",
          "bBox": {
            "x": 100.5,
            "y": 102.86,
            "w": 353.4,
            "h": 627.71
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.929
    },
    {
      "page": 37,
      "text": "Q\n\n\n                                                      PALSVACINE\n                                                      ROS ED L.\n                                                      ShanTr\n       dones\n       CINE(LIVE) I.P.         61DA1                  TT\n       a                       01/17\n Measles/MR               EXO  12/21    BCG                     IPV  DPT  Penta-\n JE                       RVV                  OPV                        valent\n\n\n\n                                                                           PCV\n                     Figure 9: Ice-pack with vials kept on it\n\n          64. What should be done if frozen vaccine vials are found at the\n          health facility or session site?\n Ans.     Freeze sensitive vaccines (Hepatitis B, Pentavalent, IPV, DPT, TT and PCV); lose\n          their potency if they freeze during storage or transportation. Therefore, if any of\n          these vaccine vials are found to be visibly frozen, they should be discarded as per the\n          guidelines.\n          A “shake test” should be performed at the health facility for any suspected frozen\n          vaccine vial i.e. if temperature falls below 0°C or there are other frozen vials in the\n          same box or there is any suspicious vial damaged due to freezing.\n          Vaccines, like OPV and Rotavirus vaccines do not lose their potency and efficacy on\n          freezing, and these vaccines can be used again once they liquefy.\n\n\n          65. What else can be stored inside vaccine carrier                  during\n Q             transportation and at session sites?\n Ans.     Vaccine carrier should only be used for transporting vaccines and diluents provided\n          under UIP to session sites. It should have four conditioned ice packs to ensure\n          appropriate temperature inside carrier. No other vaccine (non UIP), drug, food, or\n          item should be kept inside vaccine carrier. State-specific vaccines, if are part of the\n          Routine Immunization may be transported in the same vaccine carrier.\n          The droppers used for administration of oral vaccines and syringes should NOT be\n          transported inside vaccine carrier as cold temperatures can cause them to crack.\n          Note: Hard frozen ice-packs should be used in vaccine carrier in case of Polio\n          SIAs.\n\n\n\n\n\n\n\n\n\n\n 30 IFAQs on Immunization",
      "md": "\nQ64. **What should be done if frozen vaccine vials are found at the health facility or session site?**  \nAns. Freeze sensitive vaccines (Hepatitis B, Pentavalent, IPV, DPT, TT and PCV); lose their potency if they freeze during storage or transportation. Therefore, if any of these vaccine vials are found to be visibly frozen, they should be discarded as per the guidelines.\n\nA **“shake test”** should be performed at the health facility for any suspected frozen vaccine vial i.e. if temperature falls below 0°C or there are other frozen vials in the same box or there is any suspicious vial damaged due to freezing.\n\nVaccines, like OPV and Rotavirus vaccines do not lose their potency and efficacy on freezing, and these vaccines can be used again once they liquefy.\n\n----\n\nQ65. **What else can be stored inside vaccine carrier during transportation and at session sites?**  \nAns. Vaccine carrier should only be used for transporting vaccines and diluents provided under UIP to session sites. It should have four conditioned ice packs to ensure appropriate temperature inside carrier. No other vaccine (non UIP), drug, food, or item should be kept inside vaccine carrier. State-specific vaccines, if are part of the Routine Immunization may be transported in the same vaccine carrier.\n\nThe droppers used for administration of oral vaccines and syringes should **NOT** be transported inside vaccine carrier as cold temperatures can cause them to crack.\n\n**Note: Hard frozen ice-packs should be used in vaccine carrier in case of Polio SIAs.**\n\n----\n\nFigure 9: Ice-pack with vials kept on it\n\n<table>\n  <tr>\n    <td>JE</td>\n<td>Measles/MR</td>\n<td>RVV</td>\n<td>BCG</td>\n<td>OPV</td>\n<td>TT</td>\n<td>IPV</td>\n<td>DPT</td>\n<td>Pentavalent</td>\n<td>PCV</td>\n  </tr>\n<tr>\n    <td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n  </tr>\n</table>\n\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p36_4.jpg",
          "height": 64.5,
          "width": 143.102,
          "x": 131.983,
          "y": 71.338,
          "original_width": 597,
          "original_height": 269,
          "rotation": 0
        },
        {
          "name": "img_p36_5.jpg",
          "height": 64.5,
          "width": 143.102,
          "x": 274.888,
          "y": 71.338,
          "original_width": 597,
          "original_height": 269,
          "rotation": 0
        },
        {
          "name": "img_p36_6.jpg",
          "height": 64.5,
          "width": 107.401,
          "x": 417.793,
          "y": 71.338,
          "original_width": 448,
          "original_height": 269,
          "rotation": 0
        },
        {
          "name": "img_p36_7.jpg",
          "height": 64.598,
          "width": 143.102,
          "x": 131.983,
          "y": 135.641,
          "original_width": 597,
          "original_height": 270,
          "rotation": 0,
          "ocr": [
            {
              "x": 510,
              "y": 127,
              "w": 12,
              "h": 7,
              "confidence": 0.829,
              "text": "EXO"
            },
            {
              "x": 542,
              "y": 120,
              "w": 27,
              "h": 15,
              "confidence": 0.838,
              "text": "12/21"
            },
            {
              "x": 333,
              "y": 116,
              "w": 6,
              "h": 5,
              "confidence": 0.688,
              "text": "a"
            },
            {
              "x": 541,
              "y": 111,
              "w": 29,
              "h": 17,
              "confidence": 0.769,
              "text": "01/17"
            },
            {
              "x": 341,
              "y": 103,
              "w": 65,
              "h": 21,
              "confidence": 0.964,
              "text": "(LIVE) I.P."
            },
            {
              "x": 542,
              "y": 104,
              "w": 29,
              "h": 14,
              "confidence": 0.843,
              "text": "61DA1"
            },
            {
              "x": 318,
              "y": 97,
              "w": 28,
              "h": 20,
              "confidence": 0.986,
              "text": "CINE"
            },
            {
              "x": 318,
              "y": 85,
              "w": 27,
              "h": 21,
              "confidence": 0.657,
              "text": "dones"
            }
          ]
        },
        {
          "name": "img_p36_8.jpg",
          "height": 64.598,
          "width": 143.102,
          "x": 274.888,
          "y": 135.641,
          "original_width": 597,
          "original_height": 270,
          "rotation": 0,
          "ocr": [
            {
              "x": 460,
              "y": 24,
              "w": 41,
              "h": 24,
              "confidence": 0.756,
              "text": "ShanTr"
            },
            {
              "x": 460,
              "y": 11,
              "w": 52,
              "h": 26,
              "confidence": 0.495,
              "text": "ROS ED L."
            },
            {
              "x": 466,
              "y": 2,
              "w": 55,
              "h": 25,
              "confidence": 0.698,
              "text": "PALSVACINE"
            }
          ]
        },
        {
          "name": "img_p36_9.jpg",
          "height": 64.598,
          "width": 107.401,
          "x": 417.793,
          "y": 135.641,
          "original_width": 448,
          "original_height": 270,
          "rotation": 0
        },
        {
          "name": "img_p36_10.jpg",
          "height": 32.349,
          "width": 286.007,
          "x": 131.983,
          "y": 200.041,
          "original_width": 1192,
          "original_height": 135,
          "rotation": 0
        },
        {
          "name": "img_p36_11.jpg",
          "height": 32.349,
          "width": 107.401,
          "x": 417.793,
          "y": 200.041,
          "original_width": 448,
          "original_height": 135,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_37.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "Q64. **What should be done if frozen vaccine vials are found at the health facility or session site?**  \nAns. Freeze sensitive vaccines (Hepatitis B, Pentavalent, IPV, DPT, TT and PCV); lose their potency if they freeze during storage or transportation. Therefore, if any of these vaccine vials are found to be visibly frozen, they should be discarded as per the guidelines.",
          "md": "Q64. **What should be done if frozen vaccine vials are found at the health facility or session site?**  \nAns. Freeze sensitive vaccines (Hepatitis B, Pentavalent, IPV, DPT, TT and PCV); lose their potency if they freeze during storage or transportation. Therefore, if any of these vaccine vials are found to be visibly frozen, they should be discarded as per the guidelines.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.41,
            "h": 495.3
          }
        },
        {
          "type": "text",
          "value": "A **“shake test”** should be performed at the health facility for any suspected frozen vaccine vial i.e. if temperature falls below 0°C or there are other frozen vials in the same box or there is any suspicious vial damaged due to freezing.",
          "md": "A **“shake test”** should be performed at the health facility for any suspected frozen vaccine vial i.e. if temperature falls below 0°C or there are other frozen vials in the same box or there is any suspicious vial damaged due to freezing.",
          "bBox": {
            "x": 128.4,
            "y": 160.59,
            "w": 408.37,
            "h": 348.09
          }
        },
        {
          "type": "text",
          "value": "Vaccines, like OPV and Rotavirus vaccines do not lose their potency and efficacy on freezing, and these vaccines can be used again once they liquefy.",
          "md": "Vaccines, like OPV and Rotavirus vaccines do not lose their potency and efficacy on freezing, and these vaccines can be used again once they liquefy.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.41,
            "h": 495.3
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "Q65. **What else can be stored inside vaccine carrier during transportation and at session sites?**  \nAns. Vaccine carrier should only be used for transporting vaccines and diluents provided under UIP to session sites. It should have four conditioned ice packs to ensure appropriate temperature inside carrier. No other vaccine (non UIP), drug, food, or item should be kept inside vaccine carrier. State-specific vaccines, if are part of the Routine Immunization may be transported in the same vaccine carrier.",
          "md": "Q65. **What else can be stored inside vaccine carrier during transportation and at session sites?**  \nAns. Vaccine carrier should only be used for transporting vaccines and diluents provided under UIP to session sites. It should have four conditioned ice packs to ensure appropriate temperature inside carrier. No other vaccine (non UIP), drug, food, or item should be kept inside vaccine carrier. State-specific vaccines, if are part of the Routine Immunization may be transported in the same vaccine carrier.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.42,
            "h": 548.5
          }
        },
        {
          "type": "text",
          "value": "The droppers used for administration of oral vaccines and syringes should **NOT** be transported inside vaccine carrier as cold temperatures can cause them to crack.",
          "md": "The droppers used for administration of oral vaccines and syringes should **NOT** be transported inside vaccine carrier as cold temperatures can cause them to crack.",
          "bBox": {
            "x": 128.4,
            "y": 163.39,
            "w": 394.19,
            "h": 481.56
          }
        },
        {
          "type": "text",
          "value": "**Note: Hard frozen ice-packs should be used in vaccine carrier in case of Polio SIAs.**",
          "md": "**Note: Hard frozen ice-packs should be used in vaccine carrier in case of Polio SIAs.**",
          "bBox": {
            "x": 128.4,
            "y": 163.39,
            "w": 408.4,
            "h": 519.55
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "Figure 9: Ice-pack with vials kept on it",
          "md": "Figure 9: Ice-pack with vials kept on it",
          "bBox": {
            "x": 211.8,
            "y": 163.39,
            "w": 203.48,
            "h": 91.96
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "JE",
              "Measles/MR",
              "RVV",
              "BCG",
              "OPV",
              "TT",
              "IPV",
              "DPT",
              "Pentavalent",
              "PCV"
            ]
          ],
          "html": "<table>\n  <tr>\n    <td>JE</td>\n<td>Measles/MR</td>\n<td>RVV</td>\n<td>BCG</td>\n<td>OPV</td>\n<td>TT</td>\n<td>IPV</td>\n<td>DPT</td>\n<td>Pentavalent</td>\n<td>PCV</td>\n  </tr>\n<tr>\n    <td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n<td><i>vial image</i></td>\n  </tr>\n</table>",
          "md": "| JE           | Measles/MR   | RVV          | BCG          | OPV          | TT           | IPV          | DPT          | Pentavalent  | PCV          |\n| ------------ | ------------ | ------------ | ------------ | ------------ | ------------ | ------------ | ------------ | ------------ | ------------ |\n| *vial image* | *vial image* | *vial image* | *vial image* | *vial image* | *vial image* | *vial image* | *vial image* | *vial image* | *vial image* |",
          "isPerfectTable": true,
          "csv": "\"JE\",\"Measles/MR\",\"RVV\",\"BCG\",\"OPV\",\"TT\",\"IPV\",\"DPT\",\"Pentavalent\",\"PCV\"",
          "bBox": {
            "x": 128.4,
            "y": 160.59,
            "w": 408.38,
            "h": 292.28
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.985
    },
    {
      "page": 38,
      "text": "    Maintain tempertaure between\n          -15ᵒ C to -25⁰C\n    Keep ice packs in criss-cross manner\n    Do not keep vaccines, diluents, medicines or   1-11\n    eatable items in the DF\n    Do not freeze more than 25-30 ice-packs in\n    small DF and 50-60 ice-packs in large DF\n\n\n\n\nWait for sweating to appear on the\n    ice-packs (water droplets)\n\n                                        Shake the ice-packs\n    Place ice-packs on the table    to hear the crackling sound\n\n\n\n\n    Q\n    Q                                   Wipe conditioned\n    Remove ice-packs                    dry  ice-packs\n        from DF                              and put them in\n                                        the vaccine carrier\n\n    CONDITIONING OF\n       ICE-PACKS\n                     5E51EE\n         1955555.5156\n         S5555S5\n\n                           Figure 10: Freezing and conditioning of ice-packs\n\n          66. What are vaccine diluents?\n\n    Ans.    A vaccine diluent is the liquid which is used to reconstitute a lyophilized (freeze-\n            dried) vaccine (BCG, Measles/MR and JE). A vaccine diluent may be sensitive to heat\n          or freezing, and may require transportation and storage in the cold chain.\n\n                      67. Are diluents also to be stored in cold chain at recommended\n          storage temperature?\n    Ans.  Yes. Diluents also should be stored in the ILR at the last cold chain point. If the ILR\n             has space constraints then the diluents may be stored outside ILR, but it must be\n\n\n\n\n    FAQs on ImmunizationI 31",
      "md": "\n* Keep ice packs in criss-cross manner  \n* Do not keep vaccines, diluents, medicines or eatable items in the DF  \n* Do not freeze more than 25-30 ice-packs in small DF and 50-60 ice-packs in large DF  \n\nMaintain temperature between  \n**-15°C to -25°C**\n\n----\n\n### Conditioning of Ice-Packs\n\n1. Remove ice-packs from DF  \n2. Place ice-packs on the table  \n3. Wait for sweating to appear on the ice-packs (water droplets)  \n4. Shake the ice-packs to hear the crackling sound  \n5. Wipe conditioned dry ice-packs and put them in the vaccine carrier  \n\n----\n\n### 66. What are vaccine diluents?\n\n**Ans.** A vaccine diluent is the liquid which is used to reconstitute a lyophilized (freeze-dried) vaccine (BCG, Measles/MR and JE). A vaccine diluent may be sensitive to heat or freezing, and may require transportation and storage in the cold chain.\n\n----\n\n### 67. Are diluents also to be stored in cold chain at recommended storage temperature?\n\n**Ans.** Yes. Diluents also should be stored in the ILR at the last cold chain point. If the ILR has space constraints then the diluents may be stored outside ILR, but it must be\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p37_2.png",
          "height": 37.44,
          "width": 414.24,
          "x": 97.2,
          "y": 585.57,
          "original_width": 1726,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p37_3.png",
          "height": 37.44,
          "width": 414.24,
          "x": 97.2,
          "y": 688.53,
          "original_width": 1726,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p37_6.jpg",
          "height": 25.613,
          "width": 26.989,
          "x": 118.377,
          "y": 495.592,
          "original_width": 112,
          "original_height": 106,
          "rotation": 0
        },
        {
          "name": "img_p37_7.jpg",
          "height": 25.612,
          "width": 26.99,
          "x": 145.113,
          "y": 495.826,
          "original_width": 112,
          "original_height": 106,
          "rotation": 0
        },
        {
          "name": "img_p37_8.jpg",
          "height": 25.629,
          "width": 26.989,
          "x": 118.156,
          "y": 520.939,
          "original_width": 112,
          "original_height": 106,
          "rotation": 0,
          "ocr": [
            {
              "x": 28,
              "y": 72,
              "w": 83,
              "h": 20,
              "confidence": 0.318,
              "text": "S5555S5"
            },
            {
              "x": 34,
              "y": 41,
              "w": 76,
              "h": 20,
              "confidence": 0.55,
              "text": "1955555.5"
            }
          ]
        },
        {
          "name": "img_p37_9.jpg",
          "height": 25.629,
          "width": 26.99,
          "x": 144.892,
          "y": 521.172,
          "original_width": 112,
          "original_height": 106,
          "rotation": 0,
          "ocr": [
            {
              "x": 1,
              "y": 42,
              "w": 19,
              "h": 18,
              "confidence": 0.541,
              "text": "156"
            },
            {
              "x": 57,
              "y": 7,
              "w": 37,
              "h": 25,
              "confidence": 0.373,
              "text": "5E51EE"
            }
          ]
        },
        {
          "name": "img_p37_10.jpg",
          "height": 41.481,
          "width": 60.648,
          "x": 174.303,
          "y": 402.292,
          "original_width": 253,
          "original_height": 173,
          "rotation": 0
        },
        {
          "name": "img_p37_11.jpg",
          "height": 51.922,
          "width": 48.154,
          "x": 276.665,
          "y": 363.059,
          "original_width": 201,
          "original_height": 217,
          "rotation": 0
        },
        {
          "name": "img_p37_12.jpg",
          "height": 50.343,
          "width": 49.767,
          "x": 366.653,
          "y": 395.935,
          "original_width": 208,
          "original_height": 210,
          "rotation": 0
        },
        {
          "name": "img_p37_13.jpg",
          "height": 51.575,
          "width": 62.343,
          "x": 424.341,
          "y": 495.462,
          "original_width": 260,
          "original_height": 215,
          "rotation": 0
        },
        {
          "name": "img_p37_14.jpg",
          "height": 69.766,
          "width": 101.808,
          "x": 258.814,
          "y": 64.336,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0
        },
        {
          "name": "img_p37_15.jpg",
          "height": 69.766,
          "width": 101.89,
          "x": 360.457,
          "y": 64.336,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0
        },
        {
          "name": "img_p37_16.jpg",
          "height": 208.887,
          "width": 34.018,
          "x": 462.183,
          "y": 64.336,
          "original_width": 142,
          "original_height": 871,
          "rotation": 0
        },
        {
          "name": "img_p37_17.jpg",
          "height": 69.684,
          "width": 101.808,
          "x": 258.814,
          "y": 133.937,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0
        },
        {
          "name": "img_p37_18.jpg",
          "height": 69.684,
          "width": 101.89,
          "x": 360.457,
          "y": 133.937,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0
        },
        {
          "name": "img_p37_19.jpg",
          "height": 69.767,
          "width": 101.808,
          "x": 258.814,
          "y": 203.456,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0,
          "ocr": [
            {
              "x": 53,
              "y": 116,
              "w": 142,
              "h": 88,
              "confidence": 0.516,
              "text": "1-11"
            }
          ]
        },
        {
          "name": "img_p37_20.jpg",
          "height": 69.767,
          "width": 101.89,
          "x": 360.457,
          "y": 203.456,
          "original_width": 425,
          "original_height": 291,
          "rotation": 0
        },
        {
          "name": "img_p37_21.jpg",
          "height": 34.924,
          "width": 203.533,
          "x": 258.814,
          "y": 273.058,
          "original_width": 849,
          "original_height": 146,
          "rotation": 0
        },
        {
          "name": "img_p37_22.jpg",
          "height": 34.924,
          "width": 34.018,
          "x": 462.183,
          "y": 273.058,
          "original_width": 142,
          "original_height": 146,
          "rotation": 0
        },
        {
          "name": "page_38.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "* Keep ice packs in criss-cross manner  \n* Do not keep vaccines, diluents, medicines or eatable items in the DF  \n* Do not freeze more than 25-30 ice-packs in small DF and 50-60 ice-packs in large DF",
          "md": "* Keep ice packs in criss-cross manner  \n* Do not keep vaccines, diluents, medicines or eatable items in the DF  \n* Do not freeze more than 25-30 ice-packs in small DF and 50-60 ice-packs in large DF",
          "bBox": {
            "x": 115.56,
            "y": 218.73,
            "w": 364.83,
            "h": 294.7
          }
        },
        {
          "type": "text",
          "value": "Maintain temperature between  \n**-15°C to -25°C**",
          "md": "Maintain temperature between  \n**-15°C to -25°C**",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Conditioning of Ice-Packs",
          "md": "### Conditioning of Ice-Packs",
          "bBox": {
            "x": 258.92,
            "y": 450.64,
            "w": 221.47,
            "h": 62.78
          }
        },
        {
          "type": "text",
          "value": "1. Remove ice-packs from DF  \n2. Place ice-packs on the table  \n3. Wait for sweating to appear on the ice-packs (water droplets)  \n4. Shake the ice-packs to hear the crackling sound  \n5. Wipe conditioned dry ice-packs and put them in the vaccine carrier",
          "md": "1. Remove ice-packs from DF  \n2. Place ice-packs on the table  \n3. Wait for sweating to appear on the ice-packs (water droplets)  \n4. Shake the ice-packs to hear the crackling sound  \n5. Wipe conditioned dry ice-packs and put them in the vaccine carrier",
          "bBox": {
            "x": 108.7,
            "y": 326.73,
            "w": 390.47,
            "h": 186.7
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "66. What are vaccine diluents?",
          "md": "### 66. What are vaccine diluents?",
          "bBox": {
            "x": 103.11,
            "y": 591.71,
            "w": 196.13,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "**Ans.** A vaccine diluent is the liquid which is used to reconstitute a lyophilized (freeze-dried) vaccine (BCG, Measles/MR and JE). A vaccine diluent may be sensitive to heat or freezing, and may require transportation and storage in the cold chain.",
          "md": "**Ans.** A vaccine diluent is the liquid which is used to reconstitute a lyophilized (freeze-dried) vaccine (BCG, Measles/MR and JE). A vaccine diluent may be sensitive to heat or freezing, and may require transportation and storage in the cold chain.",
          "bBox": {
            "x": 58.46,
            "y": 436.63,
            "w": 452.76,
            "h": 304.65
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "67. Are diluents also to be stored in cold chain at recommended storage temperature?",
          "md": "### 67. Are diluents also to be stored in cold chain at recommended storage temperature?",
          "bBox": {
            "x": 103.11,
            "y": 691.01,
            "w": 405.8,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Yes. Diluents also should be stored in the ILR at the last cold chain point. If the ILR has space constraints then the diluents may be stored outside ILR, but it must be",
          "md": "**Ans.** Yes. Diluents also should be stored in the ILR at the last cold chain point. If the ILR has space constraints then the diluents may be stored outside ILR, but it must be",
          "bBox": {
            "x": 58.5,
            "y": 625.48,
            "w": 452.72,
            "h": 130.3
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.979
    },
    {
      "page": 39,
      "text": "Q ensured that they are kept in ILR at least 24 hours before use or issuing to sessions to\n        ensure that vaccines and diluents are at same temperature (i.e. +2° to +8°C) during\n        reconstitution. When mixed, the diluent and vaccine should be approximately at\n        the same temperature; otherwise, it can lead to thermal shock that is, the death of\n        some or all the essential live organisms in the vaccine.\n        The glass of diluent ampoules is too fragile and it should be stored in top of the ILR\n        (above all the vaccines) to prevent cracking. Diluents should be transported along\n        with the vaccines, in the vaccine carrier to the session sites.\n\n         68. What precautions should be taken regarding use of diluents?\n\nAns.     à  ONLY the diluents supplied by the same manufacturer (bundled) along with\n            vaccine are to be used as these are specifically designed for the needs of that\n            vaccine, with respect to volume, pH level and chemical properties. No other\n            diluents should be used even if they are chemically same.\n         à  Diluents should be checked for expiry date, batch numbers and breakage\n            (cracks and leaks). Care should be taken to ensure that freeze dried vaccine\n            (BCG, Measles/ MR and JE) are issued with corresponding diluents.\n         à  Only the recommended volume of diluent must be used to reconstitute the\n            vaccine.\n        “Bundling” ensures that vaccines are always supplied with diluents, AD syringes and\n        reconstitution syringes, in corresponding quantities, at each level of the supply chain.\n\n\n\n  Break the diluent at the                               Draw the diluent\n  Break the diluent at the                               Draw the diluent\n      point of filing\n                                                                adandiululukes\n                                                               maluudiumdlukes\n\n                              2)\n                              2)\n                                                         3)\n                                                         3)\n                                                         3)\n                                                         3)\n                                                         3)\n            7\n              1)\n              1)\n              1)\n                                ml (0.05                 2.5ml-5\n                                Bacillus Calma           VACC\n                                 Live attenuated B\n                                   contains betwer\n                                Dose:O\n                                CGSNO             RS. JEV\n                                    ow instrud\n                               Manufactured by\n                                      SERUM INSTIT\n                              212/2, Hadassar,                  4)\n                               USE IMVEDIATELY                  4)\n                                       DISCARD\n\n    File the neck of the                                 5)\n                                                         5)\n      diluent ampoule                                    5)                   Reconstitute\n                                                                              the vaccine\n                                            6)\n                                            6)\n Mention\n Mention date\n            date and\n                 and time\n Mention date and time\n                     time       0002462  P\n  of opening the vial\n  of opening the vial           dn 1o\n(Use\n(Use within\n  within 4\n     4 hours\n            hours of\n                  of opening)\n                     opening)\n\n                                                                Shake the vial\n                         Figure 11: Procedure of reconstitution\n\n\n\n32 IFAQs on Immunization",
      "md": "\nensured that they are kept in ILR at least 24 hours before use or issuing to sessions to ensure that vaccines and diluents are at same temperature (i.e. +2° to +8°C) during reconstitution. When mixed, the diluent and vaccine should be approximately at the same temperature; otherwise, it can lead to thermal shock that is, the death of some or all the essential live organisms in the vaccine.\n\nThe glass of diluent ampoules is too fragile and it should be stored in top of the ILR (above all the vaccines) to prevent cracking. Diluents should be transported along with the vaccines, in the vaccine carrier to the session sites.\n\n## 68. What precautions should be taken regarding use of diluents?\n\n**Ans.**  \n* ONLY the diluents supplied by the same manufacturer (bundled) along with vaccine are to be used as these are specifically designed for the needs of that vaccine, with respect to volume, pH level and chemical properties. No other diluents should be used even if they are chemically same.  \n* Diluents should be checked for expiry date, batch numbers and breakage (cracks and leaks). Care should be taken to ensure that freeze dried vaccine (BCG, Measles/ MR and JE) are issued with corresponding diluents.  \n* Only the recommended volume of diluent must be used to reconstitute the vaccine.\n\n*“Bundling” ensures that vaccines are always supplied with diluents, AD syringes and reconstitution syringes, in corresponding quantities, at each level of the supply chain.*\n\n<table>\n  <tr>\n    <td colspan=\"2\" rowspan=\"2\">Break the diluent at the point of filing</td>\n    <td colspan=\"2\">Draw the diluent</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">[Image of hand drawing diluent with syringe]</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">File the neck of the diluent ampoule</td>\n    <td colspan=\"2\" rowspan=\"2\">Reconstitute the vaccine</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">Mention date and time of opening the vial  \n    <br><i>(Use within 4 hours of opening)</i></td>\n  </tr>\n<tr>\n    <td colspan=\"4\" style=\"text-align:center;\">Shake the vial</td>\n  </tr>\n<tr>\n    <td colspan=\"4\" style=\"text-align:center;\">\n      <b>Figure 11: Procedure of reconstitution</b>\n    </td>\n  </tr>\n</table>\n\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p38_4.jpg",
          "height": 100.336,
          "width": 135.796,
          "x": 226.962,
          "y": 436.512,
          "original_width": 596,
          "original_height": 421,
          "rotation": 0
        },
        {
          "name": "img_p38_5.png",
          "height": 13.168,
          "width": 26.968,
          "x": 229.071,
          "y": 463.72,
          "original_width": 124,
          "original_height": 48,
          "rotation": 0
        },
        {
          "name": "img_p38_6.jpg",
          "height": 81.606,
          "width": 134.752,
          "x": 370.507,
          "y": 443.1,
          "original_width": 562,
          "original_height": 341,
          "rotation": 0,
          "ocr": [
            {
              "x": 212,
              "y": 190,
              "w": 107,
              "h": 32,
              "confidence": 0.522,
              "text": "adandiululukes"
            }
          ]
        },
        {
          "name": "img_p38_8.jpg",
          "height": 97.799,
          "width": 34.097,
          "x": 436.359,
          "y": 649.814,
          "original_width": 143,
          "original_height": 408,
          "rotation": 0
        },
        {
          "name": "img_p38_9.jpg",
          "height": 65.251,
          "width": 68.032,
          "x": 368.489,
          "y": 682.362,
          "original_width": 284,
          "original_height": 272,
          "rotation": 0
        },
        {
          "name": "img_p38_10.jpg",
          "height": 125.581,
          "width": 60.45,
          "x": 466.822,
          "y": 524.49,
          "original_width": 252,
          "original_height": 524,
          "rotation": 0
        },
        {
          "name": "img_p38_13.jpg",
          "height": 38.094,
          "width": 41.146,
          "x": 300.213,
          "y": 687.224,
          "original_width": 132,
          "original_height": 104,
          "rotation": 0,
          "ocr": [
            {
              "x": 52,
              "y": 19,
              "w": 26,
              "h": 13,
              "confidence": 0.555,
              "text": "dn 1o"
            },
            {
              "x": 99,
              "y": 2,
              "w": 5,
              "h": 8,
              "confidence": 0.263,
              "text": "P"
            },
            {
              "x": 50,
              "y": 0,
              "w": 37,
              "h": 12,
              "confidence": 0.869,
              "text": "0002462"
            }
          ]
        },
        {
          "name": "img_p38_14.jpg",
          "height": 103.504,
          "width": 86.057,
          "x": 163.467,
          "y": 540.9,
          "original_width": 312,
          "original_height": 395,
          "rotation": 0
        },
        {
          "name": "img_p38_15.jpg",
          "height": 67.088,
          "width": 35.378,
          "x": 354.119,
          "y": 472.569,
          "original_width": 148,
          "original_height": 280,
          "rotation": 0
        },
        {
          "name": "img_p38_16.jpg",
          "height": 200.615,
          "width": 70.345,
          "x": 249.08,
          "y": 505.918,
          "original_width": 294,
          "original_height": 836,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 125,
              "w": 294,
              "h": 423,
              "confidence": 0.998,
              "text": "7"
            }
          ]
        },
        {
          "name": "img_p38_17.png",
          "height": 33.739,
          "width": 35.24,
          "x": 319.152,
          "y": 505.918,
          "original_width": 147,
          "original_height": 141,
          "rotation": 0
        },
        {
          "name": "img_p38_18.jpg",
          "height": 167.266,
          "width": 35.241,
          "x": 389.223,
          "y": 505.918,
          "original_width": 147,
          "original_height": 697,
          "rotation": 0
        },
        {
          "name": "img_p38_19.jpg",
          "height": 100.437,
          "width": 70.345,
          "x": 319.152,
          "y": 606.096,
          "original_width": 294,
          "original_height": 419,
          "rotation": 0
        },
        {
          "name": "img_p38_20.jpg",
          "height": 56.042,
          "width": 70.249,
          "x": 305.499,
          "y": 528.129,
          "original_width": 293,
          "original_height": 234,
          "rotation": 0,
          "ocr": [
            {
              "x": 156,
              "y": 222,
              "w": 30,
              "h": 12,
              "confidence": 0.912,
              "text": "ml (0.05"
            }
          ]
        },
        {
          "name": "img_p38_21.jpg",
          "height": 111.942,
          "width": 35.2,
          "x": 375.598,
          "y": 528.129,
          "original_width": 147,
          "original_height": 467,
          "rotation": 0,
          "ocr": [
            {
              "x": 19,
              "y": 233,
              "w": 39,
              "h": 21,
              "confidence": 0.983,
              "text": "VACC"
            },
            {
              "x": 17,
              "y": 219,
              "w": 44,
              "h": 22,
              "confidence": 0.927,
              "text": "2.5ml-5"
            }
          ]
        },
        {
          "name": "img_p38_22.jpg",
          "height": 56.042,
          "width": 70.249,
          "x": 305.499,
          "y": 584.029,
          "original_width": 293,
          "original_height": 234,
          "rotation": 0,
          "ocr": [
            {
              "x": 135,
              "y": 138,
              "w": 41,
              "h": 14,
              "confidence": 0.956,
              "text": "DISCARD"
            },
            {
              "x": 110,
              "y": 127,
              "w": 66,
              "h": 13,
              "confidence": 0.946,
              "text": "USE IMVEDIATELY"
            },
            {
              "x": 108,
              "y": 116,
              "w": 67,
              "h": 17,
              "confidence": 0.81,
              "text": "212/2, Hadassar,"
            },
            {
              "x": 106,
              "y": 105,
              "w": 71,
              "h": 21,
              "confidence": 0.94,
              "text": "SERUM INSTIT"
            },
            {
              "x": 109,
              "y": 97,
              "w": 67,
              "h": 15,
              "confidence": 0.996,
              "text": "Manufactured by"
            },
            {
              "x": 141,
              "y": 91,
              "w": 35,
              "h": 10,
              "confidence": 0.91,
              "text": "ow instrud"
            },
            {
              "x": 219,
              "y": 77,
              "w": 50,
              "h": 18,
              "confidence": 0.933,
              "text": "RS. JEV"
            },
            {
              "x": 107,
              "y": 53,
              "w": 71,
              "h": 32,
              "confidence": 0.946,
              "text": "CGSNO"
            },
            {
              "x": 132,
              "y": 47,
              "w": 35,
              "h": 11,
              "confidence": 0.95,
              "text": "Dose:O"
            },
            {
              "x": 97,
              "y": 33,
              "w": 80,
              "h": 20,
              "confidence": 0.732,
              "text": "contains betwer"
            },
            {
              "x": 116,
              "y": 29,
              "w": 61,
              "h": 11,
              "confidence": 0.99,
              "text": "Live attenuated B"
            },
            {
              "x": 111,
              "y": 2,
              "w": 86,
              "h": 19,
              "confidence": 0.972,
              "text": "Bacillus Calma"
            }
          ]
        },
        {
          "name": "img_p38_23.jpg",
          "height": 62.832,
          "width": 113.507,
          "x": 249.144,
          "y": 472.682,
          "original_width": 473,
          "original_height": 262,
          "rotation": 0
        },
        {
          "name": "img_p38_24.jpg",
          "height": 53.333,
          "width": 96.571,
          "x": 370.51,
          "y": 472.698,
          "original_width": 403,
          "original_height": 223,
          "rotation": 0,
          "ocr": [
            {
              "x": 209,
              "y": 67,
              "w": 110,
              "h": 32,
              "confidence": 0.425,
              "text": "maluudiumdlukes"
            }
          ]
        },
        {
          "name": "img_p38_25.jpg",
          "height": 62.39,
          "width": 98.469,
          "x": 368.57,
          "y": 643.939,
          "original_width": 411,
          "original_height": 260,
          "rotation": 0
        },
        {
          "name": "img_p38_26.jpg",
          "height": 118.317,
          "width": 42.971,
          "x": 424.094,
          "y": 525.758,
          "original_width": 180,
          "original_height": 493,
          "rotation": 0
        },
        {
          "name": "img_p38_28.png",
          "height": 6.107,
          "width": 42.887,
          "x": 424.152,
          "y": 643.939,
          "original_width": 179,
          "original_height": 26,
          "rotation": 0
        },
        {
          "name": "img_p38_29.jpg",
          "height": 64.26,
          "width": 65.279,
          "x": 265.141,
          "y": 640.841,
          "original_width": 164,
          "original_height": 221,
          "rotation": 0
        },
        {
          "name": "img_p38_30.jpg",
          "height": 43.973,
          "width": 48.293,
          "x": 299.113,
          "y": 681.414,
          "original_width": 164,
          "original_height": 111,
          "rotation": 0
        },
        {
          "name": "page_39.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "ensured that they are kept in ILR at least 24 hours before use or issuing to sessions to ensure that vaccines and diluents are at same temperature (i.e. +2° to +8°C) during reconstitution. When mixed, the diluent and vaccine should be approximately at the same temperature; otherwise, it can lead to thermal shock that is, the death of some or all the essential live organisms in the vaccine.",
          "md": "ensured that they are kept in ILR at least 24 hours before use or issuing to sessions to ensure that vaccines and diluents are at same temperature (i.e. +2° to +8°C) during reconstitution. When mixed, the diluent and vaccine should be approximately at the same temperature; otherwise, it can lead to thermal shock that is, the death of some or all the essential live organisms in the vaccine.",
          "bBox": {
            "x": 128.4,
            "y": 69.94,
            "w": 408.39,
            "h": 641.53
          }
        },
        {
          "type": "text",
          "value": "The glass of diluent ampoules is too fragile and it should be stored in top of the ILR (above all the vaccines) to prevent cracking. Diluents should be transported along with the vaccines, in the vaccine carrier to the session sites.",
          "md": "The glass of diluent ampoules is too fragile and it should be stored in top of the ILR (above all the vaccines) to prevent cracking. Diluents should be transported along with the vaccines, in the vaccine carrier to the session sites.",
          "bBox": {
            "x": 128.4,
            "y": 136.92,
            "w": 408.39,
            "h": 553.96
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "68. What precautions should be taken regarding use of diluents?",
          "md": "## 68. What precautions should be taken regarding use of diluents?",
          "bBox": {
            "x": 130.38,
            "y": 207.66,
            "w": 400.28,
            "h": 483.22
          }
        },
        {
          "type": "text",
          "value": "**Ans.**  \n* ONLY the diluents supplied by the same manufacturer (bundled) along with vaccine are to be used as these are specifically designed for the needs of that vaccine, with respect to volume, pH level and chemical properties. No other diluents should be used even if they are chemically same.  \n* Diluents should be checked for expiry date, batch numbers and breakage (cracks and leaks). Care should be taken to ensure that freeze dried vaccine (BCG, Measles/ MR and JE) are issued with corresponding diluents.  \n* Only the recommended volume of diluent must be used to reconstitute the vaccine.",
          "md": "**Ans.**  \n* ONLY the diluents supplied by the same manufacturer (bundled) along with vaccine are to be used as these are specifically designed for the needs of that vaccine, with respect to volume, pH level and chemical properties. No other diluents should be used even if they are chemically same.  \n* Diluents should be checked for expiry date, batch numbers and breakage (cracks and leaks). Care should be taken to ensure that freeze dried vaccine (BCG, Measles/ MR and JE) are issued with corresponding diluents.  \n* Only the recommended volume of diluent must be used to reconstitute the vaccine.",
          "bBox": {
            "x": 86.4,
            "y": 245.82,
            "w": 450.4,
            "h": 445.06
          }
        },
        {
          "type": "text",
          "value": "*“Bundling” ensures that vaccines are always supplied with diluents, AD syringes and reconstitution syringes, in corresponding quantities, at each level of the supply chain.*",
          "md": "*“Bundling” ensures that vaccines are always supplied with diluents, AD syringes and reconstitution syringes, in corresponding quantities, at each level of the supply chain.*",
          "bBox": {
            "x": 128.4,
            "y": 392.15,
            "w": 408.37,
            "h": 298.73
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Break the diluent at the point of filing",
              "",
              "Draw the diluent",
              ""
            ],
            [
              "",
              "",
              "[Image of hand drawing diluent with syringe]",
              ""
            ],
            [
              "File the neck of the diluent ampoule",
              "",
              "Reconstitute the vaccine",
              ""
            ],
            [
              "Mention date and time of opening the vial<br/>",
              "",
              "",
              ""
            ],
            [
              "Shake the vial",
              "",
              "",
              ""
            ]
          ],
          "html": "<table>\n  <tr>\n    <td colspan=\"2\" rowspan=\"2\">Break the diluent at the point of filing</td>\n    <td colspan=\"2\">Draw the diluent</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">[Image of hand drawing diluent with syringe]</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">File the neck of the diluent ampoule</td>\n    <td colspan=\"2\" rowspan=\"2\">Reconstitute the vaccine</td>\n  </tr>\n<tr>\n    <td colspan=\"2\">Mention date and time of opening the vial  \n    <br /><i>(Use within 4 hours of opening)</i></td>\n  </tr>\n<tr>\n    <td colspan=\"4\" style=\"text-align:center;\">Shake the vial</td>\n  </tr>\n<tr>\n    <td colspan=\"4\" style=\"text-align:center;\">\n      <b>Figure 11: Procedure of reconstitution</b>\n    </td>\n  </tr>\n</table>",
          "md": "| Break the diluent at the point of filing                                        |   | Draw the diluent                              |   |\n| ------------------------------------------------------------------------------- | - | --------------------------------------------- | - |\n|                                                                                 |   | \\[Image of hand drawing diluent with syringe] |   |\n| File the neck of the diluent ampoule                                            |   | Reconstitute the vaccine                      |   |\n| Mention date and time of opening the vial<br/>*(Use within 4 hours of opening)* |   |                                               |   |\n| Shake the vial                                                                  |   |                                               |   |\n| **Figure 11: Procedure of reconstitution**                                      |   |                                               |   |",
          "isPerfectTable": false,
          "csv": "\"Break the diluent at the point of filing\",\"\",\"Draw the diluent\",\"\"\n\"\",\"\",\"[Image of hand drawing diluent with syringe]\",\"\"\n\"File the neck of the diluent ampoule\",\"\",\"Reconstitute the vaccine\",\"\"\n\"Mention date and time of opening the vial<br/>\",\"\",\"\",\"\"\n\"Shake the vial\",\"\",\"\",\"\"",
          "bBox": {
            "x": 86.36,
            "y": 55.44,
            "w": 450.44,
            "h": 773.27
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 40,
      "text": "Q 69. How is a VVM interpreted?\nAns.     In VVM, the inner square (placed inside outer circle) changes colour gradually when\n         exposed to high temperature. At the production facility, this square is white against\n         the blue background of outer circle. As vial is exposed to heat at different points of\n         time, the inner square begins to darken, and finally gets darker than colour of outer\n         circle.\n         If the square is visible and lighter in colour, the vaccine is safe to use, though the\n         vaccine in which the VVM is beginning to get dark should be used on priority.\n         However, if the square is not visible or is darker in colour, the vaccine is NOT safe and\n         should be discarded.\n                Usable Vaccine    Non Usable Vaccine\n\n\n\n\n             If the square is visible and lighter in colour, the         If the square is not visible or darker in colour, the\n             vaccine is safe to use.                                     vaccine is NOT safe to use.\n                                        Figure 12: VVM different stages\n         In all vaccines, VVM is present on the label;\n         but in  freeze-dried    vaccines (viz.                      BCG,\n         Measles, and JE) and Rotavirus Vaccine Vial,\n         VVM is present on the cap. The reason for\n         putting VVM on cap is that once these vials\nQ are opened for reconstitution, they should be                                                     Expiry Date:\n         used within 4 hours. For such vaccines, time                                               AU6.2019\n         after reconstitution is more important for    On all freeze-dried vaccines (BCG,  On all other vaccines vial VVM\n                                                        Measles/MR, JE) and RVV vial VVM            is present on the label\n         ensuring efficacy and safety, and therefore          is present on the cap                 OPEN VIAL POLICY IS\n                                                                         OPEN VIAL POLICY IS NOT     APPLICABLE!\n         should be discarded after 4 hours irrespective            APPLICABLE!\n         of their VVM status.                                            Figure 13: VVM placement on vials\n         Note: On all the vaccines, where the VVM is present on the label of the vial, an\n         “Open Vial Policy” is applicable on them. However, in vaccines where the VVM is\n         present on the cap of the vial, for e.g. BCG, Measles/ MR, JE, Rotavirus vaccine\n         vials, the “Open Vial Policy” is not applicable, and should be used within 4 hours of\n         opening the vial.\n\n         70. What is “Open Vial Policy”?\n\nAns.     To address the avoidable wastage and ensure optimal utilization of life-saving\n         vaccines, Ministry of Health & Family Welfare, Govt. of India, has adopted a Multi-\n         Dose Open Vial Policy (OVP). The policy underlines guidelines for the reuse and\n         storage of open vaccine vials of specific types that contain a few doses at the end of\n         a session, provided certain criteria are fulfilled.\n         Implementation of Open Vial Policy allows reuse of partially used multi dose vials of\n         applicable vaccines under UIP in subsequent session (both fixed and outreach) up to\n         four weeks (28 days) provided;\n\n\n\nFAQs on ImmunizationI 33",
      "md": "\n# 69. How is a VVM interpreted?\n\n**Ans.** In VVM, the inner square (placed inside outer circle) changes colour gradually when exposed to high temperature. At the production facility, this square is white against the blue background of outer circle. As vial is exposed to heat at different points of time, the inner square begins to darken, and finally gets darker than colour of outer circle.\n\nIf the square is visible and lighter in colour, the vaccine is safe to use, though the vaccine in which the VVM is beginning to get dark should be used on priority. However, if the square is not visible or is darker in colour, the vaccine is **NOT** safe and should be discarded.\n\n<table>\n<thead>\n<tr>\n<th>Usable Vaccine</th>\n<th>Non Usable Vaccine</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\nIf the square is visible and lighter in colour, the vaccine is safe to use.\n</td>\n<td>\nIf the square is not visible or darker in colour, the vaccine is <b>NOT</b> safe to use.\n</td>\n</tr>\n</tbody>\n</table>\n\n*Figure 12: VVM different stages*\n\nIn all vaccines, VVM is present on the label; but in freeze-dried vaccines (viz. BCG, Measles, and JE) and Rotavirus Vaccine Vial, VVM is present on the cap. The reason for putting VVM on cap is that once these vials are opened for reconstitution, they should be used within 4 hours. For such vaccines, time after reconstitution is more important for ensuring efficacy and safety, and therefore should be discarded after 4 hours irrespective of their VVM status.\n\n<table>\n<thead>\n<tr>\n<th colspan=\"2\">On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap</th>\n<th>On all other vaccines vial VVM is present on the label</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td colspan=\"2\" style=\"text-align:center;\"><b>OPEN VIAL POLICY IS NOT APPLICABLE!</b></td>\n<td style=\"text-align:center;\"><b>OPEN VIAL POLICY IS APPLICABLE!</b></td>\n</tr>\n</tbody>\n</table>\n\n*Figure 13: VVM placement on vials*\n\n> **Note:** On all the vaccines, where the VVM is present on the label of the vial, an “Open Vial Policy” is applicable on them. However, in vaccines where the VVM is present on the cap of the vial, for e.g. BCG, Measles/ MR, JE, Rotavirus vaccine vials, the “Open Vial Policy” is not applicable, and should be used within 4 hours of opening the vial.\n\n# 70. What is “Open Vial Policy”?\n\n**Ans.** To address the avoidable wastage and ensure optimal utilization of life-saving vaccines, Ministry of Health & Family Welfare, Govt. of India, has adopted a Multi-Dose Open Vial Policy (OVP). The policy underlines guidelines for the reuse and storage of open vaccine vials of specific types that contain a few doses at the end of a session, provided certain criteria are fulfilled.\n\nImplementation of Open Vial Policy allows reuse of partially used multi dose vials of applicable vaccines under UIP in subsequent session (both fixed and outreach) up to four weeks (28 days) provided;\n\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p39_2.jpg",
          "height": 34.683,
          "width": 34.53,
          "x": 358.567,
          "y": 386.091,
          "original_width": 144,
          "original_height": 145,
          "rotation": 0
        },
        {
          "name": "img_p39_3.jpg",
          "height": 34.683,
          "width": 34.53,
          "x": 358.567,
          "y": 420.713,
          "original_width": 144,
          "original_height": 145,
          "rotation": 0
        },
        {
          "name": "img_p39_4.jpg",
          "height": 30.04,
          "width": 35.368,
          "x": 450.743,
          "y": 368.467,
          "original_width": 144,
          "original_height": 121,
          "rotation": 0
        },
        {
          "name": "img_p39_5.jpg",
          "height": 30.041,
          "width": 35.369,
          "x": 451.626,
          "y": 397.392,
          "original_width": 144,
          "original_height": 121,
          "rotation": 0
        },
        {
          "name": "img_p39_6.jpg",
          "height": 30.04,
          "width": 35.369,
          "x": 452.51,
          "y": 426.318,
          "original_width": 144,
          "original_height": 121,
          "rotation": 0,
          "ocr": [
            {
              "x": 23,
              "y": 67,
              "w": 62,
              "h": 22,
              "confidence": 0.982,
              "text": "AU6.2019"
            },
            {
              "x": 42,
              "y": 58,
              "w": 45,
              "h": 16,
              "confidence": 0.949,
              "text": "Expiry Date:"
            }
          ]
        },
        {
          "name": "img_p39_7.png",
          "height": 37.44,
          "width": 414.48,
          "x": 96.96,
          "y": 598.29,
          "original_width": 1727,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p39_13.jpg",
          "height": 14.044,
          "width": 14.296,
          "x": 205.246,
          "y": 298.925,
          "original_width": 60,
          "original_height": 59,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_40.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "69. How is a VVM interpreted?",
          "md": "# 69. How is a VVM interpreted?",
          "bBox": {
            "x": 126.5,
            "y": 371.38,
            "w": 9.11,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "**Ans.** In VVM, the inner square (placed inside outer circle) changes colour gradually when exposed to high temperature. At the production facility, this square is white against the blue background of outer circle. As vial is exposed to heat at different points of time, the inner square begins to darken, and finally gets darker than colour of outer circle.",
          "md": "**Ans.** In VVM, the inner square (placed inside outer circle) changes colour gradually when exposed to high temperature. At the production facility, this square is white against the blue background of outer circle. As vial is exposed to heat at different points of time, the inner square begins to darken, and finally gets darker than colour of outer circle.",
          "bBox": {
            "x": 58.5,
            "y": 99.03,
            "w": 452.71,
            "h": 551.36
          }
        },
        {
          "type": "text",
          "value": "If the square is visible and lighter in colour, the vaccine is safe to use, though the vaccine in which the VVM is beginning to get dark should be used on priority. However, if the square is not visible or is darker in colour, the vaccine is **NOT** safe and should be discarded.",
          "md": "If the square is visible and lighter in colour, the vaccine is safe to use, though the vaccine in which the VVM is beginning to get dark should be used on priority. However, if the square is not visible or is darker in colour, the vaccine is **NOT** safe and should be discarded.",
          "bBox": {
            "x": 100.5,
            "y": 180.51,
            "w": 410.7,
            "h": 202.87
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Usable Vaccine",
              "Non Usable Vaccine"
            ],
            [
              "If the square is visible and lighter in colour, the vaccine is safe to use.",
              "If the square is not visible or darker in colour, the vaccine is  safe to use."
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th>Usable Vaccine</th>\n<th>Non Usable Vaccine</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>\nIf the square is visible and lighter in colour, the vaccine is safe to use.\n</td>\n<td>\nIf the square is not visible or darker in colour, the vaccine is <b>NOT</b> safe to use.\n</td>\n</tr>\n</tbody>\n</table>",
          "md": "| Usable Vaccine                                                              | Non Usable Vaccine                                                                    |\n| --------------------------------------------------------------------------- | ------------------------------------------------------------------------------------- |\n| If the square is visible and lighter in colour, the vaccine is safe to use. | If the square is not visible or darker in colour, the vaccine is **NOT** safe to use. |",
          "isPerfectTable": true,
          "csv": "\"Usable Vaccine\",\"Non Usable Vaccine\"\n\"If the square is visible and lighter in colour, the vaccine is safe to use.\",\"If the square is not visible or darker in colour, the vaccine is  safe to use.\"",
          "bBox": {
            "x": 166.03,
            "y": 246.16,
            "w": 272.4,
            "h": 9.22
          }
        },
        {
          "type": "text",
          "value": "*Figure 12: VVM different stages*",
          "md": "*Figure 12: VVM different stages*",
          "bBox": {
            "x": 265.38,
            "y": 345.09,
            "w": 117.11,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "In all vaccines, VVM is present on the label; but in freeze-dried vaccines (viz. BCG, Measles, and JE) and Rotavirus Vaccine Vial, VVM is present on the cap. The reason for putting VVM on cap is that once these vials are opened for reconstitution, they should be used within 4 hours. For such vaccines, time after reconstitution is more important for ensuring efficacy and safety, and therefore should be discarded after 4 hours irrespective of their VVM status.",
          "md": "In all vaccines, VVM is present on the label; but in freeze-dried vaccines (viz. BCG, Measles, and JE) and Rotavirus Vaccine Vial, VVM is present on the cap. The reason for putting VVM on cap is that once these vials are opened for reconstitution, they should be used within 4 hours. For such vaccines, time after reconstitution is more important for ensuring efficacy and safety, and therefore should be discarded after 4 hours irrespective of their VVM status.",
          "bBox": {
            "x": 100.7,
            "y": 356.89,
            "w": 394,
            "h": 156.96
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap",
              "On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap",
              "On all other vaccines vial VVM is present on the label"
            ]
          ],
          "html": "<table>\n<thead>\n<tr>\n<th colspan=\"2\">On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap</th>\n<th>On all other vaccines vial VVM is present on the label</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td colspan=\"2\" style=\"text-align:center;\"><b>OPEN VIAL POLICY IS NOT APPLICABLE!</b></td>\n<td style=\"text-align:center;\"><b>OPEN VIAL POLICY IS APPLICABLE!</b></td>\n</tr>\n</tbody>\n</table>",
          "md": "| On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap | On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap | On all other vaccines vial VVM is present on the label |\n| ----------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------- | ------------------------------------------------------ |\n| **OPEN VIAL POLICY IS NOT APPLICABLE!**                                                   |                                                                                           | **OPEN VIAL POLICY IS APPLICABLE!**                    |",
          "isPerfectTable": true,
          "csv": "\"On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap\",\"On all freeze-dried vaccines (BCG, Measles/MR, JE) and RVV vial VVM is present on the cap\",\"On all other vaccines vial VVM is present on the label\"",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "*Figure 13: VVM placement on vials*",
          "md": "*Figure 13: VVM placement on vials*",
          "bBox": {
            "x": 356.14,
            "y": 502.6,
            "w": 127.47,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "> **Note:** On all the vaccines, where the VVM is present on the label of the vial, an “Open Vial Policy” is applicable on them. However, in vaccines where the VVM is present on the cap of the vial, for e.g. BCG, Measles/ MR, JE, Rotavirus vaccine vials, the “Open Vial Policy” is not applicable, and should be used within 4 hours of opening the vial.",
          "md": "> **Note:** On all the vaccines, where the VVM is present on the label of the vial, an “Open Vial Policy” is applicable on them. However, in vaccines where the VVM is present on the cap of the vial, for e.g. BCG, Measles/ MR, JE, Rotavirus vaccine vials, the “Open Vial Policy” is not applicable, and should be used within 4 hours of opening the vial.",
          "bBox": {
            "x": 100.7,
            "y": 371.38,
            "w": 410.5,
            "h": 210.89
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "70. What is “Open Vial Policy”?",
          "md": "# 70. What is “Open Vial Policy”?",
          "bBox": {
            "x": 102.67,
            "y": 604.5,
            "w": 199.63,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "**Ans.** To address the avoidable wastage and ensure optimal utilization of life-saving vaccines, Ministry of Health & Family Welfare, Govt. of India, has adopted a Multi-Dose Open Vial Policy (OVP). The policy underlines guidelines for the reuse and storage of open vaccine vials of specific types that contain a few doses at the end of a session, provided certain criteria are fulfilled.",
          "md": "**Ans.** To address the avoidable wastage and ensure optimal utilization of life-saving vaccines, Ministry of Health & Family Welfare, Govt. of India, has adopted a Multi-Dose Open Vial Policy (OVP). The policy underlines guidelines for the reuse and storage of open vaccine vials of specific types that contain a few doses at the end of a session, provided certain criteria are fulfilled.",
          "bBox": {
            "x": 58.5,
            "y": 99.03,
            "w": 452.72,
            "h": 609.35
          }
        },
        {
          "type": "text",
          "value": "Implementation of Open Vial Policy allows reuse of partially used multi dose vials of applicable vaccines under UIP in subsequent session (both fixed and outreach) up to four weeks (28 days) provided;",
          "md": "Implementation of Open Vial Policy allows reuse of partially used multi dose vials of applicable vaccines under UIP in subsequent session (both fixed and outreach) up to four weeks (28 days) provided;",
          "bBox": {
            "x": 100.7,
            "y": 371.38,
            "w": 410.5,
            "h": 389.48
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.996
    },
    {
      "page": 41,
      "text": "à  Expiry date has not passed\nà  Vaccines are stored under appropriate cold chain conditions both during\n   transportation and storage\nà  Vaccine vial septum has not been submerged in water or contaminated in any\n   way\nà  Aseptic technique has been used to withdraw vaccine doses\nà  VVM has not reached/crossed the discard point\n\n\n\n\n\n\n         Readable and intact label                                          Usable VVM\n\n                                         Biological     lia by:\n                                                        Limited                         The vaccine is not\n                                                        20.A.P.\n                                                                             la by:\n                                                                   ological E.ia by:\n                                                                             Limited\n         Expiry date has not passed      Expiy Date:                         Limited    visibly frozen (for\n                                                                             20,A.P.\n                                         AUG.2OXX                            20,A.P.     freeze-sensitive\n                                                                             Expiy Date:\n                                                                            Expisy Date:\n                                                                            AUG.2\n                                                                            AUG.2OXX\n                                                                             OXX\n                                                                                        vaccines)\n\n                   If the vial is already open, also check the following;\n\n                   Septum is                                                            Date and time is\n                   not leaking                                     mentioned (Discard aﬅer\n                                                                   AUG.2         28 days of opening)\n\n                                  Figure 14: Points to be checked as per Open Vial Policy\n\n         71. Which are the vaccines on which “Open Vial Policy” applies?\nQ\nAns.     Open Vial Policy is applicable on the open multi-dose vials of Hep B, OPV, IPV, PCV,\n         DPT, TT and Pentavalent vaccine.\n         The policy DOES NOT apply to freeze dried vaccines (BCG, Measles/MR and JE) and\n         Rotavirus vaccines. These vaccines are to be used up to a maximum of 4 hours after\n         opening.¹⁰\n         Note: All vaccines vials must be marked with date & time of opening the vial at\n         first use.\n\n\n         72. What should be done with all returned vials (partially used\n          vials, empty vials and unopened vials) of vaccines that cannot\n          be reused during next session?\nAns.     As per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials,\n         empty vials and unopened vials) should be returned to the last cold chain point on the\n         same day. At the cold chain point, the cold chain handler should ensure appropriate\n\n10Guidelines on Open Vial Policy for using multi-dose vials in Universal Immunization Programme, September 2015.\n\n34 IFAQs on Immunization",
      "md": "\n* Expiry date has not passed  \n* Vaccines are stored under appropriate cold chain conditions both during transportation and storage  \n* Vaccine vial septum has not been submerged in water or contaminated in any way  \n* Aseptic technique has been used to withdraw vaccine doses  \n* VVM has not reached/crossed the discard point  \n\n<table>\n  <tr>\n    <td>Readable and intact label</td>\n<td>Usable VVM</td>\n  </tr>\n<tr>\n    <td colspan=\"2\" style=\"text-align:center;\">\n      <b>Expiry date has not passed</b>\n    </td>\n  </tr>\n<tr>\n    <td colspan=\"2\" style=\"text-align:center;\">\n      The vaccine is not visibly frozen (for freeze-sensitive vaccines)\n    </td>\n  </tr>\n<tr>\n    <td>Septum is not leaking</td>\n<td>Date and time is mentioned (Discard after 28 days of opening)</td>\n  </tr>\n</table>\n\n> Figure 14: Points to be checked as per Open Vial Policy\n\n----\n\n### 71. Which are the vaccines on which “Open Vial Policy” applies?\n\n**Ans.**  \nOpen Vial Policy is applicable on the open multi-dose vials of Hep B, OPV, IPV, PCV, DPT, TT and Pentavalent vaccine.  \nThe policy **DOES NOT** apply to freeze dried vaccines (BCG, Measles/MR and JE) and Rotavirus vaccines. These vaccines are to be used up to a maximum of 4 hours after opening.¹⁰  \n\n**Note:** *All vaccines vials must be marked with date & time of opening the vial at first use.*\n\n----\n\n### 72. What should be done with all returned vials (partially used vials, empty vials and unopened vials) of vaccines that cannot be reused during next session?\n\n**Ans.**  \nAs per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. At the cold chain point, the cold chain handler should ensure appropriate...\n\n----\n\n¹⁰ Guidelines on Open Vial Policy for using multi-dose vials in Universal Immunization Programme, September 2015.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p40_4.jpg",
          "height": 31.288,
          "width": 29.102,
          "x": 301.381,
          "y": 184.693,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_5.jpg",
          "height": 31.288,
          "width": 29.08,
          "x": 330.441,
          "y": 184.693,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_6.jpg",
          "height": 31.288,
          "width": 29.102,
          "x": 301.381,
          "y": 215.938,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_7.jpg",
          "height": 31.288,
          "width": 29.08,
          "x": 330.441,
          "y": 215.938,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_8.jpg",
          "height": 31.267,
          "width": 29.102,
          "x": 301.381,
          "y": 247.183,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_9.jpg",
          "height": 31.267,
          "width": 29.08,
          "x": 330.441,
          "y": 247.183,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0
        },
        {
          "name": "img_p40_10.jpg",
          "height": 31.288,
          "width": 29.102,
          "x": 301.381,
          "y": 278.407,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0,
          "ocr": [
            {
              "x": 47,
              "y": 47,
              "w": 52,
              "h": 27,
              "confidence": 0.988,
              "text": "Biological"
            }
          ]
        },
        {
          "name": "img_p40_11.jpg",
          "height": 31.288,
          "width": 29.08,
          "x": 330.441,
          "y": 278.407,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 84,
              "w": 30,
              "h": 14,
              "confidence": 0.925,
              "text": "20.A.P."
            },
            {
              "x": 0,
              "y": 56,
              "w": 43,
              "h": 20,
              "confidence": 0.959,
              "text": "Limited"
            },
            {
              "x": 0,
              "y": 47,
              "w": 27,
              "h": 14,
              "confidence": 0.932,
              "text": "lia by:"
            }
          ]
        },
        {
          "name": "img_p40_12.jpg",
          "height": 31.288,
          "width": 29.102,
          "x": 301.381,
          "y": 309.652,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0,
          "ocr": [
            {
              "x": 63,
              "y": 26,
              "w": 59,
              "h": 34,
              "confidence": 0.996,
              "text": "AUG.2"
            },
            {
              "x": 92,
              "y": 11,
              "w": 30,
              "h": 20,
              "confidence": 0.995,
              "text": "Expi"
            }
          ]
        },
        {
          "name": "img_p40_13.jpg",
          "height": 31.288,
          "width": 29.08,
          "x": 330.441,
          "y": 309.652,
          "original_width": 122,
          "original_height": 131,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 27,
              "w": 33,
              "h": 34,
              "confidence": 0.535,
              "text": "OXX"
            },
            {
              "x": 0,
              "y": 10,
              "w": 39,
              "h": 21,
              "confidence": 0.985,
              "text": "y Date:"
            }
          ]
        },
        {
          "name": "img_p40_16.jpg",
          "height": 22.685,
          "width": 22.668,
          "x": 388.023,
          "y": 300.9,
          "original_width": 95,
          "original_height": 95,
          "rotation": 0,
          "ocr": [
            {
              "x": 45,
              "y": 27,
              "w": 46,
              "h": 20,
              "confidence": 0.884,
              "text": "ological E."
            }
          ]
        },
        {
          "name": "img_p40_17.jpg",
          "height": 22.685,
          "width": 22.685,
          "x": 410.656,
          "y": 300.9,
          "original_width": 95,
          "original_height": 95,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 50,
              "w": 24,
              "h": 17,
              "confidence": 0.84,
              "text": "20,A.P."
            },
            {
              "x": 0,
              "y": 29,
              "w": 36,
              "h": 19,
              "confidence": 0.994,
              "text": "Limited"
            },
            {
              "x": 0,
              "y": 24,
              "w": 21,
              "h": 12,
              "confidence": 0.916,
              "text": "ia by:"
            }
          ]
        },
        {
          "name": "img_p40_18.jpg",
          "height": 22.668,
          "width": 22.668,
          "x": 388.023,
          "y": 323.551,
          "original_width": 95,
          "original_height": 95,
          "rotation": 0,
          "ocr": [
            {
              "x": 47,
              "y": 16,
              "w": 48,
              "h": 28,
              "confidence": 0.958,
              "text": "AUG.2"
            },
            {
              "x": 72,
              "y": 7,
              "w": 23,
              "h": 12,
              "confidence": 0.948,
              "text": "Expis"
            }
          ]
        },
        {
          "name": "img_p40_19.jpg",
          "height": 22.668,
          "width": 22.685,
          "x": 410.656,
          "y": 323.551,
          "original_width": 95,
          "original_height": 95,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 18,
              "w": 26,
              "h": 26,
              "confidence": 0.614,
              "text": "OXX"
            },
            {
              "x": 0,
              "y": 4,
              "w": 31,
              "h": 16,
              "confidence": 0.982,
              "text": "y Date:"
            }
          ]
        },
        {
          "name": "img_p40_20.jpg",
          "height": 23.18,
          "width": 23.18,
          "x": 387.528,
          "y": 300.405,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0
        },
        {
          "name": "img_p40_21.jpg",
          "height": 23.18,
          "width": 23.163,
          "x": 410.673,
          "y": 300.405,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 53,
              "w": 24,
              "h": 15,
              "confidence": 0.878,
              "text": "20,A.P."
            },
            {
              "x": 0,
              "y": 32,
              "w": 36,
              "h": 18,
              "confidence": 0.996,
              "text": "Limited"
            },
            {
              "x": 0,
              "y": 26,
              "w": 21,
              "h": 11,
              "confidence": 0.916,
              "text": "la by:"
            }
          ]
        },
        {
          "name": "img_p40_22.jpg",
          "height": 23.163,
          "width": 23.18,
          "x": 387.528,
          "y": 323.551,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 49,
              "y": 16,
              "w": 48,
              "h": 29,
              "confidence": 0.969,
              "text": "AUG.2"
            },
            {
              "x": 72,
              "y": 5,
              "w": 25,
              "h": 16,
              "confidence": 0.978,
              "text": "Expi"
            }
          ]
        },
        {
          "name": "img_p40_23.jpg",
          "height": 23.163,
          "width": 23.163,
          "x": 410.673,
          "y": 323.551,
          "original_width": 97,
          "original_height": 97,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 18,
              "w": 26,
              "h": 25,
              "confidence": 0.611,
              "text": "OXX"
            },
            {
              "x": 0,
              "y": 5,
              "w": 31,
              "h": 15,
              "confidence": 0.897,
              "text": "y Date:"
            }
          ]
        },
        {
          "name": "img_p40_24.jpg",
          "height": 22.314,
          "width": 22.615,
          "x": 380.597,
          "y": 295.828,
          "original_width": 95,
          "original_height": 93,
          "rotation": 0
        },
        {
          "name": "img_p40_25.jpg",
          "height": 15.926,
          "width": 14.492,
          "x": 388.705,
          "y": 302.197,
          "original_width": 61,
          "original_height": 67,
          "rotation": 0
        },
        {
          "name": "img_p40_26.png",
          "height": 17.017,
          "width": 15.552,
          "x": 387.66,
          "y": 301.125,
          "original_width": 65,
          "original_height": 71,
          "rotation": 0
        },
        {
          "name": "img_p40_27.jpg",
          "height": 16.455,
          "width": 15.004,
          "x": 388.193,
          "y": 301.668,
          "original_width": 63,
          "original_height": 69,
          "rotation": 0
        },
        {
          "name": "img_p40_28.jpg",
          "height": 24.301,
          "width": 24.302,
          "x": 341.715,
          "y": 389.514,
          "original_width": 102,
          "original_height": 102,
          "rotation": 0
        },
        {
          "name": "img_p40_29.jpg",
          "height": 24.301,
          "width": 24.284,
          "x": 365.981,
          "y": 389.514,
          "original_width": 102,
          "original_height": 102,
          "rotation": 0
        },
        {
          "name": "img_p40_30.jpg",
          "height": 24.284,
          "width": 24.302,
          "x": 341.715,
          "y": 413.78,
          "original_width": 102,
          "original_height": 102,
          "rotation": 0,
          "ocr": [
            {
              "x": 52,
              "y": 38,
              "w": 50,
              "h": 31,
              "confidence": 0.994,
              "text": "AUG.2"
            }
          ]
        },
        {
          "name": "page_41.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "* Expiry date has not passed  \n* Vaccines are stored under appropriate cold chain conditions both during transportation and storage  \n* Vaccine vial septum has not been submerged in water or contaminated in any way  \n* Aseptic technique has been used to withdraw vaccine doses  \n* VVM has not reached/crossed the discard point",
          "md": "* Expiry date has not passed  \n* Vaccines are stored under appropriate cold chain conditions both during transportation and storage  \n* Vaccine vial septum has not been submerged in water or contaminated in any way  \n* Aseptic technique has been used to withdraw vaccine doses  \n* VVM has not reached/crossed the discard point",
          "bBox": {
            "x": 86.36,
            "y": 55.42,
            "w": 450.42,
            "h": 498.34
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Readable and intact label",
              "Usable VVM"
            ],
            [
              "The vaccine is not visibly frozen (for freeze-sensitive vaccines)",
              ""
            ],
            [
              "Septum is not leaking",
              "Date and time is mentioned (Discard after 28 days of opening)"
            ]
          ],
          "html": "<table>\n  <tr>\n    <td>Readable and intact label</td>\n<td>Usable VVM</td>\n  </tr>\n<tr>\n    <td colspan=\"2\" style=\"text-align:center;\">\n      <b>Expiry date has not passed</b>\n    </td>\n  </tr>\n<tr>\n    <td colspan=\"2\" style=\"text-align:center;\">\n      The vaccine is not visibly frozen (for freeze-sensitive vaccines)\n    </td>\n  </tr>\n<tr>\n    <td>Septum is not leaking</td>\n<td>Date and time is mentioned (Discard after 28 days of opening)</td>\n  </tr>\n</table>",
          "md": "| Readable and intact label                                         | Usable VVM                                                    |\n| ----------------------------------------------------------------- | ------------------------------------------------------------- |\n| **Expiry date has not passed**                                    |                                                               |\n| The vaccine is not visibly frozen (for freeze-sensitive vaccines) |                                                               |\n| Septum is not leaking                                             | Date and time is mentioned (Discard after 28 days of opening) |",
          "isPerfectTable": true,
          "csv": "\"Readable and intact label\",\"Usable VVM\"\n\"The vaccine is not visibly frozen (for freeze-sensitive vaccines)\",\"\"\n\"Septum is not leaking\",\"Date and time is mentioned (Discard after 28 days of opening)\"",
          "bBox": {
            "x": 86.36,
            "y": 55.42,
            "w": 450.44,
            "h": 773.3
          }
        },
        {
          "type": "text",
          "value": "> Figure 14: Points to be checked as per Open Vial Policy",
          "md": "> Figure 14: Points to be checked as per Open Vial Policy",
          "bBox": {
            "x": 264.82,
            "y": 457.37,
            "w": 201.96,
            "h": 9.11
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "71. Which are the vaccines on which “Open Vial Policy” applies?",
          "md": "### 71. Which are the vaccines on which “Open Vial Policy” applies?",
          "bBox": {
            "x": 130.38,
            "y": 486.43,
            "w": 392.85,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "**Ans.**  \nOpen Vial Policy is applicable on the open multi-dose vials of Hep B, OPV, IPV, PCV, DPT, TT and Pentavalent vaccine.  \nThe policy **DOES NOT** apply to freeze dried vaccines (BCG, Measles/MR and JE) and Rotavirus vaccines. These vaccines are to be used up to a maximum of 4 hours after opening.¹⁰",
          "md": "**Ans.**  \nOpen Vial Policy is applicable on the open multi-dose vials of Hep B, OPV, IPV, PCV, DPT, TT and Pentavalent vaccine.  \nThe policy **DOES NOT** apply to freeze dried vaccines (BCG, Measles/MR and JE) and Rotavirus vaccines. These vaccines are to be used up to a maximum of 4 hours after opening.¹⁰",
          "bBox": {
            "x": 86.4,
            "y": 520.33,
            "w": 450.38,
            "h": 203.12
          }
        },
        {
          "type": "text",
          "value": "**Note:** *All vaccines vials must be marked with date & time of opening the vial at first use.*",
          "md": "**Note:** *All vaccines vials must be marked with date & time of opening the vial at first use.*",
          "bBox": {
            "x": 128.4,
            "y": 625.32,
            "w": 43.84,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "72. What should be done with all returned vials (partially used vials, empty vials and unopened vials) of vaccines that cannot be reused during next session?",
          "md": "### 72. What should be done with all returned vials (partially used vials, empty vials and unopened vials) of vaccines that cannot be reused during next session?",
          "bBox": {
            "x": 130.38,
            "y": 657.54,
            "w": 406.42,
            "h": 43.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.**  \nAs per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. At the cold chain point, the cold chain handler should ensure appropriate...",
          "md": "**Ans.**  \nAs per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. At the cold chain point, the cold chain handler should ensure appropriate...",
          "bBox": {
            "x": 86.4,
            "y": 520.33,
            "w": 450.39,
            "h": 232.11
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "¹⁰ Guidelines on Open Vial Policy for using multi-dose vials in Universal Immunization Programme, September 2015.",
          "md": "¹⁰ Guidelines on Open Vial Policy for using multi-dose vials in Universal Immunization Programme, September 2015.",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 42,
      "text": "segregation as “To be used” and “Not to be used”, as per the following instructions;\nTo be used\n à  Unopened vials, if the VVM is intact and in usable stage\n à  Partially used vials on which the open vial policy is applicable\nNot to be used\n à  Unopened vials, if the VVM is not in usable stage\n à  Complete defacement of label of the vial\n à  No mention of date/ time of opening on the opened vials\n à  Open vials of BCG, Measles/ MR, JE and Rotavirus Vaccine\n à  Empty vaccine vials\nAll returned vials (to be used and not be used) should be kept in the ILR. The vials\nmarked as not to be used should be discarded after 48 hours or before the next\nsession whichever is earlier. After this period, these vials should be discarded as per\nbiomedical waste management protocol.This is done to ensure availability of vaccine\nvial for investigation, in case any adverse event occurs during this period. In case of\nany reported AEFI they will not be discarded but retained for further investigation.\n\n\n\n         73. What should be done in case partially used vials are received\n         without date and time on them?\nAns.     If the date and time of opening is not mentioned on the opened vials, they should\nQ\nQ not be issued to any subsequent sessions. Such vaccine vials should be kept in ₜₕₑ\n         box “Not to be used” in ILR for 48 hours or before the next session, whichever is\n         earlier and then must be discarded as per the guidelines.\n\n\n         74. What is “electronic Vaccine Intelligence Network (eVIN)”?\n\nAns.     eVIN is a Government of India’s initiative, launched in 2015, to support UIP by\n         providing real-timeinformationonvaccinestocks andflows, andstoragetemperature\n         across all cold chain points of the country. In this system, cold chain handlers at all\n         levels are provided with smart phones equipped with eVIN application for updating\n         vaccine inventories. This is uploaded on a cloud server, which can then be viewed by\n         programme managers at district, state and national level through online dashboards.\n         In addition, system also helps to track storage temperature of vaccines through SIM-\n         enabled temperature loggers, which record temperature data every ten minutes and\n         update the server every hour via GPRS. In case of temperature breach, the logger\n         alarms and sends email and SMS alerts to responsible cold chain technicians and\n         managers.\n\n\n\n\n\n\nFAQs on ImmunizationI 35",
      "md": "\nsegregation as “**To be used**” and “**Not to be used**”, as per the following instructions;\n\n**To be used**  \n* Unopened vials, if the VVM is intact and in usable stage  \n* Partially used vials on which the open vial policy is applicable  \n\n**Not to be used**  \n* Unopened vials, if the VVM is not in usable stage  \n* Complete defacement of label of the vial  \n* No mention of date/time of opening on the opened vials  \n* Open vials of BCG, Measles/MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials  \n\n**All returned vials (to be used and not be used) should be kept in the ILR. The vials marked as not to be used should be discarded after 48 hours or before the next session whichever is earlier.** After this period, these vials should be discarded as per biomedical waste management protocol. This is done to ensure availability of vaccine vial for investigation, in case any adverse event occurs during this period. In case of any reported AEFI they will not be discarded but retained for further investigation.\n\n----\n\n### 73. What should be done in case partially used vials are received without date and time on them?\n\n**Ans.** If the date and time of opening is not mentioned on the opened vials, they should not be issued to any subsequent sessions. Such vaccine vials should be kept in the box **“Not to be used”** in ILR for 48 hours or before the next session, whichever is earlier and then must be discarded as per the guidelines.\n\n----\n\n### 74. What is “electronic Vaccine Intelligence Network (eVIN)”?\n\n**Ans.** eVIN is a Government of India’s initiative, launched in 2015, to support UIP by providing real-time information on vaccine stocks and flows, and storage temperature across all cold chain points of the country. In this system, cold chain handlers at all levels are provided with smart phones equipped with eVIN application for updating vaccine inventories. This is uploaded on a cloud server, which can then be viewed by programme managers at district, state and national level through online dashboards.\n\nIn addition, system also helps to track storage temperature of vaccines through SIM-enabled temperature loggers, which record temperature data every ten minutes and update the server every hour via GPRS. In case of temperature breach, the logger alarms and sends email and SMS alerts to responsible cold chain technicians and managers.\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p7_18.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 436.629,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_42.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "segregation as “**To be used**” and “**Not to be used**”, as per the following instructions;",
          "md": "segregation as “**To be used**” and “**Not to be used**”, as per the following instructions;",
          "bBox": {
            "x": 100.5,
            "y": 78.87,
            "w": 72.55,
            "h": 76.24
          }
        },
        {
          "type": "text",
          "value": "**To be used**  \n* Unopened vials, if the VVM is intact and in usable stage  \n* Partially used vials on which the open vial policy is applicable",
          "md": "**To be used**  \n* Unopened vials, if the VVM is intact and in usable stage  \n* Partially used vials on which the open vial policy is applicable",
          "bBox": {
            "x": 100.5,
            "y": 78.87,
            "w": 322.34,
            "h": 54.18
          }
        },
        {
          "type": "text",
          "value": "**Not to be used**  \n* Unopened vials, if the VVM is not in usable stage  \n* Complete defacement of label of the vial  \n* No mention of date/time of opening on the opened vials  \n* Open vials of BCG, Measles/MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials",
          "md": "**Not to be used**  \n* Unopened vials, if the VVM is not in usable stage  \n* Complete defacement of label of the vial  \n* No mention of date/time of opening on the opened vials  \n* Open vials of BCG, Measles/MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials",
          "bBox": {
            "x": 100.5,
            "y": 78.87,
            "w": 308.06,
            "h": 178.79
          }
        },
        {
          "type": "text",
          "value": "**All returned vials (to be used and not be used) should be kept in the ILR. The vials marked as not to be used should be discarded after 48 hours or before the next session whichever is earlier.** After this period, these vials should be discarded as per biomedical waste management protocol. This is done to ensure availability of vaccine vial for investigation, in case any adverse event occurs during this period. In case of any reported AEFI they will not be discarded but retained for further investigation.",
          "md": "**All returned vials (to be used and not be used) should be kept in the ILR. The vials marked as not to be used should be discarded after 48 hours or before the next session whichever is earlier.** After this period, these vials should be discarded as per biomedical waste management protocol. This is done to ensure availability of vaccine vial for investigation, in case any adverse event occurs during this period. In case of any reported AEFI they will not be discarded but retained for further investigation.",
          "bBox": {
            "x": 100.5,
            "y": 78.87,
            "w": 410.71,
            "h": 273.32
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "73. What should be done in case partially used vials are received without date and time on them?",
          "md": "### 73. What should be done in case partially used vials are received without date and time on them?",
          "bBox": {
            "x": 102.48,
            "y": 399.51,
            "w": 405.8,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "**Ans.** If the date and time of opening is not mentioned on the opened vials, they should not be issued to any subsequent sessions. Such vaccine vials should be kept in the box **“Not to be used”** in ILR for 48 hours or before the next session, whichever is earlier and then must be discarded as per the guidelines.",
          "md": "**Ans.** If the date and time of opening is not mentioned on the opened vials, they should not be issued to any subsequent sessions. Such vaccine vials should be kept in the box **“Not to be used”** in ILR for 48 hours or before the next session, whichever is earlier and then must be discarded as per the guidelines.",
          "bBox": {
            "x": 58.46,
            "y": 78.87,
            "w": 452.74,
            "h": 494.22
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "74. What is “electronic Vaccine Intelligence Network (eVIN)”?",
          "md": "### 74. What is “electronic Vaccine Intelligence Network (eVIN)”?",
          "bBox": {
            "x": 102.48,
            "y": 527.21,
            "w": 381.68,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "**Ans.** eVIN is a Government of India’s initiative, launched in 2015, to support UIP by providing real-time information on vaccine stocks and flows, and storage temperature across all cold chain points of the country. In this system, cold chain handlers at all levels are provided with smart phones equipped with eVIN application for updating vaccine inventories. This is uploaded on a cloud server, which can then be viewed by programme managers at district, state and national level through online dashboards.",
          "md": "**Ans.** eVIN is a Government of India’s initiative, launched in 2015, to support UIP by providing real-time information on vaccine stocks and flows, and storage temperature across all cold chain points of the country. In this system, cold chain handlers at all levels are provided with smart phones equipped with eVIN application for updating vaccine inventories. This is uploaded on a cloud server, which can then be viewed by programme managers at district, state and national level through online dashboards.",
          "bBox": {
            "x": 58.46,
            "y": 436.1,
            "w": 452.77,
            "h": 209.47
          }
        },
        {
          "type": "text",
          "value": "In addition, system also helps to track storage temperature of vaccines through SIM-enabled temperature loggers, which record temperature data every ten minutes and update the server every hour via GPRS. In case of temperature breach, the logger alarms and sends email and SMS alerts to responsible cold chain technicians and managers.",
          "md": "In addition, system also helps to track storage temperature of vaccines through SIM-enabled temperature loggers, which record temperature data every ten minutes and update the server every hour via GPRS. In case of temperature breach, the logger alarms and sends email and SMS alerts to responsible cold chain technicians and managers.",
          "bBox": {
            "x": 100.5,
            "y": 657.07,
            "w": 410.71,
            "h": 69.98
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.99
    },
    {
      "page": 43,
      "text": "36 IFAQs on Immunization",
      "md": "36 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_43.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "36 IFAQs on Immunization",
          "md": "36 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 135.69,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 44,
      "text": "SECTION: 8\nBio-medical Waste Management\n\n\n\n\n\n\n\n             75. What should be done with partially and fully used vaccine at the\n             session site?\nAns.     As per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty\n         vials and unopened vials) should be returned to the last cold chain point on the same day.\n         The vials should be segregated as under;\n         To be used\n          à  Unopened vials, if the VVM is in usable stage\n          à  Partially used vials on which the open vial policy is applicable\n         Not to be used\n          à  Open vials of BCG, Measles/ MR, JE and Rotavirus Vaccine\n          à  Empty vaccine vials\n          à  Vaccines with unusable VVM\n         The vials should be kept separately in properly sealed zipper pouches/bags in the vaccine\n         carrier under the cold chain (reverse cold chain) and ensure carrier is picked up by the\n         alternate vaccine delivery (AVD) mechanism to deliver at the designated vaccine/cold\n         storage point.\n\n               76. How should the used syringes and needles be discarded at the\n             session site?\nAns.     At the session site, cut the needle of the AD Syringe immediately after administering the\n         injection using the hub cutter that cuts the plastic hub of the syringe and not the metal\n         part of the needle. The waste should be segregated as follows:\n\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  37\n                 37",
      "md": "\n# SECTION: 8  \n# Bio-medical Waste Management\n\n**75. What should be done with partially and fully used vaccine at the session site?**  \n**Ans.** As per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. The vials should be segregated as under;\n\n**To be used**  \n* Unopened vials, if the VVM is in usable stage  \n* Partially used vials on which the open vial policy is applicable  \n\n**Not to be used**  \n* Open vials of BCG, Measles/ MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials  \n* Vaccines with unusable VVM  \n\nThe vials should be kept separately in properly sealed zipper pouches/bags in the vaccine carrier under the cold chain (reverse cold chain) and ensure carrier is picked up by the alternate vaccine delivery (AVD) mechanism to deliver at the designated vaccine/cold storage point.\n\n**76. How should the used syringes and needles be discarded at the session site?**  \n**Ans.** At the session site, cut the needle of the AD Syringe immediately after administering the injection using the hub cutter that cuts the plastic hub of the syringe and not the metal part of the needle. The waste should be segregated as follows:\n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_7.png",
          "height": 35.76,
          "width": 245.76,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1024,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_18.jpg",
          "height": 136.5,
          "width": 50.117,
          "x": 560.462,
          "y": 171.33,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p43_27.png",
          "height": 37.44,
          "width": 440.16,
          "x": 96.96,
          "y": 339.57,
          "original_width": 1834,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p43_28.png",
          "height": 35.45,
          "width": 169.335,
          "x": 95.263,
          "y": 322.306,
          "original_width": 713,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "img_p43_29.png",
          "height": 37.44,
          "width": 440.16,
          "x": 96.96,
          "y": 654.93,
          "original_width": 1834,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p43_30.jpg",
          "height": 18.756,
          "width": 34.068,
          "x": 58.789,
          "y": 357.948,
          "original_width": 142,
          "original_height": 79,
          "rotation": 0
        },
        {
          "name": "page_44.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 8",
          "md": "# SECTION: 8  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "Bio-medical Waste Management",
          "md": "# Bio-medical Waste Management",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**75. What should be done with partially and fully used vaccine at the session site?**  \n**Ans.** As per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. The vials should be segregated as under;",
          "md": "**75. What should be done with partially and fully used vaccine at the session site?**  \n**Ans.** As per the “Open Vial Policy” guidelines, 2015, all vaccine vials (partially used vials, empty vials and unopened vials) should be returned to the last cold chain point on the same day. The vials should be segregated as under;",
          "bBox": {
            "x": 58.5,
            "y": 342.01,
            "w": 478.28,
            "h": 486.7
          }
        },
        {
          "type": "text",
          "value": "**To be used**  \n* Unopened vials, if the VVM is in usable stage  \n* Partially used vials on which the open vial policy is applicable",
          "md": "**To be used**  \n* Unopened vials, if the VVM is in usable stage  \n* Partially used vials on which the open vial policy is applicable",
          "bBox": {
            "x": 100.5,
            "y": 432.09,
            "w": 398.95,
            "h": 396.63
          }
        },
        {
          "type": "text",
          "value": "**Not to be used**  \n* Open vials of BCG, Measles/ MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials  \n* Vaccines with unusable VVM",
          "md": "**Not to be used**  \n* Open vials of BCG, Measles/ MR, JE and Rotavirus Vaccine  \n* Empty vaccine vials  \n* Vaccines with unusable VVM",
          "bBox": {
            "x": 100.5,
            "y": 432.09,
            "w": 398.95,
            "h": 396.63
          }
        },
        {
          "type": "text",
          "value": "The vials should be kept separately in properly sealed zipper pouches/bags in the vaccine carrier under the cold chain (reverse cold chain) and ensure carrier is picked up by the alternate vaccine delivery (AVD) mechanism to deliver at the designated vaccine/cold storage point.",
          "md": "The vials should be kept separately in properly sealed zipper pouches/bags in the vaccine carrier under the cold chain (reverse cold chain) and ensure carrier is picked up by the alternate vaccine delivery (AVD) mechanism to deliver at the designated vaccine/cold storage point.",
          "bBox": {
            "x": 100.5,
            "y": 580.19,
            "w": 436.28,
            "h": 248.52
          }
        },
        {
          "type": "text",
          "value": "**76. How should the used syringes and needles be discarded at the session site?**  \n**Ans.** At the session site, cut the needle of the AD Syringe immediately after administering the injection using the hub cutter that cuts the plastic hub of the syringe and not the metal part of the needle. The waste should be segregated as follows:",
          "md": "**76. How should the used syringes and needles be discarded at the session site?**  \n**Ans.** At the session site, cut the needle of the AD Syringe immediately after administering the injection using the hub cutter that cuts the plastic hub of the syringe and not the metal part of the needle. The waste should be segregated as follows:",
          "bBox": {
            "x": 58.5,
            "y": 357.01,
            "w": 478.28,
            "h": 471.71
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.99
    },
    {
      "page": 45,
      "text": "         Hub-cutter:\n         Hub-cutter:\n          à  The cut needles that will get collected in the puncture-proof container of the\n             hub cutter.\n          à  The broken vials/ diluent ampoules (sharps) may also be put in the container of\n             the hub-cutter, depending on the capacity of the hub cutter or may be stored\n             in a separate puncture proof container.\n         Red bag:\nBIOHAZARD\n          à  Plastic part of syringes (after cutting the needle)\n         Black bag:\n          à  Needle caps/ wrappers\n         The red, black bags and the hub-cutter should be sent to the PHC for disinfection\n         and disposal by the designated person at the PHC.\n\n\n         77. How should the immunization waste be managed at the PHC?\n\nAns.     At the PHC,\n         à  The black bag (containing the needle caps and wrappers) should be disposed\n            as municipal waste.\n         à  The collected material in the   red  bag    (plastic part of the syringe)\n            should  be autoclaved. If unable to  impart autoclaving, boil the   waste\n            in  water for  10  minutes or      provide  chemical treatment   (treating\n            the waste in   hypochlorite solution for    30 minutes).  The         autoclaved,\n            boiled  or chemically disinfected  syringes should   be sent for       recycling.\n            Note: All returned vials that cannot be used (reconstituted, empty and\n            unbroken vaccine vials and vaccine vials with unusable VVM) should be kept\n            in the ILR and should be discarded using the same protocol after 48 hours or\nQ à before the next session, whichever is earlier.\n            The collected material in the hub cutter (cut needles, broken vials and ampoules)\n            should also be autoclaved, boiled or chemically disinfected and should be\n            disposed off in a safety pit/ tank.\n         à  The hub cutter should be washed properly with sodium hypochlorite before\n            reuse.\n\n\n\n\n\n\n\n\n\n\n38 IFAQs on Immunization",
      "md": "\n**Hub-cutter:**\n* The cut needles that will get collected in the puncture-proof container of the hub cutter.\n* The broken vials/ diluent ampoules (sharps) may also be put in the container of the hub-cutter, depending on the capacity of the hub cutter or may be stored in a separate puncture proof container.\n\n**Red bag:**\n* Plastic part of syringes (after cutting the needle)\n\n**Black bag:**\n* Needle caps/ wrappers\n\nThe red, black bags and the hub-cutter should be sent to the PHC for disinfection and disposal by the designated person at the PHC.\n\n----\n\n### 77. How should the immunization waste be managed at the PHC?\n\n**Ans.** At the PHC,  \n* The black bag (containing the needle caps and wrappers) should be disposed as municipal waste.  \n* The collected material in the **red bag** (plastic part of the syringe) should be autoclaved. If unable to impart autoclaving, boil the waste in water for 10 minutes or provide chemical treatment (treating the waste in hypochlorite solution for 30 minutes). The autoclaved, boiled or chemically disinfected syringes should be sent for recycling.  \n> **Note:** *All returned vials that cannot be used (reconstituted, empty and unbroken vaccine vials and vaccine vials with unusable VVM) should be kept in the ILR and should be discarded using the same protocol after 48 hours or before the next session, whichever is earlier.*  \n* The collected material in the hub cutter (cut needles, broken vials and ampoules) should also be autoclaved, boiled or chemically disinfected and should be disposed off in a safety pit/ tank.  \n* The hub cutter should be washed properly with sodium hypochlorite before reuse.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p44_2.jpg",
          "height": 18.556,
          "width": 34.984,
          "x": 91.242,
          "y": 67.529,
          "original_width": 146,
          "original_height": 78,
          "rotation": 0
        },
        {
          "name": "img_p44_3.jpg",
          "height": 6.484,
          "width": 34.95,
          "x": 91.259,
          "y": 61.095,
          "original_width": 146,
          "original_height": 28,
          "rotation": 0
        },
        {
          "name": "img_p44_4.jpg",
          "height": 6.485,
          "width": 34.95,
          "x": 91.259,
          "y": 61.094,
          "original_width": 2102,
          "original_height": 390,
          "rotation": 0
        },
        {
          "name": "img_p44_5.jpg",
          "height": 35.333,
          "width": 28.071,
          "x": 92.268,
          "y": 151.867,
          "original_width": 117,
          "original_height": 148,
          "rotation": 0,
          "ocr": [
            {
              "x": 33,
              "y": 100,
              "w": 44,
              "h": 10,
              "confidence": 0.979,
              "text": "BIOHAZARD"
            }
          ]
        },
        {
          "name": "img_p44_6.jpg",
          "height": 27.463,
          "width": 21.974,
          "x": 95.316,
          "y": 204.192,
          "original_width": 92,
          "original_height": 115,
          "rotation": 0
        },
        {
          "name": "img_p44_7.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.8,
          "y": 299.25,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_45.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Hub-cutter:**\n* The cut needles that will get collected in the puncture-proof container of the hub cutter.\n* The broken vials/ diluent ampoules (sharps) may also be put in the container of the hub-cutter, depending on the capacity of the hub cutter or may be stored in a separate puncture proof container.",
          "md": "**Hub-cutter:**\n* The cut needles that will get collected in the puncture-proof container of the hub cutter.\n* The broken vials/ diluent ampoules (sharps) may also be put in the container of the hub-cutter, depending on the capacity of the hub cutter or may be stored in a separate puncture proof container.",
          "bBox": {
            "x": 128.4,
            "y": 55.42,
            "w": 408.38,
            "h": 407.6
          }
        },
        {
          "type": "text",
          "value": "**Red bag:**\n* Plastic part of syringes (after cutting the needle)",
          "md": "**Red bag:**\n* Plastic part of syringes (after cutting the needle)",
          "bBox": {
            "x": 128.4,
            "y": 161.18,
            "w": 371.96,
            "h": 301.84
          }
        },
        {
          "type": "text",
          "value": "**Black bag:**\n* Needle caps/ wrappers",
          "md": "**Black bag:**\n* Needle caps/ wrappers",
          "bBox": {
            "x": 128.4,
            "y": 204.8,
            "w": 242.69,
            "h": 202.2
          }
        },
        {
          "type": "text",
          "value": "The red, black bags and the hub-cutter should be sent to the PHC for disinfection and disposal by the designated person at the PHC.",
          "md": "The red, black bags and the hub-cutter should be sent to the PHC for disinfection and disposal by the designated person at the PHC.",
          "bBox": {
            "x": 128.4,
            "y": 248.92,
            "w": 408.37,
            "h": 214.11
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "77. How should the immunization waste be managed at the PHC?",
          "md": "### 77. How should the immunization waste be managed at the PHC?",
          "bBox": {
            "x": 130.57,
            "y": 305.43,
            "w": 406.4,
            "h": 157.6
          }
        },
        {
          "type": "text",
          "value": "**Ans.** At the PHC,  \n* The black bag (containing the needle caps and wrappers) should be disposed as municipal waste.  \n* The collected material in the **red bag** (plastic part of the syringe) should be autoclaved. If unable to impart autoclaving, boil the waste in water for 10 minutes or provide chemical treatment (treating the waste in hypochlorite solution for 30 minutes). The autoclaved, boiled or chemically disinfected syringes should be sent for recycling.  \n> **Note:** *All returned vials that cannot be used (reconstituted, empty and unbroken vaccine vials and vaccine vials with unusable VVM) should be kept in the ILR and should be discarded using the same protocol after 48 hours or before the next session, whichever is earlier.*  \n* The collected material in the hub cutter (cut needles, broken vials and ampoules) should also be autoclaved, boiled or chemically disinfected and should be disposed off in a safety pit/ tank.  \n* The hub cutter should be washed properly with sodium hypochlorite before reuse.",
          "md": "**Ans.** At the PHC,  \n* The black bag (containing the needle caps and wrappers) should be disposed as municipal waste.  \n* The collected material in the **red bag** (plastic part of the syringe) should be autoclaved. If unable to impart autoclaving, boil the waste in water for 10 minutes or provide chemical treatment (treating the waste in hypochlorite solution for 30 minutes). The autoclaved, boiled or chemically disinfected syringes should be sent for recycling.  \n> **Note:** *All returned vials that cannot be used (reconstituted, empty and unbroken vaccine vials and vaccine vials with unusable VVM) should be kept in the ILR and should be discarded using the same protocol after 48 hours or before the next session, whichever is earlier.*  \n* The collected material in the hub cutter (cut needles, broken vials and ampoules) should also be autoclaved, boiled or chemically disinfected and should be disposed off in a safety pit/ tank.  \n* The hub cutter should be washed properly with sodium hypochlorite before reuse.",
          "bBox": {
            "x": 86.6,
            "y": 339.32,
            "w": 450.4,
            "h": 263.95
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 46,
      "text": "    Cold Chain Point    Immunization Site\n\n\n\n\n\n\n\n\n\n\n    Cut Hub of AD syringe    Plastic part of syringe    Needle cap/ Wrappers\n\n\n\n\n                  Handle\n                  Insertion Hole\nPuncture          Cut\n  proof           Hub           BIOHAZARD\n    container     Needle\n\n\n    STOP\n\n\n\n\n\n\n    BIOHAZARD\n\n\n\n\n\n\n\n\n\n\n    1) Cut needles and hub\n    2) Broken vials and ampoules\n\nDisinfect in Hypochlorite Solution (for 30    Disinfect in Hypochlorite Solution (for 30     Dispose as\n                 minutes)         minutes)                                                   Municipal Waste\n\n    Dispose in Sharps Disposal Pit\n\n\n\n    RECYCLE\n\n\n\n\n\n\n\n\n\n\n    Figure 15: Bio-medical waste management\n\n\n\n\n\n\n\n\n\n\n    FAQs on ImmunizationI 39",
      "md": "\n# Bio-medical waste management\n\n## Immunization Site\n\n* **Cut Hub of AD syringe**\n  - Puncture proof container\n  - Handle\n  - Insertion Hole\n  - Cut Hub\n  - Needle\n\n* **Plastic part of syringe**\n  - Biohazard bag\n\n* **Needle cap / Wrappers**\n  - Black bag\n\n----\n\n## Cold Chain Point\n\n* For **Cut needles and hub** and **Broken vials and ampoules**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Dispose in Sharps Disposal Pit\n\n* For **Plastic part of syringe**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Recycle\n\n* For **Needle cap / Wrappers**:\n  - Dispose as Municipal Waste\n\n----\n\n### Sharps Disposal Pit (illustration details)\n\n* Cover with lock\n* Steel pipe\n* Concrete slab\n* Ground surface\n* Disinfected needles and broken vials\n* Brick, masonry or concrete rings\n\n----\n\n**Figure 15: Bio-medical waste management**\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p45_2.jpg",
          "height": 84.063,
          "width": 105.359,
          "x": 55.172,
          "y": 186.385,
          "original_width": 439,
          "original_height": 351,
          "rotation": 0
        },
        {
          "name": "img_p45_3.jpg",
          "height": 84.063,
          "width": 105.358,
          "x": 160.327,
          "y": 186.385,
          "original_width": 439,
          "original_height": 351,
          "rotation": 0
        },
        {
          "name": "img_p45_4.jpg",
          "height": 84.063,
          "width": 105.46,
          "x": 265.482,
          "y": 186.385,
          "original_width": 440,
          "original_height": 351,
          "rotation": 0,
          "ocr": [
            {
              "x": 363,
              "y": 74,
              "w": 41,
              "h": 14,
              "confidence": 1,
              "text": "STOP"
            }
          ]
        },
        {
          "name": "img_p45_5.jpg",
          "height": 84.063,
          "width": 105.359,
          "x": 370.738,
          "y": 186.385,
          "original_width": 439,
          "original_height": 351,
          "rotation": 0,
          "ocr": [
            {
              "x": 346,
              "y": 320,
              "w": 64,
              "h": 14,
              "confidence": 0.995,
              "text": "BIOHAZARD"
            }
          ]
        },
        {
          "name": "img_p45_6.jpg",
          "height": 111.982,
          "width": 35.256,
          "x": 475.893,
          "y": 186.385,
          "original_width": 147,
          "original_height": 467,
          "rotation": 0
        },
        {
          "name": "img_p45_7.jpg",
          "height": 28.123,
          "width": 385.873,
          "x": 55.172,
          "y": 270.244,
          "original_width": 1608,
          "original_height": 118,
          "rotation": 0
        },
        {
          "name": "img_p45_8.jpg",
          "height": 28.123,
          "width": 35.255,
          "x": 440.842,
          "y": 270.244,
          "original_width": 147,
          "original_height": 118,
          "rotation": 0
        },
        {
          "name": "img_p45_9.jpg",
          "height": 11.718,
          "width": 454.958,
          "x": 55.681,
          "y": 186.487,
          "original_width": 1896,
          "original_height": 49,
          "rotation": 0
        },
        {
          "name": "img_p45_10.jpg",
          "height": 7.846,
          "width": 455.773,
          "x": 55.274,
          "y": 298.061,
          "original_width": 1900,
          "original_height": 33,
          "rotation": 0
        },
        {
          "name": "img_p45_13.jpg",
          "height": 26.418,
          "width": 67.48,
          "x": 122.077,
          "y": 106.44,
          "original_width": 282,
          "original_height": 111,
          "rotation": 0
        },
        {
          "name": "img_p45_14.jpg",
          "height": 26.375,
          "width": 67.48,
          "x": 122.077,
          "y": 132.772,
          "original_width": 282,
          "original_height": 110,
          "rotation": 0
        },
        {
          "name": "img_p45_15.jpg",
          "height": 26.418,
          "width": 67.48,
          "x": 122.077,
          "y": 159.062,
          "original_width": 282,
          "original_height": 111,
          "rotation": 0
        },
        {
          "name": "img_p45_16.jpg",
          "height": 56.671,
          "width": 61.781,
          "x": 95.957,
          "y": 317.455,
          "original_width": 258,
          "original_height": 237,
          "rotation": 0
        },
        {
          "name": "img_p45_17.jpg",
          "height": 56.671,
          "width": 61.713,
          "x": 157.603,
          "y": 317.455,
          "original_width": 258,
          "original_height": 237,
          "rotation": 0
        },
        {
          "name": "img_p45_18.jpg",
          "height": 28.436,
          "width": 123.359,
          "x": 95.957,
          "y": 373.992,
          "original_width": 514,
          "original_height": 119,
          "rotation": 0
        },
        {
          "name": "img_p45_19.jpg",
          "height": 25.54,
          "width": 26.567,
          "x": 293.719,
          "y": 124.808,
          "original_width": 111,
          "original_height": 107,
          "rotation": 0
        },
        {
          "name": "img_p45_20.jpg",
          "height": 25.54,
          "width": 26.567,
          "x": 320.217,
          "y": 124.808,
          "original_width": 111,
          "original_height": 107,
          "rotation": 0
        },
        {
          "name": "img_p45_21.jpg",
          "height": 25.505,
          "width": 26.567,
          "x": 293.719,
          "y": 150.279,
          "original_width": 111,
          "original_height": 107,
          "rotation": 0,
          "ocr": [
            {
              "x": 64,
              "y": 47,
              "w": 47,
              "h": 17,
              "confidence": 0.999,
              "text": "BIOHA"
            }
          ]
        },
        {
          "name": "img_p45_22.jpg",
          "height": 25.505,
          "width": 26.567,
          "x": 320.217,
          "y": 150.279,
          "original_width": 111,
          "original_height": 107,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 46,
              "w": 37,
              "h": 19,
              "confidence": 0.999,
              "text": "ZARD"
            }
          ]
        },
        {
          "name": "img_p45_23.jpg",
          "height": 28.498,
          "width": 31.81,
          "x": 323.355,
          "y": 111.954,
          "original_width": 117,
          "original_height": 65,
          "rotation": 0
        },
        {
          "name": "img_p45_24.jpg",
          "height": 27.992,
          "width": 31.469,
          "x": 318,
          "y": 120.399,
          "original_width": 117,
          "original_height": 63,
          "rotation": 0
        },
        {
          "name": "img_p45_28.jpg",
          "height": 21.383,
          "width": 22.458,
          "x": 324.353,
          "y": 111.954,
          "original_width": 75,
          "original_height": 58,
          "rotation": 0
        },
        {
          "name": "img_p45_29.jpg",
          "height": 21.695,
          "width": 21.39,
          "x": 320.639,
          "y": 120.314,
          "original_width": 63,
          "original_height": 68,
          "rotation": 0
        },
        {
          "name": "page_46.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "Bio-medical waste management",
          "md": "# Bio-medical waste management",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Immunization Site",
          "md": "## Immunization Site",
          "bBox": {
            "x": 63.6,
            "y": 99.91,
            "w": 10.12,
            "h": 75.17
          }
        },
        {
          "type": "text",
          "value": "* **Cut Hub of AD syringe**\n  - Puncture proof container\n  - Handle\n  - Insertion Hole\n  - Cut Hub\n  - Needle",
          "md": "* **Cut Hub of AD syringe**\n  - Puncture proof container\n  - Handle\n  - Insertion Hole\n  - Cut Hub\n  - Needle",
          "bBox": {
            "x": 83.07,
            "y": 90.47,
            "w": 144.19,
            "h": 88.27
          }
        },
        {
          "type": "text",
          "value": "* **Plastic part of syringe**\n  - Biohazard bag",
          "md": "* **Plastic part of syringe**\n  - Biohazard bag",
          "bBox": {
            "x": 288.07,
            "y": 90.47,
            "w": 181.07,
            "h": 175.9
          }
        },
        {
          "type": "text",
          "value": "* **Needle cap / Wrappers**\n  - Black bag",
          "md": "* **Needle cap / Wrappers**\n  - Black bag",
          "bBox": {
            "x": 176.78,
            "y": 90.47,
            "w": 316.32,
            "h": 86.73
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Cold Chain Point",
          "md": "## Cold Chain Point",
          "bBox": {
            "x": 67.26,
            "y": 325.1,
            "w": 10.12,
            "h": 71.62
          }
        },
        {
          "type": "text",
          "value": "* For **Cut needles and hub** and **Broken vials and ampoules**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Dispose in Sharps Disposal Pit",
          "md": "* For **Cut needles and hub** and **Broken vials and ampoules**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Dispose in Sharps Disposal Pit",
          "bBox": {
            "x": 82.84,
            "y": 152.56,
            "w": 312.1,
            "h": 320.38
          }
        },
        {
          "type": "text",
          "value": "* For **Plastic part of syringe**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Recycle",
          "md": "* For **Plastic part of syringe**:\n  - Disinfect in Hypochlorite Solution (for 30 minutes)\n  - Recycle",
          "bBox": {
            "x": 82.84,
            "y": 90.47,
            "w": 312.1,
            "h": 423.89
          }
        },
        {
          "type": "text",
          "value": "* For **Needle cap / Wrappers**:\n  - Dispose as Municipal Waste",
          "md": "* For **Needle cap / Wrappers**:\n  - Dispose as Municipal Waste",
          "bBox": {
            "x": 176.78,
            "y": 90.47,
            "w": 316.32,
            "h": 358.84
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Sharps Disposal Pit (illustration details)",
          "md": "### Sharps Disposal Pit (illustration details)",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "* Cover with lock\n* Steel pipe\n* Concrete slab\n* Ground surface\n* Disinfected needles and broken vials\n* Brick, masonry or concrete rings",
          "md": "* Cover with lock\n* Steel pipe\n* Concrete slab\n* Ground surface\n* Disinfected needles and broken vials\n* Brick, masonry or concrete rings",
          "bBox": {
            "x": 176.78,
            "y": 169.84,
            "w": 20.53,
            "h": 7.36
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Figure 15: Bio-medical waste management**",
          "md": "**Figure 15: Bio-medical waste management**",
          "bBox": {
            "x": 210.55,
            "y": 650.16,
            "w": 160.04,
            "h": 9.11
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.711
    },
    {
      "page": 47,
      "text": "40 IFAQs on Immunization",
      "md": "40 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_47.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "40 IFAQs on Immunization",
          "md": "40 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 136.32,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 48,
      "text": "SECTION: 9\nImmunization Campaigns\n\n\n\n\n\n\n\n         78. What is Mission Indradhanush?\n\nAns.     Mission Indhradhanush isa healthinitiative launched by Ministryof Health & FamilyWelfare\n         (MoHFW), Government of India, in December 2014, with the ultimate goal to ensure\n         full immunization with all available vaccines for children up to two years and pregnant\n         women. The mission is based on 4 guiding principles – identify (the unimmunized),\n         validate (vaccination status), plan (for vaccine delivery), vaccinate (the unimmunized).\n         Government of India has identified 201 high focus districts across 28 states in the\n         country that have the highest number of partially immunized and unimmunized children,\n         and Mission Indradhanush target these districts through intensive efforts and special\n         immunization drives to improve the routine immunization coverage in the country.\n\n         79. What is Intensified Mission Indradhanush?\n\nAns.     Fourth phase of Mission Indradhanush (2017-18) has been named as Intensified Mission\n         Indradhanush (IMI). It aims to rapidly build up immunization coverage by December 2018\n         and sustain thereafter through routine immunization.\n         IMI will be implemented in 108 districts across 16 states, 52 districts across 8 north eastern\n         states, and 17 urban areas across 8 states, with special focus on children up to 2 years of age\n         and pregnant women. This intensified mode will be characterized by better convergence\n         with other departments besides health, intensive monitoring by health ministry and\n         partners, prioritization of urban areas, and rewards on achievement of targets .\n\n         80. Should vaccines be given to children who come from other states\n             where it has not been introduced?\nAns.     Yes. Vaccines should be given to children as per the guidelines irrespective of their original\n         state or place of residence, or the length of stay. Example, if a three-year child comes\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  41\n                 41",
      "md": "\n# SECTION: 9  \n# Immunization Campaigns\n\n**78. What is Mission Indradhanush?**  \nAns. Mission Indradhanush is a health initiative launched by Ministry of Health & Family Welfare (MoHFW), Government of India, in December 2014, with the ultimate goal to ensure full immunization with all available vaccines for children up to two years and pregnant women. The mission is based on 4 guiding principles – identify (the unimmunized), validate (vaccination status), plan (for vaccine delivery), vaccinate (the unimmunized).\n\nGovernment of India has identified 201 high focus districts across 28 states in the country that have the highest number of partially immunized and unimmunized children, and Mission Indradhanush target these districts through intensive efforts and special immunization drives to improve the routine immunization coverage in the country.\n\n**79. What is Intensified Mission Indradhanush?**  \nAns. Fourth phase of Mission Indradhanush (2017-18) has been named as **Intensified Mission Indradhanush (IMI).** It aims to rapidly build up immunization coverage by December 2018 and sustain thereafter through routine immunization.\n\nIMI will be implemented in 108 districts across 16 states, 52 districts across 8 north eastern states, and 17 urban areas across 8 states, with special focus on children up to 2 years of age and pregnant women. This intensified mode will be characterized by better convergence with other departments besides health, intensive monitoring by health ministry and partners, prioritization of urban areas, and rewards on achievement of targets.\n\n**80. Should vaccines be given to children who come from other states where it has not been introduced?**  \nAns. **Yes.** Vaccines should be given to children as per the guidelines irrespective of their original state or place of residence, or the length of stay. Example, if a three-year child comes\n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p47_7.png",
          "height": 35.76,
          "width": 175.68,
          "x": 314.88,
          "y": 315.33,
          "original_width": 732,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_12.png",
          "height": 175.92,
          "width": 35.76,
          "x": 559.92,
          "y": -0.27,
          "original_width": 149,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_19.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p47_27.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 334.29,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p47_28.png",
          "height": 46.283,
          "width": 221.572,
          "x": 94.461,
          "y": 311.498,
          "original_width": 933,
          "original_height": 99,
          "rotation": 0
        },
        {
          "name": "img_p47_29.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 518.13,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p47_30.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 691.17,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "page_48.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 9",
          "md": "# SECTION: 9  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "Immunization Campaigns",
          "md": "# Immunization Campaigns",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**78. What is Mission Indradhanush?**  \nAns. Mission Indradhanush is a health initiative launched by Ministry of Health & Family Welfare (MoHFW), Government of India, in December 2014, with the ultimate goal to ensure full immunization with all available vaccines for children up to two years and pregnant women. The mission is based on 4 guiding principles – identify (the unimmunized), validate (vaccination status), plan (for vaccine delivery), vaccinate (the unimmunized).",
          "md": "**78. What is Mission Indradhanush?**  \nAns. Mission Indradhanush is a health initiative launched by Ministry of Health & Family Welfare (MoHFW), Government of India, in December 2014, with the ultimate goal to ensure full immunization with all available vaccines for children up to two years and pregnant women. The mission is based on 4 guiding principles – identify (the unimmunized), validate (vaccination status), plan (for vaccine delivery), vaccinate (the unimmunized).",
          "bBox": {
            "x": 58.5,
            "y": 340.31,
            "w": 478.3,
            "h": 488.4
          }
        },
        {
          "type": "text",
          "value": "Government of India has identified 201 high focus districts across 28 states in the country that have the highest number of partially immunized and unimmunized children, and Mission Indradhanush target these districts through intensive efforts and special immunization drives to improve the routine immunization coverage in the country.",
          "md": "Government of India has identified 201 high focus districts across 28 states in the country that have the highest number of partially immunized and unimmunized children, and Mission Indradhanush target these districts through intensive efforts and special immunization drives to improve the routine immunization coverage in the country.",
          "bBox": {
            "x": 100.5,
            "y": 446.83,
            "w": 436.28,
            "h": 381.89
          }
        },
        {
          "type": "text",
          "value": "**79. What is Intensified Mission Indradhanush?**  \nAns. Fourth phase of Mission Indradhanush (2017-18) has been named as **Intensified Mission Indradhanush (IMI).** It aims to rapidly build up immunization coverage by December 2018 and sustain thereafter through routine immunization.",
          "md": "**79. What is Intensified Mission Indradhanush?**  \nAns. Fourth phase of Mission Indradhanush (2017-18) has been named as **Intensified Mission Indradhanush (IMI).** It aims to rapidly build up immunization coverage by December 2018 and sustain thereafter through routine immunization.",
          "bBox": {
            "x": 58.5,
            "y": 372.85,
            "w": 440.95,
            "h": 455.87
          }
        },
        {
          "type": "text",
          "value": "IMI will be implemented in 108 districts across 16 states, 52 districts across 8 north eastern states, and 17 urban areas across 8 states, with special focus on children up to 2 years of age and pregnant women. This intensified mode will be characterized by better convergence with other departments besides health, intensive monitoring by health ministry and partners, prioritization of urban areas, and rewards on achievement of targets.",
          "md": "IMI will be implemented in 108 districts across 16 states, 52 districts across 8 north eastern states, and 17 urban areas across 8 states, with special focus on children up to 2 years of age and pregnant women. This intensified mode will be characterized by better convergence with other departments besides health, intensive monitoring by health ministry and partners, prioritization of urban areas, and rewards on achievement of targets.",
          "bBox": {
            "x": 100.5,
            "y": 604.71,
            "w": 436.29,
            "h": 224
          }
        },
        {
          "type": "text",
          "value": "**80. Should vaccines be given to children who come from other states where it has not been introduced?**  \nAns. **Yes.** Vaccines should be given to children as per the guidelines irrespective of their original state or place of residence, or the length of stay. Example, if a three-year child comes",
          "md": "**80. Should vaccines be given to children who come from other states where it has not been introduced?**  \nAns. **Yes.** Vaccines should be given to children as per the guidelines irrespective of their original state or place of residence, or the length of stay. Example, if a three-year child comes",
          "bBox": {
            "x": 58.5,
            "y": 372.85,
            "w": 478.28,
            "h": 455.87
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.978
    },
    {
      "page": 49,
      "text": "Q to a JE endemic state for a month from another place where JE vaccination is not\n         provided under UIP. This child should be given one dose of JE vaccine while s/he is\n         residing in the endemic state where vaccine is provided under UIP.\n\n         81. If a child has received all doses of a vaccine through routine\n             immunization. Will s/he still require additional doses during a\n             campaign?\nAns.     Yes. Even if the child has received the age-specific and recommended vaccines in\n         routine immunization, s/he should be given “additional” doses of the vaccine during\n         the campaigns such as pulse polio or measles/MR campaigns. Also, if a child has\n         received doses of a vaccine during a campaign, s/he should complete the vaccine\n         schedule through routine immunization as well.\n         These additional doses during campaigns can be given/ administered irrespective of\n         days since last dose was received. For example, if a child has received second dose\n         of OPV three weeks before, s/he can still receive an additional dose during the pulse\n         polio campaign.\n\n         82. Why is vaccine against rubella being introduced into UIP?\n\nAns.     MR/ MMR vaccines have been in use in private sector for a long time. Now, Rubella\n         vaccine is being introduced in UIP as Measles-Rubella (MR) vaccine to prevent\n         rubella infection in children and young adults.\n         Rubella is a viral disease, and during pregnancy this infection can cause abortion,\n         stillbirth and may also lead to multiple birth defects in the new-born (like blindness,\n         deafness, heart defects, development delays, and many other lifelong disabilities),\n         known as Congenital Rubella Syndrome (CRS). This condition is a significant public\n         health problem, as India accounts for around one-third of all children born worldwide\n         with CRS.\n         Introduction of MR vaccine in UIP is an interim strategy to ensure measles elimination\n         and rubella control in South-East Asia Region by 2020.\nQ\nQ\nQ 83. If rubella vaccine aims to prevent infection in pregnant women\n             and subsequent birth defects in new-borns, why boys are also\n             being vaccinated with this vaccine?\nAns.     Both boys and girls are equally susceptible and at risk of getting rubella infection.\n         Boys who get infected may cause transmission of rubella virus to unvaccinated\n         children and young adults, so both boys and girls should be vaccinated with MR\n         vaccine during MR campaigns and in routine immunization.\n\n\n         84. Why is Measles Rubella (MR) vaccination campaign being\n         conducted?\nAns.     MR vaccination campaign is a special campaign to vaccinate all children in the age\n         group of 9 months to less than 15 years with one additional dose of MR vaccine,\n         irrespective of their previous vaccination status with measles vaccine. This wide age-\n         range campaign has been recommended by the NTAGI as this will provide a second\n         opportunity for those children who were left out due to either vaccine failure or\n\n\n\n\n42 IFAQs on Immunization",
      "md": "\nQ to a JE endemic state for a month from another place where JE vaccination is not provided under UIP. This child should be given one dose of JE vaccine while s/he is residing in the endemic state where vaccine is provided under UIP.\n\n**81. If a child has received all doses of a vaccine through routine immunization. Will s/he still require additional doses during a campaign?**  \nAns. **Yes.** Even if the child has received the age-specific and recommended vaccines in routine immunization, s/he should be given “additional” doses of the vaccine during the campaigns such as pulse polio or measles/MR campaigns. Also, if a child has received doses of a vaccine during a campaign, s/he should complete the vaccine schedule through routine immunization as well.\n\nThese additional doses during campaigns can be given/administered irrespective of days since last dose was received. For example, if a child has received second dose of OPV three weeks before, s/he can still receive an additional dose during the pulse polio campaign.\n\n**82. Why is vaccine against rubella being introduced into UIP?**  \nAns. MR/MMR vaccines have been in use in private sector for a long time. Now, Rubella vaccine is being introduced in UIP as Measles-Rubella (MR) vaccine to prevent rubella infection in children and young adults.\n\nRubella is a viral disease, and during pregnancy this infection can cause abortion, stillbirth and may also lead to multiple birth defects in the new-born (like blindness, deafness, heart defects, development delays, and many other lifelong disabilities), known as **Congenital Rubella Syndrome (CRS)**. This condition is a significant public health problem, as India accounts for around one-third of all children born worldwide with CRS.\n\nIntroduction of MR vaccine in UIP is an interim strategy to ensure measles elimination and rubella control in South-East Asia Region by 2020.\n\n**83. If rubella vaccine aims to prevent infection in pregnant women and subsequent birth defects in new-borns, why boys are also being vaccinated with this vaccine?**  \nAns. Both boys and girls are equally susceptible and at risk of getting rubella infection. Boys who get infected may cause transmission of rubella virus to unvaccinated children and young adults, so both boys and girls should be vaccinated with MR vaccine during MR campaigns and in routine immunization.\n\n**84. Why is Measles Rubella (MR) vaccination campaign being conducted?**  \nAns. MR vaccination campaign is a special campaign to vaccinate all children in the age group of 9 months to less than 15 years with one additional dose of MR vaccine, irrespective of their previous vaccination status with measles vaccine. This wide age-range campaign has been recommended by the NTAGI as this will provide a second opportunity for those children who were left out due to either vaccine failure or\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p48_2.png",
          "height": 46.8,
          "width": 412.56,
          "x": 124.56,
          "y": 110.85,
          "original_width": 1719,
          "original_height": 195,
          "rotation": 0
        },
        {
          "name": "img_p48_3.png",
          "height": 36.48,
          "width": 412.56,
          "x": 124.56,
          "y": 305.73,
          "original_width": 1719,
          "original_height": 152,
          "rotation": 0
        },
        {
          "name": "img_p48_4.png",
          "height": 47.28,
          "width": 412.56,
          "x": 124.56,
          "y": 525.33,
          "original_width": 1719,
          "original_height": 197,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_49.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "Q to a JE endemic state for a month from another place where JE vaccination is not provided under UIP. This child should be given one dose of JE vaccine while s/he is residing in the endemic state where vaccine is provided under UIP.",
          "md": "Q to a JE endemic state for a month from another place where JE vaccination is not provided under UIP. This child should be given one dose of JE vaccine while s/he is residing in the endemic state where vaccine is provided under UIP.",
          "bBox": {
            "x": 86.36,
            "y": 55.42,
            "w": 450.41,
            "h": 498.34
          }
        },
        {
          "type": "text",
          "value": "**81. If a child has received all doses of a vaccine through routine immunization. Will s/he still require additional doses during a campaign?**  \nAns. **Yes.** Even if the child has received the age-specific and recommended vaccines in routine immunization, s/he should be given “additional” doses of the vaccine during the campaigns such as pulse polio or measles/MR campaigns. Also, if a child has received doses of a vaccine during a campaign, s/he should complete the vaccine schedule through routine immunization as well.",
          "md": "**81. If a child has received all doses of a vaccine through routine immunization. Will s/he still require additional doses during a campaign?**  \nAns. **Yes.** Even if the child has received the age-specific and recommended vaccines in routine immunization, s/he should be given “additional” doses of the vaccine during the campaigns such as pulse polio or measles/MR campaigns. Also, if a child has received doses of a vaccine during a campaign, s/he should complete the vaccine schedule through routine immunization as well.",
          "bBox": {
            "x": 86.36,
            "y": 110.49,
            "w": 450.42,
            "h": 592.89
          }
        },
        {
          "type": "text",
          "value": "These additional doses during campaigns can be given/administered irrespective of days since last dose was received. For example, if a child has received second dose of OPV three weeks before, s/he can still receive an additional dose during the pulse polio campaign.",
          "md": "These additional doses during campaigns can be given/administered irrespective of days since last dose was received. For example, if a child has received second dose of OPV three weeks before, s/he can still receive an additional dose during the pulse polio campaign.",
          "bBox": {
            "x": 128.4,
            "y": 233.92,
            "w": 408.39,
            "h": 50.99
          }
        },
        {
          "type": "text",
          "value": "**82. Why is vaccine against rubella being introduced into UIP?**  \nAns. MR/MMR vaccines have been in use in private sector for a long time. Now, Rubella vaccine is being introduced in UIP as Measles-Rubella (MR) vaccine to prevent rubella infection in children and young adults.",
          "md": "**82. Why is vaccine against rubella being introduced into UIP?**  \nAns. MR/MMR vaccines have been in use in private sector for a long time. Now, Rubella vaccine is being introduced in UIP as Measles-Rubella (MR) vaccine to prevent rubella infection in children and young adults.",
          "bBox": {
            "x": 86.4,
            "y": 159.94,
            "w": 450.39,
            "h": 543.44
          }
        },
        {
          "type": "text",
          "value": "Rubella is a viral disease, and during pregnancy this infection can cause abortion, stillbirth and may also lead to multiple birth defects in the new-born (like blindness, deafness, heart defects, development delays, and many other lifelong disabilities), known as **Congenital Rubella Syndrome (CRS)**. This condition is a significant public health problem, as India accounts for around one-third of all children born worldwide with CRS.",
          "md": "Rubella is a viral disease, and during pregnancy this infection can cause abortion, stillbirth and may also lead to multiple birth defects in the new-born (like blindness, deafness, heart defects, development delays, and many other lifelong disabilities), known as **Congenital Rubella Syndrome (CRS)**. This condition is a significant public health problem, as India accounts for around one-third of all children born worldwide with CRS.",
          "bBox": {
            "x": 128.4,
            "y": 393.58,
            "w": 408.39,
            "h": 76.98
          }
        },
        {
          "type": "text",
          "value": "Introduction of MR vaccine in UIP is an interim strategy to ensure measles elimination and rubella control in South-East Asia Region by 2020.",
          "md": "Introduction of MR vaccine in UIP is an interim strategy to ensure measles elimination and rubella control in South-East Asia Region by 2020.",
          "bBox": {
            "x": 128.4,
            "y": 480.55,
            "w": 408.38,
            "h": 25
          }
        },
        {
          "type": "text",
          "value": "**83. If rubella vaccine aims to prevent infection in pregnant women and subsequent birth defects in new-borns, why boys are also being vaccinated with this vaccine?**  \nAns. Both boys and girls are equally susceptible and at risk of getting rubella infection. Boys who get infected may cause transmission of rubella virus to unvaccinated children and young adults, so both boys and girls should be vaccinated with MR vaccine during MR campaigns and in routine immunization.",
          "md": "**83. If rubella vaccine aims to prevent infection in pregnant women and subsequent birth defects in new-borns, why boys are also being vaccinated with this vaccine?**  \nAns. Both boys and girls are equally susceptible and at risk of getting rubella infection. Boys who get infected may cause transmission of rubella virus to unvaccinated children and young adults, so both boys and girls should be vaccinated with MR vaccine during MR campaigns and in routine immunization.",
          "bBox": {
            "x": 86.36,
            "y": 159.94,
            "w": 450.42,
            "h": 543.44
          }
        },
        {
          "type": "text",
          "value": "**84. Why is Measles Rubella (MR) vaccination campaign being conducted?**  \nAns. MR vaccination campaign is a special campaign to vaccinate all children in the age group of 9 months to less than 15 years with one additional dose of MR vaccine, irrespective of their previous vaccination status with measles vaccine. This wide age-range campaign has been recommended by the NTAGI as this will provide a second opportunity for those children who were left out due to either vaccine failure or",
          "md": "**84. Why is Measles Rubella (MR) vaccination campaign being conducted?**  \nAns. MR vaccination campaign is a special campaign to vaccinate all children in the age group of 9 months to less than 15 years with one additional dose of MR vaccine, irrespective of their previous vaccination status with measles vaccine. This wide age-range campaign has been recommended by the NTAGI as this will provide a second opportunity for those children who were left out due to either vaccine failure or",
          "bBox": {
            "x": 86.4,
            "y": 159.94,
            "w": 450.39,
            "h": 595.43
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.998
    },
    {
      "page": 50,
      "text": "Q failure to vaccinate.This will ensure attainment of high levels of population ⁱᵐᵐᵘⁿⁱᵗʸ\n         by reaching wide age group, including children missed under routine immunization\n         program.¹¹\n         The purpose to conduct MR campaign is to boost the immunity, protect children\n         from infection, and eliminate transmission of these disease-causing agents from\n         the community by vaccinating 100 percent target children with MR vaccine. Further,\n         follow-up campaigns may be required to sustain high population immunity against\n         both measles and rubella besides maintaining high routine immunization coverage\n         for both the antigens.\n\n         85. Is MR vaccine being used during the campaigns safe for\n         children?\nAns.     Yes. The Measles-rubella (MR) vaccine used in campaigns as well as immunization\n         programme is a live attenuated vaccine and safe and effective. The vaccine being\n         used is WHO pre-qualified and is used in India, along with several other neighbouring\n         countries like Bangladesh, Sri Lanka, Nepal, and Myanmar. Some children may have\n         transient, self-limiting, low fever and mild rash, which is due to the immune response\n         elicited by the vaccine, and should not be a cause of concern.\n\n\n\n\n\n\n\n\n\n\n11Introduction to Measles-Rubella Vaccine National Guidelines 2017\n\n                                                                  FAQs on ImmunizationI 43",
      "md": "\nfailure to vaccinate. This will ensure attainment of high levels of population immunity by reaching wide age group, including children missed under routine immunization program.¹¹\n\nThe purpose to conduct MR campaign is to boost the immunity, protect children from infection, and eliminate transmission of these disease-causing agents from the community by vaccinating 100 percent target children with MR vaccine. Further, follow-up campaigns may be required to sustain high population immunity against both measles and rubella besides maintaining high routine immunization coverage for both the antigens.\n\n**85. Is MR vaccine being used during the campaigns safe for children?**  \n**Ans.** Yes. The Measles-rubella (MR) vaccine used in campaigns as well as immunization programme is a live attenuated vaccine and safe and effective. The vaccine being used is WHO pre-qualified and is used in India, along with several other neighbouring countries like Bangladesh, Sri Lanka, Nepal, and Myanmar. Some children may have transient, self-limiting, low fever and mild rash, which is due to the immune response elicited by the vaccine, and should not be a cause of concern.\n\n----\n\n¹¹ Introduction to Measles-Rubella Vaccine National Guidelines 2017\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_50.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "failure to vaccinate. This will ensure attainment of high levels of population immunity by reaching wide age group, including children missed under routine immunization program.¹¹",
          "md": "failure to vaccinate. This will ensure attainment of high levels of population immunity by reaching wide age group, including children missed under routine immunization program.¹¹",
          "bBox": {
            "x": 100.5,
            "y": 68.42,
            "w": 410.71,
            "h": 25
          }
        },
        {
          "type": "text",
          "value": "The purpose to conduct MR campaign is to boost the immunity, protect children from infection, and eliminate transmission of these disease-causing agents from the community by vaccinating 100 percent target children with MR vaccine. Further, follow-up campaigns may be required to sustain high population immunity against both measles and rubella besides maintaining high routine immunization coverage for both the antigens.",
          "md": "The purpose to conduct MR campaign is to boost the immunity, protect children from infection, and eliminate transmission of these disease-causing agents from the community by vaccinating 100 percent target children with MR vaccine. Further, follow-up campaigns may be required to sustain high population immunity against both measles and rubella besides maintaining high routine immunization coverage for both the antigens.",
          "bBox": {
            "x": 100.5,
            "y": 103.42,
            "w": 410.71,
            "h": 76.98
          }
        },
        {
          "type": "text",
          "value": "**85. Is MR vaccine being used during the campaigns safe for children?**  \n**Ans.** Yes. The Measles-rubella (MR) vaccine used in campaigns as well as immunization programme is a live attenuated vaccine and safe and effective. The vaccine being used is WHO pre-qualified and is used in India, along with several other neighbouring countries like Bangladesh, Sri Lanka, Nepal, and Myanmar. Some children may have transient, self-limiting, low fever and mild rash, which is due to the immune response elicited by the vaccine, and should not be a cause of concern.",
          "md": "**85. Is MR vaccine being used during the campaigns safe for children?**  \n**Ans.** Yes. The Measles-rubella (MR) vaccine used in campaigns as well as immunization programme is a live attenuated vaccine and safe and effective. The vaccine being used is WHO pre-qualified and is used in India, along with several other neighbouring countries like Bangladesh, Sri Lanka, Nepal, and Myanmar. Some children may have transient, self-limiting, low fever and mild rash, which is due to the immune response elicited by the vaccine, and should not be a cause of concern.",
          "bBox": {
            "x": 58.5,
            "y": 201.43,
            "w": 452.71,
            "h": 113.21
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "¹¹ Introduction to Measles-Rubella Vaccine National Guidelines 2017",
          "md": "¹¹ Introduction to Measles-Rubella Vaccine National Guidelines 2017",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.989
    },
    {
      "page": 51,
      "text": "44 IFAQs on Immunization",
      "md": "44 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_51.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "44 IFAQs on Immunization",
          "md": "44 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 136.35,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 52,
      "text": "SECTION: 10\nVitamin-A\n\n\n\n\n\n\n\n         86. Is Vitamin A also a vaccine?\n\nAns.     No. Vitamin A is not a vaccine. It is a micronutrient required by body for growth and\n         development. It also helps in maintaining immunity and supports good vision.\n\n         87. What are the signs of Vitamin A deficiency in children?\n\nAns.     Night blindness is the first sign of Vitamin A deficiency, and in this condition affected\n         children have poor vision in darkness but can see normally when adequate light is present.\n         There are other signs which can be detected by medical officer at any health facility.\n\n\n         88. What is the schedule for giving Vitamin A?\n\nAns.     Total 9 prophylactic doses of Vitamin A are given to children. First dose is given along with\n         measles vaccine at 9 months (completed), second dose with measles at 16-24 months,\n         and 3rd to 9th dose biannually till the age of 5 years. Minimum difference of 6 months\n         must be ensured between any two subsequent doses of vitamin A.\n         First dose of vitamin A syrup is 1 ml or 1,00,000 IU (half spoon), and second to ninth\n         dose is 2 ml or 2,00,000 IU (full spoon).\n\n         89. How is Vitamin A administered to children?\n\nAns.     Vitamin A is available as syrup in dark coloured bottles. The syrup should be given with\n         spoon (having dose markings) provided with the bottle.\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  45\n                 45",
      "md": "\n# SECTION: 10  \n## Vitamin-A\n\n**86. Is Vitamin A also a vaccine?**  \n**Ans.** No. Vitamin A is not a vaccine. It is a micronutrient required by body for growth and development. It also helps in maintaining immunity and supports good vision.\n\n**87. What are the signs of Vitamin A deficiency in children?**  \n**Ans.** Night blindness is the first sign of Vitamin A deficiency, and in this condition affected children have poor vision in darkness but can see normally when adequate light is present. There are other signs which can be detected by medical officer at any health facility.\n\n**88. What is the schedule for giving Vitamin A?**  \n**Ans.** Total 9 prophylactic doses of Vitamin A are given to children. First dose is given along with measles vaccine at 9 months (completed), second dose with measles at 16-24 months, and 3rd to 9th dose biannually till the age of 5 years. Minimum difference of 6 months must be ensured between any two subsequent doses of vitamin A.  \n**First dose of vitamin A syrup is 1 ml or 1,00,000 IU (half spoon), and second to ninth dose is 2 ml or 2,00,000 IU (full spoon).**\n\n**89. How is Vitamin A administered to children?**  \n**Ans.** Vitamin A is available as syrup in dark coloured bottles. The syrup should be given with spoon (having dose markings) provided with the bottle.\n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_7.png",
          "height": 35.76,
          "width": 245.76,
          "x": 244.8,
          "y": 315.33,
          "original_width": 1024,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_18.jpg",
          "height": 136.5,
          "width": 50.117,
          "x": 560.462,
          "y": 171.33,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p47_29.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 518.13,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p51_28.png",
          "height": 35.475,
          "width": 169.57,
          "x": 95.028,
          "y": 322.306,
          "original_width": 714,
          "original_height": 76,
          "rotation": 0
        },
        {
          "name": "img_p47_29.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 518.13,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p47_29.png",
          "height": 37.44,
          "width": 440.4,
          "x": 96.72,
          "y": 518.13,
          "original_width": 1835,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "page_52.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 10",
          "md": "# SECTION: 10  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Vitamin-A",
          "md": "## Vitamin-A",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**86. Is Vitamin A also a vaccine?**  \n**Ans.** No. Vitamin A is not a vaccine. It is a micronutrient required by body for growth and development. It also helps in maintaining immunity and supports good vision.",
          "md": "**86. Is Vitamin A also a vaccine?**  \n**Ans.** No. Vitamin A is not a vaccine. It is a micronutrient required by body for growth and development. It also helps in maintaining immunity and supports good vision.",
          "bBox": {
            "x": 58.5,
            "y": 345.71,
            "w": 478.28,
            "h": 483
          }
        },
        {
          "type": "text",
          "value": "**87. What are the signs of Vitamin A deficiency in children?**  \n**Ans.** Night blindness is the first sign of Vitamin A deficiency, and in this condition affected children have poor vision in darkness but can see normally when adequate light is present. There are other signs which can be detected by medical officer at any health facility.",
          "md": "**87. What are the signs of Vitamin A deficiency in children?**  \n**Ans.** Night blindness is the first sign of Vitamin A deficiency, and in this condition affected children have poor vision in darkness but can see normally when adequate light is present. There are other signs which can be detected by medical officer at any health facility.",
          "bBox": {
            "x": 58.5,
            "y": 379.6,
            "w": 478.28,
            "h": 449.11
          }
        },
        {
          "type": "text",
          "value": "**88. What is the schedule for giving Vitamin A?**  \n**Ans.** Total 9 prophylactic doses of Vitamin A are given to children. First dose is given along with measles vaccine at 9 months (completed), second dose with measles at 16-24 months, and 3rd to 9th dose biannually till the age of 5 years. Minimum difference of 6 months must be ensured between any two subsequent doses of vitamin A.  \n**First dose of vitamin A syrup is 1 ml or 1,00,000 IU (half spoon), and second to ninth dose is 2 ml or 2,00,000 IU (full spoon).**",
          "md": "**88. What is the schedule for giving Vitamin A?**  \n**Ans.** Total 9 prophylactic doses of Vitamin A are given to children. First dose is given along with measles vaccine at 9 months (completed), second dose with measles at 16-24 months, and 3rd to 9th dose biannually till the age of 5 years. Minimum difference of 6 months must be ensured between any two subsequent doses of vitamin A.  \n**First dose of vitamin A syrup is 1 ml or 1,00,000 IU (half spoon), and second to ninth dose is 2 ml or 2,00,000 IU (full spoon).**",
          "bBox": {
            "x": 58.5,
            "y": 379.6,
            "w": 478.28,
            "h": 449.11
          }
        },
        {
          "type": "text",
          "value": "**89. How is Vitamin A administered to children?**  \n**Ans.** Vitamin A is available as syrup in dark coloured bottles. The syrup should be given with spoon (having dose markings) provided with the bottle.",
          "md": "**89. How is Vitamin A administered to children?**  \n**Ans.** Vitamin A is available as syrup in dark coloured bottles. The syrup should be given with spoon (having dose markings) provided with the bottle.",
          "bBox": {
            "x": 58.5,
            "y": 379.6,
            "w": 478.27,
            "h": 449.11
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.991
    },
    {
      "page": 53,
      "text": "Q\nQ 90. Can Vitamin A be given along with other orally ᵃᵈᵐⁱⁿⁱˢᵗᵉʳᵉᵈ\n             vaccines?\nAns.     Yes. Vitamin A can be given along with other orally administered vaccines, like OPV\n         and Rotavirus Vaccine. However, they should not be mixed.\n\n          91. What precautions are required with Vitamin A?\n\nAns.     Take the following precautions while using and administering vitamin A. These are:\n          à  Vitamin A bottle once opened should be used within 8 weeks. Therefore, date\n             of opening a bottle should be clearly mentioned on its label.\n          à  Bottles should be kept away from direct sunlight.\n          à  Vitamin A syrup must only be administered with spoon (having dose markings)\n             provided with the bottle.\n          à  Expiry date and date of opening the bottle should be checked before\n             administration.\n\n\n\n                           Amno\nHEALTH SECURE\n                                        Do not keep in\n                                        direct sunlight\n\n                             ORAL SL    The label should be intact\n                               a\nSolution\nA [synthetic]     10000O1U 0\n                  U/grom)    O          Expiry date has not passed\n                  ml not less\n20                ctivily\n\nured              100    Date of opening should be mentioned\n                  2.00\nQ  hute                    ( Use within 8 weeks of opening)\n\n\nFigure 16: Vitamin-A and formulation\n\n\n         92. What is the therapeutic treatment schedule for children with\n         clinical signs of Vitamin A deficiency?\nAns.     In children having clinical signs of Vitamin A deficiency, it is recommended to\n         administer 200,000 IU (2 ml) of Vitamin A immediately after diagnosis, followed by\n         another dose of 200,000 IU (2 ml), 1-4 weeks later.\n\n\n\n\n\n\n\n\n46 IFAQs on Immunization",
      "md": "\n**90. Can Vitamin A be given along with other orally administered vaccines?**  \n**Ans.** Yes. Vitamin A can be given along with other orally administered vaccines, like OPV and Rotavirus Vaccine. However, they should not be mixed.\n\n**91. What precautions are required with Vitamin A?**  \n**Ans.** Take the following precautions while using and administering vitamin A. These are:  \n* Vitamin A bottle once opened should be used within 8 weeks. Therefore, date of opening a bottle should be clearly mentioned on its label.  \n* Bottles should be kept away from direct sunlight.  \n* Vitamin A syrup must only be administered with spoon (having dose markings) provided with the bottle.  \n* Expiry date and date of opening the bottle should be checked before administration.\n\n<table>\n<tr>\n<td colspan=\"2\" align=\"center\"><b>Vitamin-A and formulation</b></td>\n</tr>\n<tr>\n<td>\n- Do not keep in direct sunlight  \n- The label should be intact  \n- Expiry date has not passed  \n- Date of opening should be mentioned (Use within 8 weeks of opening)\n</td>\n<td>\n[Image of Vitamin A bottle with red cap and spoon showing dose markings, with arrows pointing to the above precautions]\n</td>\n</tr>\n</table>\n\n**92. What is the therapeutic treatment schedule for children with clinical signs of Vitamin A deficiency?**  \n**Ans.** In children having clinical signs of Vitamin A deficiency, it is recommended to administer 200,000 IU (2 ml) of Vitamin A immediately after diagnosis, followed by another dose of 200,000 IU (2 ml), 1-4 weeks later.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_6.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 516.966,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p52_8.jpg",
          "height": 243.24,
          "width": 235.424,
          "x": 131.02,
          "y": 338.425,
          "original_width": 994,
          "original_height": 1027,
          "rotation": 0,
          "ocr": [
            {
              "x": 674,
              "y": 744,
              "w": 28,
              "h": 19,
              "confidence": 0.45,
              "text": "hute"
            },
            {
              "x": 780,
              "y": 727,
              "w": 17,
              "h": 9,
              "confidence": 0.843,
              "text": "2.00"
            },
            {
              "x": 775,
              "y": 717,
              "w": 15,
              "h": 7,
              "confidence": 0.406,
              "text": "100"
            },
            {
              "x": 692,
              "y": 693,
              "w": 22,
              "h": 13,
              "confidence": 0.996,
              "text": "ured"
            },
            {
              "x": 711,
              "y": 684,
              "w": 7,
              "h": 5,
              "confidence": 0.276,
              "text": "D"
            },
            {
              "x": 687,
              "y": 668,
              "w": 7,
              "h": 5,
              "confidence": 0.274,
              "text": "20"
            },
            {
              "x": 765,
              "y": 659,
              "w": 24,
              "h": 9,
              "confidence": 0.99,
              "text": "ctivily"
            },
            {
              "x": 767,
              "y": 643,
              "w": 51,
              "h": 15,
              "confidence": 0.936,
              "text": "ml not less"
            },
            {
              "x": 826,
              "y": 628,
              "w": 30,
              "h": 46,
              "confidence": 0.212,
              "text": "O"
            },
            {
              "x": 765,
              "y": 620,
              "w": 42,
              "h": 15,
              "confidence": 0.92,
              "text": "U/grom)"
            },
            {
              "x": 770,
              "y": 605,
              "w": 52,
              "h": 18,
              "confidence": 0.746,
              "text": "10000O1U"
            },
            {
              "x": 683,
              "y": 604,
              "w": 46,
              "h": 17,
              "confidence": 0.931,
              "text": "[synthetic]"
            },
            {
              "x": 827,
              "y": 598,
              "w": 29,
              "h": 31,
              "confidence": 0.187,
              "text": "0"
            },
            {
              "x": 664,
              "y": 600,
              "w": 10,
              "h": 7,
              "confidence": 0.977,
              "text": "A"
            },
            {
              "x": 752,
              "y": 552,
              "w": 95,
              "h": 29,
              "confidence": 1,
              "text": "Solution"
            },
            {
              "x": 872,
              "y": 500,
              "w": 10,
              "h": 10,
              "confidence": 0.81,
              "text": "a"
            },
            {
              "x": 826,
              "y": 459,
              "w": 71,
              "h": 48,
              "confidence": 0.871,
              "text": "ORAL SL"
            },
            {
              "x": 675,
              "y": 160,
              "w": 135,
              "h": 49,
              "confidence": 0.952,
              "text": "HEALTH SECURE"
            },
            {
              "x": 809,
              "y": 132,
              "w": 43,
              "h": 24,
              "confidence": 0.274,
              "text": "Amno"
            }
          ]
        },
        {
          "name": "img_p52_9.png",
          "height": 35.053,
          "width": 168.397,
          "x": 365.97,
          "y": 338.425,
          "original_width": 711,
          "original_height": 148,
          "rotation": 0
        },
        {
          "name": "img_p52_10.jpg",
          "height": 208.66,
          "width": 34.106,
          "x": 365.97,
          "y": 373.005,
          "original_width": 144,
          "original_height": 881,
          "rotation": 0
        },
        {
          "name": "img_p52_11.jpg",
          "height": 208.66,
          "width": 101.132,
          "x": 433.235,
          "y": 373.005,
          "original_width": 427,
          "original_height": 881,
          "rotation": 0
        },
        {
          "name": "img_p52_12.jpg",
          "height": 173.844,
          "width": 34.106,
          "x": 399.602,
          "y": 407.821,
          "original_width": 144,
          "original_height": 734,
          "rotation": 0
        },
        {
          "name": "img_p52_14.png",
          "height": 6.737,
          "width": 33.395,
          "x": 394.069,
          "y": 351.086,
          "original_width": 113,
          "original_height": 557,
          "rotation": 0
        },
        {
          "name": "img_p52_16.jpg",
          "height": 66.154,
          "width": 52.083,
          "x": 409.059,
          "y": 345.421,
          "original_width": 218,
          "original_height": 276,
          "rotation": 0
        },
        {
          "name": "img_p52_17.jpg",
          "height": 66.154,
          "width": 26.133,
          "x": 383.048,
          "y": 345.421,
          "original_width": 109,
          "original_height": 276,
          "rotation": 0
        },
        {
          "name": "img_p52_19.jpg",
          "height": 46.786,
          "width": 26.9,
          "x": 420.823,
          "y": 361.002,
          "original_width": 195,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "img_p52_20.jpg",
          "height": 46.786,
          "width": 26.948,
          "x": 393.972,
          "y": 361.002,
          "original_width": 195,
          "original_height": 113,
          "rotation": 0
        },
        {
          "name": "page_53.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**90. Can Vitamin A be given along with other orally administered vaccines?**  \n**Ans.** Yes. Vitamin A can be given along with other orally administered vaccines, like OPV and Rotavirus Vaccine. However, they should not be mixed.",
          "md": "**90. Can Vitamin A be given along with other orally administered vaccines?**  \n**Ans.** Yes. Vitamin A can be given along with other orally administered vaccines, like OPV and Rotavirus Vaccine. However, they should not be mixed.",
          "bBox": {
            "x": 86.4,
            "y": 75.56,
            "w": 450.37,
            "h": 606.23
          }
        },
        {
          "type": "text",
          "value": "**91. What precautions are required with Vitamin A?**  \n**Ans.** Take the following precautions while using and administering vitamin A. These are:  \n* Vitamin A bottle once opened should be used within 8 weeks. Therefore, date of opening a bottle should be clearly mentioned on its label.  \n* Bottles should be kept away from direct sunlight.  \n* Vitamin A syrup must only be administered with spoon (having dose markings) provided with the bottle.  \n* Expiry date and date of opening the bottle should be checked before administration.",
          "md": "**91. What precautions are required with Vitamin A?**  \n**Ans.** Take the following precautions while using and administering vitamin A. These are:  \n* Vitamin A bottle once opened should be used within 8 weeks. Therefore, date of opening a bottle should be clearly mentioned on its label.  \n* Bottles should be kept away from direct sunlight.  \n* Vitamin A syrup must only be administered with spoon (having dose markings) provided with the bottle.  \n* Expiry date and date of opening the bottle should be checked before administration.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.43,
            "h": 623.32
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "- Do not keep in direct sunlight - The label should be intact - Expiry date has not passed - Date of opening should be mentioned (Use within 8 weeks of opening)",
              "[Image of Vitamin A bottle with red cap and spoon showing dose markings, with arrows pointing to the above precautions]"
            ]
          ],
          "html": "<table>\n<tr>\n<td colspan=\"2\" align=\"center\"><b>Vitamin-A and formulation</b></td>\n</tr>\n<tr>\n<td>\n- Do not keep in direct sunlight  \n- The label should be intact  \n- Expiry date has not passed  \n- Date of opening should be mentioned (Use within 8 weeks of opening)\n</td>\n<td>\n[Image of Vitamin A bottle with red cap and spoon showing dose markings, with arrows pointing to the above precautions]\n</td>\n</tr>\n</table>",
          "md": "|                                                                   **Vitamin-A and formulation**                                                                  |                                                                                                                          |\n| :--------------------------------------------------------------------------------------------------------------------------------------------------------------: | ------------------------------------------------------------------------------------------------------------------------ |\n| - Do not keep in direct sunlight - The label should be intact - Expiry date has not passed - Date of opening should be mentioned (Use within 8 weeks of opening) | \\[Image of Vitamin A bottle with red cap and spoon showing dose markings, with arrows pointing to the above precautions] |",
          "isPerfectTable": true,
          "csv": "\"- Do not keep in direct sunlight - The label should be intact - Expiry date has not passed - Date of opening should be mentioned (Use within 8 weeks of opening)\",\"[Image of Vitamin A bottle with red cap and spoon showing dose markings, with arrows pointing to the above precautions]\"",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**92. What is the therapeutic treatment schedule for children with clinical signs of Vitamin A deficiency?**  \n**Ans.** In children having clinical signs of Vitamin A deficiency, it is recommended to administer 200,000 IU (2 ml) of Vitamin A immediately after diagnosis, followed by another dose of 200,000 IU (2 ml), 1-4 weeks later.",
          "md": "**92. What is the therapeutic treatment schedule for children with clinical signs of Vitamin A deficiency?**  \n**Ans.** In children having clinical signs of Vitamin A deficiency, it is recommended to administer 200,000 IU (2 ml) of Vitamin A immediately after diagnosis, followed by another dose of 200,000 IU (2 ml), 1-4 weeks later.",
          "bBox": {
            "x": 86.4,
            "y": 96.8,
            "w": 450.4,
            "h": 610.98
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 54,
      "text": "    Q 93. Why Vitamin A is given during measles outbreak?\n    Ans.     Vitamin A supplementation is recommended for children who are infected during\n             the measles outbreak. This markedly reduces measles associated mortality among\n             the affected children. Utilization of Vitamin A is impaired during measles infection,\n             irrespective of the total body stores of the vitamin. Vitamin A should be given to\n             all measles cases, irrespective of whether it has previously been administered\n             prophylactically or given as routine immunization.¹²\n             Recommended Vitamin A dosage schedule for measles treatment is as follows:\n\n\n    Age    Immediately on diag-    Next day\n           nosis\n\n\n Infants < 6 months    50,000 IU       50,000 IU\n\nInfants 6-11 months    1,00,000 IU    1,00,000 IU\n\nChildren >12 months  2,00,000 IU      2,00,000 IU\n\n    Table 4: Vitamin A dosage during a measles outbreak\n\n\n\n\n\n\n\n\n\n\n    12Measles surveillance and outbreak investigation, Field Guide; Department of Family Welfare, New Delhi, November 2005\n\n    FAQs on ImmunizationI 47",
      "md": "\n# 93. Why Vitamin A is given during measles outbreak?\n\n**Ans.** Vitamin A supplementation is recommended for children who are infected during the measles outbreak. This markedly reduces measles associated mortality among the affected children. Utilization of Vitamin A is impaired during measles infection, irrespective of the total body stores of the vitamin. Vitamin A should be given to all measles cases, irrespective of whether it has previously been administered prophylactically or given as routine immunization.¹²\n\nRecommended Vitamin A dosage schedule for measles treatment is as follows:\n\n<table>\n  <thead>\n    <tr>\n      <th>Age</th>\n      <th>Immediately on diagnosis</th>\n      <th>Next day</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>Infants &lt; 6 months</td>\n<td>50,000 IU</td>\n<td>50,000 IU</td>\n    </tr>\n<tr>\n      <td>Infants 6-11 months</td>\n<td>1,00,000 IU</td>\n<td>1,00,000 IU</td>\n    </tr>\n<tr>\n      <td>Children &gt;12 months</td>\n<td>2,00,000 IU</td>\n<td>2,00,000 IU</td>\n    </tr>\n  </tbody>\n</table>\n\nTable 4: Vitamin A dosage during a measles outbreak\n\n> ¹² Measles surveillance and outbreak investigation, Field Guide; Department of Family Welfare, New Delhi, November 2005\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p9_2.png",
          "height": 37.44,
          "width": 414.72,
          "x": 96.72,
          "y": 58.05,
          "original_width": 1728,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p9_4.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 58.464,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_54.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "93. Why Vitamin A is given during measles outbreak?",
          "md": "# 93. Why Vitamin A is given during measles outbreak?",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Ans.** Vitamin A supplementation is recommended for children who are infected during the measles outbreak. This markedly reduces measles associated mortality among the affected children. Utilization of Vitamin A is impaired during measles infection, irrespective of the total body stores of the vitamin. Vitamin A should be given to all measles cases, irrespective of whether it has previously been administered prophylactically or given as routine immunization.¹²",
          "md": "**Ans.** Vitamin A supplementation is recommended for children who are infected during the measles outbreak. This markedly reduces measles associated mortality among the affected children. Utilization of Vitamin A is impaired during measles infection, irrespective of the total body stores of the vitamin. Vitamin A should be given to all measles cases, irrespective of whether it has previously been administered prophylactically or given as routine immunization.¹²",
          "bBox": {
            "x": 58.5,
            "y": 96.8,
            "w": 452.72,
            "h": 76.98
          }
        },
        {
          "type": "text",
          "value": "Recommended Vitamin A dosage schedule for measles treatment is as follows:",
          "md": "Recommended Vitamin A dosage schedule for measles treatment is as follows:",
          "bBox": {
            "x": 100.5,
            "y": 183.8,
            "w": 386.93,
            "h": 53.29
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Age",
              "Immediately on diagnosis",
              "Next day"
            ],
            [
              "Infants < 6 months",
              "50,000 IU",
              "50,000 IU"
            ],
            [
              "Infants 6-11 months",
              "1,00,000 IU",
              "1,00,000 IU"
            ],
            [
              "Children >12 months",
              "2,00,000 IU",
              "2,00,000 IU"
            ]
          ],
          "html": "<table>\n  <thead>\n    <tr>\n      <th>Age</th>\n      <th>Immediately on diagnosis</th>\n      <th>Next day</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td>Infants &#x3C; 6 months</td>\n<td>50,000 IU</td>\n<td>50,000 IU</td>\n    </tr>\n<tr>\n      <td>Infants 6-11 months</td>\n<td>1,00,000 IU</td>\n<td>1,00,000 IU</td>\n    </tr>\n<tr>\n      <td>Children >12 months</td>\n<td>2,00,000 IU</td>\n<td>2,00,000 IU</td>\n    </tr>\n  </tbody>\n</table>",
          "md": "| Age                 | Immediately on diagnosis | Next day    |\n| ------------------- | ------------------------ | ----------- |\n| Infants < 6 months  | 50,000 IU                | 50,000 IU   |\n| Infants 6-11 months | 1,00,000 IU              | 1,00,000 IU |\n| Children >12 months | 2,00,000 IU              | 2,00,000 IU |",
          "isPerfectTable": false,
          "csv": "\"Age\",\"Immediately on diagnosis\",\"Next day\"\n\"Infants < 6 months\",\"50,000 IU\",\"50,000 IU\"\n\"Infants 6-11 months\",\"1,00,000 IU\",\"1,00,000 IU\"\n\"Children >12 months\",\"2,00,000 IU\",\"2,00,000 IU\"",
          "bBox": {
            "x": 100.5,
            "y": 183.8,
            "w": 386.93,
            "h": 193.97
          }
        },
        {
          "type": "text",
          "value": "Table 4: Vitamin A dosage during a measles outbreak",
          "md": "Table 4: Vitamin A dosage during a measles outbreak",
          "bBox": {
            "x": 175.76,
            "y": 226.09,
            "w": 200.31,
            "h": 151.69
          }
        },
        {
          "type": "text",
          "value": "> ¹² Measles surveillance and outbreak investigation, Field Guide; Department of Family Welfare, New Delhi, November 2005",
          "md": "> ¹² Measles surveillance and outbreak investigation, Field Guide; Department of Family Welfare, New Delhi, November 2005",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.987
    },
    {
      "page": 55,
      "text": "48 IFAQs on Immunization",
      "md": "48 IFAQs on Immunization",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_55.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "48 IFAQs on Immunization",
          "md": "48 IFAQs on Immunization",
          "bBox": {
            "x": 86.4,
            "y": 804.71,
            "w": 136.33,
            "h": 24
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 56,
      "text": "SECTION: 11\nProgram Planning and\nImplementation\n\n\n\n\n         94. What is immunization component of Mother and Child Protection\n             (MCP) card?\nAns.\nAns.     MCP\n         MCP card\n             card is\n                  is a\n                     a document\n                       document mentioning\n                                mentioning the\n                                the record\n                                                    record of\n                                                                 of vaccines\n                                                                    vaccines\n         received (date and age), and dates for vaccines due. This card\n         received (date and age), and dates for vaccines due. This card\n         is given to all beneficiaries (pregnant women and children), free\n         is given to all beneficiaries (pregnant women and children), free\n         of cost, at first contact or at time of administering first vaccine\n         of cost, at first contact or at time of administering first vaccine\n         as per schedule.You should emphasize to caregivers the\n         as per schedule.You should emphasize to caregivers the\n         importance of keeping this card safe and bringing it\n         importance of keeping this card safe and bringing it\n         along every time they come for vaccination.\n         MCP card is given to a pregnant woman at time of\n         MCP card is given to a pregnant woman at time of\n         confirmation of pregnancy and administration\n         confirmation of pregnancy and administration\n         of first dose of TT vaccine, and the same card\n         of first dose of TT vaccine, and the same card\n         continues till complete vaccination (including\n         continues till complete vaccination (including\n         boosters and vitamin A doses) of her child.\n         However, if a pregnant woman has not\n         received or has lost her card, then a new card may\n         received or has lost her card, then a new card may\n         be issued to her child.\n\n\n\n         95. What should be done if parents/caretakers have lost or have not\n         brought MCP card along with them for vaccination?\nAns.     In these situations, beneficiaries should never be denied for vaccination. If MCP card is\n         lost, then re-issue a new card after filling the old entries from their facility register. Please\n         explain to parents/caregivers about importance of keeping MCP card safe for ensuring\n         timely and complete vaccination. In case, parents have forgotten to bring the card, then\n         refer to the records and give the next vaccine due to the beneficiary.\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  49\n                 49",
      "md": "\n# SECTION: 11  \n## Program Planning and Implementation\n\n**94. What is immunization component of Mother and Child Protection (MCP) card?**  \n**Ans.**  \nMCP card is a document mentioning the record of vaccines received (date and age), and dates for vaccines due. This card is given to all beneficiaries (pregnant women and children), free of cost, at first contact or at time of administering first vaccine as per schedule. You should emphasize to caregivers the importance of keeping this card safe and bringing it along every time they come for vaccination.\n\nMCP card is given to a pregnant woman at time of confirmation of pregnancy and administration of first dose of TT vaccine, and the same card continues till complete vaccination (including boosters and vitamin A doses) of her child. However, if a pregnant woman has not received or has lost her card, then a new card may be issued to her child.\n\n**95. What should be done if parents/caretakers have lost or have not brought MCP card along with them for vaccination?**  \n**Ans.**  \nIn these situations, beneficiaries should never be denied for vaccination. If MCP card is lost, then re-issue a new card after filling the old entries from their facility register. Please explain to parents/caregivers about importance of keeping MCP card safe for ensuring timely and complete vaccination. In case, parents have forgotten to bring the card, then refer to the records and give the next vaccine due to the beneficiary.\n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p55_3.png",
          "height": 246.24,
          "width": 105.84,
          "x": 489.84,
          "y": 595.89,
          "original_width": 441,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p55_5.png",
          "height": 246.24,
          "width": 105.84,
          "x": 244.8,
          "y": 350.37,
          "original_width": 441,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p55_6.png",
          "height": 316.32,
          "width": 70.8,
          "x": 524.88,
          "y": 280.29,
          "original_width": 295,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p55_7.png",
          "height": 70.8,
          "width": 175.68,
          "x": 349.92,
          "y": 315.33,
          "original_width": 732,
          "original_height": 295,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_11.png",
          "height": 35.76,
          "width": 35.76,
          "x": 489.84,
          "y": 280.29,
          "original_width": 149,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_12.png",
          "height": 175.92,
          "width": 35.76,
          "x": 559.92,
          "y": -0.27,
          "original_width": 149,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_19.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p55_30.png",
          "height": 12.24,
          "width": 262.56,
          "x": 58.32,
          "y": 378.69,
          "original_width": 1094,
          "original_height": 51,
          "rotation": 0
        },
        {
          "name": "page_56.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 11",
          "md": "# SECTION: 11  ",
          "bBox": {
            "x": 58.5,
            "y": 196.4,
            "w": 440.95,
            "h": 632.31
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Program Planning and Implementation",
          "md": "## Program Planning and Implementation",
          "bBox": {
            "x": 58.5,
            "y": 224.17,
            "w": 440.95,
            "h": 604.55
          }
        },
        {
          "type": "text",
          "value": "**94. What is immunization component of Mother and Child Protection (MCP) card?**  \n**Ans.**  \nMCP card is a document mentioning the record of vaccines received (date and age), and dates for vaccines due. This card is given to all beneficiaries (pregnant women and children), free of cost, at first contact or at time of administering first vaccine as per schedule. You should emphasize to caregivers the importance of keeping this card safe and bringing it along every time they come for vaccination.",
          "md": "**94. What is immunization component of Mother and Child Protection (MCP) card?**  \n**Ans.**  \nMCP card is a document mentioning the record of vaccines received (date and age), and dates for vaccines due. This card is given to all beneficiaries (pregnant women and children), free of cost, at first contact or at time of administering first vaccine as per schedule. You should emphasize to caregivers the importance of keeping this card safe and bringing it along every time they come for vaccination.",
          "bBox": {
            "x": 58.5,
            "y": 336.61,
            "w": 478.3,
            "h": 492.1
          }
        },
        {
          "type": "text",
          "value": "MCP card is given to a pregnant woman at time of confirmation of pregnancy and administration of first dose of TT vaccine, and the same card continues till complete vaccination (including boosters and vitamin A doses) of her child. However, if a pregnant woman has not received or has lost her card, then a new card may be issued to her child.",
          "md": "MCP card is given to a pregnant woman at time of confirmation of pregnancy and administration of first dose of TT vaccine, and the same card continues till complete vaccination (including boosters and vitamin A doses) of her child. However, if a pregnant woman has not received or has lost her card, then a new card may be issued to her child.",
          "bBox": {
            "x": 100.5,
            "y": 375.71,
            "w": 398.95,
            "h": 453.01
          }
        },
        {
          "type": "text",
          "value": "**95. What should be done if parents/caretakers have lost or have not brought MCP card along with them for vaccination?**  \n**Ans.**  \nIn these situations, beneficiaries should never be denied for vaccination. If MCP card is lost, then re-issue a new card after filling the old entries from their facility register. Please explain to parents/caregivers about importance of keeping MCP card safe for ensuring timely and complete vaccination. In case, parents have forgotten to bring the card, then refer to the records and give the next vaccine due to the beneficiary.",
          "md": "**95. What should be done if parents/caretakers have lost or have not brought MCP card along with them for vaccination?**  \n**Ans.**  \nIn these situations, beneficiaries should never be denied for vaccination. If MCP card is lost, then re-issue a new card after filling the old entries from their facility register. Please explain to parents/caregivers about importance of keeping MCP card safe for ensuring timely and complete vaccination. In case, parents have forgotten to bring the card, then refer to the records and give the next vaccine due to the beneficiary.",
          "bBox": {
            "x": 58.5,
            "y": 375.71,
            "w": 478.28,
            "h": 453.01
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.992
    },
    {
      "page": 57,
      "text": "Q\nQ 96. What should be done if due vaccine is not available at the\n         health facility or session site?\nAns.     In such a situation, administer all available and scheduled vaccines to the child and\n         advice to return in the next immunization session. Put the name of the child in\n         “missed-dose tracking” and ensure that the child receives the scheduled vaccines\n         in the next session. However, the parents/caretakers can also take their children to\n         higher level health facility for getting the scheduled vaccines.\n\n         97. What are the specific roles and responsibilities of health\n         worker, ASHA, and Anganwadi worker in UIP?\nAns.     All these three cadres of health functionaries share responsibility to: generate\n         awareness regarding benefitsof immunization,removefalse beliefsin thecommunity\n         concerning immunization and vaccines, and ensure that timely vaccination is given\n         to all beneficiaries.\n         ASHA workers play a specific role by preparing due list of beneficiaries to be\n         immunized during a session and updating it on a monthly basis, mobilizing them\n         to come to the session site where immunization services are being provided, and\n         support health worker in organizing the session. She maintains a record of all\n         immunization beneficiaries and updates it by adding vaccines administered to\n         individual beneficiaries on the session day.\n         Anganwadi worker also plays an important role by mobilizing beneficiaries,\n         supporting health workers in organizing sessions, and communicating important\n         messages to parents and caretakers. Immunization of adolescent girls and boys is\n         also a responsibility of Anganwadi workers.\n         also a responsibility of Anganwadi workers.\n         Health worker administers vaccines, maintains cold chain,\n         Health worker administers vaccines, maintains cold chain,\n         ensures injection safety, updates records, and prepares\n         ensures injection safety, updates records, and prepares\n         reports for submission to higher levels. They are also\n         reports for submission to higher levels. They are also\n         responsible for providing support to ASHA, Anganwadi\n         responsible for providing support to ASHA, Anganwadi\n         workers, and other frontline functionaries in fulfilling\n         workers, and other frontline functionaries in fulfilling\n         their responsibilities.\n         their responsibilities.\n\n\n\n\n\n\n\n\n\n\n50 IFAQs on Immunization",
      "md": "\n**Q 96. What should be done if due vaccine is not available at the health facility or session site?**  \nAns. In such a situation, administer all available and scheduled vaccines to the child and advice to return in the next immunization session. Put the name of the child in **“missed-dose tracking”** and ensure that the child receives the scheduled vaccines in the next session. However, the parents/caretakers can also take their children to higher level health facility for getting the scheduled vaccines.\n\n**Q 97. What are the specific roles and responsibilities of health worker, ASHA, and Anganwadi worker in UIP?**  \nAns. All these three cadres of health functionaries share responsibility to: generate awareness regarding benefits of immunization, remove false beliefs in the community concerning immunization and vaccines, and ensure that timely vaccination is given to all beneficiaries.\n\nASHA workers play a specific role by preparing due list of beneficiaries to be immunized during a session and updating it on a monthly basis, mobilizing them to come to the session site where immunization services are being provided, and support health worker in organizing the session. She maintains a record of all immunization beneficiaries and updates it by adding vaccines administered to individual beneficiaries on the session day.\n\nAnganwadi worker also plays an important role by mobilizing beneficiaries, supporting health workers in organizing sessions, and communicating important messages to parents and caretakers. Immunization of adolescent girls and boys is also a responsibility of Anganwadi workers.\n\nHealth worker administers vaccines, maintains cold chain, ensures injection safety, updates records, and prepares reports for submission to higher levels. They are also responsible for providing support to ASHA, Anganwadi workers, and other frontline functionaries in fulfilling their responsibilities.\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_3.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 516.69,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p8_5.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 58.464,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.951,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p56_6.png",
          "height": 34.293,
          "width": 104.126,
          "x": 86.269,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_7.png",
          "height": 34.293,
          "width": 104.061,
          "x": 190.264,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_8.png",
          "height": 34.293,
          "width": 104.127,
          "x": 294.193,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_9.jpg",
          "height": 34.293,
          "width": 104.06,
          "x": 398.189,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_10.jpg",
          "height": 102.618,
          "width": 34.818,
          "x": 502.118,
          "y": 453.967,
          "original_width": 146,
          "original_height": 428,
          "rotation": 0
        },
        {
          "name": "img_p56_11.png",
          "height": 34.293,
          "width": 104.126,
          "x": 86.269,
          "y": 488.129,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_7.png",
          "height": 34.293,
          "width": 104.061,
          "x": 190.264,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_13.png",
          "height": 34.293,
          "width": 104.127,
          "x": 294.193,
          "y": 488.129,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_14.jpg",
          "height": 34.293,
          "width": 104.06,
          "x": 398.189,
          "y": 488.129,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_6.png",
          "height": 34.293,
          "width": 104.126,
          "x": 86.269,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_7.png",
          "height": 34.293,
          "width": 104.061,
          "x": 190.264,
          "y": 453.967,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_17.jpg",
          "height": 34.294,
          "width": 104.127,
          "x": 294.193,
          "y": 522.291,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_18.jpg",
          "height": 34.294,
          "width": 104.06,
          "x": 398.189,
          "y": 522.291,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_19.jpg",
          "height": 34.293,
          "width": 104.126,
          "x": 86.269,
          "y": 556.454,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_20.jpg",
          "height": 34.293,
          "width": 104.061,
          "x": 190.264,
          "y": 556.454,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_21.jpg",
          "height": 34.293,
          "width": 104.127,
          "x": 294.193,
          "y": 556.454,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_22.jpg",
          "height": 34.293,
          "width": 104.06,
          "x": 398.189,
          "y": 556.454,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_23.jpg",
          "height": 102.618,
          "width": 34.818,
          "x": 502.118,
          "y": 556.454,
          "original_width": 146,
          "original_height": 428,
          "rotation": 0
        },
        {
          "name": "img_p56_24.jpg",
          "height": 34.293,
          "width": 104.126,
          "x": 86.269,
          "y": 590.616,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_25.jpg",
          "height": 34.293,
          "width": 104.061,
          "x": 190.264,
          "y": 590.616,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_26.jpg",
          "height": 34.293,
          "width": 104.127,
          "x": 294.193,
          "y": 590.616,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_27.jpg",
          "height": 34.293,
          "width": 104.06,
          "x": 398.189,
          "y": 590.616,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_28.jpg",
          "height": 34.294,
          "width": 104.126,
          "x": 86.269,
          "y": 624.778,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_29.jpg",
          "height": 34.294,
          "width": 104.061,
          "x": 190.264,
          "y": 624.778,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p56_30.jpg",
          "height": 34.294,
          "width": 104.127,
          "x": 294.193,
          "y": 624.778,
          "original_width": 434,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "page_57.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**Q 96. What should be done if due vaccine is not available at the health facility or session site?**  \nAns. In such a situation, administer all available and scheduled vaccines to the child and advice to return in the next immunization session. Put the name of the child in **“missed-dose tracking”** and ensure that the child receives the scheduled vaccines in the next session. However, the parents/caretakers can also take their children to higher level health facility for getting the scheduled vaccines.",
          "md": "**Q 96. What should be done if due vaccine is not available at the health facility or session site?**  \nAns. In such a situation, administer all available and scheduled vaccines to the child and advice to return in the next immunization session. Put the name of the child in **“missed-dose tracking”** and ensure that the child receives the scheduled vaccines in the next session. However, the parents/caretakers can also take their children to higher level health facility for getting the scheduled vaccines.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.43,
            "h": 186.82
          }
        },
        {
          "type": "text",
          "value": "**Q 97. What are the specific roles and responsibilities of health worker, ASHA, and Anganwadi worker in UIP?**  \nAns. All these three cadres of health functionaries share responsibility to: generate awareness regarding benefits of immunization, remove false beliefs in the community concerning immunization and vaccines, and ensure that timely vaccination is given to all beneficiaries.",
          "md": "**Q 97. What are the specific roles and responsibilities of health worker, ASHA, and Anganwadi worker in UIP?**  \nAns. All these three cadres of health functionaries share responsibility to: generate awareness regarding benefits of immunization, remove false beliefs in the community concerning immunization and vaccines, and ensure that timely vaccination is given to all beneficiaries.",
          "bBox": {
            "x": 86.36,
            "y": 58.46,
            "w": 450.42,
            "h": 230.31
          }
        },
        {
          "type": "text",
          "value": "ASHA workers play a specific role by preparing due list of beneficiaries to be immunized during a session and updating it on a monthly basis, mobilizing them to come to the session site where immunization services are being provided, and support health worker in organizing the session. She maintains a record of all immunization beneficiaries and updates it by adding vaccines administered to individual beneficiaries on the session day.",
          "md": "ASHA workers play a specific role by preparing due list of beneficiaries to be immunized during a session and updating it on a monthly basis, mobilizing them to come to the session site where immunization services are being provided, and support health worker in organizing the session. She maintains a record of all immunization beneficiaries and updates it by adding vaccines administered to individual beneficiaries on the session day.",
          "bBox": {
            "x": 128.4,
            "y": 300.27,
            "w": 408.39,
            "h": 84.48
          }
        },
        {
          "type": "text",
          "value": "Anganwadi worker also plays an important role by mobilizing beneficiaries, supporting health workers in organizing sessions, and communicating important messages to parents and caretakers. Immunization of adolescent girls and boys is also a responsibility of Anganwadi workers.",
          "md": "Anganwadi worker also plays an important role by mobilizing beneficiaries, supporting health workers in organizing sessions, and communicating important messages to parents and caretakers. Immunization of adolescent girls and boys is also a responsibility of Anganwadi workers.",
          "bBox": {
            "x": 128.4,
            "y": 396.24,
            "w": 408.38,
            "h": 55.56
          }
        },
        {
          "type": "text",
          "value": "Health worker administers vaccines, maintains cold chain, ensures injection safety, updates records, and prepares reports for submission to higher levels. They are also responsible for providing support to ASHA, Anganwadi workers, and other frontline functionaries in fulfilling their responsibilities.",
          "md": "Health worker administers vaccines, maintains cold chain, ensures injection safety, updates records, and prepares reports for submission to higher levels. They are also responsible for providing support to ASHA, Anganwadi workers, and other frontline functionaries in fulfilling their responsibilities.",
          "bBox": {
            "x": 128.4,
            "y": 463.23,
            "w": 290,
            "h": 84.57
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.975
    },
    {
      "page": 58,
      "text": "              98. What are the four key messages that you must be given to\n                 parents after each vaccination?\n\n    Ans.     As per the national guidelines, the four key messages that need to be delivered to\n             parents and caregivers are:\n\n              à  What vaccine was given, and what disease it prevents\n              à  When and where to come for the next visit\n              à  What minor adverse event could occur, and how to deal with them\n              à  To keep the immunization card safe and to bring along for the next visit\n\n             After vaccination, ensure that the parents/ caregivers wait for at least 30 minutes at\n             the session site. Parents should be advised to immediately inform the ASHA/ AWW/\n             ANM/MO of nearest health facility, in case of any problem faced by the child or\n             mother even after 30 minutes.\n\n\n\n    MOTHER AND CHILD\n    ) je-Stop\n    Vaccine\n             CANAAA\n\n\nWhat vaccine was given    When and where to   What minor adverse    To keep the\n  and what disease it    come for the next visit    event could occur,  Immunization Cardsafe\n    prevents                                        and how to deal with   and bring it along for\n                                                    them                   the next visit\n\n\n    T                                                   ImmunizationSchedule                                                                                                       Be Wise!\n    For Pregnant Women                                                      For Infants                                                 For Children and\n                                                                                                                                                                Adolescents\n\n                                                           VACCInE        WHEN TO GIV!                    ROUTE        SITE\n    Noaw ecine allabe kr                                                                         ml Datra-\n    protection an                                                         il one year of age\n\n    Rotavirus                                                                                                      mic-thigh\n\n                                                                                                                   Oral\n                                                                                                 ops\n                                                           OPV 1,2&3                                                                    VALCINE\n\n                                                                                                                   of left mid-thich\n                                                                                                 0.S               Antero-lateral aspect\n                                                            1283weeks                             m       muscula  of left mid-thigh    OPV Booster16-24 menths     2 drops    Oral  Oral\n                                                           containing                            0.9ml                                                                         Scb-\n                                                           Pentavalent                                    municularof lft mid\n                                                           1,2&3**\n                            VACCINE    ROUTE\n                                                                                                 0.Sml\n\n                                                                                                 0.ₘ                                                                               Upper Arm\n\n                                       0.5 m\n                                            muscularAem                   9 coempletec months                                                                      b age of\n                                                            Vitamin A9 completed months with     1mR Oral                                                                  lekh JU]\n                                                            (1\" dose)ᴹᵉᵃˢˡᵉˢ\n  * Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give                                                                                         e TT to a woman in labour, if she\n                            has not previously received TT.\n ** Pentavalent vaccines contain a combination of DPT, HepB and HiB. In the                                                                                        T 1,2 & 3 and Hepatitis B 1, 2 &\n3. Hepatitis B birth dose and booster doses of DpT will continue as before.\n   JE Vaccine (SA 14-14-2) is given in select endemic districts, after th                        mpaign\n                                       The 2re to 9u                                                                                                               TCDS.\n\n\n\n\n\n    STOP\n\n\n    PO ROLOLOND\n\n\n    BIOHAZARD\n\n\n\n\n\n\n\n\n\n\n    Figure 17: Four key messages\n\n\n\n\n\n\n    FAQs on ImmunizationI 51",
      "md": "\n# 98. What are the four key messages that you must be given to parents after each vaccination?\n\n**Ans.**  \nAs per the national guidelines, the four key messages that need to be delivered to parents and caregivers are:\n\n* What vaccine was given, and what disease it prevents  \n* When and where to come for the next visit  \n* What minor adverse event could occur, and how to deal with them  \n* To keep the immunization card safe and to bring along for the next visit  \n\nAfter vaccination, ensure that the parents/caregivers wait for at least 30 minutes at the session site. Parents should be advised to immediately inform the ASHA/AWW/ANM/MO of nearest health facility, in case of any problem faced by the child or mother even after 30 minutes.\n\n----\n\n<table>\n  <tr>\n    <td><b>What vaccine was given and what disease it prevents</b></td>\n<td><b>When and where to come for the next visit</b></td>\n<td><b>What minor adverse event could occur, and how to deal with them</b></td>\n<td><b>To keep the Immunization Cardsafe and bring it along for the next visit</b></td>\n  </tr>\n</table>\n\n----\n\n### Immunization Schedule\n\n<table>\n  <thead>\n    <tr>\n      <th colspan=\"4\">For Pregnant Women</th>\n      <th colspan=\"4\">For Infants</th>\n      <th colspan=\"4\">For Children and Adolescents</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td colspan=\"4\">\n        *Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give TT to a woman in labour, if she has not previously received TT.\n      </td>\n<td><b>Vaccine</b></td>\n<td><b>When to Give</b></td>\n<td><b>Route</b></td>\n<td><b>Site</b></td>\n<td><b>Vaccine</b></td>\n<td><b>When to Give</b></td>\n<td><b>Route</b></td>\n<td><b>Site</b></td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Rotavirus</td>\n<td>Within one year of age</td>\n<td>Oral</td>\n<td>Oral</td>\n<td>OPV 1, 2 & 3</td>\n<td>6, 10, 14 weeks</td>\n<td>Oral</td>\n<td>Antero-lateral aspect of left mid-thigh</td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Pentavalent 1, 2 & 3**</td>\n<td>6, 10, 14 weeks</td>\n<td>Intramuscular 0.5 ml</td>\n<td>Mid-thigh</td>\n<td>OPV Booster</td>\n<td>16-24 months</td>\n<td>Oral 2 drops</td>\n<td>Oral</td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Vitamin A (1st dose)</td>\n<td>9 completed months</td>\n<td>Oral 1 ml</td>\n<td>Oral</td>\n<td>Measles</td>\n<td>9 completed months</td>\n<td>Subcutaneous</td>\n<td>Upper arm</td>\n    </tr>\n  </tbody>\n</table>\n\n**Notes:**  \n- Pentavalent vaccines contain a combination of DPT, HepB and HiB.  \n- Hepatitis B birth dose and booster doses of DPT will continue as before.  \n- JE Vaccine (SA 14-14-2) is given in select endemic districts, after the campaign.\n\n----\n\n[The image shows a healthcare worker explaining the immunization schedule to a mother and father holding a child, with vaccine vials, syringes, and immunization cards on the table. There is a biohazard disposal bag on the floor.]\n\n----\n\n**Figure 17: Four key messages**\n\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p57_2.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 91.241,
          "y": 407.004,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 180,
              "y": 239,
              "w": 52,
              "h": 27,
              "confidence": 0.952,
              "text": "Rotavirus"
            },
            {
              "x": 198,
              "y": 213,
              "w": 59,
              "h": 29,
              "confidence": 0.869,
              "text": "protection an"
            },
            {
              "x": 199,
              "y": 195,
              "w": 79,
              "h": 32,
              "confidence": 0.664,
              "text": "Noaw ecine allabe kr"
            }
          ]
        },
        {
          "name": "img_p57_3.jpg",
          "height": 103.576,
          "width": 104.188,
          "x": 195.224,
          "y": 407.004,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 328,
              "y": 412,
              "w": 24,
              "h": 6,
              "confidence": 0.804,
              "text": "Measles"
            },
            {
              "x": 292,
              "y": 411,
              "w": 33,
              "h": 9,
              "confidence": 0.798,
              "text": "(1\" dose)"
            },
            {
              "x": 423,
              "y": 405,
              "w": 11,
              "h": 8,
              "confidence": 0.786,
              "text": "1m"
            },
            {
              "x": 327,
              "y": 403,
              "w": 73,
              "h": 11,
              "confidence": 0.988,
              "text": "9 completed months with"
            },
            {
              "x": 292,
              "y": 404,
              "w": 34,
              "h": 10,
              "confidence": 0.997,
              "text": "Vitamin A"
            },
            {
              "x": 246,
              "y": 394,
              "w": 17,
              "h": 12,
              "confidence": 0.637,
              "text": "Aem"
            },
            {
              "x": 215,
              "y": 395,
              "w": 27,
              "h": 9,
              "confidence": 0.983,
              "text": "muscular"
            },
            {
              "x": 184,
              "y": 389,
              "w": 25,
              "h": 13,
              "confidence": 0.947,
              "text": "0.5 m"
            },
            {
              "x": 424,
              "y": 392,
              "w": 10,
              "h": 8,
              "confidence": 0.787,
              "text": "0."
            },
            {
              "x": 328,
              "y": 391,
              "w": 60,
              "h": 9,
              "confidence": 0.948,
              "text": "9 coempletec months"
            },
            {
              "x": 216,
              "y": 391,
              "w": 16,
              "h": 6,
              "confidence": 0.909,
              "text": "Intra-"
            },
            {
              "x": 248,
              "y": 390,
              "w": 18,
              "h": 7,
              "confidence": 0.997,
              "text": "Upoer"
            },
            {
              "x": 329,
              "y": 380,
              "w": 84,
              "h": 7,
              "confidence": 0.968,
              "text": "received at 9-12 months age)"
            },
            {
              "x": 329,
              "y": 373,
              "w": 70,
              "h": 7,
              "confidence": 0.916,
              "text": "(qhve up to S years if not"
            },
            {
              "x": 309,
              "y": 373,
              "w": 15,
              "h": 7,
              "confidence": 0.975,
              "text": "dose"
            },
            {
              "x": 187,
              "y": 373,
              "w": 20,
              "h": 8,
              "confidence": 0.81,
              "text": "0.5 ml"
            },
            {
              "x": 216,
              "y": 371,
              "w": 16,
              "h": 7,
              "confidence": 0.914,
              "text": "Intra-"
            },
            {
              "x": 248,
              "y": 370,
              "w": 18,
              "h": 8,
              "confidence": 0.987,
              "text": "Upoer"
            },
            {
              "x": 424,
              "y": 368,
              "w": 10,
              "h": 9,
              "confidence": 0.876,
              "text": "0."
            },
            {
              "x": 289,
              "y": 366,
              "w": 35,
              "h": 7,
              "confidence": 0.993,
              "text": "Measles 1"
            },
            {
              "x": 219,
              "y": 362,
              "w": 23,
              "h": 6,
              "confidence": 0.904,
              "text": "suscular"
            },
            {
              "x": 327,
              "y": 359,
              "w": 70,
              "h": 9,
              "confidence": 0.951,
              "text": "9 completed montins-12"
            },
            {
              "x": 187,
              "y": 358,
              "w": 21,
              "h": 6,
              "confidence": 0.878,
              "text": "0.5.ml"
            },
            {
              "x": 216,
              "y": 355,
              "w": 15,
              "h": 7,
              "confidence": 0.91,
              "text": "Intre"
            },
            {
              "x": 248,
              "y": 354,
              "w": 18,
              "h": 8,
              "confidence": 0.992,
              "text": "Upoer"
            },
            {
              "x": 329,
              "y": 350,
              "w": 20,
              "h": 7,
              "confidence": 0.673,
              "text": "Ha3"
            },
            {
              "x": 327,
              "y": 341,
              "w": 83,
              "h": 11,
              "confidence": 0.626,
              "text": "Penan3 r OPV3/PT3"
            },
            {
              "x": 312,
              "y": 343,
              "w": 12,
              "h": 8,
              "confidence": 0.992,
              "text": "IPV"
            },
            {
              "x": 424,
              "y": 342,
              "w": 11,
              "h": 9,
              "confidence": 0.766,
              "text": "0.S"
            },
            {
              "x": 251,
              "y": 341,
              "w": 14,
              "h": 8,
              "confidence": 0.499,
              "text": "SInE"
            },
            {
              "x": 218,
              "y": 339,
              "w": 22,
              "h": 10,
              "confidence": 0.878,
              "text": "ROUTE"
            },
            {
              "x": 188,
              "y": 341,
              "w": 18,
              "h": 8,
              "confidence": 0.792,
              "text": "DOSt"
            },
            {
              "x": 126,
              "y": 341,
              "w": 43,
              "h": 7,
              "confidence": 0.936,
              "text": "WHIN TO GIVI"
            },
            {
              "x": 87,
              "y": 340,
              "w": 27,
              "h": 10,
              "confidence": 0.975,
              "text": "VACCINE"
            },
            {
              "x": 330,
              "y": 338,
              "w": 78,
              "h": 6,
              "confidence": 0.916,
              "text": "14 weeks, along with OPv3/"
            },
            {
              "x": 290,
              "y": 325,
              "w": 36,
              "h": 12,
              "confidence": 0.969,
              "text": "1,2&3**"
            },
            {
              "x": 286,
              "y": 319,
              "w": 39,
              "h": 10,
              "confidence": 0.995,
              "text": "Pentavalent"
            },
            {
              "x": 424,
              "y": 317,
              "w": 11,
              "h": 9,
              "confidence": 0.938,
              "text": "0.9"
            },
            {
              "x": 289,
              "y": 312,
              "w": 36,
              "h": 11,
              "confidence": 0.961,
              "text": "containing"
            },
            {
              "x": 328,
              "y": 300,
              "w": 20,
              "h": 8,
              "confidence": 0.993,
              "text": "weeks"
            },
            {
              "x": 300,
              "y": 297,
              "w": 26,
              "h": 10,
              "confidence": 0.806,
              "text": "1283"
            },
            {
              "x": 424,
              "y": 294,
              "w": 10,
              "h": 9,
              "confidence": 0.687,
              "text": "0.S"
            },
            {
              "x": 327,
              "y": 292,
              "w": 79,
              "h": 10,
              "confidence": 0.865,
              "text": "At @ weeks, 10 weeks & 24"
            },
            {
              "x": 289,
              "y": 291,
              "w": 36,
              "h": 7,
              "confidence": 0.917,
              "text": "Hepatitis B"
            },
            {
              "x": 425,
              "y": 280,
              "w": 9,
              "h": 5,
              "confidence": 0.386,
              "text": "0."
            },
            {
              "x": 288,
              "y": 279,
              "w": 36,
              "h": 6,
              "confidence": 0.925,
              "text": "DPT1.283"
            },
            {
              "x": 422,
              "y": 265,
              "w": 12,
              "h": 8,
              "confidence": 0.927,
              "text": "26"
            },
            {
              "x": 286,
              "y": 264,
              "w": 39,
              "h": 10,
              "confidence": 0.943,
              "text": "OPV 1,2&3"
            },
            {
              "x": 329,
              "y": 256,
              "w": 65,
              "h": 7,
              "confidence": 0.904,
              "text": "within che firit 15 days"
            },
            {
              "x": 293,
              "y": 256,
              "w": 31,
              "h": 7,
              "confidence": 0.98,
              "text": "Zero dose"
            },
            {
              "x": 422,
              "y": 253,
              "w": 12,
              "h": 7,
              "confidence": 0.825,
              "text": "2d"
            },
            {
              "x": 329,
              "y": 250,
              "w": 85,
              "h": 6,
              "confidence": 0.979,
              "text": "At birth or as earty as possible"
            },
            {
              "x": 310,
              "y": 249,
              "w": 14,
              "h": 7,
              "confidence": 0.994,
              "text": "OPV"
            },
            {
              "x": 329,
              "y": 240,
              "w": 44,
              "h": 7,
              "confidence": 0.964,
              "text": "within 24 hours"
            },
            {
              "x": 291,
              "y": 240,
              "w": 33,
              "h": 7,
              "confidence": 0.881,
              "text": "Birth dode"
            },
            {
              "x": 425,
              "y": 237,
              "w": 9,
              "h": 6,
              "confidence": 0.859,
              "text": "0."
            },
            {
              "x": 289,
              "y": 233,
              "w": 36,
              "h": 7,
              "confidence": 0.969,
              "text": "Hepaticis B"
            },
            {
              "x": 327,
              "y": 212,
              "w": 57,
              "h": 11,
              "confidence": 0.934,
              "text": "il one year of age"
            },
            {
              "x": 351,
              "y": 185,
              "w": 43,
              "h": 7,
              "confidence": 0.909,
              "text": "WHEN TO GIV!"
            },
            {
              "x": 289,
              "y": 183,
              "w": 29,
              "h": 10,
              "confidence": 0.88,
              "text": "VACCInE"
            },
            {
              "x": 377,
              "y": 157,
              "w": 57,
              "h": 7,
              "confidence": 0.951,
              "text": "Birth till 1.2 Month"
            },
            {
              "x": 127,
              "y": 129,
              "w": 105,
              "h": 10,
              "confidence": 1,
              "text": "For Pregnant Women"
            },
            {
              "x": 376,
              "y": 115,
              "w": 56,
              "h": 10,
              "confidence": 0.993,
              "text": "For Infants"
            },
            {
              "x": 121,
              "y": 87,
              "w": 25,
              "h": 15,
              "confidence": 0.447,
              "text": "T"
            },
            {
              "x": 233,
              "y": 71,
              "w": 202,
              "h": 38,
              "confidence": 0.995,
              "text": "Immunizat"
            }
          ]
        },
        {
          "name": "img_p57_4.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 299.208,
          "y": 407.004,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 18,
              "y": 407,
              "w": 15,
              "h": 10,
              "confidence": 0.884,
              "text": "Oral"
            },
            {
              "x": 0,
              "y": 404,
              "w": 13,
              "h": 16,
              "confidence": 0.371,
              "text": "R"
            },
            {
              "x": 265,
              "y": 398,
              "w": 26,
              "h": 10,
              "confidence": 0.853,
              "text": "lekh JU]"
            },
            {
              "x": 340,
              "y": 396,
              "w": 13,
              "h": 8,
              "confidence": 0.964,
              "text": "Oral"
            },
            {
              "x": 301,
              "y": 396,
              "w": 14,
              "h": 8,
              "confidence": 0.944,
              "text": "Oral"
            },
            {
              "x": 231,
              "y": 396,
              "w": 24,
              "h": 9,
              "confidence": 0.973,
              "text": "b age of"
            },
            {
              "x": 18,
              "y": 395,
              "w": 31,
              "h": 7,
              "confidence": 0.85,
              "text": "cueaneous"
            },
            {
              "x": 267,
              "y": 393,
              "w": 22,
              "h": 7,
              "confidence": 0.662,
              "text": "2mi(2"
            },
            {
              "x": 1,
              "y": 392,
              "w": 9,
              "h": 8,
              "confidence": 0.684,
              "text": "ml"
            },
            {
              "x": 18,
              "y": 389,
              "w": 15,
              "h": 7,
              "confidence": 0.923,
              "text": "Sub-"
            },
            {
              "x": 234,
              "y": 383,
              "w": 13,
              "h": 8,
              "confidence": 0.979,
              "text": "OPV"
            },
            {
              "x": 18,
              "y": 373,
              "w": 31,
              "h": 7,
              "confidence": 0.949,
              "text": "cutaneous"
            },
            {
              "x": 301,
              "y": 371,
              "w": 25,
              "h": 7,
              "confidence": 0.944,
              "text": "muscula"
            },
            {
              "x": 2,
              "y": 370,
              "w": 7,
              "h": 5,
              "confidence": 0.922,
              "text": "m"
            },
            {
              "x": 339,
              "y": 366,
              "w": 34,
              "h": 10,
              "confidence": 0.999,
              "text": "Upper Arm"
            },
            {
              "x": 268,
              "y": 367,
              "w": 20,
              "h": 8,
              "confidence": 0.93,
              "text": "0.5 ml"
            },
            {
              "x": 18,
              "y": 365,
              "w": 15,
              "h": 8,
              "confidence": 0.82,
              "text": "Subr"
            },
            {
              "x": 301,
              "y": 364,
              "w": 17,
              "h": 7,
              "confidence": 0.957,
              "text": "Intra"
            },
            {
              "x": 301,
              "y": 353,
              "w": 24,
              "h": 7,
              "confidence": 0.738,
              "text": "muscla"
            },
            {
              "x": 340,
              "y": 349,
              "w": 31,
              "h": 7,
              "confidence": 0.965,
              "text": "Upper Arm"
            },
            {
              "x": 268,
              "y": 349,
              "w": 20,
              "h": 7,
              "confidence": 0.953,
              "text": "0.5 ml"
            },
            {
              "x": 18,
              "y": 347,
              "w": 28,
              "h": 7,
              "confidence": 0.961,
              "text": "muscular"
            },
            {
              "x": 301,
              "y": 345,
              "w": 17,
              "h": 8,
              "confidence": 0.927,
              "text": "Intra"
            },
            {
              "x": 1,
              "y": 343,
              "w": 10,
              "h": 8,
              "confidence": 0.826,
              "text": "ml"
            },
            {
              "x": 52,
              "y": 340,
              "w": 17,
              "h": 7,
              "confidence": 0.978,
              "text": "Arter"
            },
            {
              "x": 18,
              "y": 340,
              "w": 18,
              "h": 7,
              "confidence": 0.979,
              "text": "Intra-"
            },
            {
              "x": 301,
              "y": 334,
              "w": 29,
              "h": 6,
              "confidence": 0.988,
              "text": "cutaneous"
            },
            {
              "x": 268,
              "y": 330,
              "w": 20,
              "h": 7,
              "confidence": 0.877,
              "text": "0.5 me"
            },
            {
              "x": 301,
              "y": 327,
              "w": 15,
              "h": 7,
              "confidence": 0.862,
              "text": "Sub-"
            },
            {
              "x": 215,
              "y": 327,
              "w": 39,
              "h": 7,
              "confidence": 0.95,
              "text": "with DPT/OPV"
            },
            {
              "x": 18,
              "y": 321,
              "w": 27,
              "h": 7,
              "confidence": 0.878,
              "text": "municular"
            },
            {
              "x": 50,
              "y": 318,
              "w": 35,
              "h": 12,
              "confidence": 0.899,
              "text": "of lft mid"
            },
            {
              "x": 1,
              "y": 317,
              "w": 9,
              "h": 8,
              "confidence": 0.897,
              "text": "ml"
            },
            {
              "x": 52,
              "y": 314,
              "w": 40,
              "h": 7,
              "confidence": 0.956,
              "text": "Artero-lateral"
            },
            {
              "x": 18,
              "y": 314,
              "w": 17,
              "h": 7,
              "confidence": 0.846,
              "text": "Dntra"
            },
            {
              "x": 340,
              "y": 311,
              "w": 46,
              "h": 7,
              "confidence": 0.957,
              "text": "Right upper Am"
            },
            {
              "x": 268,
              "y": 311,
              "w": 20,
              "h": 7,
              "confidence": 0.817,
              "text": "0.5 ml"
            },
            {
              "x": 189,
              "y": 311,
              "w": 25,
              "h": 7,
              "confidence": 0.949,
              "text": " Months"
            },
            {
              "x": 300,
              "y": 305,
              "w": 16,
              "h": 11,
              "confidence": 0.728,
              "text": "Scb-"
            },
            {
              "x": 18,
              "y": 299,
              "w": 26,
              "h": 7,
              "confidence": 0.853,
              "text": "muscula"
            },
            {
              "x": 52,
              "y": 297,
              "w": 47,
              "h": 10,
              "confidence": 0.955,
              "text": "of left mid-thigh"
            },
            {
              "x": 299,
              "y": 297,
              "w": 15,
              "h": 7,
              "confidence": 0.987,
              "text": "Oral"
            },
            {
              "x": 267,
              "y": 297,
              "w": 22,
              "h": 7,
              "confidence": 0.991,
              "text": "2 drops"
            },
            {
              "x": 173,
              "y": 297,
              "w": 40,
              "h": 7,
              "confidence": 0.956,
              "text": "16-24 menths"
            },
            {
              "x": 337,
              "y": 294,
              "w": 15,
              "h": 11,
              "confidence": 0.927,
              "text": "Oral"
            },
            {
              "x": 127,
              "y": 295,
              "w": 43,
              "h": 10,
              "confidence": 0.93,
              "text": "OPV Booster"
            },
            {
              "x": 2,
              "y": 296,
              "w": 7,
              "h": 5,
              "confidence": 0.879,
              "text": "m"
            },
            {
              "x": 51,
              "y": 289,
              "w": 63,
              "h": 11,
              "confidence": 0.973,
              "text": "Antero-lateral aspect"
            },
            {
              "x": 18,
              "y": 291,
              "w": 16,
              "h": 8,
              "confidence": 0.997,
              "text": "Intra"
            },
            {
              "x": 339,
              "y": 287,
              "w": 47,
              "h": 7,
              "confidence": 0.944,
              "text": "side of mid-thigh"
            },
            {
              "x": 300,
              "y": 287,
              "w": 26,
              "h": 7,
              "confidence": 0.917,
              "text": "musculer"
            },
            {
              "x": 145,
              "y": 287,
              "w": 24,
              "h": 7,
              "confidence": 0.997,
              "text": "booster"
            },
            {
              "x": 268,
              "y": 284,
              "w": 20,
              "h": 7,
              "confidence": 0.869,
              "text": "0.5 ml"
            },
            {
              "x": 172,
              "y": 283,
              "w": 42,
              "h": 9,
              "confidence": 0.938,
              "text": "16-24 menths"
            },
            {
              "x": 51,
              "y": 280,
              "w": 47,
              "h": 10,
              "confidence": 0.935,
              "text": "of left mid-thich"
            },
            {
              "x": 18,
              "y": 282,
              "w": 28,
              "h": 6,
              "confidence": 0.799,
              "text": "musolar"
            },
            {
              "x": 339,
              "y": 281,
              "w": 39,
              "h": 6,
              "confidence": 0.959,
              "text": "Antero-iateral"
            },
            {
              "x": 299,
              "y": 281,
              "w": 18,
              "h": 7,
              "confidence": 0.901,
              "text": "Inbre"
            },
            {
              "x": 146,
              "y": 281,
              "w": 23,
              "h": 6,
              "confidence": 0.969,
              "text": "DPT1-"
            },
            {
              "x": 2,
              "y": 280,
              "w": 9,
              "h": 5,
              "confidence": 0.967,
              "text": "m"
            },
            {
              "x": 52,
              "y": 276,
              "w": 60,
              "h": 7,
              "confidence": 0.935,
              "text": "Anbero-lateral ascect"
            },
            {
              "x": 18,
              "y": 276,
              "w": 17,
              "h": 7,
              "confidence": 0.865,
              "text": "Intra-"
            },
            {
              "x": 270,
              "y": 268,
              "w": 17,
              "h": 7,
              "confidence": 0.862,
              "text": "DUSE"
            },
            {
              "x": 193,
              "y": 268,
              "w": 44,
              "h": 7,
              "confidence": 0.992,
              "text": "WHEN TO GIVE"
            },
            {
              "x": 356,
              "y": 267,
              "w": 15,
              "h": 8,
              "confidence": 0.699,
              "text": "SITE"
            },
            {
              "x": 307,
              "y": 267,
              "w": 21,
              "h": 8,
              "confidence": 0.968,
              "text": "ROUTE"
            },
            {
              "x": 133,
              "y": 266,
              "w": 28,
              "h": 10,
              "confidence": 0.945,
              "text": "VALCINE"
            },
            {
              "x": 52,
              "y": 265,
              "w": 14,
              "h": 8,
              "confidence": 0.913,
              "text": "Cral"
            },
            {
              "x": 18,
              "y": 265,
              "w": 14,
              "h": 8,
              "confidence": 0.967,
              "text": "Oral"
            },
            {
              "x": 0,
              "y": 263,
              "w": 12,
              "h": 11,
              "confidence": 0.792,
              "text": "ops"
            },
            {
              "x": 0,
              "y": 254,
              "w": 12,
              "h": 6,
              "confidence": 0.768,
              "text": "aps"
            },
            {
              "x": 18,
              "y": 253,
              "w": 14,
              "h": 6,
              "confidence": 0.687,
              "text": "Oual"
            },
            {
              "x": 218,
              "y": 252,
              "w": 76,
              "h": 6,
              "confidence": 0.933,
              "text": "16 Months till 16 Years"
            },
            {
              "x": 52,
              "y": 252,
              "w": 15,
              "h": 9,
              "confidence": 0.882,
              "text": "Oral"
            },
            {
              "x": 51,
              "y": 239,
              "w": 31,
              "h": 10,
              "confidence": 0.957,
              "text": "mic-thigh"
            },
            {
              "x": 18,
              "y": 240,
              "w": 28,
              "h": 7,
              "confidence": 0.857,
              "text": "musoular"
            },
            {
              "x": 2,
              "y": 237,
              "w": 7,
              "h": 5,
              "confidence": 0.986,
              "text": "m"
            },
            {
              "x": 18,
              "y": 233,
              "w": 18,
              "h": 7,
              "confidence": 0.917,
              "text": "Bntra-"
            },
            {
              "x": 0,
              "y": 217,
              "w": 14,
              "h": 7,
              "confidence": 0.822,
              "text": "thof"
            },
            {
              "x": 18,
              "y": 214,
              "w": 22,
              "h": 7,
              "confidence": 0.917,
              "text": "dermal"
            },
            {
              "x": 53,
              "y": 211,
              "w": 43,
              "h": 7,
              "confidence": 0.95,
              "text": "Left Upper Arme"
            },
            {
              "x": 0,
              "y": 210,
              "w": 11,
              "h": 7,
              "confidence": 0.665,
              "text": "11"
            },
            {
              "x": 18,
              "y": 207,
              "w": 19,
              "h": 7,
              "confidence": 0.875,
              "text": "Datra-"
            },
            {
              "x": 1,
              "y": 204,
              "w": 12,
              "h": 7,
              "confidence": 0.912,
              "text": "ml"
            },
            {
              "x": 76,
              "y": 184,
              "w": 14,
              "h": 8,
              "confidence": 0.77,
              "text": "SITE"
            },
            {
              "x": 22,
              "y": 182,
              "w": 22,
              "h": 10,
              "confidence": 0.893,
              "text": "ROUTE"
            },
            {
              "x": 228,
              "y": 134,
              "w": 61,
              "h": 10,
              "confidence": 1,
              "text": "Adolescents"
            },
            {
              "x": 217,
              "y": 122,
              "w": 85,
              "h": 13,
              "confidence": 0.966,
              "text": "For Children and"
            },
            {
              "x": 76,
              "y": 71,
              "w": 188,
              "h": 37,
              "confidence": 0.999,
              "text": "Schedule"
            },
            {
              "x": 343,
              "y": 78,
              "w": 35,
              "h": 10,
              "confidence": 0.972,
              "text": "Be Wise!"
            },
            {
              "x": 0,
              "y": 71,
              "w": 75,
              "h": 36,
              "confidence": 0.999,
              "text": "ion"
            }
          ]
        },
        {
          "name": "img_p57_5.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 403.192,
          "y": 407.004,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0
        },
        {
          "name": "img_p57_6.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 91.241,
          "y": 510.376,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0
        },
        {
          "name": "img_p57_7.jpg",
          "height": 103.576,
          "width": 104.188,
          "x": 195.224,
          "y": 510.376,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 131,
              "y": 66,
              "w": 54,
              "h": 6,
              "confidence": 0.836,
              "text": "The 2re to 9u"
            },
            {
              "x": 117,
              "y": 48,
              "w": 302,
              "h": 11,
              "confidence": 0.99,
              "text": "JE Vaccine (SA 14-14-2) is given in select endemic districts, after th"
            },
            {
              "x": 105,
              "y": 34,
              "w": 322,
              "h": 9,
              "confidence": 0.979,
              "text": "3. Hepatitis B birth dose and booster doses of DpT will continue as before."
            },
            {
              "x": 96,
              "y": 24,
              "w": 338,
              "h": 10,
              "confidence": 0.981,
              "text": "** Pentavalent vaccines contain a combination of DPT, HepB and HiB. In the"
            },
            {
              "x": 105,
              "y": 9,
              "w": 137,
              "h": 9,
              "confidence": 0.991,
              "text": "has not previously received TT."
            },
            {
              "x": 105,
              "y": 0,
              "w": 324,
              "h": 10,
              "confidence": 0.985,
              "text": "* Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give"
            }
          ]
        },
        {
          "name": "img_p57_8.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 299.208,
          "y": 510.376,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 237,
              "y": 289,
              "w": 39,
              "h": 15,
              "confidence": 1,
              "text": "STOP"
            },
            {
              "x": 231,
              "y": 64,
              "w": 26,
              "h": 9,
              "confidence": 0.745,
              "text": "TCDS."
            },
            {
              "x": 1,
              "y": 51,
              "w": 37,
              "h": 7,
              "confidence": 0.986,
              "text": "mpaign"
            },
            {
              "x": 234,
              "y": 24,
              "w": 141,
              "h": 10,
              "confidence": 0.973,
              "text": "T 1,2 & 3 and Hepatitis B 1, 2 &"
            },
            {
              "x": 219,
              "y": 0,
              "w": 144,
              "h": 10,
              "confidence": 0.976,
              "text": "e TT to a woman in labour, if she"
            }
          ]
        },
        {
          "name": "img_p57_9.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 403.192,
          "y": 510.376,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0
        },
        {
          "name": "img_p57_10.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 91.241,
          "y": 613.748,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0
        },
        {
          "name": "img_p57_11.jpg",
          "height": 103.576,
          "width": 104.188,
          "x": 195.224,
          "y": 613.748,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0
        },
        {
          "name": "img_p57_12.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 299.208,
          "y": 613.748,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 9,
              "w": 63,
              "h": 6,
              "confidence": 0.303,
              "text": "M ONE WIOW"
            },
            {
              "x": 0,
              "y": 0,
              "w": 61,
              "h": 10,
              "confidence": 0.376,
              "text": "PO ROLOLOND"
            }
          ]
        },
        {
          "name": "img_p57_13.jpg",
          "height": 103.576,
          "width": 104.187,
          "x": 403.192,
          "y": 613.748,
          "original_width": 435,
          "original_height": 432,
          "rotation": 0,
          "ocr": [
            {
              "x": 225,
              "y": 106,
              "w": 65,
              "h": 16,
              "confidence": 0.999,
              "text": "BIOHAZARD"
            }
          ]
        },
        {
          "name": "img_p57_16.jpg",
          "height": 58.119,
          "width": 38.461,
          "x": 141.83,
          "y": 306.447,
          "original_width": 161,
          "original_height": 243,
          "rotation": 0
        },
        {
          "name": "img_p57_17.jpg",
          "height": 51.295,
          "width": 46.416,
          "x": 129.716,
          "y": 315.171,
          "original_width": 232,
          "original_height": 58,
          "rotation": 0,
          "ocr": [
            {
              "x": 135,
              "y": 18,
              "w": 27,
              "h": 13,
              "confidence": 0.853,
              "text": "je-Stop"
            }
          ]
        },
        {
          "name": "img_p57_18.jpg",
          "height": 58.119,
          "width": 22.121,
          "x": 115.938,
          "y": 306.447,
          "original_width": 93,
          "original_height": 243,
          "rotation": 0,
          "ocr": [
            {
              "x": 15,
              "y": 51,
              "w": 69,
              "h": 164,
              "confidence": 0.994,
              "text": ")"
            }
          ]
        },
        {
          "name": "img_p57_19.jpg",
          "height": 22.358,
          "width": 23.574,
          "x": 124.98,
          "y": 306.482,
          "original_width": 99,
          "original_height": 94,
          "rotation": 0
        },
        {
          "name": "img_p57_20.jpg",
          "height": 22.359,
          "width": 23.574,
          "x": 124.98,
          "y": 328.825,
          "original_width": 99,
          "original_height": 94,
          "rotation": 0,
          "ocr": [
            {
              "x": 18,
              "y": 14,
              "w": 66,
              "h": 16,
              "confidence": 0.999,
              "text": "Vaccine"
            }
          ]
        },
        {
          "name": "img_p57_21.jpg",
          "height": 15.86,
          "width": 13.429,
          "x": 135.125,
          "y": 335.324,
          "original_width": 56,
          "original_height": 67,
          "rotation": 0
        },
        {
          "name": "img_p57_22.jpg",
          "height": 29.159,
          "width": 64.453,
          "x": 221.083,
          "y": 337.365,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_23.jpg",
          "height": 29.16,
          "width": 64.453,
          "x": 221.083,
          "y": 308.305,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_24.jpg",
          "height": 33.986,
          "width": 35.394,
          "x": 235.612,
          "y": 316.802,
          "original_width": 148,
          "original_height": 142,
          "rotation": 0,
          "ocr": [
            {
              "x": 14,
              "y": 83,
              "w": 124,
              "h": 22,
              "confidence": 0.381,
              "text": "CANAAA"
            }
          ]
        },
        {
          "name": "img_p57_25.jpg",
          "height": 29.159,
          "width": 64.454,
          "x": 326.897,
          "y": 337.365,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_26.jpg",
          "height": 29.16,
          "width": 64.454,
          "x": 326.897,
          "y": 308.305,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_27.jpg",
          "height": 33.986,
          "width": 35.343,
          "x": 342.483,
          "y": 316.802,
          "original_width": 148,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p57_28.jpg",
          "height": 29.159,
          "width": 64.453,
          "x": 429.571,
          "y": 337.365,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_29.jpg",
          "height": 29.16,
          "width": 64.453,
          "x": 429.571,
          "y": 308.305,
          "original_width": 269,
          "original_height": 122,
          "rotation": 0
        },
        {
          "name": "img_p57_30.jpg",
          "height": 47.973,
          "width": 25.663,
          "x": 447.307,
          "y": 308.548,
          "original_width": 68,
          "original_height": 190,
          "rotation": 0,
          "ocr": [
            {
              "x": 11,
              "y": 17,
              "w": 45,
              "h": 10,
              "confidence": 0.991,
              "text": "MOTHER AND CHILD"
            }
          ]
        },
        {
          "name": "page_58.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "98. What are the four key messages that you must be given to parents after each vaccination?",
          "md": "# 98. What are the four key messages that you must be given to parents after each vaccination?",
          "bBox": {
            "x": 102.48,
            "y": 60.57,
            "w": 408.71,
            "h": 418.6
          }
        },
        {
          "type": "text",
          "value": "**Ans.**  \nAs per the national guidelines, the four key messages that need to be delivered to parents and caregivers are:",
          "md": "**Ans.**  \nAs per the national guidelines, the four key messages that need to be delivered to parents and caregivers are:",
          "bBox": {
            "x": 58.5,
            "y": 99.66,
            "w": 452.7,
            "h": 379.51
          }
        },
        {
          "type": "text",
          "value": "* What vaccine was given, and what disease it prevents  \n* When and where to come for the next visit  \n* What minor adverse event could occur, and how to deal with them  \n* To keep the immunization card safe and to bring along for the next visit",
          "md": "* What vaccine was given, and what disease it prevents  \n* When and where to come for the next visit  \n* What minor adverse event could occur, and how to deal with them  \n* To keep the immunization card safe and to bring along for the next visit",
          "bBox": {
            "x": 98.24,
            "y": 135.72,
            "w": 407.81,
            "h": 355.2
          }
        },
        {
          "type": "text",
          "value": "After vaccination, ensure that the parents/caregivers wait for at least 30 minutes at the session site. Parents should be advised to immediately inform the ASHA/AWW/ANM/MO of nearest health facility, in case of any problem faced by the child or mother even after 30 minutes.",
          "md": "After vaccination, ensure that the parents/caregivers wait for at least 30 minutes at the session site. Parents should be advised to immediately inform the ASHA/AWW/ANM/MO of nearest health facility, in case of any problem faced by the child or mother even after 30 minutes.",
          "bBox": {
            "x": 100.5,
            "y": 218.64,
            "w": 410.7,
            "h": 260.53
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "table",
          "rows": [],
          "html": "<table>\n  <tr>\n    <td><b>What vaccine was given and what disease it prevents</b></td>\n<td><b>When and where to come for the next visit</b></td>\n<td><b>What minor adverse event could occur, and how to deal with them</b></td>\n<td><b>To keep the Immunization Cardsafe and bring it along for the next visit</b></td>\n  </tr>\n</table>",
          "md": "| **What vaccine was given and what disease it prevents** | **When and where to come for the next visit** | **What minor adverse event could occur, and how to deal with them** | **To keep the Immunization Cardsafe and bring it along for the next visit** |\n| ------------------------------------------------------- | --------------------------------------------- | ------------------------------------------------------------------- | --------------------------------------------------------------------------- |",
          "isPerfectTable": true,
          "csv": "",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Immunization Schedule",
          "md": "### Immunization Schedule",
          "bBox": {
            "x": 224.21,
            "y": 424.03,
            "w": 138.23,
            "h": 55.14
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "For Pregnant Women",
              "For Pregnant Women",
              "For Pregnant Women",
              "For Pregnant Women",
              "For Infants",
              "For Infants",
              "For Infants",
              "For Infants",
              "For Children and Adolescents",
              "For Children and Adolescents",
              "For Children and Adolescents",
              "For Children and Adolescents"
            ],
            [
              "*Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give TT to a woman in labour, if she has not previously received TT.",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              "",
              ""
            ],
            [
              "",
              "",
              "",
              "",
              "Rotavirus",
              "Within one year of age",
              "Oral",
              "Oral",
              "OPV 1, 2 & 3",
              "6, 10, 14 weeks",
              "Oral",
              "Antero-lateral aspect of left mid-thigh"
            ],
            [
              "",
              "",
              "",
              "",
              "Pentavalent 1, 2 & 3**",
              "6, 10, 14 weeks",
              "Intramuscular 0.5 ml",
              "Mid-thigh",
              "OPV Booster",
              "16-24 months",
              "Oral 2 drops",
              "Oral"
            ],
            [
              "",
              "",
              "",
              "",
              "Vitamin A (1st dose)",
              "9 completed months",
              "Oral 1 ml",
              "Oral",
              "Measles",
              "9 completed months",
              "Subcutaneous",
              "Upper arm"
            ]
          ],
          "html": "<table>\n  <thead>\n    <tr>\n      <th colspan=\"4\">For Pregnant Women</th>\n      <th colspan=\"4\">For Infants</th>\n      <th colspan=\"4\">For Children and Adolescents</th>\n    </tr>\n  </thead>\n  <tbody>\n    <tr>\n      <td colspan=\"4\">\n        *Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give TT to a woman in labour, if she has not previously received TT.\n      </td>\n<td><b>Vaccine</b></td>\n<td><b>When to Give</b></td>\n<td><b>Route</b></td>\n<td><b>Site</b></td>\n<td><b>Vaccine</b></td>\n<td><b>When to Give</b></td>\n<td><b>Route</b></td>\n<td><b>Site</b></td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Rotavirus</td>\n<td>Within one year of age</td>\n<td>Oral</td>\n<td>Oral</td>\n<td>OPV 1, 2 &#x26; 3</td>\n<td>6, 10, 14 weeks</td>\n<td>Oral</td>\n<td>Antero-lateral aspect of left mid-thigh</td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Pentavalent 1, 2 &#x26; 3**</td>\n<td>6, 10, 14 weeks</td>\n<td>Intramuscular 0.5 ml</td>\n<td>Mid-thigh</td>\n<td>OPV Booster</td>\n<td>16-24 months</td>\n<td>Oral 2 drops</td>\n<td>Oral</td>\n    </tr>\n<tr>\n      <td colspan=\"4\"></td>\n<td>Vitamin A (1st dose)</td>\n<td>9 completed months</td>\n<td>Oral 1 ml</td>\n<td>Oral</td>\n<td>Measles</td>\n<td>9 completed months</td>\n<td>Subcutaneous</td>\n<td>Upper arm</td>\n    </tr>\n  </tbody>\n</table>",
          "md": "| For Pregnant Women                                                                                                                       | For Pregnant Women | For Pregnant Women | For Pregnant Women | For Infants              | For Infants            | For Infants          | For Infants | For Children and Adolescents | For Children and Adolescents | For Children and Adolescents | For Children and Adolescents            |\n| ---------------------------------------------------------------------------------------------------------------------------------------- | ------------------ | ------------------ | ------------------ | ------------------------ | ---------------------- | -------------------- | ----------- | ---------------------------- | ---------------------------- | ---------------------------- | --------------------------------------- |\n| \\*Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give TT to a woman in labour, if she has not previously received TT. |                    |                    |                    | **Vaccine**              | **When to Give**       | **Route**            | **Site**    | **Vaccine**                  | **When to Give**             | **Route**                    | **Site**                                |\n|                                                                                                                                          |                    |                    |                    | Rotavirus                | Within one year of age | Oral                 | Oral        | OPV 1, 2 & 3                 | 6, 10, 14 weeks              | Oral                         | Antero-lateral aspect of left mid-thigh |\n|                                                                                                                                          |                    |                    |                    | Pentavalent 1, 2 & 3\\*\\* | 6, 10, 14 weeks        | Intramuscular 0.5 ml | Mid-thigh   | OPV Booster                  | 16-24 months                 | Oral 2 drops                 | Oral                                    |\n|                                                                                                                                          |                    |                    |                    | Vitamin A (1st dose)     | 9 completed months     | Oral 1 ml            | Oral        | Measles                      | 9 completed months           | Subcutaneous                 | Upper arm                               |",
          "isPerfectTable": false,
          "csv": "\"For Pregnant Women\",\"For Pregnant Women\",\"For Pregnant Women\",\"For Pregnant Women\",\"For Infants\",\"For Infants\",\"For Infants\",\"For Infants\",\"For Children and Adolescents\",\"For Children and Adolescents\",\"For Children and Adolescents\",\"For Children and Adolescents\"\n\"*Give TT-2 or Booster doses before 36 weeks of pregnancy. However, give TT to a woman in labour, if she has not previously received TT.\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\",\"\"\n\"\",\"\",\"\",\"\",\"Rotavirus\",\"Within one year of age\",\"Oral\",\"Oral\",\"OPV 1, 2 & 3\",\"6, 10, 14 weeks\",\"Oral\",\"Antero-lateral aspect of left mid-thigh\"\n\"\",\"\",\"\",\"\",\"Pentavalent 1, 2 & 3**\",\"6, 10, 14 weeks\",\"Intramuscular 0.5 ml\",\"Mid-thigh\",\"OPV Booster\",\"16-24 months\",\"Oral 2 drops\",\"Oral\"\n\"\",\"\",\"\",\"\",\"Vitamin A (1st dose)\",\"9 completed months\",\"Oral 1 ml\",\"Oral\",\"Measles\",\"9 completed months\",\"Subcutaneous\",\"Upper arm\"",
          "bBox": {
            "x": 58.5,
            "y": 60.57,
            "w": 454.33,
            "h": 768.15
          }
        },
        {
          "type": "text",
          "value": "**Notes:**  \n- Pentavalent vaccines contain a combination of DPT, HepB and HiB.  \n- Hepatitis B birth dose and booster doses of DPT will continue as before.  \n- JE Vaccine (SA 14-14-2) is given in select endemic districts, after the campaign.",
          "md": "**Notes:**  \n- Pentavalent vaccines contain a combination of DPT, HepB and HiB.  \n- Hepatitis B birth dose and booster doses of DPT will continue as before.  \n- JE Vaccine (SA 14-14-2) is given in select endemic districts, after the campaign.",
          "bBox": {
            "x": 119.51,
            "y": 318.64,
            "w": 188.8,
            "h": 205.88
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "[The image shows a healthcare worker explaining the immunization schedule to a mother and father holding a child, with vaccine vials, syringes, and immunization cards on the table. There is a biohazard disposal bag on the floor.]",
          "md": "[The image shows a healthcare worker explaining the immunization schedule to a mother and father holding a child, with vaccine vials, syringes, and immunization cards on the table. There is a biohazard disposal bag on the floor.]",
          "bBox": {
            "x": 129.27,
            "y": 332.16,
            "w": 343.38,
            "h": 310.84
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "**Figure 17: Four key messages**",
          "md": "**Figure 17: Four key messages**",
          "bBox": {
            "x": 231.59,
            "y": 477.97,
            "w": 108.61,
            "h": 273.03
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 59,
      "text": "         99. What is routine immunization microplanning?\n\nAns.     RI microplanning is the basis for the delivery of UIP services to a community. The\n         availability of updated and complete micro-plans at a planning unit (urban/rural)\n         demonstrates preparedness of a unit and directly affects the quality of services\n\nQ provided. Micro-plans are prepared for a one year period but must be reviewed\n         every quarter.¹³\n         According to national guidelines for immunization programme, all government\n         health facilities should prepare monthly plans for immunization service delivery to\n         each and every outreach area (i.e. villages, slums, other habitations, etc.) situated\n         within their catchment zones. These plans should be realistic, based on number of\n         beneficiaries identified from house to house survey, developed jointly by health\n         workers and frontline functionaries, and should be updated on quarterly basis.\n         ASHA worker is given incentive for conducting a house to house survey.\n         These plans for immunization service delivery are known as micro-plans as they\n         include specific details like – weekday and exact location of session, estimated\n         number of beneficiaries, estimate of vaccines and syringe requirement for a session,\n         names of vaccinator and other service providers (ASHA and Anganwadi worker),\n         timing of session (from – to), name of person responsible for vaccine delivery, name\n         of supervisor, etc.\n\n                 100. Why is head count and house to house survey important for\n         improving immunization coverage?\nAns.     These are important activities undertaken to improve immunization coverage.\n         These activities provide details of all beneficiaries (children and pregnant women)\n         in a specific area, ensuring that no beneficiary is missed out. This further helps in\n         developing complete due lists for session days, and correct estimates of injection\n         load, outreach sessions required, and requirement per session of different vaccines\nQ and syringes.\nQ 101. Is it useful to monitor vaccine consumption, wastage, and\n\n         coverage achieved?\nAns.     Vaccines are life-saving and involve lot of financial and human resources in purchase,\n         distribution and administration. Therefore, monitoring of vaccine consumption and\n         wastage, and matching it with the immunization coverage will help to ensure their\n         optimum utilization.\n\n\n\n\n\n\n\n\n\n\n13Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officer 2016\n\n52 IFAQs on Immunization",
      "md": "\n**99. What is routine immunization microplanning?**\n\nAns. RI microplanning is the basis for the delivery of UIP services to a community. The availability of updated and complete micro-plans at a planning unit (urban/rural) demonstrates preparedness of a unit and directly affects the quality of services provided. Micro-plans are prepared for a one year period but must be reviewed every quarter.¹³\n\nAccording to national guidelines for immunization programme, all government health facilities should prepare monthly plans for immunization service delivery to each and every outreach area (i.e. villages, slums, other habitations, etc.) situated within their catchment zones. These plans should be realistic, based on number of beneficiaries identified from house to house survey, developed jointly by health workers and frontline functionaries, and should be updated on quarterly basis. ASHA worker is given incentive for conducting a house to house survey.\n\nThese plans for immunization service delivery are known as micro-plans as they include specific details like – weekday and exact location of session, estimated number of beneficiaries, estimate of vaccines and syringe requirement for a session, names of vaccinator and other service providers (ASHA and Anganwadi worker), timing of session (from – to), name of person responsible for vaccine delivery, name of supervisor, etc.\n\n**100. Why is head count and house to house survey important for improving immunization coverage?**\n\nAns. These are important activities undertaken to improve immunization coverage. These activities provide details of all beneficiaries (children and pregnant women) in a specific area, ensuring that no beneficiary is missed out. This further helps in developing complete due lists for session days, and correct estimates of injection load, outreach sessions required, and requirement per session of different vaccines and syringes.\n\n**101. Is it useful to monitor vaccine consumption, wastage, and coverage achieved?**\n\nAns. Vaccines are life-saving and involve lot of financial and human resources in purchase, distribution and administration. Therefore, monitoring of vaccine consumption and wastage, and matching it with the immunization coverage will help to ensure their optimum utilization.\n\n----\n\n¹³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officer 2016\n",
      "images": [
        {
          "name": "img_p18_1.png",
          "height": 210.96,
          "width": 282.24,
          "x": 66.96,
          "y": 631.17,
          "original_width": 1176,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_2.png",
          "height": 210.96,
          "width": 247.2,
          "x": 348.48,
          "y": 631.17,
          "original_width": 1030,
          "original_height": 879,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_5.png",
          "height": 211.2,
          "width": 282.24,
          "x": 66.96,
          "y": 210.21,
          "original_width": 1176,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_6.png",
          "height": 211.2,
          "width": 247.2,
          "x": 348.48,
          "y": 210.21,
          "original_width": 1030,
          "original_height": 880,
          "rotation": 0
        },
        {
          "name": "img_p18_9.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "img_p26_15.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 612.93,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_15.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 612.93,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_15.png",
          "height": 37.44,
          "width": 412.56,
          "x": 124.56,
          "y": 612.93,
          "original_width": 1719,
          "original_height": 156,
          "rotation": 0
        },
        {
          "name": "img_p26_16.jpg",
          "height": 36.794,
          "width": 34.069,
          "x": 86.364,
          "y": 153.953,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_19.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 513.854,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "img_p26_19.jpg",
          "height": 36.795,
          "width": 34.069,
          "x": 86.364,
          "y": 513.854,
          "original_width": 142,
          "original_height": 154,
          "rotation": 0,
          "ocr": [
            {
              "x": 0,
              "y": 0,
              "w": 142,
              "h": 154,
              "confidence": 0.936,
              "text": "Q"
            }
          ]
        },
        {
          "name": "page_59.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "**99. What is routine immunization microplanning?**",
          "md": "**99. What is routine immunization microplanning?**",
          "bBox": {
            "x": 130.38,
            "y": 64.26,
            "w": 311.37,
            "h": 20
          }
        },
        {
          "type": "text",
          "value": "Ans. RI microplanning is the basis for the delivery of UIP services to a community. The availability of updated and complete micro-plans at a planning unit (urban/rural) demonstrates preparedness of a unit and directly affects the quality of services provided. Micro-plans are prepared for a one year period but must be reviewed every quarter.¹³",
          "md": "Ans. RI microplanning is the basis for the delivery of UIP services to a community. The availability of updated and complete micro-plans at a planning unit (urban/rural) demonstrates preparedness of a unit and directly affects the quality of services provided. Micro-plans are prepared for a one year period but must be reviewed every quarter.¹³",
          "bBox": {
            "x": 86.4,
            "y": 99.66,
            "w": 450.4,
            "h": 501.91
          }
        },
        {
          "type": "text",
          "value": "According to national guidelines for immunization programme, all government health facilities should prepare monthly plans for immunization service delivery to each and every outreach area (i.e. villages, slums, other habitations, etc.) situated within their catchment zones. These plans should be realistic, based on number of beneficiaries identified from house to house survey, developed jointly by health workers and frontline functionaries, and should be updated on quarterly basis. ASHA worker is given incentive for conducting a house to house survey.",
          "md": "According to national guidelines for immunization programme, all government health facilities should prepare monthly plans for immunization service delivery to each and every outreach area (i.e. villages, slums, other habitations, etc.) situated within their catchment zones. These plans should be realistic, based on number of beneficiaries identified from house to house survey, developed jointly by health workers and frontline functionaries, and should be updated on quarterly basis. ASHA worker is given incentive for conducting a house to house survey.",
          "bBox": {
            "x": 128.4,
            "y": 181.16,
            "w": 408.39,
            "h": 98.98
          }
        },
        {
          "type": "text",
          "value": "These plans for immunization service delivery are known as micro-plans as they include specific details like – weekday and exact location of session, estimated number of beneficiaries, estimate of vaccines and syringe requirement for a session, names of vaccinator and other service providers (ASHA and Anganwadi worker), timing of session (from – to), name of person responsible for vaccine delivery, name of supervisor, etc.",
          "md": "These plans for immunization service delivery are known as micro-plans as they include specific details like – weekday and exact location of session, estimated number of beneficiaries, estimate of vaccines and syringe requirement for a session, names of vaccinator and other service providers (ASHA and Anganwadi worker), timing of session (from – to), name of person responsible for vaccine delivery, name of supervisor, etc.",
          "bBox": {
            "x": 128.4,
            "y": 291.63,
            "w": 408.39,
            "h": 84.48
          }
        },
        {
          "type": "text",
          "value": "**100. Why is head count and house to house survey important for improving immunization coverage?**",
          "md": "**100. Why is head count and house to house survey important for improving immunization coverage?**",
          "bBox": {
            "x": 130.38,
            "y": 401.79,
            "w": 406.42,
            "h": 28.99
          }
        },
        {
          "type": "text",
          "value": "Ans. These are important activities undertaken to improve immunization coverage. These activities provide details of all beneficiaries (children and pregnant women) in a specific area, ensuring that no beneficiary is missed out. This further helps in developing complete due lists for session days, and correct estimates of injection load, outreach sessions required, and requirement per session of different vaccines and syringes.",
          "md": "Ans. These are important activities undertaken to improve immunization coverage. These activities provide details of all beneficiaries (children and pregnant women) in a specific area, ensuring that no beneficiary is missed out. This further helps in developing complete due lists for session days, and correct estimates of injection load, outreach sessions required, and requirement per session of different vaccines and syringes.",
          "bBox": {
            "x": 86.4,
            "y": 99.66,
            "w": 450.39,
            "h": 501.91
          }
        },
        {
          "type": "text",
          "value": "**101. Is it useful to monitor vaccine consumption, wastage, and coverage achieved?**",
          "md": "**101. Is it useful to monitor vaccine consumption, wastage, and coverage achieved?**",
          "bBox": {
            "x": 175.87,
            "y": 565.53,
            "w": 117.79,
            "h": 14
          }
        },
        {
          "type": "text",
          "value": "Ans. Vaccines are life-saving and involve lot of financial and human resources in purchase, distribution and administration. Therefore, monitoring of vaccine consumption and wastage, and matching it with the immunization coverage will help to ensure their optimum utilization.",
          "md": "Ans. Vaccines are life-saving and involve lot of financial and human resources in purchase, distribution and administration. Therefore, monitoring of vaccine consumption and wastage, and matching it with the immunization coverage will help to ensure their optimum utilization.",
          "bBox": {
            "x": 86.4,
            "y": 99.66,
            "w": 450.38,
            "h": 545.4
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "¹³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officer 2016",
          "md": "¹³ Ministry of Health and Family Welfare, Government of India, Immunization Handbook for Medical Officer 2016",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.997
    },
    {
      "page": 60,
      "text": "SECTION: 12\nVaccination Scenarios\n\n\n\n\n\n\n                    What vaccines should be given to a 15-days old infant who has not\n                                             been vaccinated?\n\nGive BCG, OPV-0     One dose of BCG, must          • Give 4 key messages\n                    be administered to a child     • Counsel the parents\n                    below one year of age.          to bring the child\n                    OPV-0 is given within 15        for subsequent\n                    days of birth.                  vaccinations on time as\n\n                    Hep-B Birth dose is given       per the NIS\n                    only within 24 hours of\n                    birth.\n\n\n\n\n\n             What vaccines should be given to a 1-month old infant who has not\n                                      been vaccinated?\n\nGive BCG     One dose of BCG must be     • Give 4 key messages\n             administered to a child     • Counsel the parents\n             below one year of age.       to bring the child\n\n             OPV-0 is given within 15     for subsequent\n             days of birth and Hep-B      vaccinations on time\n             Birth dose is given only     as per the NIS\n             within 24 hours of birth.\n\n\n\n\n\n\n\n\n\n\n         I\nFAQs     I\nFAQs on\non Immunization\n   Immunization  53\n                 53",
      "md": "\n# SECTION: 12  \n## Vaccination Scenarios\n\n### What vaccines should be given to a 15-days old infant who has not been vaccinated?\n\n- **Give BCG, OPV-0**  \n- One dose of BCG must be administered to a child below one year of age. OPV-0 is given within 15 days of birth.  \n- Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS  \n\n----\n\n### What vaccines should be given to a 1-month old infant who has not been vaccinated?\n\n- **Give BCG**  \n- One dose of BCG must be administered to a child below one year of age.  \n- OPV-0 is given within 15 days of birth and Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS  \n",
      "images": [
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_3.png",
          "height": 561.84,
          "width": 105.84,
          "x": 489.84,
          "y": 280.29,
          "original_width": 441,
          "original_height": 2341,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p23_2.png",
          "height": 246.24,
          "width": 245.76,
          "x": 244.8,
          "y": 595.89,
          "original_width": 1024,
          "original_height": 1026,
          "rotation": 0
        },
        {
          "name": "img_p19_8.png",
          "height": 35.76,
          "width": 70.56,
          "x": -0.24,
          "y": 315.33,
          "original_width": 294,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p59_7.png",
          "height": 35.76,
          "width": 350.88,
          "x": 139.68,
          "y": 315.33,
          "original_width": 1462,
          "original_height": 149,
          "rotation": 0
        },
        {
          "name": "img_p19_10.png",
          "height": 316.32,
          "width": 35.52,
          "x": -0.24,
          "y": -0.27,
          "original_width": 148,
          "original_height": 1318,
          "rotation": 0
        },
        {
          "name": "img_p19_12.png",
          "height": 175.92,
          "width": 35.76,
          "x": 559.92,
          "y": -0.27,
          "original_width": 149,
          "original_height": 733,
          "rotation": 0
        },
        {
          "name": "img_p23_10.jpg",
          "height": 67.478,
          "width": 325.999,
          "x": -0.519,
          "y": -33.697,
          "original_width": 1373,
          "original_height": 143,
          "rotation": 0
        },
        {
          "name": "img_p7_2.png",
          "height": 63.467,
          "width": 290.041,
          "x": 289.262,
          "y": -26.896,
          "original_width": 1220,
          "original_height": 142,
          "rotation": 0
        },
        {
          "name": "img_p23_12.jpg",
          "height": 338.503,
          "width": 106.885,
          "x": 2.962,
          "y": 25.733,
          "original_width": 307,
          "original_height": 1409,
          "rotation": 0
        },
        {
          "name": "img_p23_13.jpg",
          "height": 305.597,
          "width": 103.195,
          "x": 78.051,
          "y": 51.11,
          "original_width": 306,
          "original_height": 1269,
          "rotation": 0
        },
        {
          "name": "img_p23_14.jpg",
          "height": 276.258,
          "width": 135.648,
          "x": 152.931,
          "y": 72.945,
          "original_width": 459,
          "original_height": 1128,
          "rotation": 0
        },
        {
          "name": "img_p19_17.jpg",
          "height": 239.39,
          "width": 96.468,
          "x": 263.745,
          "y": 98.532,
          "original_width": 307,
          "original_height": 987,
          "rotation": 0
        },
        {
          "name": "img_p19_18.jpg",
          "height": 206.25,
          "width": 92.753,
          "x": 338.859,
          "y": 124.143,
          "original_width": 306,
          "original_height": 846,
          "rotation": 0
        },
        {
          "name": "img_p19_19.jpg",
          "height": 169.616,
          "width": 53.597,
          "x": 556.982,
          "y": 138.214,
          "original_width": 154,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_17.jpg",
          "height": 173.392,
          "width": 89.531,
          "x": 413.714,
          "y": 149.496,
          "original_width": 307,
          "original_height": 706,
          "rotation": 0
        },
        {
          "name": "img_p23_19.jpg",
          "height": 136.5,
          "width": 50.116,
          "x": 488.829,
          "y": 178.859,
          "original_width": 154,
          "original_height": 565,
          "rotation": 0
        },
        {
          "name": "img_p19_22.jpg",
          "height": 103.409,
          "width": 46.87,
          "x": 528.009,
          "y": 208.198,
          "original_width": 155,
          "original_height": 424,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p19_24.png",
          "height": 8.88,
          "width": 112.08,
          "x": 380.88,
          "y": 816.45,
          "original_width": 467,
          "original_height": 37,
          "rotation": 0
        },
        {
          "name": "img_p59_27.png",
          "height": 157.44,
          "width": 35.76,
          "x": 559.2,
          "y": -0.03,
          "original_width": 149,
          "original_height": 656,
          "rotation": 0
        },
        {
          "name": "img_p59_28.png",
          "height": 32.16,
          "width": 35.52,
          "x": -0.24,
          "y": -0.03,
          "original_width": 148,
          "original_height": 134,
          "rotation": 0
        },
        {
          "name": "img_p59_29.jpg",
          "height": 152.962,
          "width": 228.837,
          "x": 106.814,
          "y": -33.697,
          "original_width": 916,
          "original_height": 555,
          "rotation": 0
        },
        {
          "name": "img_p59_30.jpg",
          "height": 76.858,
          "width": 114.69,
          "x": -0.519,
          "y": -11.135,
          "original_width": 459,
          "original_height": 279,
          "rotation": 0
        },
        {
          "name": "page_60.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "SECTION: 12",
          "md": "# SECTION: 12  ",
          "bBox": {
            "x": 58.5,
            "y": 225.2,
            "w": 440.95,
            "h": 603.51
          }
        },
        {
          "type": "heading",
          "lvl": 2,
          "value": "Vaccination Scenarios",
          "md": "## Vaccination Scenarios",
          "bBox": {
            "x": 58.5,
            "y": 250.88,
            "w": 440.95,
            "h": 577.84
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "What vaccines should be given to a 15-days old infant who has not been vaccinated?",
          "md": "### What vaccines should be given to a 15-days old infant who has not been vaccinated?",
          "bBox": {
            "x": 166.64,
            "y": 348.18,
            "w": 332.81,
            "h": 480.53
          }
        },
        {
          "type": "text",
          "value": "- **Give BCG, OPV-0**  \n- One dose of BCG must be administered to a child below one year of age. OPV-0 is given within 15 days of birth.  \n- Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- **Give BCG, OPV-0**  \n- One dose of BCG must be administered to a child below one year of age. OPV-0 is given within 15 days of birth.  \n- Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 95.76,
            "y": 393.68,
            "w": 412.29,
            "h": 435.03
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "What vaccines should be given to a 1-month old infant who has not been vaccinated?",
          "md": "### What vaccines should be given to a 1-month old infant who has not been vaccinated?",
          "bBox": {
            "x": 155.87,
            "y": 359.18,
            "w": 343.58,
            "h": 469.53
          }
        },
        {
          "type": "text",
          "value": "- **Give BCG**  \n- One dose of BCG must be administered to a child below one year of age.  \n- OPV-0 is given within 15 days of birth and Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- **Give BCG**  \n- One dose of BCG must be administered to a child below one year of age.  \n- OPV-0 is given within 15 days of birth and Hep-B Birth dose is given only within 24 hours of birth.  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 95.76,
            "y": 404.68,
            "w": 412.29,
            "h": 424.03
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.987
    },
    {
      "page": 61,
      "text": "    What vaccines should be given to a 6-months old child who has\n    received BCG, OPV-1 and Penta-1 only?\n\n\n    Give OPV-2, Penta-2     RVV, PCV and IPV should         • Complete the schedule\n                            only be started along            for OPV and Pentavalent\n                            with 1st dose of OPV and         by ensuring the\n                            Pentavalent vaccine.             recommended interval\n                                                             between administration\n                            Thus, if a child has already     of two doses\n                            received 1st dose of            • Give 4 key messages\n                            Pentavalent and OPV s/he\n                            will NOT be started RVV,        • Counsel the parents\n                            PCV, IPV under UIP.              to bring the child for\n                                                             subsequent vaccinations\n                                                             on time as per the NIS\n\n    Remember to ensure\n    • Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n\n\n\n\n\n\n\n\nWhat vaccines should be given to a 7-months old child who has not\n                         been vaccinated?\n\n\n    Give BCG, OPV-1,         As per the NIS, BCG, OPV,       • Complete the schedule\n    RVV-1, Penta-1, IPV-     RVV, IPV, Pentavalent and                      for OPV, RVV, IPV,\n    1, PCV-1                 PCV have to be started                         Pentavalent and\n                             before 1 year of age, if the                   PCV by ensuring the\n                             child is unvaccinated after                    recommended interval\n                             6 weeks of birth.                              between administration of\n                                                                            two doses\n                             The subsequent doses            • Give 4 key messages\n                             should be administered as\n                             per NIS.                        • Counsel the parents\n                                                                            to bring the child for\n                                                                            subsequent vaccinations\n                                                                            on time as per the NIS\n\n    Remember to ensure\n    • Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n    • IPV-2 is given only with OPV-3 and Penta-3\n    • Minimum 8 weeks of interval between administration of two doses of PCV\n    • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n    vaccination\n\n\n\n\n\n\n\n\n\n\n    54 IFAQs on Immunization",
      "md": "\n# What vaccines should be given to a 6-months old child who has received BCG, OPV-1 and Penta-1 only?\n\n- **Give OPV-2, Penta-2**\n\n> RVV, PCV and IPV should only be started along with 1st dose of OPV and Pentavalent vaccine.  \n> **Thus, if a child has already received 1st dose of Pentavalent and OPV s/he will NOT be started RVV, PCV, IPV under UIP.**\n\n- • Complete the schedule for OPV and Pentavalent by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n\n----\n\n# What vaccines should be given to a 7-months old child who has not been vaccinated?\n\n- **Give BCG, OPV-1, RVV-1, Penta-1, IPV-1, PCV-1**\n\n> As per the NIS, BCG, OPV, RVV, IPV, Pentavalent and PCV have to be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.  \n> The subsequent doses should be administered as per NIS.\n\n- • Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent  \n> * IPV-2 is given only with OPV-3 and Penta-3  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_61.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 6-months old child who has received BCG, OPV-1 and Penta-1 only?",
          "md": "# What vaccines should be given to a 6-months old child who has received BCG, OPV-1 and Penta-1 only?",
          "bBox": {
            "x": 176.51,
            "y": 66.74,
            "w": 270.06,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give OPV-2, Penta-2**",
          "md": "- **Give OPV-2, Penta-2**",
          "bBox": {
            "x": 108.57,
            "y": 114.25,
            "w": 84.34,
            "h": 10
          }
        },
        {
          "type": "text",
          "value": "> RVV, PCV and IPV should only be started along with 1st dose of OPV and Pentavalent vaccine.  \n> **Thus, if a child has already received 1st dose of Pentavalent and OPV s/he will NOT be started RVV, PCV, IPV under UIP.**",
          "md": "> RVV, PCV and IPV should only be started along with 1st dose of OPV and Pentavalent vaccine.  \n> **Thus, if a child has already received 1st dose of Pentavalent and OPV s/he will NOT be started RVV, PCV, IPV under UIP.**",
          "bBox": {
            "x": 252,
            "y": 114.25,
            "w": 239.22,
            "h": 339.18
          }
        },
        {
          "type": "text",
          "value": "- • Complete the schedule for OPV and Pentavalent by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- • Complete the schedule for OPV and Pentavalent by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 115.84,
            "y": 114.24,
            "w": 417.63,
            "h": 550.44
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent",
          "md": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent",
          "bBox": {
            "x": 95.84,
            "y": 158.24,
            "w": 437.63,
            "h": 430.02
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 7-months old child who has not been vaccinated?",
          "md": "# What vaccines should be given to a 7-months old child who has not been vaccinated?",
          "bBox": {
            "x": 168.36,
            "y": 371.85,
            "w": 286.38,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give BCG, OPV-1, RVV-1, Penta-1, IPV-1, PCV-1**",
          "md": "- **Give BCG, OPV-1, RVV-1, Penta-1, IPV-1, PCV-1**",
          "bBox": {
            "x": 108.57,
            "y": 421.43,
            "w": 83.71,
            "h": 32
          }
        },
        {
          "type": "text",
          "value": "> As per the NIS, BCG, OPV, RVV, IPV, Pentavalent and PCV have to be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.  \n> The subsequent doses should be administered as per NIS.",
          "md": "> As per the NIS, BCG, OPV, RVV, IPV, Pentavalent and PCV have to be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.  \n> The subsequent doses should be administered as per NIS.",
          "bBox": {
            "x": 256.18,
            "y": 421.43,
            "w": 235.04,
            "h": 109
          }
        },
        {
          "type": "text",
          "value": "- • Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- • Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses  \n- • Give 4 key messages  \n- • Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 115.84,
            "y": 114.24,
            "w": 417.63,
            "h": 550.44
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent  \n> * IPV-2 is given only with OPV-3 and Penta-3  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "md": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent  \n> * IPV-2 is given only with OPV-3 and Penta-3  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "bBox": {
            "x": 95.84,
            "y": 158.24,
            "w": 437.63,
            "h": 506.44
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 62,
      "text": "    What vaccines should be given to a 8-months old child who has\n    received OPV-1, RVV-1 and Penta-1 only?\n\n\n    Give BCG, OPV-2,     One dose of BCG, must         • Complete the schedule\n    RVV-2, Penta-2       be administered to a child     for OPV, RVV and\n                         below one year of age.         Pentavalent by ensuring\n                                                        the recommended\n                         For OPV, RVV and               interval between\n                         Pentavalent, if at least       administration of two\n                         one dose is given before       doses\n                         one year of age, then         • Give 4 key messages\n                         remaining doses should be\n                         administered as per NIS       • Counsel the parents\n                                                        to bring the child for\n                                                        subsequent vaccinations\n                                                        on time as per the NIS\n\n    Remember to ensure\n    • Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n    Vaccine.\n\n\n\n\n\nWhat vaccines should be given to a 9-months old child who has\n   received BCG, OPV-2, RVV-1, Penta-2, IPV-1, PCV-1 only?\n\n\n    Give OPV-3, RVV-2,       For OPV, RVV, IPV,            • Complete the schedule for\n    IPV-2, Penta-3, PCV-     pentavalent and PCV, if        RVV and PCV by ensuring\n    2, MCV-1, JE-1           at least one dose is given     the recommended\n                             before one year of age,        interval between\n                             then remaining doses           administration of two\n                             should be administered as      doses\n                             per NIS.                      • Give 4 key messages\n\n                                                           • Counsel the parents\n                                                            to bring the child for\n                                                            subsequent vaccinations\n                                                            on time as per the NIS\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of RVV\n     • Minimum 8 weeks of interval between administration of two doses of PCV\n     • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n     vaccination\n\n\n\n\n\n\n\n\n\n\n    FAQs on ImmunizationI 55",
      "md": "\n# What vaccines should be given to a 8-months old child who has received OPV-1, RVV-1 and Penta-1 only?\n\n- **Give BCG, OPV-2, RVV-2, Penta-2**\n\n> One dose of BCG must be administered to a child below one year of age.\n\n> For OPV, RVV and Pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.\n\n- Complete the schedule for OPV, RVV and Pentavalent by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent Vaccine.\n\n----\n\n# What vaccines should be given to a 9-months old child who has received BCG, OPV-2, RVV-1, Penta-2, IPV-1, PCV-1 only?\n\n- **Give OPV-3, RVV-2, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**\n\n> For OPV, RVV, IPV, pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.\n\n- Complete the schedule for RVV and PCV by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of RVV  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_62.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 8-months old child who has received OPV-1, RVV-1 and Penta-1 only?",
          "md": "# What vaccines should be given to a 8-months old child who has received OPV-1, RVV-1 and Penta-1 only?",
          "bBox": {
            "x": 150.48,
            "y": 71.38,
            "w": 270.12,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give BCG, OPV-2, RVV-2, Penta-2**",
          "md": "- **Give BCG, OPV-2, RVV-2, Penta-2**",
          "bBox": {
            "x": 81.67,
            "y": 121.78,
            "w": 73.17,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "> One dose of BCG must be administered to a child below one year of age.",
          "md": "> One dose of BCG must be administered to a child below one year of age.",
          "bBox": {
            "x": 224.14,
            "y": 132.78,
            "w": 106.38,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "> For OPV, RVV and Pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "md": "> For OPV, RVV and Pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "bBox": {
            "x": 224.14,
            "y": 132.78,
            "w": 245.86,
            "h": 375.88
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for OPV, RVV and Pentavalent by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for OPV, RVV and Pentavalent by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 93.64,
            "y": 132.78,
            "w": 405,
            "h": 522.75
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent Vaccine.",
          "md": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent Vaccine.",
          "bBox": {
            "x": 68.94,
            "y": 165.78,
            "w": 417.96,
            "h": 430.45
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 9-months old child who has received BCG, OPV-2, RVV-1, Penta-2, IPV-1, PCV-1 only?",
          "md": "# What vaccines should be given to a 9-months old child who has received BCG, OPV-2, RVV-1, Penta-2, IPV-1, PCV-1 only?",
          "bBox": {
            "x": 150.35,
            "y": 382.76,
            "w": 270.07,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give OPV-3, RVV-2, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**",
          "md": "- **Give OPV-3, RVV-2, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**",
          "bBox": {
            "x": 81.67,
            "y": 433.16,
            "w": 83.99,
            "h": 32
          }
        },
        {
          "type": "text",
          "value": "> For OPV, RVV, IPV, pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "md": "> For OPV, RVV, IPV, pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "bBox": {
            "x": 224.14,
            "y": 187.78,
            "w": 197.47,
            "h": 320.88
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for RVV and PCV by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for RVV and PCV by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 93.64,
            "y": 154.78,
            "w": 409.31,
            "h": 500.75
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of RVV  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "md": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of RVV  \n> * Minimum 8 weeks of interval between administration of two doses of PCV  \n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "bBox": {
            "x": 68.94,
            "y": 165.78,
            "w": 417.96,
            "h": 489.75
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 63,
      "text": "    What vaccines should be given to a 10-months old child who has never\n    been vaccinated?\n\n\n    Give BCG, OPV-1,           As per the NIS, BCG, OPV,      • Complete the schedule\n    RVV-1, IPV-1, Penta-1,     RVV, IPV, Penta and PCV                       for OPV, RVV, IPV,\n    PCV-1, MCV-1, JE-1         must be started before                        Pentavalent and\n                               1 year of age, if the child                   PCV by ensuring the\n                               is unvaccinated after 6                       recommended interval\n                               weeks of birth.                               between administration of\n                                                                             two doses\n                               MCV and JE must be             • Give 4 key messages\n                               started for a child below\n                               5 years and 15 years of        • Counsel the parents\n                               age respectively and                          to bring the child for\n                               is unvaccinated after 9                       subsequent vaccinations\n                               months of birth.                              on time as per the NIS\n\n                               The subsequent doses\n                               should be administered as\n                               per NIS\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n     • IPV-2 is given only with OPV-3 and Penta-3\n     • Minimum 8 weeks of interval between administration of two doses of PCV\n     • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n     vaccination\n\n\n\n\n\nWhat vaccines should be given to a 11-months old child who has received\n     BCG, OPV- 2, RVV-2, IPV-1 , Penta-2, PCV-1, MCV-1, JE-1 only?\n\n\n     Give OPV-3, RVV-3,     For OPV, RVV, IPV,            • Complete the schedule\n     IPV-2, Penta-3,        Pentavalent and PCV, if                         for PCV by ensuring the\n     PCV-2                  at least one dose is given                      recommended interval\n                            before one year of age,                         between administration of\n                            then remaining doses                            two doses\n                            should be administered as     • Give 4 key messages\n                            per NIS.\n                                                          • Counsel the parents\n                                                                            to bring the child for\n                                                                            subsequent vaccinations\n                                                                            on time as per the NIS\n\n    Remember to ensure\n    • Minimum 8 weeks of interval between administration of two doses of PCV\n    • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n     vaccination\n\n\n\n\n\n\n\n\n\n\n    56 IFAQs on Immunization",
      "md": "\n# What vaccines should be given to a 10-months old child who has never been vaccinated?\n\n- **Give:** BCG, OPV-1, RVV-1, IPV-1, Penta-1, PCV-1, MCV-1, JE-1\n\n- **As per the NIS,** BCG, OPV, RVV, IPV, Penta and PCV must be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.\n\n- MCV and JE must be started for a child below 5 years and 15 years of age respectively and is unvaccinated after 9 months of birth.\n\n- The subsequent doses should be administered as per NIS.\n\n- **Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses**\n\n- **Give 4 key messages**\n\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**\n\n> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n> * IPV-2 is given only with OPV-3 and Penta-3\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n\n# What vaccines should be given to a 11-months old child who has received BCG, OPV-2, RVV-2, IPV-1, Penta-2, PCV-1, MCV-1, JE-1 only?\n\n- **Give:** OPV-3, RVV-3, IPV-2, Penta-3, PCV-2\n\n- For OPV, RVV, IPV, Pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.\n\n- **Complete the schedule for PCV by ensuring the recommended interval between administration of two doses**\n\n- **Give 4 key messages**\n\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**\n\n> **Remember to ensure**\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_63.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 10-months old child who has never been vaccinated?",
          "md": "# What vaccines should be given to a 10-months old child who has never been vaccinated?",
          "bBox": {
            "x": 161.11,
            "y": 66.74,
            "w": 300.81,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give:** BCG, OPV-1, RVV-1, IPV-1, Penta-1, PCV-1, MCV-1, JE-1",
          "md": "- **Give:** BCG, OPV-1, RVV-1, IPV-1, Penta-1, PCV-1, MCV-1, JE-1",
          "bBox": {
            "x": 108.57,
            "y": 125.29,
            "w": 90.83,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **As per the NIS,** BCG, OPV, RVV, IPV, Penta and PCV must be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.",
          "md": "- **As per the NIS,** BCG, OPV, RVV, IPV, Penta and PCV must be started before 1 year of age, if the child is unvaccinated after 6 weeks of birth.",
          "bBox": {
            "x": 256.18,
            "y": 125.29,
            "w": 101.37,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- MCV and JE must be started for a child below 5 years and 15 years of age respectively and is unvaccinated after 9 months of birth.",
          "md": "- MCV and JE must be started for a child below 5 years and 15 years of age respectively and is unvaccinated after 9 months of birth.",
          "bBox": {
            "x": 256.18,
            "y": 191.29,
            "w": 99.14,
            "h": 65
          }
        },
        {
          "type": "text",
          "value": "- The subsequent doses should be administered as per NIS.",
          "md": "- The subsequent doses should be administered as per NIS.",
          "bBox": {
            "x": 256.18,
            "y": 268.29,
            "w": 109.72,
            "h": 321.56
          }
        },
        {
          "type": "text",
          "value": "- **Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses**",
          "md": "- **Complete the schedule for OPV, RVV, IPV, Pentavalent and PCV by ensuring the recommended interval between administration of two doses**",
          "bBox": {
            "x": 258.44,
            "y": 125.29,
            "w": 276.08,
            "h": 442.56
          }
        },
        {
          "type": "text",
          "value": "- **Give 4 key messages**",
          "md": "- **Give 4 key messages**",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "md": "- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "bBox": {
            "x": 115.84,
            "y": 225.53,
            "w": 410.18,
            "h": 480.9
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n> * IPV-2 is given only with OPV-3 and Penta-3\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "md": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, RVV and Pentavalent\n> * IPV-2 is given only with OPV-3 and Penta-3\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "bBox": {
            "x": 95.84,
            "y": 169.29,
            "w": 438.68,
            "h": 537.14
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 11-months old child who has received BCG, OPV-2, RVV-2, IPV-1, Penta-2, PCV-1, MCV-1, JE-1 only?",
          "md": "# What vaccines should be given to a 11-months old child who has received BCG, OPV-2, RVV-2, IPV-1, Penta-2, PCV-1, MCV-1, JE-1 only?",
          "bBox": {
            "x": 108.57,
            "y": 136.29,
            "w": 361.61,
            "h": 351.01
          }
        },
        {
          "type": "text",
          "value": "- **Give:** OPV-3, RVV-3, IPV-2, Penta-3, PCV-2",
          "md": "- **Give:** OPV-3, RVV-3, IPV-2, Penta-3, PCV-2",
          "bBox": {
            "x": 111.76,
            "y": 524.85,
            "w": 61.34,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- For OPV, RVV, IPV, Pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "md": "- For OPV, RVV, IPV, Pentavalent and PCV, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "bBox": {
            "x": 256.18,
            "y": 125.29,
            "w": 242.92,
            "h": 464.56
          }
        },
        {
          "type": "text",
          "value": "- **Complete the schedule for PCV by ensuring the recommended interval between administration of two doses**",
          "md": "- **Complete the schedule for PCV by ensuring the recommended interval between administration of two doses**",
          "bBox": {
            "x": 424.25,
            "y": 147.29,
            "w": 110.26,
            "h": 420.56
          }
        },
        {
          "type": "text",
          "value": "- **Give 4 key messages**",
          "md": "- **Give 4 key messages**",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "text",
          "value": "- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "md": "- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "bBox": {
            "x": 115.84,
            "y": 225.53,
            "w": 410.18,
            "h": 480.9
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "md": "> **Remember to ensure**\n> * Minimum 8 weeks of interval between administration of two doses of PCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination",
          "bBox": {
            "x": 95.84,
            "y": 169.29,
            "w": 438.68,
            "h": 537.14
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 64,
      "text": "What vaccines should be given to a 12-months old child who has never\n                          been vaccinated?\n\n\n    Give OPV-1, DPT-1,     According to NIS, if the    • Complete the schedule for\n    MCV-1, JE-1            first dose of BCG, RVV,     OPV and DPT by ensuring\n                           Penta and IPV is not        the recommended interval\n                           administered before         between administration of\n                           one year of age, then       two doses\n                           these vaccines cannot be    • Give 4 key messages\n                           administered to the child\n                           under UIP.                  • Counsel the parents\n\n                           Upper age limit of the      to bring the child for\n                           vaccines are: OPV (up       subsequent vaccinations\n                           to 5 years), DPT (up to     on time as per the NIS\n                           7 years), MCV (up to 5\n                           years), JE (up to 15 years).\n\n    Remember to ensure\n    • Minimum 4 weeks of interval between administration of two doses of OPV and DPT\n\n\n\n\n\n\n\n\nWhat vaccines should be given to a 14-months old child who has\n          received BCG, OPV-1, IPV-1, Penta-1 only?\n\n\n    Give OPV-2,           For pentavalent, if at least     • Complete the schedule\n    Penta-2, MCV-1,       one dose is given before                           for OPV, IPV, Pentavalent\n    JE-1                  one year of age, then                              and JE by ensuring the\n                          remaining doses should                             recommended interval\n                          be administered as per                             between administration of\n                          NIS.                                               two doses\n\n                          Schedule for MCV and             • Give 4 key messages\n                          JE must be started for           • Counsel the parents\n                          children for children                              to bring the child for\n                          below 5 years and 15                               subsequent vaccinations\n                          years respectively.                                on time as per the NIS\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of OPV and Pentavalent\n     • IPV-2 is given only with OPV-3 and Penta-3\n     • Minimum 12 weeks of interval between administration of two doses of JE\n     • Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of\n     DPT, OPV respectively\n\n\n\n\n\n\n\n\n\n\n    FAQs on ImmunizationI 57",
      "md": "\n# What vaccines should be given to a 12-months old child who has never been vaccinated?\n\n- Give OPV-1, DPT-1, MCV-1, JE-1\n\n> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.\n\n> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).\n\n- Complete the schedule for OPV and DPT by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and DPT\n\n----\n\n# What vaccines should be given to a 14-months old child who has received BCG, OPV-1, IPV-1, Penta-1 only?\n\n- Give OPV-2, Penta-2, MCV-1, JE-1\n\n> For pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.\n\n> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.\n\n- Complete the schedule for OPV, IPV, Pentavalent and JE by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and Pentavalent  \n* IPV-2 is given only with OPV-3 and Penta-3  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_64.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 12-months old child who has never been vaccinated?",
          "md": "# What vaccines should be given to a 12-months old child who has never been vaccinated?",
          "bBox": {
            "x": 133.89,
            "y": 66.74,
            "w": 300.65,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- Give OPV-1, DPT-1, MCV-1, JE-1",
          "md": "- Give OPV-1, DPT-1, MCV-1, JE-1",
          "bBox": {
            "x": 82.6,
            "y": 114.29,
            "w": 79.98,
            "h": 369.5
          }
        },
        {
          "type": "text",
          "value": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "md": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "bBox": {
            "x": 230.14,
            "y": 114.29,
            "w": 102.91,
            "h": 369.5
          }
        },
        {
          "type": "text",
          "value": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).",
          "md": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).",
          "bBox": {
            "x": 230.14,
            "y": 213.29,
            "w": 106.03,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for OPV and DPT by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for OPV and DPT by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 396.95,
            "y": 125.29,
            "w": 110.6,
            "h": 458.74
          }
        },
        {
          "type": "text",
          "value": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and DPT",
          "md": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and DPT",
          "bBox": {
            "x": 67.54,
            "y": 147.29,
            "w": 440.01,
            "h": 463.33
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 14-months old child who has received BCG, OPV-1, IPV-1, Penta-1 only?",
          "md": "# What vaccines should be given to a 14-months old child who has received BCG, OPV-1, IPV-1, Penta-1 only?",
          "bBox": {
            "x": 148.18,
            "y": 404.24,
            "w": 274.79,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- Give OPV-2, Penta-2, MCV-1, JE-1",
          "md": "- Give OPV-2, Penta-2, MCV-1, JE-1",
          "bBox": {
            "x": 82.6,
            "y": 125.29,
            "w": 67.24,
            "h": 358.5
          }
        },
        {
          "type": "text",
          "value": "> For pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "md": "> For pentavalent, if at least one dose is given before one year of age, then remaining doses should be administered as per NIS.",
          "bBox": {
            "x": 230.14,
            "y": 158.29,
            "w": 107.5,
            "h": 358.5
          }
        },
        {
          "type": "text",
          "value": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.",
          "md": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.",
          "bBox": {
            "x": 230.21,
            "y": 528.79,
            "w": 91.61,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for OPV, IPV, Pentavalent and JE by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for OPV, IPV, Pentavalent and JE by ensuring the recommended interval between administration of two doses\n- Give 4 key messages\n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 396.95,
            "y": 136.29,
            "w": 110.6,
            "h": 447.74
          }
        },
        {
          "type": "text",
          "value": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and Pentavalent  \n* IPV-2 is given only with OPV-3 and Penta-3  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively",
          "md": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV and Pentavalent  \n* IPV-2 is given only with OPV-3 and Penta-3  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively",
          "bBox": {
            "x": 67.54,
            "y": 147.29,
            "w": 440.01,
            "h": 539.75
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.994
    },
    {
      "page": 65,
      "text": "What vaccines should be given to a 16-months old child who has never\n                          been vaccinated?\n\n\n    Give OPV-1, DPT-1,     According to NIS, if the      • Complete the schedule\n    MCV-1, JE-1            first dose of BCG, RVV,                           OPV, DPT, MCV and\n                           Penta and IPV is not                              JE by ensuring the\n                           administered before                               recommended interval\n                           one year of age, then                             between administration of\n                           these vaccines cannot be                          two doses\n                           administered to the child     • Give 4 key messages\n                           under UIP.\n\n                           Upper age limit of the        • Counsel the parents\n                           vaccines are: OPV (up                             to bring the child for\n                           to 5 years), DPT (up to                           subsequent vaccinations\n                           7 years), MCV (up to 5                            on time as per the NIS\n                           years), JE (up to 15 years).\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV\n     • Minimum 12 weeks of interval between administration of two doses of JE\n     • Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of\n     DPT, OPV respectively\n\n\n\n\n\n\nWhat vaccines should be given to a 18-months old child who has\n   received BCG, OPV-2, RVV- 2, IPV-1 Penta-2, PCV-1 only?\n\n\n    Give OPV-3, RVV-3,       For pentavalent, IPV,      • Complete the schedule\n    IPV-2, Penta-3, PCV-     PCV and RVV, if at                              for PCV, MCV and\n    2, MCV-1, JE-1           least one dose is given                         JE by ensuring the\n                             before one year of age,                         recommended interval\n                             then remaining doses                            between administration of\n                             can be administered                             two doses\n                             and schedule must be       • Give 4 key messages\n                             completed irrespective of\n                             the age of child.          • Counsel the parents\n\n                             Schedule for MCV and                            to bring the child for\n                             JE must be started for                          subsequent vaccinations\n                             children for children                           on time as per the NIS\n                             below 5 years and 15\n                             years respectively\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of MCV\n     • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n     vaccination\n     • Minimum 12 weeks of interval between administration of two doses of JE\n     • Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of\n     DPT, OPV respectively\n\n\n\n\n\n    58 IFAQs on Immunization",
      "md": "\n# What vaccines should be given to a 16-months old child who has never been vaccinated?\n\n- **Give OPV-1, DPT-1, MCV-1, JE-1**\n\n> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.\n\n> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).\n\n- **Complete the schedule OPV, DPT, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**\n\n> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively\n\n# What vaccines should be given to a 18-months old child who has received BCG, OPV-2, RVV-2, IPV-1 Penta-2, PCV-1 only?\n\n- **Give OPV-3, RVV-3, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**\n\n> For pentavalent, IPV, PCV and RVV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child.\n\n> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.\n\n- **Complete the schedule for PCV, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**\n\n> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of MCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively\n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_65.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 16-months old child who has never been vaccinated?",
          "md": "# What vaccines should be given to a 16-months old child who has never been vaccinated?",
          "bBox": {
            "x": 158.61,
            "y": 66.74,
            "w": 301.16,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give OPV-1, DPT-1, MCV-1, JE-1**",
          "md": "- **Give OPV-1, DPT-1, MCV-1, JE-1**",
          "bBox": {
            "x": 106.25,
            "y": 114.29,
            "w": 79.12,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "md": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "bBox": {
            "x": 253.86,
            "y": 114.29,
            "w": 102.91,
            "h": 403.03
          }
        },
        {
          "type": "text",
          "value": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).",
          "md": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years).",
          "bBox": {
            "x": 253.86,
            "y": 213.29,
            "w": 106.03,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- **Complete the schedule OPV, DPT, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "md": "- **Complete the schedule OPV, DPT, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "bBox": {
            "x": 119.66,
            "y": 125.29,
            "w": 411.48,
            "h": 583.66
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "md": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "bBox": {
            "x": 99.66,
            "y": 158.29,
            "w": 431.48,
            "h": 595.9
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 18-months old child who has received BCG, OPV-2, RVV-2, IPV-1 Penta-2, PCV-1 only?",
          "md": "# What vaccines should be given to a 18-months old child who has received BCG, OPV-2, RVV-2, IPV-1 Penta-2, PCV-1 only?",
          "bBox": {
            "x": 171.69,
            "y": 426.77,
            "w": 275.07,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- **Give OPV-3, RVV-3, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**",
          "md": "- **Give OPV-3, RVV-3, IPV-2, Penta-3, PCV-2, MCV-1, JE-1**",
          "bBox": {
            "x": 106.25,
            "y": 125.29,
            "w": 83.99,
            "h": 381.03
          }
        },
        {
          "type": "text",
          "value": "> For pentavalent, IPV, PCV and RVV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child.",
          "md": "> For pentavalent, IPV, PCV and RVV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective of the age of child.",
          "bBox": {
            "x": 253.86,
            "y": 158.29,
            "w": 105.03,
            "h": 414.03
          }
        },
        {
          "type": "text",
          "value": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.",
          "md": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively.",
          "bBox": {
            "x": 253.86,
            "y": 584.32,
            "w": 91.61,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- **Complete the schedule for PCV, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "md": "- **Complete the schedule for PCV, MCV and JE by ensuring the recommended interval between administration of two doses**\n- **Give 4 key messages**\n- **Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS**",
          "bBox": {
            "x": 119.66,
            "y": 136.29,
            "w": 411.48,
            "h": 572.66
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of MCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively",
          "md": "> **Remember to ensure**\n> * Minimum 4 weeks of interval between administration of two doses of MCV\n> * Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination\n> * Minimum 12 weeks of interval between administration of two doses of JE\n> * Minimum 6 months to 1 year of gap between the primary doses of Penta, OPV and booster doses of DPT, OPV respectively",
          "bBox": {
            "x": 99.66,
            "y": 158.29,
            "w": 431.48,
            "h": 595.9
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.995
    },
    {
      "page": 66,
      "text": "What vaccines should be given to a 24-months old child (2 years) who\n                     has never been vaccinated?\n\n\n    Give OPV-1, DPT-1,     According to NIS, if the     • Complete the schedule for\n    MCV-1, JE-1            first dose of BCG, RVV,                           OPV, DPT, MCV and JE\n                           Penta and IPV is not         • Give 4 key messages\n                           administered before\n                           one year of age, then        • Counsel the parents\n                           these vaccines cannot be                          to bring the child for\n                           administered to the child                         subsequent vaccinations\n                           under UIP.                                        on time as per the NIS\n\n                           Upper age limit of the\n                           vaccines are: OPV (up\n                           to 5 years), DPT (up to\n                           7 years), MCV (up to 5\n                           years), JE (up to 15 years)\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV\n     • Minimum 12 weeks of interval between administration of two doses of JE\n     • Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of\n     DPT, OPV respectively\n\n\n\n\n\n\nWhat vaccines should be given to a 3 years old child who has received\n           BCG, OPV-3, RVV- 3, IPV-2, Penta-3, PCV-2 only?\n\n\n    Give PCV-B (ensure a 8       For PCV, if at least one     • Complete the schedule\n    weeks gap between PCV-       dose is given before          for MCV by ensuring the\n    2 and PCV-B), MCV-1, JE-     one year of age, then         recommended interval\n    1, DPT-B, OPV-B (ensure      remaining doses can           between administration of\n    6months to 1 year gap        be administered and           two doses\n    between the booster and      schedule must be             • Give 4 key messages\n    primary vaccination)         completed irrespective as\n                                 per NIS.                     • Counsel the parents\n\n                                 Schedule for MCV and          to bring the child for\n                                 JE must be started for        subsequent vaccinations\n                                 children for children         on time as per the NIS\n                                 below 5 years and 15\n                                 years respectively\n\n    Remember to ensure\n     • Minimum 4 weeks of interval between administration of two doses of MCV\n     • Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for\n     vaccination\n     • Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of\n     DPT, OPV respectively\n\n\n\n\n\n\n\n\n    FAQs on ImmunizationI 59",
      "md": "\n# What vaccines should be given to a 24-months old child (2 years) who has never been vaccinated?\n\n- Give OPV-1, DPT-1, MCV-1, JE-1\n\n> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.\n\n> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years)\n\n- Complete the schedule for OPV, DPT, MCV and JE  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively  \n\n----\n\n# What vaccines should be given to a 3 years old child who has received BCG, OPV-3, RVV-3, IPV-2, Penta-3, PCV-2 only?\n\n- Give PCV-B (ensure a 8 weeks gap between PCV-2 and PCV-B), MCV-1, JE-1, DPT-B, OPV-B (ensure 6 months to 1 year gap between the booster and primary vaccination)\n\n> For PCV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective as per NIS.\n\n> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively\n\n- Complete the schedule for MCV by ensuring the recommended interval between administration of two doses  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\n\n**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of MCV  \n* Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively  \n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_66.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 24-months old child (2 years) who has never been vaccinated?",
          "md": "# What vaccines should be given to a 24-months old child (2 years) who has never been vaccinated?",
          "bBox": {
            "x": 135.57,
            "y": 66.96,
            "w": 296.17,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- Give OPV-1, DPT-1, MCV-1, JE-1",
          "md": "- Give OPV-1, DPT-1, MCV-1, JE-1",
          "bBox": {
            "x": 80.67,
            "y": 114.51,
            "w": 79.12,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "md": "> According to NIS, if the first dose of BCG, RVV, Penta and IPV is not administered before one year of age, then these vaccines cannot be administered to the child under UIP.",
          "bBox": {
            "x": 228.28,
            "y": 114.51,
            "w": 102.91,
            "h": 392.05
          }
        },
        {
          "type": "text",
          "value": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years)",
          "md": "> Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years)",
          "bBox": {
            "x": 228.28,
            "y": 213.51,
            "w": 103.39,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for OPV, DPT, MCV and JE  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for OPV, DPT, MCV and JE  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 93.08,
            "y": 125.51,
            "w": 404.05,
            "h": 571.08
          }
        },
        {
          "type": "text",
          "value": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "md": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of OPV, DPT and MCV  \n* Minimum 12 weeks of interval between administration of two doses of JE  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "bBox": {
            "x": 73.08,
            "y": 284.4,
            "w": 432.48,
            "h": 440.3
          }
        },
        {
          "type": "text",
          "value": "----",
          "md": "----",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        },
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 3 years old child who has received BCG, OPV-3, RVV-3, IPV-2, Penta-3, PCV-2 only?",
          "md": "# What vaccines should be given to a 3 years old child who has received BCG, OPV-3, RVV-3, IPV-2, Penta-3, PCV-2 only?",
          "bBox": {
            "x": 135.44,
            "y": 427.01,
            "w": 296.43,
            "h": 21
          }
        },
        {
          "type": "text",
          "value": "- Give PCV-B (ensure a 8 weeks gap between PCV-2 and PCV-B), MCV-1, JE-1, DPT-B, OPV-B (ensure 6 months to 1 year gap between the booster and primary vaccination)",
          "md": "- Give PCV-B (ensure a 8 weeks gap between PCV-2 and PCV-B), MCV-1, JE-1, DPT-B, OPV-B (ensure 6 months to 1 year gap between the booster and primary vaccination)",
          "bBox": {
            "x": 68.78,
            "y": 125.51,
            "w": 104.3,
            "h": 571.08
          }
        },
        {
          "type": "text",
          "value": "> For PCV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective as per NIS.",
          "md": "> For PCV, if at least one dose is given before one year of age, then remaining doses can be administered and schedule must be completed irrespective as per NIS.",
          "bBox": {
            "x": 228.28,
            "y": 158.51,
            "w": 105.46,
            "h": 403.05
          }
        },
        {
          "type": "text",
          "value": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively",
          "md": "> Schedule for MCV and JE must be started for children below 5 years and 15 years respectively",
          "bBox": {
            "x": 228.28,
            "y": 573.56,
            "w": 91.61,
            "h": 54
          }
        },
        {
          "type": "text",
          "value": "- Complete the schedule for MCV by ensuring the recommended interval between administration of two doses  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "md": "- Complete the schedule for MCV by ensuring the recommended interval between administration of two doses  \n- Give 4 key messages  \n- Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS",
          "bBox": {
            "x": 93.08,
            "y": 170.75,
            "w": 412.48,
            "h": 525.84
          }
        },
        {
          "type": "text",
          "value": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of MCV  \n* Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "md": "**Remember to ensure**  \n* Minimum 4 weeks of interval between administration of two doses of MCV  \n* Minimum 8 weeks of interval between administration of PCV-2 and PCV-B if child is delayed for vaccination  \n* Minimum 6 months to 1 year of gap between the primary doses of DPT, OPV and booster doses of DPT, OPV respectively",
          "bBox": {
            "x": 73.08,
            "y": 284.4,
            "w": 432.48,
            "h": 440.3
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.995
    },
    {
      "page": 67,
      "text": "What vaccines should be given to a 5-years old child who has never\nbeen vaccinated?\n\n\nGive DPT-1, JE-1     Upper age limit of the         • Complete the schedule\n                     vaccines are: OPV (up           for DPT by ensuring the\n                     to 5 years), DPT (up to         recommended interval\n                     7 years), MCV (up to 5          between administration of\n                     years), JE (up to 15 years)     two doses\n                                                    • Give 4 key messages\n                                                    • Counsel the parents\n                                                     to bring the child for\n                                                     subsequent vaccinations\n                                                     on time as per the NIS\n\nRemember to ensure\n• Minimum 4 weeks of interval between administration of two doses of DPT\n• Minimum 6 months to 1 year of gap between the primary doses and booster doses of DPT\n\n\n\n\n\n\n\n\n\n\n60 IFAQs on Immunization",
      "md": "\n# What vaccines should be given to a 5-years old child who has never been vaccinated?\n\n| Give DPT-1, JE-1 | Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years) |  \n|------------------|--------------------------------------------------------------------------------------------------------------------|  \n|                  | * Complete the schedule for DPT by ensuring the recommended interval between administration of two doses            |  \n|                  | * Give 4 key messages                                                                                                |  \n|                  | * Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS                          |  \n\n> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of DPT  \n> * Minimum 6 months to 1 year of gap between the primary doses and booster doses of DPT  \n",
      "images": [
        {
          "name": "img_p8_1.png",
          "height": 842.431,
          "width": 67.815,
          "x": -0.158,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_67.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "What vaccines should be given to a 5-years old child who has never been vaccinated?",
          "md": "# What vaccines should be given to a 5-years old child who has never been vaccinated?",
          "bBox": {
            "x": 168.75,
            "y": 66.96,
            "w": 285.52,
            "h": 21
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "Give DPT-1, JE-1",
              "Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years)"
            ],
            [
              "",
              "* Complete the schedule for DPT by ensuring the recommended interval between administration of two doses"
            ],
            [
              "",
              "* Give 4 key messages"
            ],
            [
              "",
              "* Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS"
            ]
          ],
          "md": "| Give DPT-1, JE-1 | Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years) |\n| ---------------- | ----------------------------------------------------------------------------------------------------------------------- |\n|                  | \\* Complete the schedule for DPT by ensuring the recommended interval between administration of two doses               |\n|                  | \\* Give 4 key messages                                                                                                  |\n|                  | \\* Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS                            |",
          "isPerfectTable": false,
          "csv": "\"Give DPT-1, JE-1\",\"Upper age limit of the vaccines are: OPV (up to 5 years), DPT (up to 7 years), MCV (up to 5 years), JE (up to 15 years)\"\n\"\",\"* Complete the schedule for DPT by ensuring the recommended interval between administration of two doses\"\n\"\",\"* Give 4 key messages\"\n\"\",\"* Counsel the parents to bring the child for subsequent vaccinations on time as per the NIS\"",
          "bBox": {
            "x": 86.4,
            "y": 66.96,
            "w": 447.06,
            "h": 761.76
          }
        },
        {
          "type": "text",
          "value": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of DPT  \n> * Minimum 6 months to 1 year of gap between the primary doses and booster doses of DPT",
          "md": "> **Remember to ensure**  \n> * Minimum 4 weeks of interval between administration of two doses of DPT  \n> * Minimum 6 months to 1 year of gap between the primary doses and booster doses of DPT",
          "bBox": {
            "x": 100.98,
            "y": 147.51,
            "w": 432.48,
            "h": 114.1
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.983
    },
    {
      "page": 68,
      "text": "         National Immunization Schedule\n\nVaccine  Dose       Recommended Age  Volume  Route and site of administration\nInfants and Children\n\n<table>\n    <thead>\n    <tr>\n        <th>BCG</th>\n        <th>Single</th>\n        <th>At birth</th>\n        <th>0.05 ml¹</th>\n        <th>Intradermal (LEFT upper arm)</th>\n    </tr>\n    </thead>\n    <tr>\n        <td>Hepatitis B</td>\n        <td>Birth dose</td>\n        <td>At birth</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"5\">OPV</td>\n        <td>Zero dose</td>\n        <td>At birth</td>\n        <td>2 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>First</td>\n        <td>6 weeks</td>\n        <td>2 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>10 weeks</td>\n        <td>2 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>Th\nird</td>\n        <td>14 weeks</td>\n        <td>2 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>Booster</td>\n        <td>16-24 months</td>\n        <td>2 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"3\">Penta-\nvalent</td>\n        <td>First</td>\n        <td>6 weeks</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>10 weeks</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td>Th\nird</td>\n        <td>14 weeks</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"3\">Rotavirus*</td>\n        <td>First</td>\n        <td>6 weeks</td>\n        <td>5 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>10 weeks</td>\n        <td>5 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td>Th\nird</td>\n        <td>14 weeks</td>\n        <td>5 drops</td>\n        <td>Oral (mouth)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"3\">PCV*</td>\n        <td>First</td>\n        <td>6 weeks</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of RIGHT midthigh)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>14 weeks</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td>Booster</td>\n        <td>9 months</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"2\">IPV</td>\n        <td>First</td>\n        <td>6 weeks</td>\n        <td>0.1 ml</td>\n        <td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>14 weeks</td>\n        <td>0.1 ml</td>\n        <td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"2\">Measles/\nMR*</td>\n        <td>First</td>\n        <td>9-12 months</td>\n        <td>0.5 ml</td>\n        <td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n    <tr>\n        <td>Booster</td>\n        <td>16-24 months</td>\n        <td>0.5 ml</td>\n        <td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"2\">JE*²</td>\n        <td>First</td>\n        <td>9-12 months</td>\n        <td>0.5 ml</td>\n        <td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>16-24 months</td>\n        <td>0.5 ml</td>\n        <td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"2\">DPT</td>\n        <td>First \nbooster</td>\n        <td>16-24 months</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n    <tr>\n        <td>Second \nbooster</td>\n        <td>5-6 years</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (upper arm)</td>\n    </tr>\n    <tr>\n        <td rowspan=\"2\">TT</td>\n        <td>First</td>\n        <td>10 years</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (upper arm)</td>\n    </tr>\n    <tr>\n        <td>Second</td>\n        <td>16 years</td>\n        <td>0.5 ml</td>\n        <td>Intramuscular (upper arm)</td>\n    </tr></table>\n\n\n\n\n\n\n\n\n\n\n\nPregnant women\n       First       Earliest possible               0.5 ml                  Intramuscular (upper arm)\n\nTT     Second      4 week aﬅer 1st dose            0.5 ml                  Intramuscular (upper arm)\n       Booster     If received 2 TT doses in a     0.5 ml                  Intramuscular (upper arm)\n                   pregnancy within the last 3\n                   years\n(1) If BCG is administered after one month of age, then dose will be 0.1 ml\n(2) JE vaccine is given only in endemic districts.\n\n                                                                                                    *Wherever applicable\n                        Table 5:National Immunization Schedule\n\n\n\n\n\n\n\n\n\n\nFAQs on ImmunizationI 61",
      "md": "\n# National Immunization Schedule\n\nVaccine\nDose\nRecommended Age\nVolume\nRoute and site of administration\n\n<b>Infants and Children</b>\n\n<table>\n    <thead>\n    <tr>\n        <th>BCG</th>\n        <th>Single</th>\n        <th>At birth</th>\n        <th>0.05 ml¹</th>\n        <th>Intradermal (LEFT upper arm)</th>\n    </tr>\n    </thead>\n    <tr>\n        <td>Hepatitis B</td>\n<td>Birth dose</td>\n<td>At birth</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"5\">OPV</td>\n<td>Zero dose</td>\n<td>At birth</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>First</td>\n<td>6 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>16-24 months</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">Penta-\nvalent</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">Rotavirus*</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">PCV*</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT midthigh)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>14 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>9 months</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">IPV</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.1 ml</td>\n<td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>14 weeks</td>\n<td>0.1 ml</td>\n<td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">Measles/\nMR*</td>\n<td>First</td>\n<td>9-12 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">JE*²</td>\n<td>First</td>\n<td>9-12 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">DPT</td>\n<td>First \nbooster</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Second \nbooster</td>\n<td>5-6 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">TT</td>\n<td>First</td>\n<td>10 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>16 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr></table>\n\n<b>Pregnant women</b>\n\nTT\nFirst\nEarliest possible\n0.5 ml\nIntramuscular (upper arm)\n\nSecond\n4 week after 1st dose\n0.5 ml\nIntramuscular (upper arm)\n\nBooster\nIf received 2 TT doses in a pregnancy within the last 3 years\n0.5 ml\nIntramuscular (upper arm)\n\n(1) If BCG is administered after one month of age, then dose will be 0.1 ml  \n(2) JE vaccine is given only in endemic districts.\n\n*Wherever applicable*  \n\nTable 5: National Immunization Schedule\n",
      "images": [
        {
          "name": "img_p9_1.png",
          "height": 842.431,
          "width": 67.814,
          "x": 527.619,
          "y": -0.264,
          "original_width": 283,
          "original_height": 3510,
          "rotation": 0
        },
        {
          "name": "page_68.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "National Immunization Schedule",
          "md": "# National Immunization Schedule",
          "bBox": {
            "x": 113.45,
            "y": 52.27,
            "w": 368.38,
            "h": 24
          }
        },
        {
          "type": "text",
          "value": "Vaccine\nDose\nRecommended Age\nVolume\nRoute and site of administration",
          "md": "Vaccine\nDose\nRecommended Age\nVolume\nRoute and site of administration",
          "bBox": {
            "x": 63.29,
            "y": 92.2,
            "w": 398.01,
            "h": 10.07
          }
        },
        {
          "type": "text",
          "value": "<b>Infants and Children</b>",
          "md": "<b>Infants and Children</b>",
          "bBox": {
            "x": 63.3,
            "y": 107.02,
            "w": 90.38,
            "h": 10.07
          }
        },
        {
          "type": "table",
          "rows": [
            [
              "BCG",
              "Single",
              "At birth",
              "0.05 ml¹",
              "Intradermal (LEFT upper arm)"
            ],
            [
              "Hepatitis B",
              "Birth dose",
              "At birth",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of LEFT mid-thigh)"
            ],
            [
              "OPV",
              "Zero dose",
              "At birth",
              "2 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "First",
              "6 weeks",
              "2 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "Second",
              "10 weeks",
              "2 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "Th ird",
              "14 weeks",
              "2 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "Booster",
              "16-24 months",
              "2 drops",
              "Oral (mouth)"
            ],
            [
              "Penta- valent",
              "First",
              "6 weeks",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of LEFT mid-thigh)"
            ],
            [
              "",
              "Second",
              "10 weeks",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of LEFT mid-thigh)"
            ],
            [
              "",
              "Th ird",
              "14 weeks",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of LEFT mid-thigh)"
            ],
            [
              "Rotavirus*",
              "First",
              "6 weeks",
              "5 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "Second",
              "10 weeks",
              "5 drops",
              "Oral (mouth)"
            ],
            [
              "",
              "Th ird",
              "14 weeks",
              "5 drops",
              "Oral (mouth)"
            ],
            [
              "PCV*",
              "First",
              "6 weeks",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of RIGHT midthigh)"
            ],
            [
              "",
              "Second",
              "14 weeks",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of RIGHT mid-thigh)"
            ],
            [
              "",
              "Booster",
              "9 months",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of RIGHT mid-thigh)"
            ],
            [
              "IPV",
              "First",
              "6 weeks",
              "0.1 ml",
              "Intradermal (RIGHT upper arm)"
            ],
            [
              "",
              "Second",
              "14 weeks",
              "0.1 ml",
              "Intradermal (RIGHT upper arm)"
            ],
            [
              "Measles/ MR*",
              "First",
              "9-12 months",
              "0.5 ml",
              "Subcutaneous (RIGHT upper arm)"
            ],
            [
              "",
              "Booster",
              "16-24 months",
              "0.5 ml",
              "Subcutaneous (RIGHT upper arm)"
            ],
            [
              "JE*²",
              "First",
              "9-12 months",
              "0.5 ml",
              "Subcutaneous (LEFT upper arm)"
            ],
            [
              "",
              "Second",
              "16-24 months",
              "0.5 ml",
              "Subcutaneous (LEFT upper arm)"
            ],
            [
              "DPT",
              "First booster",
              "16-24 months",
              "0.5 ml",
              "Intramuscular (Antero-lateral side of LEFT mid-thigh)"
            ],
            [
              "",
              "Second booster",
              "5-6 years",
              "0.5 ml",
              "Intramuscular (upper arm)"
            ],
            [
              "TT",
              "First",
              "10 years",
              "0.5 ml",
              "Intramuscular (upper arm)"
            ],
            [
              "",
              "Second",
              "16 years",
              "0.5 ml",
              "Intramuscular (upper arm)"
            ]
          ],
          "html": "<table>\n    <thead>\n    <tr>\n        <th>BCG</th>\n        <th>Single</th>\n        <th>At birth</th>\n        <th>0.05 ml¹</th>\n        <th>Intradermal (LEFT upper arm)</th>\n    </tr>\n    </thead>\n    <tbody><tr>\n        <td>Hepatitis B</td>\n<td>Birth dose</td>\n<td>At birth</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"5\">OPV</td>\n<td>Zero dose</td>\n<td>At birth</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>First</td>\n<td>6 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>16-24 months</td>\n<td>2 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">Penta-\nvalent</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">Rotavirus*</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>10 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td>Th\nird</td>\n<td>14 weeks</td>\n<td>5 drops</td>\n<td>Oral (mouth)</td>\n    </tr>\n<tr>\n        <td rowspan=\"3\">PCV*</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT midthigh)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>14 weeks</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>9 months</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of RIGHT mid-thigh)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">IPV</td>\n<td>First</td>\n<td>6 weeks</td>\n<td>0.1 ml</td>\n<td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>14 weeks</td>\n<td>0.1 ml</td>\n<td>Intradermal (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">Measles/\nMR*</td>\n<td>First</td>\n<td>9-12 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td>Booster</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (RIGHT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">JE*²</td>\n<td>First</td>\n<td>9-12 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Subcutaneous (LEFT upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">DPT</td>\n<td>First \nbooster</td>\n<td>16-24 months</td>\n<td>0.5 ml</td>\n<td>Intramuscular (Antero-lateral side of LEFT mid-thigh)</td>\n    </tr>\n<tr>\n        <td>Second \nbooster</td>\n<td>5-6 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr>\n<tr>\n        <td rowspan=\"2\">TT</td>\n<td>First</td>\n<td>10 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr>\n<tr>\n        <td>Second</td>\n<td>16 years</td>\n<td>0.5 ml</td>\n<td>Intramuscular (upper arm)</td>\n    </tr></tbody></table>",
          "md": "| BCG           | Single         | At birth     | 0.05 ml¹ | Intradermal (LEFT upper arm)                           |\n| ------------- | -------------- | ------------ | -------- | ------------------------------------------------------ |\n| Hepatitis B   | Birth dose     | At birth     | 0.5 ml   | Intramuscular (Antero-lateral side of LEFT mid-thigh)  |\n| OPV           | Zero dose      | At birth     | 2 drops  | Oral (mouth)                                           |\n|               | First          | 6 weeks      | 2 drops  | Oral (mouth)                                           |\n|               | Second         | 10 weeks     | 2 drops  | Oral (mouth)                                           |\n|               | Th ird         | 14 weeks     | 2 drops  | Oral (mouth)                                           |\n|               | Booster        | 16-24 months | 2 drops  | Oral (mouth)                                           |\n| Penta- valent | First          | 6 weeks      | 0.5 ml   | Intramuscular (Antero-lateral side of LEFT mid-thigh)  |\n|               | Second         | 10 weeks     | 0.5 ml   | Intramuscular (Antero-lateral side of LEFT mid-thigh)  |\n|               | Th ird         | 14 weeks     | 0.5 ml   | Intramuscular (Antero-lateral side of LEFT mid-thigh)  |\n| Rotavirus\\*   | First          | 6 weeks      | 5 drops  | Oral (mouth)                                           |\n|               | Second         | 10 weeks     | 5 drops  | Oral (mouth)                                           |\n|               | Th ird         | 14 weeks     | 5 drops  | Oral (mouth)                                           |\n| PCV\\*         | First          | 6 weeks      | 0.5 ml   | Intramuscular (Antero-lateral side of RIGHT midthigh)  |\n|               | Second         | 14 weeks     | 0.5 ml   | Intramuscular (Antero-lateral side of RIGHT mid-thigh) |\n|               | Booster        | 9 months     | 0.5 ml   | Intramuscular (Antero-lateral side of RIGHT mid-thigh) |\n| IPV           | First          | 6 weeks      | 0.1 ml   | Intradermal (RIGHT upper arm)                          |\n|               | Second         | 14 weeks     | 0.1 ml   | Intradermal (RIGHT upper arm)                          |\n| Measles/ MR\\* | First          | 9-12 months  | 0.5 ml   | Subcutaneous (RIGHT upper arm)                         |\n|               | Booster        | 16-24 months | 0.5 ml   | Subcutaneous (RIGHT upper arm)                         |\n| JE\\*²         | First          | 9-12 months  | 0.5 ml   | Subcutaneous (LEFT upper arm)                          |\n|               | Second         | 16-24 months | 0.5 ml   | Subcutaneous (LEFT upper arm)                          |\n| DPT           | First booster  | 16-24 months | 0.5 ml   | Intramuscular (Antero-lateral side of LEFT mid-thigh)  |\n|               | Second booster | 5-6 years    | 0.5 ml   | Intramuscular (upper arm)                              |\n| TT            | First          | 10 years     | 0.5 ml   | Intramuscular (upper arm)                              |\n|               | Second         | 16 years     | 0.5 ml   | Intramuscular (upper arm)                              |",
          "isPerfectTable": false,
          "csv": "\"BCG\",\"Single\",\"At birth\",\"0.05 ml¹\",\"Intradermal (LEFT upper arm)\"\n\"Hepatitis B\",\"Birth dose\",\"At birth\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of LEFT mid-thigh)\"\n\"OPV\",\"Zero dose\",\"At birth\",\"2 drops\",\"Oral (mouth)\"\n\"\",\"First\",\"6 weeks\",\"2 drops\",\"Oral (mouth)\"\n\"\",\"Second\",\"10 weeks\",\"2 drops\",\"Oral (mouth)\"\n\"\",\"Th ird\",\"14 weeks\",\"2 drops\",\"Oral (mouth)\"\n\"\",\"Booster\",\"16-24 months\",\"2 drops\",\"Oral (mouth)\"\n\"Penta- valent\",\"First\",\"6 weeks\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of LEFT mid-thigh)\"\n\"\",\"Second\",\"10 weeks\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of LEFT mid-thigh)\"\n\"\",\"Th ird\",\"14 weeks\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of LEFT mid-thigh)\"\n\"Rotavirus*\",\"First\",\"6 weeks\",\"5 drops\",\"Oral (mouth)\"\n\"\",\"Second\",\"10 weeks\",\"5 drops\",\"Oral (mouth)\"\n\"\",\"Th ird\",\"14 weeks\",\"5 drops\",\"Oral (mouth)\"\n\"PCV*\",\"First\",\"6 weeks\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of RIGHT midthigh)\"\n\"\",\"Second\",\"14 weeks\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of RIGHT mid-thigh)\"\n\"\",\"Booster\",\"9 months\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of RIGHT mid-thigh)\"\n\"IPV\",\"First\",\"6 weeks\",\"0.1 ml\",\"Intradermal (RIGHT upper arm)\"\n\"\",\"Second\",\"14 weeks\",\"0.1 ml\",\"Intradermal (RIGHT upper arm)\"\n\"Measles/ MR*\",\"First\",\"9-12 months\",\"0.5 ml\",\"Subcutaneous (RIGHT upper arm)\"\n\"\",\"Booster\",\"16-24 months\",\"0.5 ml\",\"Subcutaneous (RIGHT upper arm)\"\n\"JE*²\",\"First\",\"9-12 months\",\"0.5 ml\",\"Subcutaneous (LEFT upper arm)\"\n\"\",\"Second\",\"16-24 months\",\"0.5 ml\",\"Subcutaneous (LEFT upper arm)\"\n\"DPT\",\"First booster\",\"16-24 months\",\"0.5 ml\",\"Intramuscular (Antero-lateral side of LEFT mid-thigh)\"\n\"\",\"Second booster\",\"5-6 years\",\"0.5 ml\",\"Intramuscular (upper arm)\"\n\"TT\",\"First\",\"10 years\",\"0.5 ml\",\"Intramuscular (upper arm)\"\n\"\",\"Second\",\"16 years\",\"0.5 ml\",\"Intramuscular (upper arm)\"",
          "bBox": {
            "x": 60,
            "y": 52.27,
            "w": 453.36,
            "h": 776.45
          }
        },
        {
          "type": "text",
          "value": "<b>Pregnant women</b>",
          "md": "<b>Pregnant women</b>",
          "bBox": {
            "x": 63.29,
            "y": 487.92,
            "w": 77.78,
            "h": 10.07
          }
        },
        {
          "type": "text",
          "value": "TT\nFirst\nEarliest possible\n0.5 ml\nIntramuscular (upper arm)",
          "md": "TT\nFirst\nEarliest possible\n0.5 ml\nIntramuscular (upper arm)",
          "bBox": {
            "x": 63.29,
            "y": 503.07,
            "w": 345.51,
            "h": 34.87
          }
        },
        {
          "type": "text",
          "value": "Second\n4 week after 1st dose\n0.5 ml\nIntramuscular (upper arm)",
          "md": "Second\n4 week after 1st dose\n0.5 ml\nIntramuscular (upper arm)",
          "bBox": {
            "x": 108.91,
            "y": 92.2,
            "w": 299.89,
            "h": 445.73
          }
        },
        {
          "type": "text",
          "value": "Booster\nIf received 2 TT doses in a pregnancy within the last 3 years\n0.5 ml\nIntramuscular (upper arm)",
          "md": "Booster\nIf received 2 TT doses in a pregnancy within the last 3 years\n0.5 ml\nIntramuscular (upper arm)",
          "bBox": {
            "x": 63.29,
            "y": 92.2,
            "w": 345.51,
            "h": 459.67
          }
        },
        {
          "type": "text",
          "value": "(1) If BCG is administered after one month of age, then dose will be 0.1 ml  \n(2) JE vaccine is given only in endemic districts.",
          "md": "(1) If BCG is administered after one month of age, then dose will be 0.1 ml  \n(2) JE vaccine is given only in endemic districts.",
          "bBox": {
            "x": 63.29,
            "y": 92.2,
            "w": 218.43,
            "h": 480.61
          }
        },
        {
          "type": "text",
          "value": "*Wherever applicable*",
          "md": "*Wherever applicable*",
          "bBox": {
            "x": 439.36,
            "y": 581.34,
            "w": 71.86,
            "h": 8
          }
        },
        {
          "type": "text",
          "value": "Table 5: National Immunization Schedule",
          "md": "Table 5: National Immunization Schedule",
          "bBox": {
            "x": 113.45,
            "y": 52.27,
            "w": 368.38,
            "h": 546.46
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 69,
      "text": "NO_CONTENT_HERE",
      "md": "NO_CONTENT_HERE",
      "images": [
        {
          "name": "page_69.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        },
        {
          "name": "page_69.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "text",
          "value": "NO_CONTENT_HERE",
          "md": "NO_CONTENT_HERE",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "WARNING",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": true,
      "noTextContent": true,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null
    },
    {
      "page": 70,
      "text": "    LIST OF CONTRIBUTORS\n\n\n\n                 Advisors\nMs. Vandana Gurnani, MoHFW, Govt. of India\nDr. Pradeep Haldar, MoHFW, Govt. of India\n  Dr. M.K Agarwal, MoHFW, Govt. of India\n Ms. Manisha Verma, MoHFW, Govt. of India\n\n\n           Developing team\nDr. M.K Agarwal, MoHFW, Govt. of India\n       Dr. Pritu Dhalaria, JSI\n     Dr. Manish Jain, Consultant\n         Dr. Akash Malik, JSI\n        Dr. Sumeet Juneja, JSI\n      Chahat Narula Thakur, JSI\n  Shubhneet Kaur Gujral, Consultant\n\n\n          Special thanks to\nDr. Praful Bharadwaj, Gavi Secretariat\n    Dr. Sheenu Chaudhary, JSI-ITSU\n     Dr. Amit Harshana, JSI-ITSU\n\n\n    John Snow India acknowledges the inputs and support of other partners, including BMGF, ITSU,\nUNDP, UNICEF, WHO India, NCCVMRC, and CHAI in finalizing the content based on\n                  queries of various groups of stakeholders.\n\n\n\n\n    Compiled and edited by JSI India (for MoHFW, Govt. of India)",
      "md": "\n# LIST OF CONTRIBUTORS\n\n### Advisors\nMs. Vandana Gurnani, MoHFW, Govt. of India  \nDr. Pradeep Haldar, MoHFW, Govt. of India  \nDr. M.K Agarwal, MoHFW, Govt. of India  \nMs. Manisha Verma, MoHFW, Govt. of India  \n\n### Developing team\nDr. M.K Agarwal, MoHFW, Govt. of India  \nDr. Pritu Dhalaria, JSI  \nDr. Manish Jain, Consultant  \nDr. Akash Malik, JSI  \nDr. Sumeet Juneja, JSI  \nChahat Narula Thakur, JSI  \nShubhneet Kaur Gujral, Consultant  \n\n### Special thanks to\nDr. Praful Bharadwaj, Gavi Secretariat  \nDr. Sheenu Chaudhary, JSI-ITSU  \nDr. Amit Harshana, JSI-ITSU  \n\nJohn Snow India acknowledges the inputs and support of other partners, including BMGF, ITSU, UNDP, UNICEF, WHO India, NCCVMRC, and CHAI in finalizing the content based on queries of various groups of stakeholders.\n\nCompiled and edited by JSI India (for MoHFW, Govt. of India)\n",
      "images": [
        {
          "name": "page_70.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "LIST OF CONTRIBUTORS",
          "md": "# LIST OF CONTRIBUTORS",
          "bBox": {
            "x": 208.6,
            "y": 54.4,
            "w": 177.08,
            "h": 16
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Advisors",
          "md": "### Advisors",
          "bBox": {
            "x": 276.51,
            "y": 114.51,
            "w": 42.49,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "Ms. Vandana Gurnani, MoHFW, Govt. of India  \nDr. Pradeep Haldar, MoHFW, Govt. of India  \nDr. M.K Agarwal, MoHFW, Govt. of India  \nMs. Manisha Verma, MoHFW, Govt. of India",
          "md": "Ms. Vandana Gurnani, MoHFW, Govt. of India  \nDr. Pradeep Haldar, MoHFW, Govt. of India  \nDr. M.K Agarwal, MoHFW, Govt. of India  \nMs. Manisha Verma, MoHFW, Govt. of India",
          "bBox": {
            "x": 186.42,
            "y": 138,
            "w": 222.67,
            "h": 152.99
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Developing team",
          "md": "### Developing team",
          "bBox": {
            "x": 255.33,
            "y": 255.49,
            "w": 84.88,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "Dr. M.K Agarwal, MoHFW, Govt. of India  \nDr. Pritu Dhalaria, JSI  \nDr. Manish Jain, Consultant  \nDr. Akash Malik, JSI  \nDr. Sumeet Juneja, JSI  \nChahat Narula Thakur, JSI  \nShubhneet Kaur Gujral, Consultant",
          "md": "Dr. M.K Agarwal, MoHFW, Govt. of India  \nDr. Pritu Dhalaria, JSI  \nDr. Manish Jain, Consultant  \nDr. Akash Malik, JSI  \nDr. Sumeet Juneja, JSI  \nChahat Narula Thakur, JSI  \nShubhneet Kaur Gujral, Consultant",
          "bBox": {
            "x": 198.77,
            "y": 184.99,
            "w": 197.97,
            "h": 246.97
          }
        },
        {
          "type": "heading",
          "lvl": 3,
          "value": "Special thanks to",
          "md": "### Special thanks to",
          "bBox": {
            "x": 255.51,
            "y": 466.97,
            "w": 84.48,
            "h": 12
          }
        },
        {
          "type": "text",
          "value": "Dr. Praful Bharadwaj, Gavi Secretariat  \nDr. Sheenu Chaudhary, JSI-ITSU  \nDr. Amit Harshana, JSI-ITSU",
          "md": "Dr. Praful Bharadwaj, Gavi Secretariat  \nDr. Sheenu Chaudhary, JSI-ITSU  \nDr. Amit Harshana, JSI-ITSU",
          "bBox": {
            "x": 204.69,
            "y": 490.47,
            "w": 186.14,
            "h": 58.99
          }
        },
        {
          "type": "text",
          "value": "John Snow India acknowledges the inputs and support of other partners, including BMGF, ITSU, UNDP, UNICEF, WHO India, NCCVMRC, and CHAI in finalizing the content based on queries of various groups of stakeholders.",
          "md": "John Snow India acknowledges the inputs and support of other partners, including BMGF, ITSU, UNDP, UNICEF, WHO India, NCCVMRC, and CHAI in finalizing the content based on queries of various groups of stakeholders.",
          "bBox": {
            "x": 63.04,
            "y": 584.46,
            "w": 469.42,
            "h": 40.99
          }
        },
        {
          "type": "text",
          "value": "Compiled and edited by JSI India (for MoHFW, Govt. of India)",
          "md": "Compiled and edited by JSI India (for MoHFW, Govt. of India)",
          "bBox": {
            "x": 148.3,
            "y": 683.95,
            "w": 298.89,
            "h": 12
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 1
    },
    {
      "page": 71,
      "text": "NOTES",
      "md": "\n# NOTES\n\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n",
      "images": [
        {
          "name": "page_71.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "NOTES",
          "md": "# NOTES",
          "bBox": {
            "x": 279.35,
            "y": 54.91,
            "w": 44.13,
            "h": 14
          }
        },
        {
          "type": "text",
          "value": "........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................",
          "md": "........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.333
    },
    {
      "page": 72,
      "text": "NOTES",
      "md": "\n# NOTES\n\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n",
      "images": [
        {
          "name": "page_72.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "NOTES",
          "md": "# NOTES",
          "bBox": {
            "x": 278.85,
            "y": 54.91,
            "w": 44.13,
            "h": 14
          }
        },
        {
          "type": "text",
          "value": "........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................",
          "md": "........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................\n........................................................................................................",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.333
    },
    {
      "page": 73,
      "text": "NOTES",
      "md": "\n# NOTES\n\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n\n",
      "images": [
        {
          "name": "page_73.jpg",
          "height": 841.89,
          "width": 595.276,
          "x": 0,
          "y": 0,
          "original_width": 2263,
          "original_height": 3200,
          "rotation": 0,
          "type": "full_page_screenshot"
        }
      ],
      "charts": [],
      "items": [
        {
          "type": "heading",
          "lvl": 1,
          "value": "NOTES",
          "md": "# NOTES",
          "bBox": {
            "x": 279.35,
            "y": 54.91,
            "w": 44.13,
            "h": 14
          }
        },
        {
          "type": "text",
          "value": "............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................",
          "md": "............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................\n............................................................................................................",
          "bBox": {
            "x": 0,
            "y": 0,
            "w": 595.28,
            "h": 841.89
          }
        }
      ],
      "status": "OK",
      "originalOrientationAngle": 0,
      "links": [],
      "width": 595.276,
      "height": 841.89,
      "triggeredAutoMode": false,
      "parsingMode": "premium",
      "structuredData": null,
      "noStructuredContent": false,
      "noTextContent": false,
      "pageHeaderMarkdown": "",
      "pageFooterMarkdown": "",
      "slideSpeakerNotes": null,
      "slideSectionName": null,
      "confidence": 0.333
    }
  ],
  "job_metadata": {
    "credits_used": 0,
    "job_credits_usage": 0,
    "job_pages": 73,
    "job_auto_mode_triggered_pages": 0,
    "job_is_cache_hit": false
  }
}